
<html lang="en"     class="pb-page"  data-request-id="5114cab4-9772-4f82-a736-3f9c7004e29f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2010.53.issue-10;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm901870q;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of GSK1070916, a Potent and Selective Inhibitor of Aurora B/C Kinase" /></meta><meta name="dc.Creator" content="Nicholas D.  Adams" /></meta><meta name="dc.Creator" content="Jerry L.  Adams" /></meta><meta name="dc.Creator" content="Joelle L.  Burgess" /></meta><meta name="dc.Creator" content="Amita M.  Chaudhari" /></meta><meta name="dc.Creator" content="Robert A.  Copeland" /></meta><meta name="dc.Creator" content="Carla A.  Donatelli" /></meta><meta name="dc.Creator" content="David H.  Drewry" /></meta><meta name="dc.Creator" content="Kelly E.  Fisher" /></meta><meta name="dc.Creator" content="Toshihiro  Hamajima" /></meta><meta name="dc.Creator" content="Mary Ann  Hardwicke" /></meta><meta name="dc.Creator" content="William F.  Huffman" /></meta><meta name="dc.Creator" content="Kristin K.  Koretke-Brown" /></meta><meta name="dc.Creator" content="Zhihong V.  Lai" /></meta><meta name="dc.Creator" content="Octerloney B.  McDonald" /></meta><meta name="dc.Creator" content="Hiroko  Nakamura" /></meta><meta name="dc.Creator" content="Ken A.  Newlander" /></meta><meta name="dc.Creator" content="Catherine A.  Oleykowski" /></meta><meta name="dc.Creator" content="Cynthia A.  Parrish" /></meta><meta name="dc.Creator" content="Denis R.  Patrick" /></meta><meta name="dc.Creator" content="Ramona  Plant" /></meta><meta name="dc.Creator" content="Martha A.  Sarpong" /></meta><meta name="dc.Creator" content="Kosuke  Sasaki" /></meta><meta name="dc.Creator" content="Stanley J.  Schmidt" /></meta><meta name="dc.Creator" content="Domingos J.  Silva" /></meta><meta name="dc.Creator" content="David  Sutton" /></meta><meta name="dc.Creator" content="Jun  Tang" /></meta><meta name="dc.Creator" content="Christine S.  Thompson" /></meta><meta name="dc.Creator" content="Peter J.  Tummino" /></meta><meta name="dc.Creator" content="Jamin C.  Wang" /></meta><meta name="dc.Creator" content="Hong  Xiang" /></meta><meta name="dc.Creator" content="Jingsong  Yang" /></meta><meta name="dc.Creator" content="Dashyant  Dhanak" /></meta><meta name="dc.Description" content="The Aurora kinases play critical roles in the regulation of mitosis and are frequently overexpressed or amplified in human tumors. Selective inhibitors may provide a new therapy for the treatment o..." /></meta><meta name="Description" content="The Aurora kinases play critical roles in the regulation of mitosis and are frequently overexpressed or amplified in human tumors. Selective inhibitors may provide a new therapy for the treatment o..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 26, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm901870q" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm901870q" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm901870q" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm901870q" /></link>
        
    
    

<title>Discovery of GSK1070916, a Potent and Selective Inhibitor of Aurora B/C Kinase | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm901870q" /></meta><meta property="og:title" content="Discovery of GSK1070916, a Potent and Selective Inhibitor of Aurora B/C Kinase" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0016.jpeg" /></meta><meta property="og:description" content="The Aurora kinases play critical roles in the regulation of mitosis and are frequently overexpressed or amplified in human tumors. Selective inhibitors may provide a new therapy for the treatment of tumors with Aurora kinase amplification. Herein we describe our lead optimization efforts within a 7-azaindole-based series culminating in the identification of GSK1070916 (17k). Key to the advancement of the series was the introduction of a 2-aryl group containing a basic amine onto the azaindole leading to significantly improved cellular activity. Compound 17k is a potent and selective ATP-competitive inhibitor of Aurora B and C with Ki* values of 0.38 ± 0.29 and 1.5 ± 0.4 nM, respectively, and is &gt;250-fold selective over Aurora A. Biochemical characterization revealed that compound 17k has an extremely slow dissociation half-life from Aurora B (&gt;480 min), distinguishing it from clinical compounds 1 and 2. In vitro treatment of A549 human lung cancer cells with compound 17k results in a potent antiproliferative effect (EC50 = 7 nM). Intraperitoneal administration of 17k in mice bearing human tumor xenografts leads to inhibition of histone H3 phosphorylation at serine 10 in human colon cancer (Colo205) and tumor regression in human leukemia (HL-60). Compound 17k is being progressed to human clinical trials." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm901870q"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm901870q">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm901870q&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm901870q&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm901870q&amp;href=/doi/10.1021/jm901870q" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 3973-4001</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm901805m" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm901853b" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of GSK1070916, a Potent and Selective Inhibitor of Aurora B/C Kinase</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas+D.++Adams">Nicholas D. Adams</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jerry+L.++Adams">Jerry L. Adams</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joelle+L.++Burgess">Joelle L. Burgess</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amita+M.++Chaudhari">Amita M. Chaudhari</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+A.++Copeland">Robert A. Copeland</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carla+A.++Donatelli">Carla A. Donatelli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+H.++Drewry">David H. Drewry</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kelly+E.++Fisher">Kelly E. Fisher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Toshihiro++Hamajima">Toshihiro Hamajima</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary+Ann++Hardwicke">Mary Ann Hardwicke</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+F.++Huffman">William F. Huffman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kristin+K.++Koretke-Brown">Kristin K. Koretke-Brown</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhihong+V.++Lai">Zhihong V. Lai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Octerloney+B.++McDonald">Octerloney B. McDonald</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hiroko++Nakamura">Hiroko Nakamura</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ken+A.++Newlander">Ken A. Newlander</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Catherine+A.++Oleykowski">Catherine A. Oleykowski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cynthia+A.++Parrish">Cynthia A. Parrish</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Denis+R.++Patrick">Denis R. Patrick</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ramona++Plant">Ramona Plant</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martha+A.++Sarpong">Martha A. Sarpong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kosuke++Sasaki">Kosuke Sasaki</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stanley+J.++Schmidt">Stanley J. Schmidt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Domingos+J.++Silva">Domingos J. Silva</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Sutton">David Sutton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jun++Tang">Jun Tang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine+S.++Thompson">Christine S. Thompson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+J.++Tummino">Peter J. Tummino</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jamin+C.++Wang">Jamin C. Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Xiang">Hong Xiang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jingsong++Yang">Jingsong Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dashyant++Dhanak">Dashyant Dhanak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Cancer Research, Oncology R&D</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Molecular Discovery Research</span></div><div class="aff-info" id="aff4"><span class="aff-text">GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Tsukuba Research Laboratories, Japan</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: 610-917-6018. Fax: 610-917-4157. E-mail: <a href="/cdn-cgi/l/email-protection#83edeae0ebecefe2f0ade7ade2e7e2eef0c3e4f0e8ade0ecee"><span class="__cf_email__" data-cfemail="b4daddd7dcdbd8d5c79ad09ad5d0d5d9c7f4d3c7df9ad7dbd9">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm901870q&amp;href=/doi/10.1021%2Fjm901870q" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 3973–4001</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 26, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 December 2009</li><li><span class="item_label"><b>Published</b> online</span>26 April 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 May 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm901870q" title="DOI URL">https://doi.org/10.1021/jm901870q</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3973%26pageCount%3D29%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DNicholas%2BD.%2BAdams%252C%2BJerry%2BL.%2BAdams%252C%2BJoelle%2BL.%2BBurgess%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D10%26contentID%3Djm901870q%26title%3DDiscovery%2Bof%2BGSK1070916%252C%2Ba%2BPotent%2Band%2BSelective%2BInhibitor%2Bof%2BAurora%2BB%252FC%2BKinase%26numPages%3D29%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4001%26publicationDate%3DMay%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm901870q"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5528</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">72</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm901870q" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of GSK1070916, a Potent and Selective Inhibitor of Aurora B/C Kinase&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;D. Adams&quot;},{&quot;first_name&quot;:&quot;Jerry&quot;,&quot;last_name&quot;:&quot;L. Adams&quot;},{&quot;first_name&quot;:&quot;Joelle&quot;,&quot;last_name&quot;:&quot;L. Burgess&quot;},{&quot;first_name&quot;:&quot;Amita&quot;,&quot;last_name&quot;:&quot;M. Chaudhari&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;A. Copeland&quot;},{&quot;first_name&quot;:&quot;Carla&quot;,&quot;last_name&quot;:&quot;A. Donatelli&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;H. Drewry&quot;},{&quot;first_name&quot;:&quot;Kelly&quot;,&quot;last_name&quot;:&quot;E. Fisher&quot;},{&quot;first_name&quot;:&quot;Toshihiro&quot;,&quot;last_name&quot;:&quot;Hamajima&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;Ann Hardwicke&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;F. Huffman&quot;},{&quot;first_name&quot;:&quot;Kristin&quot;,&quot;last_name&quot;:&quot;K. Koretke-Brown&quot;},{&quot;first_name&quot;:&quot;Zhihong&quot;,&quot;last_name&quot;:&quot;V. Lai&quot;},{&quot;first_name&quot;:&quot;Octerloney&quot;,&quot;last_name&quot;:&quot;B. McDonald&quot;},{&quot;first_name&quot;:&quot;Hiroko&quot;,&quot;last_name&quot;:&quot;Nakamura&quot;},{&quot;first_name&quot;:&quot;Ken&quot;,&quot;last_name&quot;:&quot;A. Newlander&quot;},{&quot;first_name&quot;:&quot;Catherine&quot;,&quot;last_name&quot;:&quot;A. Oleykowski&quot;},{&quot;first_name&quot;:&quot;Cynthia&quot;,&quot;last_name&quot;:&quot;A. Parrish&quot;},{&quot;first_name&quot;:&quot;Denis&quot;,&quot;last_name&quot;:&quot;R. Patrick&quot;},{&quot;first_name&quot;:&quot;Ramona&quot;,&quot;last_name&quot;:&quot;Plant&quot;},{&quot;first_name&quot;:&quot;Martha&quot;,&quot;last_name&quot;:&quot;A. Sarpong&quot;},{&quot;first_name&quot;:&quot;Kosuke&quot;,&quot;last_name&quot;:&quot;Sasaki&quot;},{&quot;first_name&quot;:&quot;Stanley&quot;,&quot;last_name&quot;:&quot;J. Schmidt&quot;},{&quot;first_name&quot;:&quot;Domingos&quot;,&quot;last_name&quot;:&quot;J. Silva&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Sutton&quot;},{&quot;first_name&quot;:&quot;Jun&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;S. Thompson&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;J. Tummino&quot;},{&quot;first_name&quot;:&quot;Jamin&quot;,&quot;last_name&quot;:&quot;C. Wang&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Xiang&quot;},{&quot;first_name&quot;:&quot;Jingsong&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Dashyant&quot;,&quot;last_name&quot;:&quot;Dhanak&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;26&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;3973-4001&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm901870q&quot;},&quot;abstract&quot;:&quot;The Aurora kinases play critical roles in the regulation of mitosis and are frequently overexpressed or amplified in human tumors. Selective inhibitors may provide a new therapy for the treatment of tumors with Aurora kinase amplification. Herein we describe our lead optimization efforts within a 7-azaindole-based series culminating in the identification of GSK1070916 (17k). Key to the advancement of the series was the introduction of a 2-aryl group containing a basic amine onto the azaindole leading to significantly improved cellular activity. Compound 17k is a potent and selective ATP-competitive inhibitor of Aurora B and C with Ki* values of 0.38 ± 0.29 and 1.5 ± 0.4 nM, respectively, and is &gt;250-fold selective over Aurora A. Biochemical characterization revealed that compound 17k has an extremely slow dissociation half-life from Aurora B (&gt;480 min), distinguishing it from clinical compounds 1 and 2. In vitro treatment of A549 human lung cancer cells with compound 17k results in a potent antiproliferative &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901870q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901870q" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901870q&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901870q" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901870q&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901870q" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm901870q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901870q&amp;href=/doi/10.1021/jm901870q" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm901870q" /></input><a href="/doi/pdf/10.1021/jm901870q" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm901870q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm901870q%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DAdams%26date%3D2010%26atitle%3DDiscovery%2Bof%2BGSK1070916%252C%2Ba%2BPotent%2Band%2BSelective%2BInhibitor%2Bof%2BAurora%2BB%252FC%2BKinase%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D10%26spage%3D3973%26epage%3D4001%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291683" title="Dissociation">Dissociation</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901870q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The Aurora kinases play critical roles in the regulation of mitosis and are frequently overexpressed or amplified in human tumors. Selective inhibitors may provide a new therapy for the treatment of tumors with Aurora kinase amplification. Herein we describe our lead optimization efforts within a 7-azaindole-based series culminating in the identification of GSK1070916 (<b>17k</b>). Key to the advancement of the series was the introduction of a 2-aryl group containing a basic amine onto the azaindole leading to significantly improved cellular activity. Compound <b>17k</b> is a potent and selective ATP-competitive inhibitor of Aurora B and C with <i>K</i><sub>i</sub>* values of 0.38 ± 0.29 and 1.5 ± 0.4 nM, respectively, and is >250-fold selective over Aurora A. Biochemical characterization revealed that compound <b>17k</b> has an extremely slow dissociation half-life from Aurora B (>480 min), distinguishing it from clinical compounds <b>1</b> and <b>2</b>. In vitro treatment of A549 human lung cancer cells with compound <b>17k</b> results in a potent antiproliferative effect (EC<sub>50</sub> = 7 nM). Intraperitoneal administration of <b>17k</b> in mice bearing human tumor xenografts leads to inhibition of histone H3 phosphorylation at serine 10 in human colon cancer (Colo205) and tumor regression in human leukemia (HL-60). Compound <b>17k</b> is being progressed to human clinical trials.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24105" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24105" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The mammalian Aurora kinases (A, B, and C) are a family of Ser/Thr protein kinases that play key roles in regulating cell cycle progression through mitosis.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1-5)</a> Along with its cellular binding partner TPX2<a class="ref internalNav" href="#fn1" aria-label="a">a</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: TPX2, target protein of <i>Xenopus</i> kinesin-like protein 2; INCENP, inner centromere protein; DNAUC, dose normalized area under the curve.</p></div>, Aurora A plays an essential role in bipolar spindle assembly, including centrosome separation and maturation.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a> Small molecule inhibition of Aurora A kinase activity causes defects in centrosome separation, with the formation of characteristic monopolar spindles.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Aurora B is a chromosomal passenger protein that functions together with its binding partners INCENP, survivin, and borealin, to ensure proper kinetochore-microtubule attachments.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13">(10-13)</a> During mitosis, Aurora B is required for phosphorylation of histone H3 at serine 10 prior to chromosome condensation and plays a key role in chromosome segregation and cytokinesis.<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14-16)</a> Inhibition of Aurora B kinase activity with small molecules leads to failure in cytokinesis and abnormal exit from mitosis, resulting in endoreduplication, polyploid cells, and ultimately apoptosis.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> Aurora C has a more restricted expression profile with low levels in most somatic tissues and high levels in the testis, and although its function is not as well understood, recent studies suggest that it has overlapping functions and similar localization patterns to Aurora B.<a onclick="showRef(event, 'ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22">(19-22)</a></div><div class="NLM_p">A number of small molecule inhibitors of Aurora kinases have been progressed to clinical development.<a onclick="showRef(event, 'ref3 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref3 ref23 ref24 ref25">(3, 23, 24, 25)</a> VX-680/MK-0457 (<b>1</b>, Vertex/Merck) inhibits all three Aurora kinase isoforms with approximately equal potency and was the first inhibitor to show the potential for in vivo activity (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Examples of Aurora isoform selective agents include AZD1152 (<b>2</b>, AstraZeneca, Aurora B/C selective),<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> MLN8054 (<b>3</b>, Millenium, Aurora A selective),<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and most recently MK-5108 (Merck, Aurora A selective).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Although it is not clear whether inhibition of all three Aurora isoforms is necessary for optimal antitumor efficacy, in cell culture most of the reported pan-Aurora inhibitors induce an Aurora B inhibition phenotype, i.e., chromosomal endoreduplication abnormalities. This observation suggests that Aurora B inhibition alone may be sufficient for antitumor activity. In this report, we describe our efforts to improve the activity and selectivity profile of a 7-azaindole-based lead series culminating in the identification of GSK1070916 (<b>17k</b>),<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> a potent and selective ATP-competitive inhibitor of Aurora B and C with >250-fold selectivity over Aurora A.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures and activities of lead Aurora inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901870q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i2" class="anchor-spacer"></div><h3 class="article-section__title" id="_i2"> Lead Profile</h3><div class="NLM_p">Screening of small molecules for Aurora kinase inhibitors and subsequent SAR refinement identified compound <b>12c</b> as a lead with good Aurora B potency and selectivity over Aurora A (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Although <b>12c</b> also displayed potent antiproliferative activity vs A549 lung cancer cells, other properties (activity vs non-Aurora kinases, high in vivo blood clearance in rodents, and potent CYP2C9 and CYP2D6 inhibition) were pharmaceutically unattractive. A putative binding mode of compound <b>12c</b> in an Aurora B homology model is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Compound <b>12c</b> is proposed to reside in the ATP-binding pocket with the azaindole interacting with the hinge region and the phenylurea occupying a hydrophobic pocket (back pocket). Relative to Aurora B/INCENP, Aurora A/TPX2 has a smaller and less accessible hydrophobic pocket where the urea moiety is proposed to reside, and this structural difference potentially explains the isoform selectivity of <b>12c</b> and related compounds.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The pyrazole ring occupies the ATP sugar pocket and the azaindole 2-position points toward the solvent accessible surface. Guided by this putative binding mode, our medicinal chemistry strategy consisted of exploring the SAR around three main areas of the molecule, the pyrazole ring (R1), the 2-position of the 7-azaindole ring (R2), and the phenylurea (R3), in a concerted effort to maintain Aurora B inhibitory activity and address the shortcomings of the lead.</div><div class="NLM_p">Recent reports highlighting the use of drug-target residence time (i.e., dissociation half-life) as an additional parameter for compound optimization prompted us to evaluate compounds of interest for time dependence.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> Accordingly, compound <b>12c</b> was tested for time dependent inhibition against Aurora B/INCENP with rapid dilution experiments and found to have a short residence time (7.7 ± 0.8 min), indicating the formation of a rapidly reversible, short-lived enzyme−inhibitor complex.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Aurora B/INCENP dissociation half-lives of <30 min were also reported for clinical compounds <b>1</b> and <b>2</b>.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Biological profile and putative binding mode of inhibitor <b>12c</b> in an Aurora B homology model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901870q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86003" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86003" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The synthesis of derivatives <b>12a</b>−<b>o</b> which modify the pyrazole group (R1) commenced with the preparation of pyrazoles <b>5a</b>−<b>c</b> by reaction of 1-(4-nitrophenyl)ethanone with <i>N</i>,<i>N</i>-dimethylformamide dimethylacetal, followed by treatment with the appropriate hydrazine in ethanol (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Bromination with <i>N</i>-bromosuccinimide provided intermediate bromides <b>6a</b>−<b>c</b>. Alkylation of pyrazole <b>6a</b> under basic conditions provided regioisomeric mixtures which were readily separable by chromatographic methods to give <b>7a</b>−<b>e</b>. Bromides <b>7a</b>−<b>e</b> were used as is or converted to their corresponding boronates for the final palladium catalyzed Suzuki cross-coupling step with their azaindole counterparts. Synthesis of pyrazole bromides incorporating the phenylurea R3 group were prepared through Sn(0) or Zn(0) mediated reduction of the nitrophenyl derivatives <b>6a</b>, <b>6c</b>, or <b>7a</b>−<b>b</b> to their corresponding anilines and subsequent conversion to the phenylurea with phenyl isocyanate. These intermediates were either used as is or converted to their corresponding boronates for the subsequent Suzuki cross-coupling reactions with the requisite azaindole fragment.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of R1 Substituted Azaindole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901870q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DMF·DMA, DMF, 80 °C; (b) hydrazine monohydrate or <i>t</i>-butylhydrazine·hydrochloride, EtOH, 70 °C; (c) NBS, DMF, rt; (d) R1-Br, NaH, DMF, 0 °C to rt; (e) bis(pinacolato)diboron, KOAc, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 1,4-dioxane, 100 °C; (f) Sn(0), 6N HCl, EtOH, 70 °C or Zn, AcOH, rt; (g) PhNCO, pyr, rt; (h) Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF, NaHCO<sub>3</sub> (aq), 100 °C; (i) <b>12i</b>: OsO<sub>4</sub>, NMO, <i>t</i>-BuOH, H<sub>2</sub>O, acetone, rt; <b>12j</b>: 9-BBN, 6N NaOH, 30% H<sub>2</sub>O<sub>2</sub> (aq), THF, H<sub>2</sub>O, 0 °C to rt; (j) <b>12m</b>: ethyl chloroformate, NH<sub>4</sub>OH, TEA, THF, 0 °C to rt; <b>12n</b>: NH<sub>2</sub>Et, EDCI, DMAP, DMF, rt; <b>12o</b>: morpholine, CDI, DMF, rt .</p></p></figure><div class="NLM_p">Synthesis of compounds <b>17a</b>−<b>u</b> where R2 and R3 are functionalized is outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Sequential Suzuki cross-coupling of 4-bromo-2-iodo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>13</b>)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> with the appropriate phenyl boronic acids followed by pyrazole boronic acid <b>8a</b> provided intermediates <b>15a</b>−<b>h</b>. Aldehyde intermediates <b>15a</b>−<b>d</b> underwent reductive amination reactions to provide amines <b>15i</b>−<b>n</b>. With the pyrazole-azaindole core in place, the 4-nitrophenyl derivatives <b>15g</b>−<b>n</b> were reduced to their corresponding anilines, deprotected under basic conditions, and capped with appropriate R3-group, thereby providing target molecules <b>17c</b>−<b>u</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of R2 and R3 Substituted Azaindole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901870q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R2-Ph-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF, NaHCO<sub>3</sub> (aq), 100 °C; (b) <b>8a</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF, NaHCO<sub>3</sub> (aq), 100 °C; (c) amine, NaBH(OAc)<sub>3</sub>, THF, rt; (d) Sn(0), 6N HCl, EtOH, 70 °C or Zn, AcOH, rt; then 6N NaOH (aq), MeOH, 70 °C; (e) PhNCO or EtNCO, pyr, rt (or TEA, THF, rt), or 4-nitrophenyl chloroformate, TEA, THF, rt, HNMe<sub>2</sub>. *Compounds <b>17a</b> and <b>17b</b> were prepared from <b>15e</b> and <b>15f</b>, respectively, through reduction of the nitro group with palladium hydroxide/hydrogen, urea formation with PhNCO and subsequent deprotection of the phenylsulfonyl group with 6N NaOH (aq); see the <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a> for details.</p></p></figure><div class="NLM_p">A synthesis of compounds <b>22a</b>−<b>c</b>, where R2 is an amide group, is outlined in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Regioselective bromination of ethyl 1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carboxylate 7-oxide (<b>18</b>)<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> provided bromide <b>19</b>, which underwent Suzuki coupling with boronate <b>8a</b>. The Suzuki conditions also served to hydrolyze the ester, providing acid <b>20</b> from which the amide was installed via EDC or 1,1-carbonyldiimidazole mediated couplings. The phenyl urea was introduced along the lines described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> to provide the target compounds.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of R2 Amide Azaindole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901870q&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Me<sub>4</sub>NBr, (MeSO<sub>2</sub>)<sub>2</sub>O, DME; (b) <b>8a</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M K<sub>2</sub>CO<sub>3</sub> (aq), dioxane, 100 °C; (c) EDC or 1,1-carbonyldiimidazole, NH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>R2′′, DMF, rt; (d) Sn(0), 6N HCl, EtOH, 70 °C; (e) PhNCO, pyr, rt.</p></p></figure><div class="NLM_p">Derivatives which incorporate a substituted methylamino moiety at R2 (<b>28a</b>−<b>f</b>) were prepared using 2-formyl intermediate <b>24</b>, synthesized by phenylsulfonyl-directed metalation of <b>23</b> with LDA and trapping of the resulting anion with DMF (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Reductive amination of aldehydes <b>24</b> or <b>26</b> with an amine in the presence of sodium triacetoxyborohydride afforded the desired aminomethyl intermediates, which were then converted to final compounds <b>27a</b>−<b>f</b> through a similar sequence described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of R2 Methylamino Azaindole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901870q&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) LDA, THF, hexanes, −78 °C, (ii) DMF; (b) HNR′′′, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>:AcOH (4:1); (c) bis(pinacolato)diboron, KOAc, PdCl<sub>2</sub>(dppf)·CH<sub>2</sub>Cl<sub>2</sub>, 1,4-dioxane, 90 °C; (d) <b>10c</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, satd aq NaHCO<sub>3</sub>, DMF, 100 °C; (e) 6N NaOH, MeOH, 70 °C.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Biological Evaluation of Inhibitors</h3><div class="NLM_p">The ability of azaindole derivatives to inhibit Aurora B/INCENP and Aurora A/TPX2 protein kinase activity was determined using a LEADSeeker (Amersham Biosciences) scintillation proximity assay (SPA) format as previously described.<a onclick="showRef(event, 'ref30 ref34'); return false;" href="javascript:void(0);" class="ref ref30 ref34">(30, 34)</a> Compounds were assayed for their antiproliferative activity against the human lung cancer cell line A549 using Promega CellTiter-Glo reagents as previously described.<a onclick="showRef(event, 'ref30 ref37'); return false;" href="javascript:void(0);" class="ref ref30 ref37">(30, 37)</a></div><div class="NLM_p">We first investigated the regiochemical preference for the pyrazole substituent (depicted as <i>N1</i> and <i>N2</i> in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) while maintaining the phenyl urea at R3. Transposition of the ethyl group from the <i>N1</i>-position to the <i>Ν2</i>-position led to a 12-fold decrease in Aurora B inhibitory activity and concomitant loss in antiproliferative activity (cf. compound <b>12c</b> vs <b>12b</b>). Deleting the ethyl group of <b>12c</b> to give unsubstitued pyrazole <b>12a</b> resulted in ∼15-fold lower potency against Aurora B and a concomitant loss in cellular potency. Initial structure−activity relationship (SAR) studies also established that modification of the phenyl urea, such as substituting the phenyl ring with electron withdrawing and/or donating groups, replacement of the phenyl group with alkyl groups, or replacement of the urea moiety with amides, sulfonamides, or carbamates, did not lead to substantial improvement in activity relative to <b>12c</b> (data not shown). Transposing the <i>para</i>-phenyl urea (<b>12c</b>) to the <i>meta</i> position led to significant loss in Aurora B inhibitory potency, presumably due to the <i>para</i>-substituent having a more favorable trajectory to access the hydrophobic back pocket region adjacent to the ATP binding site. Taken together, these data suggested that the enzyme preferred a bulky lipophilic <i>para</i>-R3 group albeit in combination with the unsubstituted azaindole core (R2 = H).</div><div class="NLM_p">With the pyrazole <i>N1</i>-position identified as the preferred position for Aurora B enzymatic and cellular activity, our SAR efforts focused on exploring different pyrazole R1 substituents with a goal of further improving the cellular potency of this series. On the basis of the putative binding mode (vida supra), the pyrazole ring occupies the sugar pocket region of the ATP-binding site. Therefore we incorporated polar hydrogen bond donating groups in an effort to enhance potency. Indeed, incorporation of ethanol (<b>12g</b>), propanol (<b>12j</b>), or 1,2-propanediol (<b>12i</b>) moieties resulted in the identification of compounds with high Aurora B inhibitory activity but with significant erosion in antiproliferative activity. The attenuated cellular activity of alcohols <b>12g</b>, <b>12j</b>, and <b>12i</b> is potentially due to their reduced cell permeability (artificial membrane permeability 27, 3, and 41 nm s<sup>−1</sup>, respectively) relative to <b>12c</b> (artificial membrane permeability =170 nm s<sup>−1</sup>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Substitution of the pyrazole with various substituted acetamides (compounds <b>12m</b>−<b>o</b>) was also not fruitful. Taken together, small R1-alkyl groups were the substituents of choice during the course of further SAR investigations.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biochemical and Cellular Data for Substituted Pyrazole Derivatives (R1)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0007.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0008.gif" alt="" id="fx2" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">NT = not tested.</p></div></div></div><div class="NLM_p">Although an inhibitor bound Aurora B cocrystal structure was not available during these investigations, our putative binding mode revealed a solvent accessible area toward the front pocket of the Aurora B ATP-binding pocket and could potentially accommodate a wide variety of functionality (vide supra).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> We reasoned that incorporation of an appropriately substituted aryl group adjacent to the presumed hinge binding moiety would allow for access to the solvent accessible area of the enzyme without interfering with hinge binding and also enable modulation of physicochemical properties. A number of such compounds were prepared and evaluated in the A549 cell proliferation assay in the presence and absence of 70% human serum in order to assess the effect of inhibitor binding to serum proteins on their antiproliferative activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). A comparable 10−20-fold decrease in cellular potency in the presence of 70% human serum was noted for this set of derivatives (data not shown). Incorporation of a 3-<i>N</i>-acetylaniline at R2 (<b>17a</b>) led to a 20-fold attenuation in the in vitro Aurora B inhibitory activity relative to unsubstituted azaindole <b>12c</b>; surprisingly, however, cellular activity was not diminished (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Compound <b>17a</b> has much slower Aurora B/INCENP dissociation half-life (320 ± 120 min) relative to <b>12c</b> (7.7 ± 0.8 min), and it is possible that its true potency is underestimated in our in vitro biochemical assay even with a 30 min enzyme−inhibitor preincubation.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> This could potentially explain the level of cellular activity for compound <b>17a</b>. Incorporation of a <i>meta</i>-dimethlyaminomethyl-phenyl R2 group (<b>17c</b>) resulted in a further improvement in antiproliferative activity in A549 cells (EC<sub>50</sub> = 14 nM). Interestingly, however, selectivity over Aurora A was diminished (cf. <b>12c</b>, 315-fold vs 3-fold). Reasons for the diminished Aurora A selectivity of compound <b>17c</b> and related compounds (e.g., <b>17a</b>, <b>17b</b>, <b>17e</b>) relative to <b>12c</b> are not clear, but a potential explanation is that the substituted phenyl group (R2) plays a role in orienting the phenylurea in the lipophilic back pocket, which is smaller and less accessible in Aurora A/TPX2.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In general, the presence of an R2-phenyl group containing a basic amine (e.g., dimethylamine (<b>17c</b>−<b>f</b>,<b>j</b>−<b>m</b>), morpholine (<b>17h</b>−<b>i</b>,<b>r</b>−<b>u</b>), or pyrrolidine (<b>17g</b>,<b>n</b>−<b>q</b>)) led to improved cellular activity. Replacing the phenyl group with amides (<b>22a</b>−<b>c</b>) resulted in potent Aurora B inhibitors but modest cellular potency. Aminomethyl derivatives <b>28a</b>−<b>f</b> exhibited reduced biochemical and cellular potency. No significant solubility or cell permeability differences were noted that could account for the attenuated activity of <b>28a</b>−<b>f</b>. On the basis of their improved potency in cells, R2-aryl groups containing a basic amine were selected for further SAR investigations.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Biochemical and Cellular Data for R2 Group Derivatives<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0009.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0010.gif" alt="" id="fx4" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">NT = not tested.</p></div></div></div><div class="NLM_p">With the addition of aryl amines at the R2-position, we reinvestigated phenyl urea SAR with the intention of identifying groups that led to a reduction in overall molecular weight and lipophilicity of the compounds. Furthermore, taking into account the previously discussed SAR trends, we postulated that various combinations of R2 and R3 groups would affect the Aurora B potency and selectivity over Aurora A. As such, R2 and R3 combination analogues were prepared and evaluated in the biological assays (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). A majority of the hybrid derivatives were highly potent against Aurora B and demonstrated excellent antiproliferative activity against A549 tumor cells. In fact, some compounds from this set have in vitro Aurora B/INCENP IC<sub>50</sub>s that are similar to their EC<sub>50</sub>s on cells, for example compound <b>17c</b>. Compound <b>17c</b> also has a slow Aurora B/INCENP dissociation half-life (520 ± 110 min) and, as discussed above, it is possible that its true potency is underestimated in our in vitro biochemical assay even with a 30 min enzyme−inhibitor preincubation.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Biochemical and Cellular Data for R2 and R3 Group Combinations</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0011.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0012.gif" alt="" id="fx6" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">NT = not tested.</p></div></div></div><div class="NLM_p">Modulation in selectivity over Aurora A depending on the R2/R3 combination was also noted. For example, replacement of the phenylurea of <b>17c</b> with an ethylurea (<b>17j</b>) resulted in a modest improvement in Aurora B inhibitory activity and an increase in selectivity over Aurora A from 3-fold to 42-fold while maintaining excellent antiproliferative activity. Selectivity was further improved to 252-fold through combination of the R3-dimethylurea group with the R2-<i>meta</i>-(dimethylaminomethyl)phenyl, providing <b>17k</b>. The observed selectivity may be attributed to the corresponding R2 group’s potential role in orienting the urea group in the distinct lipophilic back pockets of Aurora B/INCENP and Aurora A/TPX2.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In addition to good selectivity over Aurora A, <b>17k</b> demonstrated excellent Aurora B inhibition (IC<sub>50</sub> = 5 nM) and antiproliferative activity (A549 EC<sub>50</sub> = 7 nM). Transposition of the dimethylaminomethyl tail moiety to the <i>para</i>-position (<b>17m</b>) led to retention in biochemical and cellular activity (cf. <b>17k</b>) and a slight diminution in Aurora B/A selectivity, from 252- to 156-fold. In general, <i>meta</i>-dimethylamino and morpholino tails were slightly favored over their <i>para</i> counterparts with respect to Aurora B vs A selectivity, regardless of the R3 group (cf. <b>17k</b> vs <b>17m</b> and <b>17s</b> vs <b>17u</b>) for this set of derivatives.</div><div class="NLM_p">Selectivity over a panel of non-Aurora kinases was assessed for several of the compounds that showed potent in vitro activity and/or selectivity over Aurora A (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Compound <b>12c</b> demonstrated >70-fold selectivity against this panel of kinases; however, when an aminoaryl group was introduced at the azaindole 2-position (compound <b>17c</b>), significant activity against LCK, LYN, MET, and ROCK was observed. Truncating the phenylurea moiety of compound <b>17c</b> to an ethylurea (compound <b>17j</b>) resulted in significant attenuation of these off-target activities, and even further attenuation (>140-fold selectivity) was observed with dimethylurea <b>17k</b>. Compound <b>17k</b> represented the best combination of biochemical/cellular potency and selectivity within this set of analogues and was thus selected for further study.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0013.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Kinase selectivity comparison for compounds <b>12c</b>, <b>17c</b>, <b>17j</b>, and <b>17k</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901870q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Evaluation of <b>17k</b></h3><div class="NLM_p">The selectivity of <b>17k</b> was further determined by measuring its ability to inhibit 328 unique human protein and lipid kinases using either in vitro activity or binding assays.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Furthermore, we generated full dose−response analysis for a subset of 58 kinases to determine their IC<sub>50</sub> values. In addition to the Aurora kinases, only five kinases were identified with IC<sub>50</sub> values below 100 nM (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), indicating that compound <b>17k</b> is a highly selective inhibitor of Aurora B and C kinase.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibitory Activity of <b>17k</b> against Other Kinases</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AurA/TPX2</td><td class="colsep0 rowsep0" align="char" char=".">1259</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AurB/INCENP</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AurC/INCENP</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FLT1</td><td class="colsep0 rowsep0" align="char" char=".">42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FLT4</td><td class="colsep0 rowsep0" align="char" char=".">74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TIE2</td><td class="colsep0 rowsep0" align="char" char=".">59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SIK</td><td class="colsep0 rowsep0" align="char" char=".">70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR1</td><td class="colsep0 rowsep0" align="char" char=".">76</td></tr></tbody></table></div></div><div class="NLM_p">We recently reported that compound <b>17k</b> is a reversible, ATP-competitive inhibitor of Aurora B/INCENP and Aurora C/INCENP with <i>K</i><sub>i</sub>* values of 0.38 ± 0.29 and 1.5 ± 0.4 nM, respectively, and is >250-fold selective over Aurora A/TPX2, which had a <i>K</i><sub>i</sub> value of 490 ± 60 nM.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The <i>K</i><sub>i</sub>* values take into account the slow onset of inhibition and define the true potency of <b>17k</b> against the enzyme, as previously described.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Remarkably, <b>17k</b> exhibited >480 min and 270 ± 28 min dissociation half-lives in Aurora B/INCENP and Aurora C/INCENP, respectively, resulting in prolonged inhibition of kinase activity. The extremely slow off-rate of compound <b>17k</b> from Aurora B/INCENP is in contrast to compounds <b>1</b> and <b>2</b>, which display a dissociation half-life of <30 min under the same conditions.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The potential measurable advantage of <b>17k</b>’s long dissociation rate is that it may confer a selective advantage such as less frequent dosing and perhaps greater tolerance over compounds with shorter half-lives. This hypothesis will ultimately be tested in clinical trials.</div><div class="NLM_p">As we reported previously, compound <b>17k</b> follows a one-step Aurora B/INCENP binding model with an on rate of 0.022 ± 0.004 μM<sup>−1</sup> s<sup>−1</sup>, and an off rate of <0.0014 min<sup>−1</sup>, resulting in a dissociation half-life of >480 min.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> To identify inhibitor structural features that could potentially contribute to a long residence time, Aurora B/INCENP dissociation rates were determined for a number of azaindole derivatives with varying R2 and R3 groups. Compound <b>12c</b>, which lacks substitution of the azaindole 2-position (R2), had a short dissociation rate of <10 min (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Incorporation of a <i>meta</i>-(dimethylaminomethyl)phenyl group onto the azaindole 2-position in combination with a phenyl urea at R3 (<b>17c</b>) resulted in a compound with a long dissociation half-life of 520 ± 110 min. Truncating the phenyl urea of <b>17c</b> to an ethyl (<b>17j</b>) or dimethyl urea (<b>17k</b>) also provided compounds with long Aurora B/INCENP dissociation half-lives of 200 and >480 min, respectively. Furthermore, acetamide <b>17a</b> had a long dissociation half-life, indicating that a basic amine at R2 is not necessary for the prolonged residence time on Aurora B/INCENP. For this limited set of derivatives, these results suggest that incorporation of a 2-aryl group on the azaindole ring contributes to the long dissociation half-life. Although the absence of a cocrystal structure makes it difficult to rationalize inhibitor−enzyme interactions that could explain the long dissociation half-life of these inhibitors, it is possible that the back pocket may take time to undergo conformational changes until it reaches a conformation accessible to compound binding. Additional conformational change may then lock the compound in the pocket, hence giving rise to the time dependent inhibition. However, it is apparent that some other undetermined factors also contribute to the time dependence as certain back-pocket binders (e.g., <b>12c</b>) do not show significant time dependent inhibition.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Aurora B/INCENP Dissociation Half Life Values for Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±"><b>12c</b></th><th class="colsep0 rowsep0" align="center" char="±"><b>17a</b></th><th class="colsep0 rowsep0" align="center" char="±"><b>17c</b></th><th class="colsep0 rowsep0" align="center" char="±"><b>17j</b></th><th class="colsep0 rowsep0" align="center" char="."><b>17k</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Aur B/INCENP <i>t</i><sub>1/2</sub> (min)</td><td class="colsep0 rowsep0" align="char" char="±">7.7 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">320 ± 120</td><td class="colsep0 rowsep0" align="char" char="±">520 ± 110</td><td class="colsep0 rowsep0" align="char" char="±">200 ± 50</td><td class="colsep0 rowsep0" align="char" char=".">>480</td></tr></tbody></table></div></div><div class="NLM_p">To test for the potential of compound <b>17k</b> to affect the metabolism and or clearance of other coadministered agents leading to clinical drug−drug interactions, IC<sub>50</sub>s were generated against six CYP450 isozymes in human liver microsomes (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Compound <b>17k</b> displayed IC<sub>50</sub> values ≥12 μM against the panel of CYP450 isozymes, with the exception of the 3A4 (midazolam) for which it was an activator. Our P450 inhibition assay in human liver microsomes was performed using selective probe substrates, and product formation was monitored by LC/MS/MS. The enzyme activity in the presence of compound <b>17k</b> was normalized with the enzyme activity in the absence of compound and expressed as a percentage of control activity. In the study with CYP3A4 and midazolam, increased enzyme activity was observed with increased inhibitor concentration (>100% of control activity).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. CYP450 IC<sub>50</sub> Values (μM) for <b>17k</b> in Human Liver Microsomes</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">1A2 <br /></br>phenacetin</th><th class="colsep0 rowsep0" align="center" char=".">2C9 <br /></br>diclofenac</th><th class="colsep0 rowsep0" align="center" char=".">2C19 <br /></br>S-mephenytoin</th><th class="colsep0 rowsep0" align="center" char=".">2D6 <br /></br>bufuralol</th><th class="colsep0 rowsep0" align="center" char=".">3A4 <br /></br>nifedipine</th><th class="colsep0 rowsep0" align="center" char=".">3A4 <br /></br>midazolam</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">>33</td><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="char" char=".">81</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">activator</td></tr></tbody></table></div></div><div class="NLM_p">Treatment of a panel of human tumor cell lines with compound <b>17k</b> results in potent inhibition of histone H3 phosphorylation (pHH3) at serine 10, a substrate and marker of intracellular Aurora B activity.<a onclick="showRef(event, 'ref37 ref40'); return false;" href="javascript:void(0);" class="ref ref37 ref40">(37, 40)</a> In light of its on-target in vitro potency in biochemical and cellular assays and good overall kinase selectivity, <b>17k</b> made an excellent candidate for in vivo pharmacodynamic and efficacy evaluation using human tumor xenograft models in rodents. As a prelude to these studies, <b>17k</b> was evaluated for its intravenous pharmacokinetic parameters in the conscious mouse (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). Following single dose iv administration at 1 mg kg<sup>−1</sup>, <b>17k</b> showed blood clearance of 49.4 mL min<sup>−1</sup> kg<sup>−1</sup> and a dose normalized area under the curve (0 − ∞) of 345 ng·h mL<sup>−1</sup> mg<sup>−1</sup> kg <sup>−1</sup>. The iv PK profiles for <b>17k</b> in rat, dog, and monkey have been reported elseware.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Compound <b>17k</b> also demonstrates >10 mg/mL solubility in clinically acceptable formulations (pH 4).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Intravenous Pharmacokinetic Profile of <b>17k</b> in the Conscious Mouse<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose (mg kg<sup>−1</sup>)</th><th class="colsep0 rowsep0" align="center">CL<sub>b</sub> (mL min<sup>−1</sup> kg<sup>−1</sup>)</th><th class="colsep0 rowsep0" align="center">DNAUC<sub>(0−∞)</sub> (ng·h mL<sup>−1</sup> mg<sup>−1</sup> kg <sup>−1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>dss</sub> (L kg<sup>−1</sup>)</th><th class="colsep0 rowsep0" align="center">MRT (h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">49.4<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">345</td><td class="colsep0 rowsep0" align="left">0.8<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.3<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last"><i>n</i> = 3.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">CL<sub>b</sub> was calculated using AUC<sub>0−<i>t</i></sub> ; <i>V</i><sub>dss</sub> and MRT were estimated using AUC<sub>0−<i>t</i></sub> and AUMC<sub>0−<i>t</i></sub>.</p></div></div></div><div class="NLM_p">In an in vivo pharmacodynamic study, compound <b>17k</b> was assessed for its capacity to inhibit the phosphorylation of histone H3 (pHH3) at serine 10 in mice with advanced subcutaneous Colo205 tumors. The study was designed to measure the percent inhibition of pHH3 relative to control at 30 h post dose using a pHH3 ELISA. After intraperitoneal (ip) treatment of the mice with the indicated doses of <b>17k</b> at 30 h, a robust dose-dependent pharmacodynamic response, as measured by a decrease in phosphohistone H3 (serine 10), was observed and is consistent with in vivo Aurora B inhibition (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0014.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of pHH3 after treatment of advanced Colo205 tumors in mice with <b>17k</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901870q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>17k</b> was also evaluated for in vivo efficacy against human leukemia HL-60 tumors grown as a subcutaneous xenograft in nude mice (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Compound <b>17k</b> was dosed daily (ip) at 75 or 100 mg kg<sup>−1</sup> for five days and for two cycles (qdx5 × 2; doses indicated by arrows in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). In contrast to the untreated control mice, complete regression (CR) of the tumor was observed in all mice that received <b>17k</b> at both dose levels. Notably for the 100 mg kg<sup>−1</sup> dose, no tumor regrowth was observed 51 days post the last dose. Further in vivo characterization of <b>17k</b> against solid human tumor xenografts and human leukemia has been reported.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0015.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Evaluation of <b>17k</b> against advanced HL-60 (acute monocytic human leukemia) tumors in nude mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901870q&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04876" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04876" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, lead optimization efforts of a 7-azaindole series of kinase inhibitors led to the discovery of compound <b>17k</b>, a potent, selective, long acting inhibitor of Aurora B/C suitable for evaluation in cancer patients. Key to the advancement of the series was the introduction of a 2-aryl group containing a basic amine onto the azaindole, leading to significantly improved cellular activity. The presence of a 2-aryl group also allowed for truncation of the phenylurea R3 group, leading to compounds with dramatically improved kinase selectivity without compromising Aurora B activity or cellular potency. Compound <b>17k</b> is a novel, highly potent, and selective Aurora B and C/INCENP inhibitor (<i>K</i><sub>i</sub>* = 0.38 ± 0.29 and 1.5 ± 0.4 nM, respectively)<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> that exhibits potent antiproliferative activity in human tumor cell culture (A459 lung cell EC<sub>50</sub> = 7 nM).<a onclick="showRef(event, 'ref37 ref40'); return false;" href="javascript:void(0);" class="ref ref37 ref40">(37, 40)</a> This activity was manifested in vivo as measured by a dose dependent inhibition of histone H3 phosphorylation at serine 10, a hallmark of Aurora B inhibition, in human colon cancer tumors (Colo205) and tumor regression in human leukemia (HL-60) mouse xenografts following intraperitoneal administration. Isoform selectivity of compound <b>17k</b> may be attributed to the urea group (R3) imparting unfavorable interactions with the smaller, less accessible hydrophobic back pocket of Aurora A/TPX2 relative to that of Aurora B/INCENP.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The extremely slow dissociation half-life of compound <b>17k</b> from Aurora B/INCENP is a clear distinction from clinical compounds <b>1</b> and <b>2</b>. A structure based rationale for the time dependent inhibition is difficult in absence of an inhibitor−enzyme cocrystal structure. One possible explanation is that the back pocket may take time to undergo conformational changes until it reaches a conformation accessible to compound binding, and additional conformational change may then lock the compound in the pocket, hence giving rise to the time dependent inhibition. Despite Aurora B being relatively short-lived in cells prior to degradation,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> the >8 h half-life of compound <b>17k</b> suggests that it can stay bound until Aurora B is degraded. This is the maximum inhibition one can ever achieve for Aurora B. Furthermore, it is possible that the slow enzyme off-rate of the compound may in fact extend the half-life of the protein, although this has not yet been demonstrated. Although the clinical relevance of a slow dissociation rate of an enzyme−inhibitor complex remains to be seen, the long residence time of <b>17k</b> may prove advantageous by prolonged inhibition of Aurora B in vivo, after it has been cleared from systemic circulation.<a onclick="showRef(event, 'ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34">(32, 33, 34)</a> Evaluation of compound <b>17k</b> in human clinical trials is planned.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22605" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22605" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chemistry</h3><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> General Methods</h4><div class="NLM_p last">Unless otherwise noted, starting materials and reagents were purchased from commercial sources and used without further purification. Air- or moisture-sensitive reactions were carried out under a nitrogen atmosphere. Anhydrous solvents were obtained from Sigma-Aldrich. Microwave irradiation was carried out in a Personal Chemistry Emrys Optimizer microwave. Flash chromatography was performed using silica gel (EM Science, 230−400 mesh) under standard techniques or using silica gel cartridges (RediSep normal phase disposable flash columns) on an Isco CombiFlash. Reverse phase HPLC purification was conducted on a Gilson HPLC (monitoring at a wavelength of 214 or 254 nm) with a YMC ODS-A C18 column (5 μm, 75 mm × 30 mm), eluting with 5−90% CH<sub>3</sub>CN in H<sub>2</sub>0 with 0.1% TFA unless otherwise noted. <sup>1</sup>H NMR spectra were recorded on a Bruker Avance 400 MHz spectrometer. Chemical shifts (δ) are reported in ppm relative to an internal solvent reference. Apparent peak multiplicities are described as s (singlet), br s (broad singlet), d (doublet), dd (doublet of doublets), t (triplet), q (quartet), or m (multiplet). Coupling constants (<i>J</i>) are reported in hertz (Hz) after the integration. LCMS analysis was conducted on a Shimadzu 10Avp LC/UV and a PE Sciex single quadruple MS using a Thermo Aquasil column (C18, 40 mm × 1 mm, 5 μ particle diameter) and a gradient of 5−100% MeCN (0.018% TFA)/water (0.02% TFA) over 3.2 min. The retention time (<i>R</i><sub>t</sub>) is expressed in minutes at a UV detection of 214 nm. All tested compounds were determined to be ≥95% purity by LCMS unless otherwise noted. Elemental analyses were performed by Quantitative Technologies Inc., Whitehouse, NJ.</div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 4-Bromo-1-{[4-(methyloxy)phenyl]methyl}-3-(4-nitrophenyl)-1<i>H</i>-pyrazole (<b>7e</b>)</h4><div class="NLM_p last">To a solution of 4-bromo-3-(4-nitrophenyl)-1<i>H</i>-pyrazole (1.9 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (5.0 mL) was added sodium hydride as a 60% dispersion in mineral oil (2.1 mmol). After 40 min, <i>p</i>-methoxybenzylchloride (2.2 mmol) was added and the resulting mixture was stirred for 1 h. The reaction mixture was then poured into water (60 mL), and the precipitate was filtered and rinsed with water (2 × 15 mL). The brown solid was dried under vacuum to yield 97% of the title product (<b>7e</b>). MS <i>m</i>/<i>z</i> 388.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.33 (d, 2H, <i>J</i> = 8.8 Hz), 8.27 (s, 1H), 8.11 (d, 2H, <i>J</i> = 8.6 Hz), 7.32 (d, 2H, <i>J</i> = 8.6 Hz), 6.94 (d, 2H, <i>J</i> = 8.6 Hz), 5.33 (s, 2H), 3.74 (s, 3H).</div></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 1-{[4-(Methyloxy)phenyl]methyl}-3-(4-nitrophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (<b>8e</b>)</h4><div class="NLM_p last">A solution of 4-bromo-1-{[4-(methyloxy)phenyl]methyl}-3-(4-nitrophenyl)-1<i>H</i>-pyrazole (<b>7e</b>, 1.44 mmol), bis(pinacolato)diboron (1.73 mmol), potassium acetate (4.33 mmol), and dichlorobis(triphenylphosphine)palladium(II) (0.072 mmol) in dioxane (7.0 mL) was heated at 100 °C for 4 h. Crushed and activated 3 Å molecular sieves and additional dichlorobis(triphenylphosphine)palladium(II) (0.036 mmol) were added to the reaction mixture, which was heated at 100 °C for 17 h. The reaction mixture was cooled, filtered through celite, diluted with water (75 mL), and extracted with (3 × 60 mL) ethyl acetate. The combined organic layers were dried over sodium sulfate and were concentrated in vacuo. Purification of the residue by reverse phase HPLC (50−100% acetonitrile in water) and concentration in vacuo provided the title product (<b>8e</b>) as an orange solid (20%). MS <i>m</i>/<i>z</i> 435.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.26 (d, 2H, <i>J</i> = 8.9 Hz), 8.21 (d, 2H, <i>J</i> = 9.1 Hz), 7.75 (s, 1H), 7.28 (m, 2H), 6.92 (d, 2H, <i>J</i> = 8.6 Hz), 5.31 (s, 2H), 3.83 (s, 3H), 1.33 (s, 12H).</div></div><div id="sec3_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 4-[1-{[4-(Methyloxy)phenyl]methyl}-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine</h4><div class="NLM_p last">A solution of 4-bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (0.26 mmol), 1-{[4-(methyloxy)phenyl]methyl}-3-(4-nitrophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (<b>8e</b>, 0.28 mmol), and tetrakis(triphenylphosphine)palladium(0) (0.013 mmol) in 2 M aq potassium carbonate (0.75 mL) and dioxane (0.75 mL) was heated at 98 °C for 19 h. The reaction mixture was cooled, diluted with water (5 mL), and extracted with (3 × 5 mL) ethyl acetate. The combined organic layers were dried over sodium sulfate and were concentrated in vacuo. Purification of the residue by silica gel chromatography (50−70% ethyl acetate/hexanes) and concentration in vacuo provided the title product as a yellow solid containing ∼20% triphenylphosphine oxide (85% yield). The intermediate was used directly in the next step. MS <i>m</i>/<i>z</i> 426.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.73 (s, 1H), 8.34 (s, 1H), 8.16−8.14 (m, 3H), 7.62 (d, 2H, <i>J</i> = 9.1 Hz), 7.42 (m, 2H), 7.39 (m, 1H), 6.96 (d, 2H, <i>J</i> = 8.8 Hz), 6.86 (d, 1H, <i>J</i> = 5.0 Hz), 6.12 (m, 1H), 5.41 (s, 2H), 3.75 (s, 3H).</div></div><div id="sec3_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 4-[3-(4-Nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine</h4><div class="NLM_p last">A solution of 4-[1-{[4-(methyloxy)phenyl]methyl}-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (0.22 mmol) in trifluoroacetic acid (0.75 mL) was heated at 74 °C for 1.5 h. The reaction mixture was diluted with water (4 mL) and extracted with (3 × 5 mL) ethyl acetate. The combined organic layers were dried over sodium sulfate and were concentrated. Purification of the residue by reverse phase HPLC (5−85% acetonitrile in water with 0.1% TFA), neutralization of the fractions, and extraction into ethyl acetate, drying over sodium sulfate, and concentration in vacuo afforded the title product as a yellow solid (64%). MS <i>m</i>/<i>z</i> 306.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 13.62 (s, 1H), 11.70 (s, 1H), 8.22−8.16 (m, 4H), 7.64 (d, 2H, <i>J</i> = 8.6 Hz), 7.39 (m, 1H), 6.88 (d, 1H, <i>J</i> = 4.8 Hz), 6.10 (s, 1H).</div></div><div id="sec3_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 4-[4-(1<i>H</i>-Pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-3-yl]aniline</h4><div class="NLM_p last">A mixture of 4-[3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (0.13 mmol) and tin metal (0.67 mmol) in 6N aq hydrochloric acid (0.75 mL) and ethanol (0.75 mL) was heated at 70 °C for 1 h. The reaction mixture was cooled and filtered through celite, and the solution was poured into saturated aq sodium bicarbonate (60 mL) and extracted with (3 × 50 mL) ethyl acetate. The combined organic layers were dried over sodium sulfate and concentrated in vacuo. The title product (yellow solid, quantitative) was used without further purification in the next step. MS <i>m</i>/<i>z</i> 276.2 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>N</i>-Phenyl-<i>N</i>′-{4-[4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-3-yl]phenyl}urea (<b>12a</b>)</h4><div class="NLM_p">To a solution of 4-[4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-3-yl]aniline (0.13 mmol) and triethylamine (0.20 mmol) in tetrahydrofuran (1.5 mL) was added phenyl isocyanate (0.13 mmol). After 14 h, the reaction mixture was concentrated in vacuo, and the residue was purified by reverse phase HPLC (10−90% acetonitrile to water with 0.1% TFA) to provide a mixture of bis- and monourea adducts (∼2:1 ratio).</div><div class="NLM_p last">This mixture was dissolved in methanol (1.0 mL), treated with 6N aq sodium hydroxide (0.01 mL), and heated at 70 °C for 45 min. The resultant precipitate was filtered, rinsed with methanol, and dried in vacuo. Formation of the hydrochloride salt of the title product (<b>12a</b>) with 4 M HCl in dioxane gave a yellow powder in 25% yield. MS <i>m</i>/<i>z</i> 395.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 12.75 (s, 1H), 9.63 (s, 1H), 9.45 (s, 1H), 8.32 (d, 1H, <i>J</i> = 5.8 Hz), 8.24 (s, 1H), 7.65 (m, 1H), 7.48 (d, 2H, <i>J</i> = 8.5 Hz), 7.46 (d, 2H, <i>J</i> = 7.6 Hz), 7.32 (d, 2H, <i>J</i> = 8.8 Hz), 7.27 (t, 2H, <i>J</i> = 8.0 Hz), 7.16 (d, 1H, <i>J</i> = 6.0 Hz), 6.96 (t, 1H, <i>J</i> = 7.4 Hz), 6.56 (m, 1H).</div></div><div id="sec3_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 4-Bromo-1-ethyl-5-(4-nitrophenyl)-1<i>H</i>-pyrazole (<b>7a</b>)</h4><div class="NLM_p last">The crude mixture of 4-bromo-1-ethyl-5-(4-nitrophenyl)-1<i>H</i>-pyrazole (minor) and 4-bromo-1-ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazole (major) (∼15 g) was purified by silica gel chromatography, eluting with 10% ethyl acetate in hexane to 20% ethyl acetate in hexane. This provided 5.92 g of a 1:1 mixture of 4-bromo-1-ethyl-5-(4-nitrophenyl)-1<i>H</i>-pyrazole (minor) and 4-bromo-1-ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazole (major). This mixture was separated by reverse phase HPLC, eluting with acetonitrile and water (no TFA). The desired fractions were concentrated to furnish the title compound (2.542 g). MS <i>m</i>/<i>z</i> 296.6 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.26 (3 H, t, <i>J</i> = 7.20 Hz) 4.10 (2 H, d, <i>J</i> = 7.33 Hz) 7.73−7.88 (3 H, m) 8.40 (2 H, d, <i>J</i> = 8.84 Hz).</div></div><div id="sec3_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>-[4-(4-Bromo-1-ethyl-1<i>H</i>-pyrazol-5-yl)phenyl]-<i>N</i>′-phenylurea (<b>10b</b>)</h4><div class="NLM_p">A mixture of 4-bromo-1-ethyl-5-(4-nitrophenyl)-1<i>H</i>-pyrazole (<b>7a</b>, 0.5 g, 1.688 mmol), tin metal (1 g, 8.44 mmol), 6N hydrochloric acid (aq) (9 mL), and ethanol (9 mL) was stirred at 70 °C for 4.75 h. The reaction mixture was filtered, the filtrate concentrated in vacuo, and the residue used directly in the next reaction.</div><div class="NLM_p last">The residue was dissolved in pyridine (16 mL), phenylisocyanate (0.203 mL, 1.857 mmol) was added, and the reaction mixture was stirred at room temperature under an atmosphere of nitrogen for 2 h. The solution was purifed directly on a silica gel column, eluting with 40−80% ethyl acetate in hexanes to provide the title compound (<b>10b</b>, 0.37 g, 57%). MS <i>m</i>/<i>z</i> 385.3, 387.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.19−1.31 (3H, m), 4.05 (2H, q, <i>J</i> = 7.33 Hz), 6.99 (1H, t, <i>J</i> = 7.33 Hz), 7.23−7.40 (4H, m), 7.48 (2H, d, <i>J</i> = 7.58 Hz), 7.58−7.69 (3H, m), 8.79 (1H, s), 8.95 (1H, s).</div></div><div id="sec3_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>-{4-[1-Ethyl-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-5-yl]phenyl}-<i>N</i>′-phenylurea (<b>12b</b>)</h4><div class="NLM_p last">A mixture of <i>N</i>-[4-(4-bromo-1-ethyl-1<i>H</i>-pyrazol-5-yl)phenyl]-<i>N</i>′-phenylurea (<b>10b</b>, 0.135 g, 0.352 mmol), 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (86 mg, 0.352 mmol), tetrakis(triphenylphosphine)palladium(0) (20.3 mg, 0.0176 mmol), anhydrous 1,4-dioxane (2 mL), and 2.0 M aq potassium carbonate (2 mL) was stirred at 100 °C in a sealed tube for 18 h. The reaction mixture was cooled to room temperature, diluted with ethyl acetate, and the organic portion separated. The aq portion was extracted with ethyl acetate (3 × 3 mL), and the combined organic layers were dried over magnesium sulfate and concentrated in vacuo. Purification of the residue by reverse phase HPLC provided the title compound (<b>12b</b>) as a white solid (73 mg, 49%). MS <i>m</i>/<i>z</i> 423.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.33 (3H, t, <i>J</i> = 7.20 Hz), 4.07 (2H, q, <i>J</i> = 7.16 Hz), 6.38 (1H, dd, <i>J</i> = 3.54, 1.77 Hz), 6.59 (1H, d, <i>J</i> = 5.05 Hz), 6.98 (1H, t, <i>J</i> = 7.33 Hz), 7.22−7.34 (4H, m), 7.37−7.41 (1H, m), 7.46 (2H, d, <i>J</i> = 7.58 Hz), 7.55 (2H, d, <i>J</i> = 8.59 Hz), 7.91−8.05 (2H, m), 8.77 (1H, s), 8.92 (1H, s), 11.60 (1H, br s).</div></div><div id="sec3_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 5-(4-Nitrophenyl)-1<i>H</i>-pyrazole (<b>5a</b>)</h4><div class="NLM_p last">A solution of 1-(4-nitrophenyl)ethanone (100 g, 605 mmol) and <i>N</i>,<i>N</i>-dimethylformamide dimethyl acetal (86.5 g, 726 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (1000 mL) was stirred for 1 h at 80 °C. The reaction was concentrated, redissolved in ethanol, (1000 mL) and treated with hydrazine monohydrate (100 mL, 1816 mmol). After the reaction was stirred 2 h at 70 °C, it was cooled to room temperature and poured into ice−water (2000 mL). Solid precipitated out of the solution and was filtered, washed with water (4 × 500 mL), and dried to provide the title product (<b>5a</b>) as a yellow powder (98%). MS <i>m</i>/<i>z</i> 190.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.04−9.29 (m, 1H), 8.34 (d, <i>J</i> = 8.84 Hz, 2H), 8.12 (d, <i>J</i> = 8.84 Hz, 2H), 7.78 (s, 1H).</div></div><div id="sec3_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 4-Bromo-3-(4-nitrophenyl)-1<i>H</i>-pyrazole (<b>6a</b>)</h4><div class="NLM_p last">A solution of 5-(4-nitrophenyl)-1<i>H</i>-pyrazole (113 g, 595 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (1000 mL) was treated with <i>N</i>-bromosuccinimide (116 g, 654 mmol). The reaction was stirred for 30 min at room temperature and was poured into ice−water (1000 mL). Solid precipitated out of the solution and was filtered, washed with water (4 × 500 mL), and dried to provide the title product (<b>6a</b>) as an off-white powder (90%). MS <i>m</i>/<i>z</i> 269.2 [M + H]<sup>+</sup>. <sup>1</sup>HNMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.16 (d, <i>J</i> = 8.59 Hz, 2H), 8.20 (s, 1H), 8.34 (d, <i>J</i> = 8.34 Hz, 2H), 13.70 (br s, 1H).</div></div><div id="sec3_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 4-Bromo-1-ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazole (<b>7b</b>)</h4><div class="NLM_p last">A 0 °C solution of 4-bromo-3-(4-nitrophenyl)-1<i>H</i>-pyrazole (130 g, 485 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (1000 mL) was slowly treated with sodium hydride (19 g, 485 mmol) and then iodoethane (47 mL, 582 mmol). The reaction mixture was stirred for 30 min at room temperature and then poured into ice−water (1000 mL). Solid was precipitated out of the solution and was collected by filtration, washed with water (4 × 500 mL), and dried to provide 4-bromo-1-ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazole (<b>7b</b>) as a light-brown powder (94%). MS <i>m</i>/<i>z</i> 297.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.43 (t, <i>J</i> = 7.33 Hz, 3H), 4.22 (q, <i>J</i> = 7.33 Hz, 2H), 8.13 (d, <i>J</i> = 8.84 Hz, 2H), 8.22 (s, 1H), 8.34 (d, <i>J</i> = 8.84 Hz, 2H).</div></div><div id="sec3_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 1-Ethyl-3-(4-nitrophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (<b>8a</b>)</h4><div class="NLM_p last">A solution of 4-bromo-1-ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazole (8 g, 27 mmol), 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi-1,3,2-dioxaborolane (7.6 g, 30 mmol), potassium acetate (8 g, 81 mmol), and bis(triphenylphosphine)palladium(II) dichloride (758 mg, 1.08 mmol) in 1,4-dioxane (30 mL) was stirred for 3 h at 100 °C in a sealed tube. After cooling to room temperature, the reaction mixture was diluted with ethyl acetate (200 mL), filtered though a silica-gel plug, and concentrated. Purification of the residue by reverse phase HPLC provided the title product (<b>8a</b>) as a yellow powder (28%). MS <i>m</i>/<i>z</i> 344.2 [M + H]<sup>+</sup>. <sup>1</sup>HNMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.29 (s, 12 H), 1.42 (t, <i>J</i> = 7.20 Hz, 3 H), 4.23 (q, <i>J</i> = 7.16 Hz, 2 H), 8.11 (s, 1 H), 8.15−8.21 (m, 2 H), 8.26 (d, <i>J</i> = 9.09 Hz, 2 H).</div></div><div id="sec3_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 4-[1-Ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine</h4><div class="NLM_p last">4-[1-Ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine. A solution of 1-ethyl-3-(4-nitrophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (2.6 g, 7.5 mmol), 4-bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (1.2 g, 6.3 mmol), and tetrakis(tripheylyphosphine)palladium(0) (291 mg, 0.25 mmol) in 1,4-dioxane (12 mL) and 2 M aq potassium carbonate (12 mL) was stirred for 18 h at 100 °C in a sealed tube. Upon cooling to room temperature, product precipitated out of solution, which was filtered and dried to provide the title product as a light-yellow powder (80%). MS <i>m</i>/<i>z</i> 334.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.51 (t, <i>J</i> = 7.20 Hz, 3H), 4.31 (q, <i>J</i> = 7.33 Hz, 2H), 6.15 (dd, <i>J</i> = 3.41, 1.89 Hz, 1H), 6.87 (d, <i>J</i> = 4.80 Hz, 1H), 7.35−7.44 (m, 1H), 7.59−7.69 (m, 2H), 8.13−8.19 (m, 2H), 8.25 (s, 1H), 11.72 (br s, 1H).</div></div><div id="sec3_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 4-[1-Ethyl-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-3-yl]aniline</h4><div class="NLM_p last">A solution of 4-[1-ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (59 mmol) in glacial acetic acid (25 mL) was treated with zinc dust (41 mmol) and stirred for 1 h at room temperature. The reaction was then filtered and concentrated in vacuo. The resultant residue was suspended in a 1:1 mixture of ethyl acetate (10 mL) and saturated aq sodium bicarbonate (10 mL) and stirred 30 min. The organic layer was separated, filtered, washed with brine (1 × 5 mL), dried over sodium sulfate, and concentrated. Purification of the residue by flash chromatography (80−100% ethyl acetate/hexanes) provided the title product as a white powder (85%). MS <i>m</i>/<i>z</i> 304.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.46 (t, <i>J</i> = 7.20 Hz, 3H), 4.20 (q, <i>J</i> = 7.33 Hz, 2H), 5.14 (br s, 2H), 6.28 (br s, 1H), 6.45 (d, <i>J</i> = 8.59 Hz, 2H), 6.81 (d, <i>J</i> = 5.05 Hz, 1H), 7.03 (d, <i>J</i> = 8.59 Hz, 2H), 7.38 (d, <i>J</i> = 3.28 Hz, 1H), 8.02−8.12 (m, 2H), 11.67 (br s, 1H).</div></div><div id="sec3_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>N</i>-{4-[1-Ethyl-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-3-yl]phenyl}-<i>N</i>′-phenylurea (<b>12c</b>)</h4><div class="NLM_p last">A solution of 4-[1-ethyl-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-3-yl]aniline (2.2 mmol) in pyridine (4 mL) was treated with phenyl isocyanate (2.4 mmol) and stirred for 1 h at room temperature. The reaction mixture was concentrated in vacuo, and purification of the residue by flash chromatography (80−100% ethyl acetate/hexanes) provided the title product (<b>12c</b>) as a white powder (50%). MS <i>m</i>/<i>z</i> 424.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.49 (t, 3H), 4.25 (q, <i>J</i> = 7.24 Hz, 2H), 6.25 (dd, <i>J</i> = 3.41, 1.89 Hz, 1H), 6.82 (d, <i>J</i> = 5.05 Hz, 1H), 6.97 (t, <i>J</i> = 7.33 Hz, 1H), 7.21−7.33 (m, 4H), 7.34−7.41 (m, 3H), 7.45 (d, <i>J</i> = 7.58 Hz, 2H), 8.11 (d, <i>J</i> = 5.05 Hz, 1H), 8.15 (s, 1H), 8.70 (d, <i>J</i> = 11.62 Hz, 2H), 11.63 (br s, 1H).</div></div><div id="sec3_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 1-(1,1-Dimethylethyl)-5-(4-nitrophenyl)-1<i>H</i>-pyrazole (<b>5b</b>)</h4><div class="NLM_p last">To a round bottomed flask equipped with a stir bar was added 4-nitroacetophenone (2.21 g, 13.37 mmol), <i>N</i>,<i>N</i>-dimethylformamide dimethyl acetal (2.13 mL, 16.04 mmol), and <i>N</i>,<i>N</i>-dimethylformamide (33.4 mL). The reaction mixture was stirred at 80 °C under a reflux condenser for 1 h 20 min. The solution was concentrated in vacuo, the residue taken up in ethanol, treated with <i>tert</i>-butylhydrazine hydrochloride (5 g, 40.125 mmol), and the solution stirred at 70 °C for 2.5 h under an atmosphere of nitrogen. LCMS did not show complete consumption of starting material so the reaction mixture was heated for a further 5 h at 70 °C. The reaction mixture was then cooled to room temperature, poured into water, and the deep-yellow precipitate that formed was collected, washed with water (× 3). This precipitate (2.62 g, 80%) was determined to be the desired isomer (<b>5b</b>) following bromination and NOE studies. MS <i>m</i>/<i>z</i> 190.0 (M − C(CH<sub>3</sub>)<sub>3</sub> + 2H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.41 (9H, s), 6.25 (1H, d, <i>J</i> = 1.52 Hz), 7.49 (1H, d, <i>J</i> = 1.52 Hz), 7.70 (2H, app d, <i>J</i> = 8.59 Hz), 8.28 (2H, app d, <i>J</i> = 8.59 Hz).</div></div><div id="sec3_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 4-Bromo-1-(1,1-dimethylethyl)-5-(4-nitrophenyl)-1<i>H</i>-pyrazole (<b>6b</b>)</h4><div class="NLM_p last">To a solution of 1-(1,1-dimethylethyl)-5-(4-nitrophenyl)-1<i>H</i>-pyrazole (<b>5b</b>, 1.77 g, 7.22 mmol) in dry <i>N</i>,<i>N</i>-dimethylformamide (22 mL) was added <i>N</i>-bromosuccinimide (1.413 g, 7.94 mmol). The reaction mixture was stirred at room temperature for 30 min and then poured into water. The white precipitate that formed was collected and washed with water and then hexanes to provide the title compound (<b>6b</b>, 2.176 g, 93%). MS <i>m</i>/<i>z</i> 268.0, 270.0 [M − C(CH<sub>3</sub>)<sub>3</sub> + 2H]. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.38 (9H, s), 7.62−7.79 (3H, m), 8.35 (2H, d, <i>J</i> = 8.59 Hz).</div></div><div id="sec3_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 1-(1,1-Dimethylethyl)-5-(4-nitrophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (<b>8d</b>)</h4><div class="NLM_p last">In a sealed tube was combined 4-bromo-1-(1,1-dimethylethyl)-5-(4-nitrophenyl)-1<i>H</i>-pyrazole (<b>6b</b>, 2.08 g, 6.416 mmol), potassium acetate (1.89 g, 19.248 mmol), bis(pinacolato)diboron (1.792 g, 7.058 mmol), and bis(diphenylphosphino)palladium(II)dichloride (0.18 g, 0.257 mmol) followed by anhydrous 1,4-dioxane (64.16 mL). The reaction mixture was stirred at 100 °C for 16.5 h then cooled to rt. The solution was diluted with EtOAc (5 mL) and washed with water (× 1). The aq solution was extracted with ethyl acetate (× 4) and the combined organic layers dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. The residue was purified by reverse phase HPLC to give the title compound (<b>8d</b>, 0.273 g, 11%). MS <i>m</i>/<i>z</i> 315.2 [M − C(CH<sub>3</sub>)<sub>3</sub> + H]. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.03 (9H, s), 1.30 (12H, s), 7.63−7.67 (3H, m), 8.23−8.27 (2H, m).</div></div><div id="sec3_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-{4-[1-(1,1-Dimethylethyl)-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-5-yl]phenyl}-<i>N</i>′-phenylurea (<b>12d</b>)</h4><div class="NLM_p last">A mixture of 1-(1,1-dimethylethyl)-5-(4-nitrophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (<b>8d</b>, 0.103 g, 0.277 mmol), 4-bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (46 mg, 0.0.231 mmol), 1,4-dioxane (2 mL), 2 M aq potassium carbonate (2 mL), and tetrakis(triphenylphosphine)palladium(0) (26.7 mg, 0.028 mmol) in a sealed tube was stirred at 100 °C for 18 h. The solution was cooled to rt, diluted with ethyl acetate, and washed with water (× 1). The organic layer was separated, and the aqueous portion was further extracted with ethyl acetate (× 3). The combined organic solution was dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. This residue was purified by reverse phase HPLC to give the 0.100 g of 4-[1-(1,1-dimethylethyl)-5-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine with 91% purity by LCMS (0.091 g, 91%). This 91% pure material was used in the next reaction without further purification. MS <i>m</i>/<i>z</i> 362.2 [M + H]<sup>+</sup>. A mixture of 4-[1-(1,1-dimethylethyl)-5-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (∼0.100 g, 0.276 mmol), glacial acetic acid (15 mL), zinc dust (90.4 mg, 1.38 mmol), and ethanol (1.5 mL) was stirred at room temperature for 1.5 h. The reaction mixture was filtered through a fritted funnel, concentrated in vacuo, and dried in vacuo. The residue was dissolved in pyridine (2.75 mL) and phenylisocyanate (30 μL, 0.276 mmol) added. The reaction mixture was stirred at room temperature overnight. The solution was concentrated in vacuo and the residue purified by reverse phase HPLC to furnish the title compound (<b>12d</b>, 72 mg, 58%). MS <i>m</i>/<i>z</i> 451.2 [M + H]<sup>+</sup>. LCMS purity 92%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.47 (9H, s), 6.40 (1H, d, <i>J</i> = 5.05 Hz), 6.59 (1H, dd, <i>J</i> = 3.41, 1.89 Hz), 7.50−7.72 (6H, m), 7.86 (1H, d, <i>J</i> = 4.80 Hz), 7.95 (1H, s), 8.68 (4H, s), 8.77 (1H, s), 8.91 (1H, s), 11.60 (1H, br s).</div></div><div id="sec3_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 1-(1,1-Dimethylethyl)-3-(4-nitrophenyl)-1<i>H</i>-pyrazole (<b>5c</b>)</h4><div class="NLM_p last">To a round bottomed flask equipped with a stir bar was added 4-nitroacetophenone (2.21 g, 13.37 mmol), <i>N</i>,<i>N</i>-dimethylformamide dimethyl acetal (2.13 mL, 16.04 mmol), and <i>N</i>,<i>N</i>-dimethylformamide (33.4 mL). The reaction mixture was stirred at 80 °C under reflux for 1 h 20 min. The solution was concentrated in vacuo, the residue taken up in ethanol, treated with <i>tert</i>-butylhydrazine hydrochloride (5 g, 40.125 mmol), and the solution stirred at 70 °C for 2.5 h under an atmosphere of nitrogen. LCMS analysis did not show complete consumption of starting material so the reaction mixture was heated for a further 5 h at 70 °C. The reaction mixture was then cooled to room temperature and poured into water, and the deep-yellow precipitate that formed was collected and washed with water (× 3). This precipitate (2.62 g, 79.9%) was determined to be the undesired isomer after bromination and NOE studies. The filtrate was concentrated and a second crop of yellow precipitate formed, containing the desired title compound (<b>5c</b>) as the minor isomer (0.539 g, 16%). This material was used in the next step without further purification. MS <i>m</i>/<i>z</i> 190.0 [(M − C(CH<sub>3</sub>)<sub>3</sub> + 2H].</div></div><div id="sec3_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 4-Bromo-1-(1,1-dimethylethyl)-3-(4-nitrophenyl)-1<i>H</i>-pyrazole (<b>6c</b>)</h4><div class="NLM_p last">To a solution of 1-(1,1-dimethylethyl)-3-(4-nitrophenyl)-1<i>H</i>-pyrazole (<b>5c</b>, 0.375 g, 1.529 mmol) in anhydrous <i>N</i>,<i>N</i>-dimethylformamide (5 mL) was added <i>N</i>-bromosuccinimide (0.299 g, 1.68 mmol). The reaction mixture was stirred at room temperature for 30 min and then poured into water. The white precipitate that resulted was collected to furnish the title compound (<b>6c</b>) as a white solid (0.48 g, 97%). MS <i>m</i>/<i>z</i> 268.0, 270.0 [M − C(CH<sub>3</sub>)<sub>3</sub> + 2H].</div></div><div id="sec3_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-{4-[4-Bromo-1-(1,1-dimethylethyl)-1<i>H</i>-pyrazol-3-yl]phenyl}-<i>N</i>′-phenylurea (<b>10d</b>)</h4><div class="NLM_p last">A mixture of 4-bromo-1-(1,1-dimethylethyl)-3-(4-nitrophenyl)-1<i>H</i>-pyrazole (<b>6c</b>, 48 mg, 0.148 mmol), zinc dust (67.7 mg, 1.036 mmol), acetic acid (1 mL), and ethanol (1 mL) was stirred at room temperature for 5 h. The solution was filtered and the filtrate concentrated in vacuo. This residue was dissolved in anhydrous pyridine (2 mL), and phenylisocyanate (17.8 μL, 0.163 mmol) was added. The reaction mixture was stirred under an atmosphere of nitrogen for 1 h and 45 min. The solution was concentrated in vacuo to a provide a crude sample of the title compound (<b>10d</b>, 61 mg, quantitative), which was used in the next reaction without further purification. MS <i>m</i>/<i>z</i> 415.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-{4-[1-(1,1-Dimethylethyl)-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-3-yl]phenyl}-<i>N</i>′-phenylurea (<b>12e</b>)</h4><div class="NLM_p last">A mixture of <i>N</i>-{4-[4-bromo-1-(1,1-dimethylethyl)-1<i>H</i>-pyrazol-3-yl]phenyl}-<i>N</i>′-phenylurea (<b>10d</b>, 61 mg, 0.148 mmol), 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-indole (36 mg, 0.148 mmol), tetrakis(triphenylphosphine)palladium(0) (17.1 mg, 0.015 mmol), anhydrous <i>N</i>,<i>N</i>-dimethylformamide (1.5 mL), and satd aq sodium bicarbonate (0.44 mL) was stirred at 100 °C in a sealed tube for 5 h and 15 min. The reaction mixture was cooled to room temperature, filtered, and concentrated in vacuo. The residue was taken in ethyl acetate and purified by silica gel chromatography, eluting with 20−100% ethyl acetate in hexane followed by a second silica gel purification, eluting with 90−100% ethyl acetate. Final purification by reverse phase HPLC provided the title compound (<b>12e</b>) as a white solid (4 mg, 6%). MS <i>m</i>/<i>z</i> 451.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.47 (10H, s), 6.51 (1H, d, <i>J</i> = 5.31 Hz), 6.75 (1H, br s), 6.97 (1H, t, <i>J</i> = 7.33 Hz), 7.26−7.35 (5H, m), 7.47 (2H, d, <i>J</i> = 7.58 Hz), 7.52−7.59 (3H, m), 7.99 (1H, d, <i>J</i> = 5.56 Hz), 8.05 (1H, s), 9.25 (1H, s), 9.49 (1H, s), 12.08 (1H, br s).</div></div><div id="sec3_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>11</b>)</h4><div class="NLM_p last">In a sealed tube was combined 4-bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (92 mg, 0.47 mmol), potassium acetate (0.14 g, 1.40 mmol), bis(pinacolato)diboron (0.24 g, 0.93 mmol), and 1,1′-bis(diphenylphosphino)ferrocenepalladium(II)dichloride dichloromethane complex (15.25 mg, 0.018 mmol) followed by anhydrous 1,4-dioxane (3.11 mL). The reaction mixture was stirred at 90 °C for 18 h and then cooled to room temperature. After dilution with ethyl acetate (5 mL) and filtration through a pad of celite, the filtrate was concentrated in vacuo. The residue was purified by reverse phase HPLC to provide the title product (<b>11</b>) as a white solid (48 mg, 64%). MS <i>m</i>/<i>z</i> 302.2 [M − (CH<sub>3</sub>)<sub>2</sub>CC(CH<sub>3</sub>)<sub>2</sub> + 2H]. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.35 (12H, s), 6.66 (1H, dd, <i>J</i> = 3.28, 1.77 Hz), 7.29 (1H, d, <i>J</i> = 4.55 Hz), 7.48−7.59 (1H, m), 8.22 (1H, d, <i>J</i> = 4.55 Hz), 11.65 (1H, br s).</div></div><div id="sec3_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>N</i>-[4-(4-Bromo-1<i>H</i>-pyrazol-3-yl)phenyl]-<i>N</i>′-phenylurea (<b>10a</b>)</h4><div class="NLM_p last">A heterogeneous mixture of 4-bromo-3-(4-nitrophenyl)-1<i>H</i>-pyrazole (2.1 g, 7.83 mmol), elemental tin dust (4.65 g, 39.16 mmol), 6.0N aq HCl (30 mL), and absolute ethanol (30 mL) was stirred at 70 °C for 1 h. The solution was filtered through celite and concentrated in vacuo. The residue was dissolved in anhydrous pyridine (20 mL) and anhydrous CH<sub>2</sub>Cl<sub>2</sub> (10 mL). Phenylisocyanate (0.86 mL, 7.83 mmol) was added dropwise and the reaction mixture stirred at room temperature overnight. Concentration in vacuo and purification by reverse phase HPLC afforded the title compound as a white solid (<b>10a</b>, 1.6 g, 57%). MS <i>m</i>/<i>z</i> 357.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 6.91−7.04 (1H, m), 7.21−7.35 (2H, m), 7.40−7.51 (2H, m), 7.57 (2H, m, <i>J</i> = 8.59 Hz), 7.71 (2H, m, <i>J</i> = 8.59 Hz), 7.86 (1H, br s), 8.80 (1H, s), 8.91, (1H, br s), 13.29 (1H, br s).</div></div><div id="sec3_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>-{4-[4-Bromo-1-(2,2,2-trifluoroethyl)-1<i>H</i>-pyrazol-3-yl]phenyl}-<i>N</i>′-phenylurea (<b>10e</b>)</h4><div class="NLM_p last">To a solution of <i>N</i>-[4-(4-bromo-1<i>H</i>-pyrazol-3-yl)phenyl]-<i>N</i>′-phenylurea (<b>10a</b>, 0.1 g, 0.28 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (5 mL) cooled to −78 °C was added 1 M potassium <i>t</i>-butoxide in THF (0.765 mL, 0.765 mmol) slowly. The reaction mixture was stirred at −78 °C for 10 min, and then trifluoromethanesulfonic acid 2,2,2-trifluoroethylester (60.34 mg, 0.26 mmol) was added. The reaction mixture was stirred for 2 h at −78 °C and then allowed to warm to room temperature and stirred for a further 21 h. The reaction was quenched by addition of saturated ammonium chloride (aq). The solution was filtered and purified directly by reverse phase HPLC to provide the title compound (<b>10e</b>) confirmed by NOE studies (43 mg, 38%). MS <i>m</i>/<i>z</i> 439.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 5.20 (2H, q, <i>J</i> = 9.09 Hz), 6.92−7.03 (1H, m), 7.29 (2H, t, <i>J</i> = 7.96 Hz), 7.49 (2H, d, <i>J</i> = 7.58 Hz), 7.58 (2H, app d, <i>J</i> = 8.59 Hz), 7.73 (2H, app d, <i>J</i> = 8.59 Hz), 8.19 (1H, s), 9.05 (1H, s), 9.18 (1H, s).</div></div><div id="sec3_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-Phenyl-<i>N</i>′-{4-[4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1-(2,2,2-trifluoroethyl)-1<i>H</i>-pyrazol-3-yl]phenyl}urea (<b>12f</b>)</h4><div class="NLM_p last">A mixture of <i>N</i>-{4-[4-bromo-1-(2,2,2-trifluoroethyl)-1<i>H</i>-pyrazol-3-yl]phenyl}-<i>N</i>′-phenylurea (<b>10e</b>, 26 mg, 0.059 mmol), 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>11</b>, 14.5 mg, 0.059 mmol), tetrakis(triphenylphosphine)palladium(0) (3.4 mg, 0.003 mmol), saturated sodium bicarbonate (0.177 mL), and anhydrous DMF (1 mL) was stirred at 100 °C in a sealed tube for 4 h and cooled to rt. Filtration through a pad of celite, concentration in vacuo, and reverse phase HPLC purification furnished the title compound (<b>12f</b>) as a white solid (10 mg, 35%). MS <i>m</i>/<i>z</i> 477.2 [M + H]<sup>+</sup>. LCMS purity 93%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 5.15−5.39 (2H, m), 6.14−6.30 (1H, m), 6.84 (1H, d, <i>J</i> = 4.80 Hz), 6.91−7.04 (1H, m), 7.17−7.53 (9H, m), 8.14 (1H, d, <i>J</i> = 4.80 Hz), 8.28 (1H, s), 8.68−8.79 (2H, m), 11.71 (1H, br s).</div></div><div id="sec3_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-{4-[4-Bromo-1-(2-{[(1,1-dimethylethyl)(dimethyl)silyl]oxy}ethyl)-1<i>H</i>-pyrazol-3-yl]phenyl}-<i>N</i>′-phenylurea (<b>10f</b>)</h4><div class="NLM_p last">To a solution of <i>N</i>-[4-(4-bromo-1<i>H</i>-pyrazol-3-yl)phenyl]-<i>N</i>′-phenylurea (<b>10a</b>, 1 g, 2.8 mmol) in dry DMF cooled to 0 °C was added 1 M potassium <i>tert</i>-butoxide in THF (11.2 mL, 11.2 mmol). The reaction mixture was stirred for 15 min and then (2-bromoethoxy)-<i>tert</i>-butyldimethylsilane (0.6 mL, 2.8 m,mol) was added dropwise. The reaction mixture was stirred at 0 °C for 30 min and then at room temperature for 2 days. The reaction mixture was quenched with aq ammonium chloride, extracted with ethyl acetate (× 3), and the combined organic layers dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo. Purification by silica gel chromatography, eluting with 20−50% ethyl acetate in hexanes, afforded the title product (<b>10f</b>, 0.806 g, 56%) and 39% recovered starting material. MS <i>m</i>/<i>z</i> 515.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm −0.08 (6H, s), 0.80 (9H, s), 3.93 (2H, t, <i>J</i> = 4.67 Hz), 4.21 (2H, t, <i>J</i> = 5.05 Hz), 6.97−7.00 (1H, m), 7.28−7.31 (2H, m), 7.47 (2H, d, <i>J</i> = 7.58 Hz), 7.54 (2H, d, <i>J</i> = 8.59 Hz), 7.73 (2H, d, <i>J</i> = 8.59 Hz), 7.98 (1H, s), 8.72 (1H, s), 8.80 (1H, s).</div></div><div id="sec3_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-{4-[1-(2-Hydroxyethyl)-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-3-yl]phenyl}-<i>N</i>′-phenylurea (<b>12g</b>)</h4><div class="NLM_p last">A mixture of <i>N</i>-{4-[4-bromo-1-(2-{[(1,1-dimethylethyl)(dimethyl)silyl]oxy}ethyl)-1<i>H</i>-pyrazol-3-yl]phenyl}-<i>N</i>′-phenylurea (<b>10f</b>, 0.775 g, 1.503 mmol), 1-(phenylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>11</b>, 0.866 g, 2.25 mmol), tetrakis(triphenylphosphine)palladium (0.086 g, 0.0759 mmol), saturated sodium bicarbonate (aq) (4.5 mL), and <i>N</i>,<i>N</i>′-dimethylformamide (15 mL) was heated at 100 °C in a sealed pressure vessel for 15.5 h. The reaction mixture was cooled to room temperature, filtered through celite, and concentrated in vacuo. To the resulting residue was added 6N aq sodium hydroxide (5 mL) and methanol (10 mL). The solution was stirred at 70 °C under a reflux condenser overnight. The solution was concentrated in vacuo and the residue taken up in ethyl acetate and purified by silica gel chromatography, eluting with 20−50% ethyl acetate in hexane, followed by 1% methanol in ethyl acetate. The product obtained was further purified by reverse phase HPLC to provide the title compound (<b>12g</b>, 0.345 g, 52%). MS <i>m</i>/<i>z</i> 439.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.85 (2H, q, <i>J</i> = 5.56 Hz), 4.26 (2H, t, <i>J</i> = 5.56 Hz), 5.02 (1H, t, <i>J</i> = 5.31 Hz), 6.26 (1H, dd, <i>J</i> = 3.41, 1.89 Hz), 6.82 (1H, d, <i>J</i> = 5.05 Hz), 6.92−7.03 (1H, m), 7.27−7.31 (4H, m), 7.37 (1H, s), 7.38−7.41 (2H, m), 7.44 (2H, d, <i>J</i> = 7.58 Hz), 8.11 (2H, t, <i>J</i> = 2.53 Hz), 8.70 (1H, s), 8.67 (1H, s), 11.64 (1H, br s).</div></div><div id="sec3_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 4-Bromo-3-(4-nitrophenyl)-1-(2-propen-1-yl)-1<i>H</i>-pyrazole (<b>7c</b>)</h4><div class="NLM_p last">To a cooled (0 °C) solution of 4-bromo-3-(4-nitrophenyl)-1<i>H</i>-pyrazole (10 g, 37.3 mmol) in anhydrous <i>N</i>,<i>N</i>′-dimethylformamide (74.6 mL) was added sodium hydride, 60% dispersed in mineral oil (1.492 g, 37.3 mmol). This was followed by slow addition of allylbromide (3.87 mL, 44.76 mmol). The reaction mixture was stirred at room temperature for 1 h and then poured into an ice−water mixture (100 mL). The precipitate that formed was collected, washed with water, and air-dried. The precipitate was dissolved in dichloromethane and treated with hexane to crash out the product. This product was collected by suction filtration to provide the title compound (<b>7c</b>, 11.3 g, 98%). MS <i>m</i>/<i>z</i> 308.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 4.85 (2H, d, <i>J</i> = 5.81 Hz), 5.18−5.34 (2H, m), 6.07 (1H, m), 8.13 (2H, app d, <i>J</i> = 9.09 Hz), 8.19 (1H, s), 8.34 (2H, app d, <i>J</i> = 8.84 Hz).</div></div><div id="sec3_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 3-(4-Nitrophenyl)-1-(2-propen-1-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (<b>8b</b>)</h4><div class="NLM_p last">In a sealed tube was combined 4-bromo-3-(4-nitrophenyl)-1-(2-propen-1-yl)-1<i>H</i>-pyrazole (<b>7c</b>, 5 g, 16.22 mmol), potassium acetate (4.778 g, 48.69 mmol), bis(pinacolato)diboron (4.532 g, 17.849 mmol), and bis(diphenylphosphino)palladium(II)dichloride (0.4555 g, 0.649 mmol), followed by anhydrous 1,4-dioxane (160 mL). The reaction mixture was purged with nitrogen and then stirred at 100 °C for 18.75 h. The reaction mixture was filtered through celite, concentrated in vacuo, and the residue purified by reverse phase HPLC to provide the title compound (<b>8b</b>, 3.145 g, 55%). MS <i>m</i>/<i>z</i> 356.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.29 (12H, s), 4.86 (2H, d, <i>J</i> = 5.81 Hz), 5.15−5.31 (2H, m), 6.07 (1H, m), 8.09 (1H, s), 8.14−8.22 (2H, m), 8.23−8.32 (2H, m).</div></div><div id="sec3_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 4-[3-(4-Nitrophenyl)-1-(2-propen-1-yl)-1<i>H</i>-pyrazol-4-yl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine</h4><div class="NLM_p last">A mixture of 3-(4-nitrophenyl)-1-(2-propen-1-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (<b>8b</b>, 2.05 g, 5.78 mmol), 4-bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (1.14 g, 5.78 mmol), tetrakis(triphenylphosphine)palladium (0.334 g, 0.289 mmol), 2 M potassium carbonate (aq) (20 mL), and 1,4-dioxane (20 mL) was heated at 100 °C in a sealed pressure vessel overnight. The solution was cooled to room temperature, the organic layer separated, and the aqueous portion extracted with ethyl acetate. The combined organic layers were filtered through a plug of celite and the filtrate concentrated in vacuo. The residue was taken up in ethyl acetate, and the product crashed out of solution. This precipitate was purified by reverse phase HPLC to give the title compound as a bright-yellow solid (0.905 g, 46%). MS <i>m</i>/<i>z</i> 346.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 4.94 (2H, d, <i>J</i> = 6.06 Hz), 5.27−5.37 (2H, m), 6.07−6.25 (2H, m), 6.88 (1H, d, <i>J</i> = 5.05 Hz), 7.38−7.46 (1H, m), 7.59−7.67 (2H, m), 8.13−8.20 (4H, m), 8.23 (1H, s), 11.74 (2H, br s).</div></div><div id="sec3_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-Phenyl-<i>N</i>′-{4-[1-(2-propen-1-yl)-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-3-yl]phenyl}urea (<b>12h</b>)</h4><div class="NLM_p last">A mixture of 4-[3-(4-nitrophenyl)-1-(2-propen-1-yl)-1<i>H</i>-pyrazol-4-yl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (0.5 g, 1.448 mmol), tin metal (0.895 g, 7.239 mmol), 6N aq hydrochloric acid (1 mL), and ethanol (5 mL) was stirred at 70 °C for 1 h, concentrated in vacuo, and the residue taken up in ethyl acetate and washed with saturated sodium bicarbonate (aq). The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. The residue was dissolved in pyridine (5 mL), and phenylisocyanate (0.174 mL, 1.593 mmol) was added. The reaction mixture was stirred for 1 h and then concentrated in vacuo, redissolved in ethyl acetate, filtered, and the filtrate concentrated in vacuo. The residue was purified by reverse phase HPLC to provide the title compound (<b>12h</b>, 0.342 g, 54%). MS <i>m</i>/<i>z</i> 435.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 4.87 (2H, d, <i>J</i> = 5.81 Hz), 5.25−5.38 (2H, m), 6.08−6.33 (2H, m), 6.83 (1H, d, <i>J</i> = 4.80 Hz), 6.87−7.05 (6H, m), 7.33−7.43 (3H, m), 7.65−7.78 (1H, m), 8.03−8.21 (2H, m), 8.71−8.82 (2H, m), 11.65 (1H, br s).</div></div><div id="sec3_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-{4-[1-(2,3-Dihydroxypropyl)-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-3-yl]phenyl}-<i>N</i>′-phenylurea (<b>12i</b>)</h4><div class="NLM_p last">To a solution of <i>N</i>-phenyl-<i>N</i>′-{4-[1-(2-propen-1-yl)-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-3-yl]phenyl}urea (<b>12i</b>, 80 mg, 0.18 mmol) in 5:1 acetone:water (1.2 mL) was added <i>N</i>-methylmorpholine <i>N</i>-oxide (32.4 mg, 0.276 mmol) followed by a 2.5% solution of osmium tetroxide in <i>t</i>-butanol (93.5 mg). The reaction mixture was stirred at room temperature for 18 h. The reaction was quenched with satd aq Na<sub>2</sub>SO<sub>3</sub> (1 mL), filtered through a pad of celite (rinsing with ethyl acetate), and concentrated in vacuo. The residue was purified by reverse phase HPLC to afford the title compound as a white solid (<b>12i</b>, 12 mg, 14%). MS <i>m</i>/<i>z</i> 469.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.5 (2H, br s), 3.96 (2H, m), 4.05−4.17 (1H, m), 4.35 (1H, dd, <i>J</i> = 13.77, 3.66 Hz), 6.37 (1H, br s), 6.90 (1H, d, <i>J</i> = 5.31 Hz), 6.97 (1H, t, <i>J</i> = 7.33 Hz), 7.21−7.34 (4H, m), 7.36−7.56 (5H, m), 8.13−8.19 (2H, m), 8.67−8.77 (2H, m).</div></div><div id="sec3_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 3-{3-(4-Nitrophenyl)-4-[1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl]-1<i>H</i>-pyrazol-1-yl}-1-propanol</h4><div class="NLM_p last">To a solution of 0.5 M 9-borabicyclo[3.3.1]nonane in THF (6.16 mL) cooled to 0 °C was added a solution of 4-[3-(4-nitrophenyl)-1-(2-propen-1-yl)-1<i>H</i>-pyrazol-4-yl]-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (1 g, 2.06 mmol) in THF (14 mL). The reaction mixture was stirred at room temperature under an inert atmosphere for 4.5 h and then recooled to 0 °C followed by quenching with water (1.7 mL). After 15 min of stirring at 0 °C, 6N aq NaOH (1.24 mL) was added dropwise, followed by 30% aq H<sub>2</sub>O<sub>2</sub> (0.865 mL). The reaction mixture was stirred for 1.5 h at 0 °C, neutralized with 6N aq HCl, and concentrated in vacuo. Water (10 mL) was added to the residue and the solution extracted with EtOAc (3 × 15 mL), and the combined organic layers were dried over magnesium sulfate and concentrated in vacuo to afford the title compound (0.87 g, 84%). This material was used without further purification. MS <i>m</i>/<i>z</i> 504.2 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 3-[3-(4-Nitrophenyl)-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-1-yl]-1-propanol</h4><div class="NLM_p last">A solution of 3-{3-(4-nitrophenyl)-4-[1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl]-1<i>H</i>-pyrazol-1-yl}-1-propanol (1.04 g, 2.06 mmol), 6N aq NaOH (1.03 mL), and methanol (10 mL) was heated at 70 °C for 18 h. The reaction mixture was concentrated in vacuo and purified by silica gel chromatography (Analogix, 5% methanol/ethyl acetate) to afford the title compound (0.653 g, 87%). MS <i>m</i>/<i>z</i> 364.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.01−2.12 (2H, m), 3.42−3.52 (2H, m), 4.23 (2H, t, <i>J</i> = 6.95 Hz), 4.66 (1H, t, <i>J</i> = 5.18 Hz), 6.46 (1H, s), 6.70−6.84 (1H, m), 7.04 (1H, d, <i>J</i> = 8.34 Hz), 7.28−7.35 (2H, m), 7.60 (2H, dd, <i>J</i> = 7.45, 1.89 Hz), 8.06 (1H, s), 11.59 (1H, br s).</div></div><div id="sec3_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-{4-[1-(3-Hydroxypropyl)-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-3-yl]phenyl}-<i>N</i>′-phenylurea (<b>12j</b>)</h4><div class="NLM_p last">A mixture of 3-[3-(4-nitrophenyl)-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-1-yl]-1-propanol (0.653 g, 1.787 mmol), ethanol (10 mL), 6N aq hydrochloric acid (5 mL), and tin metal (1.06 g, 8.936 mmol) was heated at 70 °C for 1 h. The reaction mixture was cooled, filtered, and neutralized with saturated sodium bicarbonate (aq) and then concentrated in vacuo. The residue was dissolved in pyridine (10 mL), and phenylisocyanate (0.216 mL, 1.977 mmol) added. The reaction mixture was stirred at room temperature for 16 h and then filtered. The filtrate was concentrated in vacuo, and the residue was taken into DMSO and purified by reverse phase HPLC. The desired fractions were concentrated in vacuo to provide the title compound as a white solid (<b>12j</b>, 0.140 g, 17%). MS <i>m</i>/<i>z</i> 453.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.03 (2H, quin, <i>J</i> = 6.63 Hz), 3.49 (2H, q, <i>J</i> = 6.15 Hz), 4.28 (2H, t, <i>J</i> = 7.07 Hz), 4.67 (1H, t, <i>J</i> = 5.05 Hz), 6.25 (1H, dd, <i>J</i> = 3.54, 1.77 Hz), 6.82 (1H, d, <i>J</i> = 5.05 Hz), 6.98 (1H, q, <i>J</i> = 7.58 Hz), 7.25−7.31 (4H, m), 7.35−7.42 (3H, m), 7.44 (2H, d, <i>J</i> = 7.58 Hz), 8.08−8.18 (2H, m), 8.70 (1H, s), 8.67 (1H, s), 11.64 (1H, br s).</div></div><div id="sec3_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 1-(Phenylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine</h4><div class="NLM_p last">In a sealed tube were combined 4-bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (3.87 g, 11.48 mmol), potassium acetate (3.38 g, 34.43 mmol), bis(pinacolato)diboron (3.50 g, 13.77 mmol), and 1,1′-bis(diphenylphosphino)ferrocenepalladium(II)dichloride dichloromethane complex (0.375 g, 0.46 mmol) followed by anhydrous 1,4-dioxane (115 mL). The reaction mixture was stirred at 100 °C for 45 min and then cooled to room temperature. After dilution with EtOAc (50 mL) and filtration through a pad of celite, the filtrate was concentrated in vacuo. The residue was purified by silica gel chromatography, eluting with 20−50% ethyl acetate/hexanes to provide the title product as a white solid (4.06 g, 92%). MS <i>m</i>/<i>z</i> 384.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.32 (12H, s), 6.97 (1H, d, <i>J</i> = 4.04 Hz), 7.48 (1H, d, <i>J</i> = 4.80 Hz), 7.61 (2H, t, <i>J</i> = 7.71 Hz), 7.71 (1H, t, <i>J</i> = 7.45 Hz), 7.98 (1H, d, <i>J</i> = 4.04 Hz), 8.05−8.15 (2H, m), 8.38 (1H, d, <i>J</i> = 4.55 Hz).</div></div><div id="sec3_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>N</i>-{4-[4-Bromo-1-(tetrahydro-2-furanylmethyl)-1<i>H</i>-pyrazol-3-yl]phenyl}-<i>N</i>′-phenylurea (<b>10g</b>)</h4><div class="NLM_p last">To a solution of <i>N</i>-[4-(4-bromo-1<i>H</i>-pyrazol-3-yl)phenyl]-<i>N</i>′-phenylurea (<b>10a</b>, 0.1 g, 0.28 mmol) in anhydrous DMF (6 mL) cooled to 0 °C was added 1.0 M potassium <i>tert-</i>butoxide in THF (1.12 mL, 1.12 mmol) dropwise. The reaction mixture was stirred for a further 15 min before dropwise addition of tetrahydrofuryl bromide (31.82 uL, 0.28 mmol). The reaction mixture was stirred at room temperature overnight, followed by quenching with saturated aq NH<sub>4</sub>Cl (1 mL). The reaction mixture was diluted with water (3 mL) and extracted with EtOAc (3 × 5 mL). The combined organic layers were dried over magnesium sulfate and concentrated in vacuo. The residue was purified by reverse phase HPLC to afford the title compound (<b>10g</b>, 65 mg, 53%). MS <i>m</i>/<i>z</i> 441.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.60−1.97 (4H, m), 3.60−3.82 (2H, m), 4.09−4.26 (3H, m), 6.94−7.03 (1H, m), 7.24−7.33 (2H, m), 7.47 (2H, d, <i>J</i> = 7.58 Hz), 7.54 (2H, m, <i>J</i> = 8.59 Hz), 7.73 (2H, m, <i>J</i> = 8.59 Hz), 8.00 (1H, s), 8.82 (1 H, s), 8.93 (1 H, s).</div></div><div id="sec3_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>N</i>-Phenyl-<i>N</i>′-{4-[4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1-(tetrahydro-2-furanylmethyl)-1<i>H</i>-pyrazol-3-yl]phenyl}urea (<b>12k</b>)</h4><div class="NLM_p last">A mixture of <i>N</i>-{4-[4-bromo-1-(tetrahydro-2-furanylmethyl)-1<i>H</i>-pyrazol-3-yl]phenyl}-<i>N</i>′-phenylurea (65 mg, 0.147 mmol), 1-(phenylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (92.9 mg, 0.162 mmol), DMF (1.5 mL), saturated aq sodium bicarbonate (0.44 mL), and tetrakis(triphenylphosphine)palladium(0) (8.5 mg, 0.007 mmol) in a sealed tube was stirred at 100 °C for 18 h. The solution was cooled to rt, filtered through celite, and concentrated in vacuo. The residue was dissolved in methanol (5 mL) and 6.0N aq NaOH (1 mL) and stirred at 70 °C for 6 h. The reaction mixture was concentrated in vacuo, dissolved in water (10 mL), and extracted with EtOAc (3 × 10 mL). The combined organic extracts were dried over magnesium sulfate and concentrated in vacuo. Purification of the residue by reverse phase HPLC afforded the title compound as a white solid (<b>12k</b>, 8 mg, 11%). MS <i>m</i>/<i>z</i> 479.4 [M + H]<sup>+</sup>. LCMS purity 92%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.64−1.89 (2H, m), 3.76−3.93 (2H, m), 4.14−4.36 (3H, m), 4.80−5.00 (1H, m), 5.22−5.40 (1H, m), 6.22−6.31 (1H, m), 6.58−6.70 (1H, m), 6.80−6.86 (1H, m), 6.91−7.02 (1H, m), 7.21−7.76 (7H, m), 8.02−8.21 (3H, m), 9.01−9.23 (2H, m), 11.74 (1H, br s).</div></div><div id="sec3_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 1,1-Dimethylethyl [4-bromo-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-1-yl]acetate (<b>7d</b>)</h4><div class="NLM_p last">To a cooled (0 °C) solution of 4-bromo-3-(4-nitrophenyl)-1<i>H</i>-pyrazole (3 g, 11.12 mmol) in anhydrous DMF (25 mL) was added 60% NaH in mineral oil portionwise (0.445 g, 11.12 mmol). This was followed by slow addition of 1,1-dimethylethyl bromoacetate (1.98 mL, 13.43 mmol). The reaction mixture was stirred for 1 h at room temperature and then poured into an ice−water mixture (50 mL). The resulting precipitate was collected by filtration and washed with water (20 mL). The residue was dissolved in methylene chloride and precipitated out with hexanes to furnish the title compound as a white solid (<b>7d</b>, 3.5 g, 83%). MS <i>m</i>/<i>z</i> 382.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.45 (9H, s), 5.08 (2H, s), 8.13 (2H, m, <i>J</i> = 8.84 Hz), 8.19 (1H, s), 8.35 (2H, m, <i>J</i> = 8.84 Hz).</div></div><div id="sec3_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 1,1-Dimethylethyl [3-(4-nitrophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazol-1-yl]acetate (<b>8c</b>)</h4><div class="NLM_p last">In a sealed tube were combined 1,1-dimethylethyl [4-bromo-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-1-yl]acetate (<b>7d</b>, 2.4 g, 6.28 mmol), potassium acetate (1.849 g, 18.84 mmol), bis(pinacolato)diboron (1.754 g, 6.91 mmol), bis(triphenylphosphine)palladium(II) chloride (0.176 g, 0.25 mmol), and anhydrous dioxane (62.8 mL). The reaction mixture was stirred at 100 °C in a sealed tube for 18 h. After cooling to room temperature, the reaction mixture was diluted with EtOAc (40 mL) and washed with water (20 mL). The aqueous solution was then extracted with EtOAc (2 × 10 mL) and the combined organic solutions dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. The residue was purified by silica gel chromatography (10−30% ethyl acetate in hexane) to yield the title compound as a white solid (<b>8c</b>, 1.2 g, 44%). MS <i>m</i>/<i>z</i> 430.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.45 (9H, s), 5.06 (2H, s), 8.05−8.10 (2H, m), 8.18 (1H, s), 8.25−8.30 (2H, m).</div></div><div id="sec3_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> [3-(4-Nitrophenyl)-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-1-yl]acetic acid</h4><div class="NLM_p last">In a sealed tube was combined 1,1-dimethylethyl [3-(4-nitrophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazol-1-yl]acetate (0.272 g, 0.633 mmol), 4-bromo-7-azaindole (<b>9</b>, 0.104 g, 0.527 mmol), tetrakis(triphenylphosphine)palladium(0) (60.9 mg, 0.0527 mmol), 2.0 M aq potassium carbonate (3.25 mL), and 1,4-dioxane (3.25 mL). This mixture was stirred at 100 °C for 15 h. The reaction mixture was filtered through a pad of celite and concentrated in vacuo. Purification by reverse phase HPLC afforded the title product as a white solid (0.13 g, 68%). MS <i>m</i>/<i>z</i> 364.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 4.51 (2H, s), 6.14 (1H, d, <i>J</i> = 3.28 Hz), 6.86 (1H, d, <i>J</i> = 5.05 Hz), 7.40 (1H, d, <i>J</i> = 3.28 Hz), 7.50−7.73 (2H, m), 8.05 (1H, s), 8.10−8.22 (3H, m), 11.72 (1H, br s).</div></div><div id="sec3_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> [3-(4-{[(Phenylamino)carbonyl]amino}phenyl)-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-1-yl]acetic acid (<b>12l</b>)</h4><div class="NLM_p last">A heterogeneous mixture of [3-(4-nitrophenyl)-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-1-yl]acetic acid (0.387 g, 0.31.065 mmol), elemental tin dust (0.632 g, 5.325 mmol), 6.0N aq HCl (5.3 mL), and absolute ethanol (5.3 mL) was stirred at 70 °C for 1 h. The solution was filtered through celite and concentrated in vacuo. The residue was dissolved in anhydrous pyridine (10 mL) and phenylisocyanate (0.128 mL, 11.17 mmol) added dropwise. The reaction mixture was stirred at room temperature for 4 h. After concentration in vacuo, purification by reverse phase HPLC afforded the title compound as a white solid (<b>12l</b>, 0.45 g, 93%). MS <i>m</i>/<i>z</i> 453.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 5.09 (2H, s), 6.18−6.41 (1H, m), 6.80−7.04 (2H, m), 7.19−7.34 (4H, m), 7.37−7.52 (5H, m), 8.19 (1H, d, <i>J</i> = 5.05 Hz), 8.25 (1H, s), 8.71 (1H, s), 8.77 (1H, s), 11.94 (1H, br s), 13.21 (1H, s).</div></div><div id="sec3_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 2-[3-(4-{[(Phenylamino)carbonyl]amino}phenyl)-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-1-yl]acetamide (<b>12m</b>)</h4><div class="NLM_p last">To a cooled (0 °C) solution of [3-(4-{[(phenylamino)carbonyl]amino}phenyl)-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-1-yl]acetic acid (<b>12l</b>, 75 mg, 0.166 mmol) in anhydrous THF (3.3 mL) was added triethylamine (34.7 uL, 0.25 mmol) and ethylchloroformate (17.3 uL, 0.18 mmol). After 30 min at 0 °C, ammonium hydroxide (50 μL) was added and the reaction stirred at room temperature for 1 h. Concentration in vacuo followed by reverse phase HPLC furnished the title compound as a white solid (<b>12m</b>, 10 mg, 13%). MS <i>m</i>/<i>z</i> 452.4 [M + H]<sup>+</sup>. LCMS purity 94%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 4.88 (2H, s), 6.25 (1H, dd, <i>J</i> = 3.41, 1.64 Hz), 6.83 (1H, d, <i>J</i> = 5.05 Hz), 6.93 (1H, t, <i>J</i> = 7.33 Hz), 7.23−7.32 (4H, m), 7.33−7.51 (6H, m), 7.65 (1H, s), 8.03−8.20 (2H, m), 9.65−9.77 (2H, m), 11.65 (1H, br s).</div></div><div id="sec3_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> <i>N</i>-Ethyl-2-[3-(4-{[(phenylamino)carbonyl]amino}phenyl)-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-1-yl]acetamide (<b>12n</b>)</h4><div class="NLM_p last">To a solution of [3-(4-{[(phenylamino)carbonyl]amino}phenyl)-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-1-yl]acetic acid (<b>12l</b>, 75 mg, 0.166 mmol), EDCI (47.7 mg, 0.249 mmol), DMAP (30.4 mg, 0.249 mmol), and DMF (3.2 mL) at room temperature was added a 2 M solution of ethylamine in THF (204 mL, 0.415 mmol). The reaction mixture was stirred for 3 days at room temperature, concentrated in vacuo, taken up in DMSO, filtered, and the filtrate concentrated and purified by reverse phase HPLC to provide the title compound (<b>12n</b>, 32 mg, 40%). MS <i>m</i>/<i>z</i> 480.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.08 (3H, s), 3.16 (2H, s), 4.89 (2H, s), 6.25 (1H, br s), 6.77−7.01 (3H, m), 7.21−7.32 (3H, m), 7.34−7.49 (5H, m), 8.03−8.21 (2H, m), 8.29−8.48 (1H, m), 9.49−9.73 (2H, m), 11.67 (1H, br s).</div></div><div id="sec3_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> <i>N</i>-{4-[1-[2-(4-Morpholinyl)-2-oxoethyl]-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-3-yl]phenyl}-<i>N</i>′-phenylurea (<b>12o</b>)</h4><div class="NLM_p last">To a solution of [3-(4-{[(phenylamino)carbonyl]amino}phenyl)-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-1-yl]acetic acid (<b>12l</b>, 75 mg, 0.166 mmol) in anhydrous <i>N</i>,<i>N</i>-dimethylformamide (4 mL) was added <i>N</i>,<i>N</i>-carbonyldiimidazole (32.2 mg, 0.20 mmol). The reaction mixture was stirred at room temperature for 30 min, and then morpholine (43 uL, 0.50 mmol) was added. The reaction mixture was stirred for a further 3 h. Concentraton in vacuo and purification by reverse phase HPLC afforded the title compound as a white solid (<b>12o</b>, 23 mg, 26%). MS <i>m</i>/<i>z</i> 522.4 [M + H]<sup>+</sup>. LCMS purity 94%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.47−3.71 (8H, m), 5.18−5.34 (2H, m), 6.23 (1H, dd, <i>J</i> = 3.28, 1.77 Hz), 6.83 (1H, d, <i>J</i> = 4.80 Hz), 6.97 −7.51 (7H, m), 8.05−8.19 (2H, m), 8.68−8.83 (4H, m), 11.66 (1H, br s).</div></div><div id="sec3_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> <i>N</i>′-{4-[1-Ethyl-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-3-yl]phenyl}-<i>N</i>,<i>N</i>-dimethylurea (<b>12p</b>)</h4><div class="NLM_p last">A solution of 4-[1-ethyl-4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-3-yl]aniline (80 mg, 0.26 mmol) in pyridine (1 mL) was treated with dimethylcarbamoyl chloride (26 μL, 0.29 mmol). The reaction stirred for 18 h at room temperature and concentrated in vacuo. Purification of the residue by reverse phase HPLC provided the title product (<b>12s</b>) as a white powder (38%). MS <i>m</i>/<i>z</i> 375.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.49 (t, <i>J</i> = 7.33 Hz, 3H), 2.92 (s, 6H), 4.26 (q, <i>J</i> = 7.16 Hz, 2H), 6.40−6.52 (m, 1H), 6.97 (d, <i>J</i> = 5.56 Hz, 1H), 7.25 (d, <i>J</i> = 8.84 Hz, 2H), 7.43 (d, <i>J</i> = 8.59 Hz, 2H), 7.55−7.61 (m, 1H), 8.22 (d, <i>J</i> = 5.56 Hz, 1H), 8.30−8.37 (m, 2H), 12.22 (br s, 1H).</div></div><div id="sec3_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> <i>N</i>-{3-[4-Bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]phenyl}acetamide (<b>14e</b>)</h4><div class="NLM_p last">In a glass pressure tube was added 4-bromo-2-iodo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (1.0 g, 2.2 mmol), [3-(acetylamino)phenyl]boronic acid (0.39 g, 2.2 mmol), tetrakis(triphenylphosphine)palladium(0) (125 mg, mmol), aq satd sodium bicarbonate (5 mL), and dimethylformamide (20 mL). The reaction was purged with nitrogen, capped, and stirred at 100 °C for 16 h. After cooling to room temperature, the reaction was evaporated to dryness under vacuum, taken up in ethyl acetate, washed with water, brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under vacuum. Purification by flash chromatography on silica gel eluting with 80% ethyl acetate in hexanes gave the product (<b>14e</b>, 0.67 g, 1.4 mmol, 64% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.28 (d, <i>J</i> = 5.30 Hz, 1H), 7.93 (d, <i>J</i> = 7.33 Hz, 2H), 7.82 (s, 1H), 7.65 (d, <i>J</i> = 5.81 Hz, 2H), 7.54 (t, <i>J</i> = 7.45 Hz, 1H), 7.38−7.46 (m, 4H), 7.28 (d, <i>J</i> = 7.58 Hz, 1H), 6.60 (s, 1H), 2.24 (s, 3H). MS <i>m</i>/<i>z</i> 470.2 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> <i>N</i>-{3-[4-[1-Ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]phenyl}acetamide (<b>15e</b>)</h4><div class="NLM_p last">In a glass pressure tube was added <i>N</i>-{3-[4-bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]phenyl}acetamide (<b>14e</b>, 0.50 g, 1.0 mmol), 1-ethyl-3-(4-nitrophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (0.40 g, 1.1 mmol), tetrakis(triphenylphosphine)palladium(0) (70 mg, mmol), aq satd sodium bicarbonate (4 mL), and dimethylformamide (16 mL). The reaction was purged with nitrogen and capped and stirred at 100 °C for 6 h. After cooling to room temperature, the reaction was evaporated to dryness under vacuum, taken up in ethyl acetate, filtered to remove insolubles, and concentrated under vacuum. Purification of the residue by flash chromatography on silica gel eluting with ethyl acetate gave the product (<b>15e</b>, 0.55 g, 0.91 mmol, 91% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 10.09 (s, 1H), 8.33 (s, 1H), 8.31 (d, <i>J</i> = 5.05 Hz, 1H), 8.14 (d, <i>J</i> = 8.84 Hz, 2H), 7.90−7.92 (m, 2H), 7.85 (s, 1H), 7.73 (t, <i>J</i> = 7.45 Hz, 1H), 7.53−7.65 (m, 5H), 7.38 (t, <i>J</i> = 7.83 Hz, 1H), 7.13 (d, <i>J</i> = 7.58 Hz, 1H), 7.04 (d, <i>J</i> = 5.05 Hz, 1H), 6.55 (s, 1H), 4.26 (q, <i>J</i> = 7.24 Hz, 2H), 2.09 (s, 3H), 1.47 (t, <i>J</i> = 7.33 Hz, 3H). MS <i>m</i>/<i>z</i> 607.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> <i>N</i>-(3-{4-[1-Ethyl-3-(4-{[(phenylamino)carbonyl]amino}phenyl)-1<i>H</i>-pyrazol-4-yl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl}phenyl)acetamide (<b>17a</b>)</h4><div class="NLM_p">To a stirred solution of <i>N</i>-{3-[4-[1-ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]phenyl}acetamide (<b>15e</b>, 0.50 g, 0.8 mmol) in ethyl acetate (30 mL) was added 20 wt % palladium hydroxide on carbon (0.1 g). A balloon of hydrogen was attached, and the reaction was stirred for 3 days. The reaction was filtered through a pad of celite, rinsed with ethyl acetate, and evaporated to dryness to give the product (0.48 g, 0.8 mmol, 100% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 10.09 (s, 1H), 8.22 (d, <i>J</i> = 5.05 Hz, 1H), 8.17 (s, 1H), 7.85−7.87 (m, 2H), 7.82 (s, 1H), 7.56−7.72 (m, 5H), 7.39 (t, <i>J</i> = 7.96 Hz, 1H), 7.16 (d, <i>J</i> = 7.83 Hz, 1H), 7.01 (d, <i>J</i> = 5.05 Hz, 1H), 6.90 (d, <i>J</i> = 8.59 Hz, 2H), 6.54 (s, 1H), 6.47 (d, <i>J</i> = 8.59 Hz, 2H), 5.23 (s, 2H), 4.15 (q, <i>J</i> = 7.16 Hz, 2H), 2.10 (s, 3H), 1.42 (t, <i>J</i> = 7.20 Hz, 3H). MS <i>m</i>/<i>z</i> 577.4 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a stirred solution of <i>N</i>-{3-[4-[3-(4-aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]phenyl}acetamide (200 mg, 0.35 mmol) in THF (5 mL) was added phenylisocyanate (45 uL, 0.41 mmol) and 1 drop of triethylamine. The reaction was stirred at room temperature for 18 h and evaporated to dryness under vacuum. The residue was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum to give <i>N</i>-{3-[4-[1-ethyl-3-(4-{[(phenylamino)carbonyl]amino}phenyl)-1<i>H</i>-pyrazol-4-yl]-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]phenyl}acetamide (0.29 g, 0.42 mmol, 100% yield) as a pale-yellow solid. MS <i>m</i>/<i>z</i> 696.4 [M + H]<sup>+</sup>.</div><div class="NLM_p last">To a stirred solution of <i>N</i>-{3-[4-[1-ethyl-3-(4-{[(phenylamino)carbonyl]amino}phenyl)-1<i>H</i>-pyrazol-4-yl]-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]phenyl}acetamide (0.25 g, 0.36 mmol) in methanol (5 mL) was added aq 6 N sodium hydroxide (120 μL, 0.72 mmol). The reaction was refluxed for 8 h, cooled to room temperature, and diluted with water (5 mL). The solid which precipitated was filtered off and dried under vacuum. Purification by reverse phase HPLC (10−90% CH<sub>3</sub>CN/H<sub>2</sub>O) gave the product (<b>17a</b>, 120 mg, 0.22 mmol, 60% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.19 (br s, 1H), 10.01 (s, 1H), 8.71 (s, 1H), 8.67 (s, 1H), 8.25 (s, 1H), 8.10 (d, <i>J</i> = 4.80 Hz, 1H), 8.00 (br s, 1H), 7.55 (dd, <i>J</i> = 15.16, 7.83 Hz, 2H), 7.25−7.45 (m, 9H), 6.96 (t, <i>J</i> = 7.07 Hz, 1H), 6.81 (d, <i>J</i> = 4.55 Hz, 1H), 6.67 (br s, 1H), 4.28 (q, <i>J</i> = 6.91 Hz, 2H), 2.07 (s, 3H), 1.52 (t, <i>J</i> = 7.20 Hz, 3H). MS <i>m</i>/<i>z</i> 556.4 [M + H]<sup>+</sup>. Anal. (C<sub>33</sub>H<sub>29</sub>N<sub>7</sub>O·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> <i>N</i>-{4-[4-Bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]phenyl}acetamide (<b>14f</b>)</h4><div class="NLM_p last">The reaction used to prepare <b>14e</b> was repeated with [4-(acetylamino)phenyl]boronic acid to give the product (<b>14f</b>, 0.63 g, 1.3 mmol, 61% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 10.17 (s, 1H), 8.24 (d, <i>J</i> = 5.31 Hz, 1H), 7.79−7.81 (m, 2H), 7.66−7.73 (m, 3H), 7.61 (d, <i>J</i> = 5.31 Hz, 1H), 7.54−7.58 (m, 4H), 6.72 (s, 1H), 2.11 (s, 3H). MS <i>m</i>/<i>z</i> 470.2 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> <i>N</i>-{4-[4-[1-Ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]phenyl}acetamide (<b>15f</b>)</h4><div class="NLM_p last">The reaction used to prepare <b>15e</b> was repeated with <i>N</i>-{4-[4-bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]phenyl}acetamide to give the product (<b>15f</b>, 0.53 g, 0.87 mmol, 87% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 10.13 (s, 1H), 8.32 (s, 1H), 8.29 (d, <i>J</i> = 5.05 Hz, 1H), 8.13 (d, <i>J</i> = 8.84 Hz, 2H), 7.81−7.83 (m, 2H), 7.70−7.73 (m, 1H), 7.66 (d, <i>J</i> = 8.59 Hz, 2H), 7.57−7.61 (m, 2H), 7.53 (d, <i>J</i> = 8.84 Hz, 2H), 7.38 (d, <i>J</i> = 8.59 Hz, 2H), 7.05 (d, <i>J</i> = 5.05 Hz, 1H), 6.48 (s, 1H), 4.26 (q, <i>J</i> = 7.33 Hz, 2H), 2.09 (s, 3H), 1.47 (t, <i>J</i> = 7.20 Hz, 3H). MS <i>m</i>/<i>z</i> 607.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> <i>N</i>-(3-{4-[1-Ethyl-3-(4-{[(phenylamino)carbonyl]amino}phenyl)-1<i>H</i>-pyrazol-4-yl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl}phenyl)acetamide</h4><div class="NLM_p last">The nitro reduction reaction used to prepare <b>17a</b> was repeated with <i>N</i>-{4-[4-[1-ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]phenyl}acetamide to give the product (0.25 g, 0.43 mmol, 52% yield) as an off-white solid. MS <i>m</i>/<i>z</i> 577.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> <i>N</i>-{4-[4-[1-Ethyl-3-(4-{[(phenylamino)carbonyl]amino}phenyl)-1<i>H</i>-pyrazol-4-yl]-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]phenyl}acetamide</h4><div class="NLM_p last">To a stirred solution of <i>N</i>-{4-[4-[3-(4-aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]phenyl}acetamide (170 mg, 0.30 mmol) in THF (5 mL) was added phenylisocyanate (50 μL, 0.46 mmol) and 1 drop of triethylamine. The reaction was stirred at room temperature for 18 h and evaporated to dryness under vacuum. The residue was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum to give the product (0.21 g, 0.30 mmol, 100% yield) as a pale-yellow solid. MS <i>m</i>/<i>z</i> 696.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> <i>N</i>-(Phenyl)-1<i>H</i>-pyrazol-4-yl]-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]phenyl}acetamide (<b>17b</b>)</h4><div class="NLM_p last">To a stirred solution of <i>N</i>-{4-[4-[1-ethyl-3-(4-{[(phenylamino)carbonyl]amino}phenyl)-1<i>H</i>-pyrazol-4-yl]-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]phenyl}acetamide (0.21 g, 0.30 mmol) in methanol (5 mL) was added aq 6 N sodium hydroxide (110 uL, 0.72 mmol). The reaction was refluxed for 8 h, cooled to room temperature, and diluted with water (5 mL). The solid which precipitated was filtered off and dried under vacuum to give the product (<b>17b</b>, 110 mg, 0.20 mmol, 66% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.07 (s, 1H), 10.06 (s, 1H), 8.71 (s, 1H), 8.67 (s, 1H), 8.26 (s, 1H), 8.05 (d, <i>J</i> = 5.05 Hz, 1H), 7.83 (d, <i>J</i> = 8.59 Hz, 2H), 7.65 (d, <i>J</i> = 8.59 Hz, 2H), 7.25−7.45 (m, 8H), 6.96 (t, <i>J</i> = 7.33 Hz, 1H), 6.77 (d, <i>J</i> = 5.05 Hz, 1H), 6.75 (d, <i>J</i> = 1.77 Hz, 1H), 4.27 (q, <i>J</i> = 7.24 Hz, 2H), 2.07 (s, 3H), 1.52 (t, <i>J</i> = 7.20 Hz, 3H). MS <i>m</i>/<i>z</i> 556.4 [M + H]<sup>+</sup>. Anal. (C<sub>33</sub>H<sub>29</sub>N<sub>7</sub>O·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_1_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 4-Bromo-2-(3-formylphenyl)-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>14a</b>)</h4><div class="NLM_p last">To a glass pressure tube were added 4-bromo-2-iodo-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (1 g, 2.1 mmol), 3-formylbenzeneboronic acid (0.32 g, 2.1 mmol), dimethylformamide (15 mL), aq satd sodium bicarbonate (5 mL), and tetrakis(triphenylphosphine)palladium(0) (120 mg, 0.1 mmol). The reaction was purged with nitrogen, capped, and stirred at 100 °C for 16 h. After cooling to room temperature, the reaction was concentrated under vacuum, taken up in ethyl acetate, washed with water, brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. Purification of the residue by flash chromatography on silica gel (0−4% ethyl acetate in dichloromethane) gave the product (<b>14a</b>, 0.72 g, 1.6 mmol, 77% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 10.13 (s, 1H), 8.32 (d, <i>J</i> = 5.31 Hz, 1H), 8.06 (t, <i>J</i> = 1.52 Hz, 1H), 8.03 (dt, <i>J</i> = 7.58, 1.39 Hz, 1H), 7.91−7.97 (m, 2H), 7.89 (ddd, <i>J</i> = 7.83, 1.52, 1.26 Hz, 1H), 7.69 (t, <i>J</i> = 7.71 Hz, 1H), 7.58 (t, <i>J</i> = 6.82 Hz, 1H), 7.43 (d, <i>J</i> = 5.31 Hz, 1H), 7.46 (t, <i>J</i> = 7.83 Hz, 2H), 6.67 (s, 1H). MS <i>m</i>/<i>z</i> 441.0 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 4-[3-(4-Nitrophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-(3-formylphenyl)-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>15a</b>)</h4><div class="NLM_p last">To a sealed pressure tube were added 4-bromo-2-(3-formylphenyl)-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-b]pyridine (0.7 g, 1.6 mmol), 3-(4-nitrophenyl)-1-ethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (0.6 g, 1.7 mmol), <i>N</i>,<i>N</i>-dimethylformamide (15 mL), aq satd sodium bicarbonate (4 mL), and tetrakis(triphenylphosphine)palladium(0) (100 mg, 0.09 mmol). The reaction was purged with nitrogen, capped, and stirred at 100 °C for 16 h. After cooling to room temperature, the reaction was concentrated under vacuum, taken up in ethyl acetate, washed with water, brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. Purification of the residue by flash chromatography on silica gel (5−10% ethyl acetate in dichloromethane) gave the product (<b>15a</b>, 0.75 g, 1.3 mmol, 81% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 10.09 (s, 1H), 8.35 (s, 1H), 8.34 (d, <i>J</i> = 5.05 Hz, 1H), 8.14 (d, <i>J</i> = 8.84 Hz, 2H), 8.02 (d, <i>J</i> = 7.58 Hz, 1H), 7.96 (s, 1H), 7.88 (s, 1H), 7.86 (d, <i>J</i> = 1.26 Hz, 2H), 7.73 (q, <i>J</i> = 7.49 Hz, 2H), 7.61 (t, <i>J</i> = 7.83 Hz, 2H), 7.54 (d, <i>J</i> = 9.09 Hz, 2H), 7.07 (d, <i>J</i> = 5.05 Hz, 1H), 6.72 (s, 1H), 4.26 (q, <i>J</i> = 7.33 Hz, 2H), 1.47 (t, <i>J</i> = 7.33 Hz, 3H). MS <i>m</i>/<i>z</i> 578.3 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 4-[3-(4-Nitrophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(dimethylaminomethyl)phenyl]-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>15i</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-nitrophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-(3-formylphenyl)-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (0.75 g, 1.3 mmol) in THF (20 mL) was added a solution of 2 M dimethylamine in THF (1 mL, 2.0 mmol) followed by sodium triacetoxyborohydride (0.4 g, 1.9 mmol). The reaction was stirred at room temperature for 4 h and concentrated to dryness under vacuum. The residue was taken up in ethyl acetate, washed with aq 1N sodium carbonate, brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated under vacuum. Purification of the residue by flash chromatography on silica gel [0−5% (5% ammonium hydroxide in methanol) in dichloromethane] gave the product (<b>15i</b>, 0.69 g, 1.1 mmol, 87% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.34 (s, 1H), 8.34 (d, <i>J</i> = 5.05 Hz, 1H), 8.13 (d, <i>J</i> = 8.84 Hz, 2H), 7.86−7.88 (m, 2H), 7.74 (t, <i>J</i> = 7.45 Hz, 1H), 7.61 (t, <i>J</i> = 7.83 Hz, 2H), 7.53 (d, <i>J</i> = 8.84 Hz, 2H), 7.33−7.40 (m, 3H), 7.23 (s, 1H), 7.11 (d, <i>J</i> = 5.05 Hz, 1H), 6.43 (s, 1H), 4.26 (q, <i>J</i> = 7.33 Hz, 2H), 3.42 (s, 2H), 2.18 (s, 6H), 1.47 (t, <i>J</i> = 7.33 Hz, 3H). MS <i>m</i>/<i>z</i> 607.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 4-[3-(4-Aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(dimethylaminomethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16a</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-nitrophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(dimethylaminomethyl)phenyl]-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-b]pyridine (0.69 g, 1.1 mmol) in acetic acid (20 mL) was added portionwise zinc dust (0.52 g, 8.0 mmol) over 5 min. The reaction was stirred at room temperature for 1 h, filtered through a pad of celite, rinsed with acetic acid, and concentrated to dryness under vacuum. The residue was re-evaporated several times from methanol, followed by toluene to remove the excess acetic acid, taken up in methanol (35 mL) and treated with aq 6N sodium hydroxide (1.5 mL). The reaction was stirred and heated at 70 °C for 8 h. After cooling to room temperature, the reaction was concentrated under vacuum, triturated with cold water, filtered, washed with water, and dried under vacuum to give the crude product (<b>16a</b>, 0.49 g, 1.1 mmol, 100% yield) (87% pure by LCMS) as a pale-orange solid, which was in the next step without further purification. MS <i>m</i>/<i>z</i> 437.2 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 4-[3-(4-<i>N</i>-Phenylcarbamylaminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(dimethylaminomethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>17c</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(dimethylaminomethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (0.15 g, 0.34 mmol) in THF (5 mL) was added phenyl isocyanate (45 μL, 0.41 mmol) and two drops of triethylamine. The reaction was stirred at room temperature for 1 h and concentrated to dryness under vacuum. The remaining solid was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum. Purification of the residue by reverse phase HPLC (10−90% CH<sub>3</sub>CN/H<sub>2</sub>O with 0.1% TFA) gave the TFA salt which was basified with 1N aq sodium carbonate, extracted with dichloromethane, dried (MgSO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. The residue was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum gave the product (<b>17c</b>, 83 mg, 0.15 mmol, 44% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.15 (d, <i>J</i> = 1.77 Hz, 1H), 8.75 (s, 1H), 8.71 (s, 1H), 8.27 (s, 1H), 8.09 (d, <i>J</i> = 5.05 Hz, 1H), 7.76−7.79 (m, 2H), 7.39−7.46 (m, 5H), 7.31−7.36 (m, 2H), 7.25−7.29 (m, 3H), 6.96 (t, <i>J</i> = 7.33 Hz, 1H), 6.82 (d, <i>J</i> = 5.05 Hz, 1H), 6.74 (d, <i>J</i> = 2.02 Hz, 1H), 4.28 (q, <i>J</i> = 7.33 Hz, 2H), 3.45 (s, 2H), 2.18 (s, 6H), 1.52 (t, <i>J</i> = 7.20 Hz, 3H). MS <i>m</i>/<i>z</i> 556.4 [M + H]<sup>+</sup>. Anal. (C<sub>34</sub>H<sub>33</sub>N<sub>7</sub>O·1.0H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_1_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 3-Bromo-4-methylbenzaldehyde</h4><div class="NLM_p last">To a stirred solution of 3-bromo-4-methylbenzyl alcohol (4.43 g, 22 mmol) in chloroform (100 mL) was added manganese dioxide (15 g, 172 mmol). The reaction was stirred and refluxed (70 °C oil bath) for 18 h, cooled to room temperature, filtered through celite, rinsed with chloroform, and concentrated to dryness under vacuum. Purification of the residue by flash chromatography on silica gel (10% ethyl acetate in hexanes) gave the product (3.0 g, 15 mmol, 68% yield) as a crystalline solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.94 (s, 1H), 8.06 (d, <i>J</i> = 1.52 Hz, 1H), 7.74 (dd, <i>J</i> = 7.83, 1.52 Hz, 1H), 7.42 (d, <i>J</i> = 7.83 Hz, 1H) 2.51 (s, 3H).</div></div><div id="sec3_1_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 3-Formyl-6-methyl-phenylboronate Pinacolato Ester</h4><div class="NLM_p last">To a glass pressure bottle were added 3-bromo-4-methylbenzaldehyde (3.0 g, 15 mmol), bis(pinacolato)diboron (4.5 g, 17.7 mmol), potassium acetate (4.5 g, 45.8 mmol), dichlorobis(triphenylphosphine)palladium(II) (0.5 g, 0.7 mmol), and dioxane (50 mL). The reaction was purged with nitrogen, capped, and stirred at 100 °C for 8 h. The reaction was cooled to room temperature and concentrated to dryness under vacuum. The residue was taken up in ethyl acetate, filtered to remove insolubles, and re-evaporated to dryness under vacuum. Purification of the residue by flash chromatography on silica gel (25 to 100% dichloromethane in hexanes) gave the product (2.76 g, 11.2 mmol, 74% yield) as an oil which solidified upon standing in the refrigerator. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 10.01 (s, 1H), 8.27 (d, <i>J</i> = 2.02 Hz, 1H), 7.86 (dd, <i>J</i> = 7.83, 1.77 Hz, 1H), 7.34 (d, <i>J</i> = 7.83 Hz, 1H), 2.64 (s, 3H), 1.39 (s, 12H). MS <i>m</i>/<i>z</i> 246.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 4-Bromo-2-(3-formyl-6-methyl-phenyl)-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>14b</b>)</h4><div class="NLM_p last">To a glass pressure bottle were added 4-bromo-2-iodo-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (1.18 g, 2.5 mmol), 3-formyl-6-methyl-phenylboronate pinacolato ester (0.71 g, 2.9 mmol), dimethylformamide (15 mL), aq satd sodium bicarbonate (5 mL), and tetrakis(triphenylphosphine)palladium(0) (120 mg, 0.1 mmol). The reaction was purged with nitrogen, capped, and stirred at 100 °C for 16 h. After cooling to room temperature, the reaction was concentrated under vacuum, taken up in ethyl acetate, washed with water, brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. Purification of the residue by flash chromatography on silica gel (0−5% ethyl acetate in dichloromethane) gave the product (<b>14b</b>, 0.77 g, 1.7 mmol, 67% yield) as a white solid. MS <i>m</i>/<i>z</i> 455.0 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 4-[3-(4-Nitrophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-(3-formyl-6-methyl-phenyl)-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>15b</b>)</h4><div class="NLM_p last">To a glass pressure bottle were added 4-bromo-2-(3-formyl-6-methyl-phenyl)-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (0.77 g, 1.7 mmol), 3-(4-nitrophenyl)-1-ethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (<b>8a</b>, 0.65 g, 1.9 mmol), dimethylformamide (20 mL), aq satd sodium bicarbonate (5 mL), and tetrakis(triphenylphosphine)palladium(0) (100 mg, 0.09 mmol). The reaction was purged with nitrogen, capped, and stirred at 100 °C for 16 h. After cooling to room temperature, the reaction was concentrated under vacuum, taken up in ethyl acetate, washed with water, brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. Purification of the residue by flash chromatography on silica gel (4% ethyl acetate in dichloromethane) gave the product (<b>15b</b>, 0.80 g, 1.35 mmol, 79% yield) as a yellow solid. MS <i>m</i>/<i>z</i> 592.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 4-[3-(4-Nitrophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(dimethylaminomethyl)-6-methyl-phenyl]-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>15j</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-nitrophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-(3-formyl-6-methyl-phenyl)-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (0.80 g, 1.4 mmol) in THF (30 mL) was added a solution of 2 M dimethylamine in THF (1.35 mL, 2.7 mmol) followed by sodium triacetoxyborohydride (0.5 g, 2.4 mmol). The reaction was stirred at room temperature for 4 h and concentrated to dryness under vacuum. The residue was taken up in ethyl acetate, washed with aq 1N sodium carbonate, brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated under vacuum. Purification of the residue by flash chromatography on silica gel [3% (5% ammonium hydroxide in methanol) in dichloromethane] gave the product (<b>15j</b>, 0.70 g, 1.1 mmol, 83% yield) as a pale-yellow solid. MS <i>m</i>/<i>z</i> 621.6 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 4-[3-(4-Aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(dimethylaminomethyl)-6-methyl-phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16b</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-nitrophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(dimethylaminomethyl)-6-methyl-phenyl]-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (0.70 g, 1.1 mmol) in acetic acid (15 mL) was added portionwise zinc dust (0.32 g, 4.9 mmol) over 5 min. The reaction was stirred at room temperature for 1 h, filtered through a pad of celite, rinsed with acetic acid, and concentrated to dryness under vacuum. The residue was re-evaporated several times from methanol followed by toluene to remove the excess acetic acid, taken up in methanol (25 mL), and treated with 6N aq sodium hydroxide (1.5 mL). The reaction was stirred and heated at 70 °C for 8 h. After cooling to room temperature, the reaction was concentrated under vacuum, triturated with cold water, filtered, washed with water, and dried under vacuum to give the crude product (<b>16b</b>, 0.49 g, 1.1 mmol, 100% yield) (74% pure by LCMS) as a pale-orange solid, which was used as is. MS <i>m</i>/<i>z</i> 451.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 4-[3-(4-<i>N</i>-Phenylcarbamylaminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(dimethylaminomethyl)-6-methyl-phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>17d</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(dimethylaminomethyl)-6-methyl-phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16b</b>, 250 mg, 0.55 mmol) in THF (20 mL) was added phenyl isocyanate (73 uL, 0.67 mmol) and 2 drops of triethylamine. The reaction was stirred at room temperature for 18 h and concentrated to dryness under vacuum. The remaining solid was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum. Purification of the residue by reverse phase HPLC (10−90% CH<sub>3</sub>CN/0.1% TFA, H<sub>2</sub>O) gave the TFA salt, which was basified with 1N aq sodium carbonate, extracted with (9:1) chloroform/isopropyl alcohol, dried (MgSO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. The residue was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum gave the product (<b>17d</b>, 70.6 mg, 0.12 mmol, 22% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.85 (s, 1H), 8.78 (s, 1H), 8.73 (s, 1H), 8.20 (s, 1H), 8.13 (d, <i>J</i> = 5.05 Hz, 1H), 7.45 (d, <i>J</i> = 7.83 Hz, 2H), 7.41 (d, <i>J</i> = 8.59 Hz, 2H), 7.18 − 7.46 (m, 7H), 6.96 (t, <i>J</i> = 7.20 Hz, 1H), 6.89 (d, <i>J</i> = 5.05 Hz, 1H), 6.25 (s, 1H), 4.25 (q, <i>J</i> = 7.07 Hz, 2H), 3.36 (s, 2H), 2.29 (s, 3H), 2.13 (s, 6H), 1.49 (t, <i>J</i> = 7.33 Hz, 3H). MS <i>m</i>/<i>z</i> 570.4 [M + H]<sup>+</sup>. Anal. (C<sub>35</sub>H<sub>35</sub>N<sub>7</sub>O·1.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_1_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 4-Bromo-2-[4-(dimethylaminomethyl)phenyl]-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>14g</b>)</h4><div class="NLM_p last">To a glass pressure tube were added 4-bromo-2-iodo-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (1.2 g, 2.6 mmol), 4-[(<i>N</i>,<i>N</i>-dimethylamino)methyl]phenyl boronic acid (0.7 g, 2.17 mmol), dimethylformamide (20 mL), aq satd sodium bicarbonate (8 mL), and tetrakis(triphenylphosphine)palladium(0) (125 mg, 0.11 mmol). The reaction was purged with nitrogen, capped, and stirred at 100 °C for 16 h. After cooling to room temperature, the reaction was concentrated under vacuum, taken up in ethyl acetate, washed with water, brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. Purification of the residue by flash chromatography on silica gel (0−20% (5% ammonium hydroxide in methanol) in ethyl acetate) gave the product (<b>14g</b>, 0.81 g, 1.7 mmol, 66% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.25 (d, <i>J</i> = 5.31 Hz, 1H), 7.81−7.83 (m, 2H), 7.69 (t, <i>J</i> = 6.82 Hz, 1H), 7.62 (d, <i>J</i> = 5.31 Hz, 1H), 7.53−7.60 (m, 4H), 7.42 (d, <i>J</i> = 8.08 Hz, 2H), 6.77 (s, 1H), 3.50 (s, 2H), 2.21 (s, 6H). MS <i>m</i>/<i>z</i> 470.0 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 4-[3-(4-Nitrophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(dimethylaminomethyl)phenyl]-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>15g</b>)</h4><div class="NLM_p last">To a glass pressure tube were added 4-bromo-2-[4-(dimethylaminomethyl)phenyl]-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>14g</b>, 0.5 g, 1.0 mmol), 3-(4-nitrophenyl)-1-ethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (0.4 g, 1.1 mmol), dimethylformamide (16 mL), aq satd sodium bicarbonate (4 mL), and tetrakis(triphenylphosphine)palladium(0) (70 mg, 0.06 mmol). The reaction was purged with nitrogen, capped, and stirred at 100 °C for 8 h. After cooling to room temperature, the reaction was concentrated under vacuum, taken up in ethyl acetate, washed with water, brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. Purification of the residue by flash chromatography on silica gel [2−6% (5% ammonium hydroxide in methanol) in dichloromethane] gave the product (<b>15g</b>, 0.62 g, 1.0 mmol, 100% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.34 (s, 1H), 8.30 (d, <i>J</i> = 5.05 Hz, 1H), 8.14 (d, <i>J</i> = 9.09 Hz, 2H), 7.82−7.84 (m, 2H), 7.72 (t, <i>J</i> = 7.45 Hz, 1H), 7.59 (t, <i>J</i> = 7.83 Hz, 2H), 7.54 (d, <i>J</i> = 8.84 Hz, 2H), 7.41 (d, <i>J</i> = 8.08 Hz, 2H), 7.36 (d, <i>J</i> = 8.08 Hz, 2H), 7.05 (d, <i>J</i> = 5.05 Hz, 1H), 6.54 (s, 1H), 4.26 (q, <i>J</i> = 7.33 Hz, 2 H), 3.47 (s, 2 H), 2.19 (s, 6 H), 1.47 (t, <i>J</i> = 7.20 Hz, 3 H). MS <i>m</i>/<i>z</i> 607.6 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> 4-[3-(4-Aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(dimethylaminomethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16g</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-nitrophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(dimethylaminomethyl)phenyl]-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>15g</b>, 0.60 g, 1.0 mmol) in acetic acid (20 mL) was added portionwise zinc dust (0.46 g, 7.0 mmol) over 5 min. The reaction was stirred at room temperature for 1 h, filtered through a pad of celite, rinsed with acetic acid, and concentrated to dryness under vacuum. The residue was re-evaporated several times from methanol, toluene to remove the excess acetic acid, taken up in methanol (25 mL), and treated with 6N sodium hydroxide (1.5 mL). The reaction was stirred and heated at 70 °C for 8 h. After cooling to room temperature, the reaction was concentrated under vacuum and the residue was triturated with cold water, filtered, washed with water, and dried under vacuum to give the product (<b>16g</b>, 0.39 g, 0.90 mmol, 90% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.09 (br s, 1H), 8.20 (s, 1 H), 8.04 (d, <i>J</i> = 5.05 Hz, 1H), 7.85 (d, <i>J</i> = 8.34 Hz, 2H), 7.35 (d, <i>J</i> = 8.08 Hz, 2H), 7.08 (d, <i>J</i> = 8.34 Hz, 2H), 6.81 (s, 1H), 6.79 (d, <i>J</i> = 5.05 Hz, 1H), 6.49 (d, <i>J</i> = 8.59 Hz, 2H), 5.14 (s, 2H), 4.23 (q, <i>J</i> = 7.16 Hz, 2H), 3.41 (s, 2H), 2.16 (s, 6H), 1.49 (t, <i>J</i> = 7.33 Hz, 3H). MS <i>m</i>/<i>z</i> 437.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 4-[3-(4-<i>N</i>-Phenylcarbamylaminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(dimethylaminomethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>17e</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(dimethylaminomethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16g</b>, 0.19 g, 0.44 mmol) in THF (10 mL) was added phenyl isocyanate (71 uL, 0.65 mmol) and one drop of triethylamine. The reaction was stirred at room temperature for 1 h and concentrated to dryness under vacuum. The remaining solid was triturated with (1:1) ethyl ether, petroleum ether, filtered, and dried under vacuum. Purification of the residue by reverse phase HPLC (10−90% CH<sub>3</sub>CN/0.1% TFA, H<sub>2</sub>O) gave the TFA salt which was basified with 1N aq sodium carbonate, extracted with dichloromethane, dried (MgSO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. The residue was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum to give the product (<b>17e</b>, 50 mg, 0.09 mmol, 20% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.12 (br s, 1H), 8.71 (s, 1H), 8.67 (s, 1H), 8.27 (s, 1H), 8.08 (d, <i>J</i> = 4.80 Hz, 1H), 7.83 (d, <i>J</i> = 7.83 Hz, 2H), 7.26−7.45 (m, 10H), 6.97 (t, <i>J</i> = 7.33 Hz, 1H), 6.80 (d, <i>J</i> = 5.05 Hz, 1H), 6.75 (s, 1H), 4.27 (q, <i>J</i> = 7.07 Hz, 2H), 3.39 (s, 3H), 2.15 (s, 6H), 1.52 (t, <i>J</i> = 7.20 Hz, 3H). MS <i>m</i>/<i>z</i> 556.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 4-Bromo-5-methylbenzylalcohol</h4><div class="NLM_p last">To a stirred solution of 4-bromo-5-methylbenzoic acid (5.0 g, 23 mmol) in THF (50 mL) at 0 °C was added dropwise a solution of 1N borane tetrahydrofuran complex in THF (34 mL, 34 mmol). The reaction was allowed to warm to room temperature and stirred for 18 h. The reaction was recooled to 0 °C and slowly quenched with water (10 mL). The reaction was allowed to warm to room temperature and evaporated to dryness under vacuum. The residue was taken up in ethyl acetate, washed with 1N aq sodium carbonate followed by brine, dried (MgSO<sub>4</sub>), filtered, and evaporated to dryness to give the product (5.37 g, 26 mmol, 100% yield) as a clear liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.53 (d, <i>J</i> = 8.08 Hz, 1H), 7.26 (d, <i>J</i> = 1.77 Hz, 1H), 7.07 (dd, <i>J</i> = 8.08, 1.52 Hz, 1H), 4.65 (s, 2H), 2.42 (s, 3H).</div></div><div id="sec3_1_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 4-Bromo-5-methylbenzaldehyde</h4><div class="NLM_p last">To a stirred solution of 4-bromo-5-methylbenzyl alcohol (5.3 g, 26 mmol) in chloroform (100 mL) was added manganese dioxide (18 g, 207 mmol). The reaction was stirred and refluxed (70 °C oil bath) for 18 h, cooled to room temperature, filtered through celite, rinsed with chloroform, and concentrated to dryness under vacuum. Purification of the residue by flash chromatography on silica gel (10% ethyl acetate in hexanes) gave the product (3.53 g, 17.7 mmol, 68% yield) as a clear liquid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ ppm 9.98 (s, 1H), 7.75 (d, <i>J</i> = 1.52 Hz, 1H), 7.73 (d, <i>J</i> = 8.08 Hz, 1H), 7.57 (dd, <i>J</i> = 8.08, 1.52 Hz, 1H), 2.50 (s, 3H).</div></div><div id="sec3_1_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> 4-Formyl-6-methyl-phenylboronate Pinacolato Ester</h4><div class="NLM_p last">To a glass pressure bottle were added 4-bromo-5-methylbenzaldehyde (3.5 g, 17.5 mmol), bis(pinacolato)diboron (5.0 g, 19.6 mmol), potassium acetate (5.2 g, 53 mmol), dichlorobis(triphenylphosphine)palladium(II) (0.5 g, 0.7 mmol), and dioxane (50 mL). The reaction was purged with nitrogen, capped, and stirred at 100 °C for 8 h. The reaction was cooled to room temperature and concentrated to dryness under vacuum. The residue was taken up in ethyl acetate, filtered to remove insolubles, and re-evaporated to dryness under vacuum. Purification of the residue by flash chromatography on silica gel (25 to 100% dichloromethane in hexanes) gave the product (2.73 g, 11.1 mmol, 63% yield) as a clear oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 10.03 (s, 1H), 7.92 (d, <i>J</i> = 7.83 Hz, 1H), 7.65−7.72 (m, 2H), 2.63 (s, 3H), 1.59 (s, 1H), 1.39 (s, 12H). MS <i>m</i>/<i>z</i> 246.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> 4-Bromo-2-(4-formyl-6-methyl-phenyl)-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>14c</b>)</h4><div class="NLM_p last">To a glass pressure bottle were added 4-bromo-2-iodo-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (1.0 g, 2.1 mmol), 4-formyl-6-methyl-phenylboronate pinacolato ester (0.6 g, 2.4 mmol), dimethylformamide (15 mL), aq satd sodium bicarbonate (5 mL), and tetrakis(triphenylphosphine)palladium(0) (120 mg, 0.1 mmol). The reaction was purged with nitrogen, capped, and stirred at 100 °C for 16 h. After cooling to room temperature, the reaction was concentrated under vacuum, taken up in ethyl acetate, and washed with water and brine. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. Purification of the residue by flash chromatography on silica gel (0−2% ethyl acetate in dichloromethane) gave the product (<b>14c</b>, 0.56 g, 1.2 mmol, 58% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 10.11 (s, 1H), 8.29 (d, <i>J</i> = 5.30 Hz, 1H), 7.84−7.92 (m, 4H), 7.68−7.73 (m, 2H), 7.66 (d, <i>J</i> = 5.31 Hz, 1H), 7.70 (t, <i>J</i> = 7.58 Hz, 1H), 7.60 (t, <i>J</i> = 7.83 Hz, 2H), 6.81 (s, 1H), 2.35 (s, 3H). MS <i>m</i>/<i>z</i> 455.0 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> 4-[3-(4-Nitrophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-(4-formyl-6-methyl-phenyl)-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>15c</b>)</h4><div class="NLM_p last">To a glass pressure bottle were added 4-bromo-2-(4-formyl-6-methyl-phenyl)-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>14c</b>, 0.54 g, 1.1 mmol), 3-(4-nitrophenyl)-1-ethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (<b>8a</b>, 0.45 g, 1.3 mmol), dimethylformamide (16 mL), aq satd sodium bicarbonate (4 mL), and tetrakis(triphenylphosphine)palladium(0) (65 mg, 0.056 mmol). The reaction was purged with nitrogen, capped, and stirred at 100 °C for 8 h. After cooling to room temperature, the reaction mixture was concentrated under vacuum, taken up in ethyl acetate, and washed with water followed by brine. The organic layer was dried (MgSO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. Purification of the residue by flash chromatography on silica gel (5−10% ethyl acetate in dichloromethane) gave the product (<b>15c</b>, 0.41 g, 0.69 mmol, 63% yield) as a yellow solid. MS <i>m</i>/<i>z</i> 592.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 4-[3-(4-Nitrophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(dimethylaminomethyl)-6-methyl-phenyl]-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>15k</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-nitrophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-(4-formyl-6-methyl-phenyl)-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>15c</b>, 0.41 g, 0.69 mmol) in THF (20 mL) was added a solution of 2 M dimethylamine in THF (0.7 mL, 1.4 mmol) followed by sodium triacetoxyborohydride (0.25 g, 1.1 mmol). The reaction was stirred at room temperature for 18 h and concentrated to dryness under vacuum. The residue was taken up in ethyl acetate and washed with aq 1N sodium carbonate followed by brine. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated under vacuum. Purification of the residue by flash chromatography on silica gel (97:3 dichloromethane/5% ammonium hydroxide in methanol) gave the product (<b>15k</b>, 0.50 g, 0.69 mmol, 100% yield) as a pale-yellow solid. MS <i>m</i>/<i>z</i> 621.6 [M + H].</div></div><div id="sec3_1_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> 4-[3-(4-Aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(dimethylaminomethyl)-6-methyl-phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16c</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-nitrophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(dimethylaminomethyl)-6-methyl-phenyl]-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>15k</b>, 0.50 g, 0.69 mmol) in acetic acid (15 mL) was added portionwise zinc dust (0.32 g, 4.9 mmol) over 5 min. The reaction was stirred at room temperature for 1 h, filtered through a pad of celite, rinsed with acetic acid, and concentrated to dryness under vacuum. The residue was re-evaporated several times from methanol followed by toluene to remove the excess acetic acid, taken up in methanol (25 mL), and treated with 6N aq sodium hydroxide (1.5 mL). The reaction was stirred and heated at 70 °C for 8 h. After cooling to room temperature, the reaction was concentrated under vacuum, triturated with cold water, filtered, washed with water, and dried under vacuum to give the crude product (<b>16c</b>, 0.46 g, 1.0 mmol, 100% yield) (74% pure by LCMS) as a brown solid. MS <i>m</i>/<i>z</i> 451.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> 4-[3-(4-<i>N</i>-Phenylcarbamylaminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(dimethylaminomethyl)-6-methyl-phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>17f</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(dimethylaminomethyl)-6-methyl-phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16c</b>, 200 mg, 0.44 mmol) in THF (10 mL) was added phenyl isocyanate (58 uL, 0.53 mmol) and 2 drops of triethylamine. The reaction was stirred at room temperature for 4 h and concentrated to dryness under vacuum. The remaining solid was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum. Purification of the residue by reverse phase HPLC (10−90% CH<sub>3</sub>CN/0.1% TFA, H<sub>2</sub>O) gave the TFA salt which was basified with 1N aq sodium carbonate and extracted with (9:1) chloroform/isopropyl alcohol. The organic layer was dried (MgSO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. The residue was trituration with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum to give the product (<b>17f</b>, 57 mg, 0.10 mmol, 23% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.83 (s, 1H), 8.76 (s, 1H), 8.71 (s, 1H), 8.20 (s, 1H), 8.12 (d, <i>J</i> = 4.80 Hz, 1H), 7.46 (s, 1H), 7.45 (d, <i>J</i> = 8.59 Hz, 2H), 7.40 (d, <i>J</i> = 8.59 Hz, 2H), 7.33 (d, <i>J</i> = 8.59 Hz, 2H), 7.28 (t, <i>J</i> = 7.96 Hz, 2H), 7.21 (s, 1H), 7.18 (d, <i>J</i> = 8.08 Hz, 1H), 6.97 (t, <i>J</i> = 7.33 Hz, 1H), 6.88 (d, <i>J</i> = 5.05 Hz, 1H), 6.28 (d, <i>J</i> = 2.02 Hz, 1H), 4.25 (q, <i>J</i> = 7.24 Hz, 2H), 3.36 (s, 2H), 2.30 (s, 3H), 2.15 (s, 6H), 1.49 (t, <i>J</i> = 7.20 Hz, 3H). MS <i>m</i>/<i>z</i> 570.4 [M + H]<sup>+</sup>. Anal. (C<sub>35</sub>H<sub>35</sub>N<sub>7</sub>O·0.75H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_1_83" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> 4-[3-(4-Nitrophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(<i>N</i>-pyrrolidinylmethyl)phenyl]-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>15l</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-nitrophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-(3-formylphenyl)-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>15a</b>, 1.0 g, 1.7 mmol) in THF (25 mL) was added pyrrolidine (0.22 mL, 2.6 mmol) followed by sodium triacetoxyborohydride (0.56 g, 2.6 mmol). The reaction was stirred at room temperature for 4 h and concentrated to dryness under vacuum. The residue was taken up in ethyl acetate and washed with aq 1N sodium carbonate followed by brine. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated under vacuum to give the product (<b>15l</b>, 1.05 g, 1.66 mmol, 97% yield) as a yellow solid. MS <i>m</i>/<i>z</i> 633.6 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_84" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> 4-[3-(4-Aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(<i>N</i>-pyrrolidinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16d</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-nitrophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(<i>N</i>-pyrrolidinylmethyl)phenyl]-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>15l</b>, 1.05 g, 1.66 mmol) in acetic acid (40 mL) was added portionwise zinc dust (0.76 g, 11.6 mmol) over 5 min. The reaction was stirred at room temperature for 1 h, filtered through a pad of celite, rinsed with acetic acid, and concentrated to dryness under vacuum. The residue was re-evaporated several times from methanol followed by toluene to remove the excess acetic acid. The residue was taken up in methanol (35 mL), treated with 6N aq sodium hydroxide (1.5 mL), and heated at 70 °C for 8 h. After cooling to room temperature, the reaction was concentrated under vacuum and the residue was triturated with cold water, filtered, washed with water, and dried under vacuum. Purification of the residue by flash chromatography on silica gel (10 to 20% methanol containing 0.1% triethylamine in dichloromethane) gave the product (<b>16d</b>, 0.48 g, 1.0 mmol, 62% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.13 (s, 1H), 8.20 (s, 1H), 8.06 (d, <i>J</i> = 5.05 Hz, 1H), 7.87 (br s, 1H), 7.81 (d, <i>J</i> = 7.58 Hz, 1H), 7.42 (t, <i>J</i> = 7.58 Hz, 1H), 7.32 (d, <i>J</i> = 7.58 Hz, 2H), 7.08 (d, <i>J</i> = 8.59 Hz, 2H), 6.81 (s, 1H), 6.80 (d, <i>J</i> = 5.05 Hz, 2H), 6.49 (d, <i>J</i> = 8.59 Hz, 2H), 5.14 (br s, 2H), 4.23 (q, <i>J</i> = 7.33 Hz, 2H), 3.74 (br s, 2H), 2.60 (br s, 4H), 1.76 (br s, 4H), 1.49 (t, <i>J</i> = 7.20 Hz, 3H). MS <i>m</i>/<i>z</i> 463.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_85" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> 4-[3-(4-<i>N</i>-Phenylcarbamylaminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(<i>N</i>-pyrrolidinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>17g</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(N-pyrrolidinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-b]pyridine (<b>16d</b>, 200 mg, 0.43 mmol) in THF (10 mL) was added phenyl isocyanate (60 uL, 0.55 mmol). The reaction was stirred at room temperature for 3 h and concentrated to dryness under vacuum. The remaining solid was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum. Purification of the residue by reverse phase HPLC (10−90% CH<sub>3</sub>CN/0.1% TFA, H<sub>2</sub>O) gave the TFA salt which was basified with 1N aq sodium carbonate, extracted with (9:1) chloroform/isopropyl alcohol, dried (MgSO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. Trituration of the residue with (1:1) ethyl ether/petroleum ether, filtration, and drying under vacuum gave the product (<b>17g</b>, 166 mg, 0.28 mmol, 66% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.14 (d, <i>J</i> = 1.52 Hz, 1H), 8.74 (s, 1H), 8.70 (s, 1H), 8.26 (s, 1H), 8.10 (d, <i>J</i> = 4.80 Hz, 1H), 7.73−7.81 (m, 2H), 7.40−7.46 (m, 4H), 7.25−7.46 (m, 10H), 6.96 (t, <i>J</i> = 7.33 Hz, 1H), 6.83 (d, <i>J</i> = 5.05 Hz, 1H), 6.70 (d, <i>J</i> = 2.02 Hz, 1H), 4.28 (q, <i>J</i> = 7.24 Hz, 2H), 3.63 (s, 2H), 2.47 (br s, 4H), 1.69 (br s, 4H), 1.52 (t, <i>J</i> = 7.33 Hz, 3H). MS <i>m</i>/<i>z</i> 582.7 [M + H]<sup>+</sup>. Anal. (C<sub>36</sub>H<sub>35</sub>N<sub>7</sub>O·1.0H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_1_86" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> 4-[3-(4-Nitrophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(<i>N</i>-morpholinylmethyl)phenyl]-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>15m</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-nitrophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-(3-formylphenyl)-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>15a</b>, 1.0 g, 1.7 mmol) in THF (20 mL) was added morpholine (0.35 mL, 4.0 mmol) followed by sodium triacetoxyborohydride (0.83 g, 3.9 mmol). The reaction was stirred at room temperature for 3 days and concentrated to dryness under vacuum. The residue was taken up in ethyl acetate, washed with water, filtered free of a small amount of insolubles, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under vacuum. Purification of the residue by flash chromatography on silica gel (a gradient of 100:0 to 96:4 dichloromethane/5% ammonium hydroxide in methanol) gave the product (<b>15m</b>, 0.94 g, 1.4 mmol, 85% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.34 (s, 1H), 8.33 (d, <i>J</i> = 5.05 Hz, 1H), 8.13 (d, <i>J</i> = 8.84 Hz, 2H), 7.84−7.87 (m, 2H), 7.74 (t, <i>J</i> = 7.45 Hz, 1H), 7.61 (t, <i>J</i> = 7.83 Hz, 2H), 7.53 (d, <i>J</i> = 8.84 Hz, 2H), 7.34−7.41 (m, 3H), 7.27 (s, 1H), 7.10 (d, <i>J</i> = 5.05 Hz, 1H), 6.45 (s, 1H), 4.26 (q, <i>J</i> = 7.33 Hz, 2H), 3.59 (t, <i>J</i> = 4.29 Hz, 4H), 3.50 (s, 2H), 2.38 (br s, 4H), 1.47 (t, <i>J</i> = 7.33 Hz, 3H). MS <i>m</i>/<i>z</i> 649.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_87" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> 4-[3-(4-Aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(<i>N</i>-morpholinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16e</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-nitrophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(<i>N</i>-morpholinylmethyl)phenyl]-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>15m</b>, 0.94 g, 1.4 mmol) in acetic acid (30 mL) was added portionwise zinc dust (0.7 g, 10.7 mmol) over 5 min. The reaction was stirred at room temperature for 1 h, filtered through a pad of celite, rinsed with acetic acid, and concentrated to dryness under vacuum. The residue was re-evaporated several times from methanol followed by toluene to remove the excess acetic acid, taken up in methanol (30 mL), and treated with 6N aq sodium hydroxide (2.0 mL). The reaction mixture was stirred and heated at 70 °C for 8 h. After cooling to room temperature, the reaction was concentrated under vacuum, triturated with cold water, filtered, washed with water, and dried under vacuum to give the crude product (<b>16e</b>, 0.73 g, 1.5 mmol, 100% yield) as a pale-yellow solid. MS <i>m</i>/<i>z</i> 479.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_88" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> 4-[3-(4-<i>N</i>-Phenylcarbamylaminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(<i>N</i>-morpholinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>17h</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(<i>N</i>-morpholinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16e</b>, 150 mg, 0.31 mmol) in THF (5 mL) was added phenyl isocyanate (41 μL, 0.37 mmol) and two drops of triethylamine. The reaction was stirred at room temperature for 1 h and concentrated to dryness under vacuum. The remaining solid was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum. Purification of the residue by reverse phase HPLC (10−90% CH<sub>3</sub>CN/H<sub>2</sub>O with 0.1% TFA) gave the TFA salt which was basified with 1N aq sodium carbonate, extracted with dichloromethane, dried (MgSO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. The residue was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum to give the product (<b>17h</b>, 81 mg, 0.14 mmol, 44% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.16 (d, <i>J</i> = 1.52 Hz, 1H), 8.72 (s, 1H), 8.67 (s, 1H), 8.27 (s, 1H), 8.10 (d, <i>J</i> = 5.05 Hz, 1H), 7.74−7.82 (m, 2H), 7.39−7.46 (m, 5H), 7.31−7.35 (m, 2H), 7.27 (t, <i>J</i> = 7.83 Hz, 3H), 6.96 (t, <i>J</i> = 7.33 Hz, 1H), 6.82 (d, <i>J</i> = 5.05 Hz, 1H), 6.73 (d, <i>J</i> = 2.02 Hz, 1H), 4.28 (q, <i>J</i> = 7.16 Hz, 2H), 3.58 (t, <i>J</i> = 4.42 Hz, 4H), 3.50 (s, 2H), 2.38 (br s, 4H), 1.52 (t, <i>J</i> = 7.33 Hz, 3H). MS <i>m</i>/<i>z</i> 598.6 [M + H]<sup>+</sup>. Anal. (C<sub>36</sub>H<sub>35</sub>N<sub>7</sub>O·1.75H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_1_89" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> 4-Bromo-2-[4-(<i>N</i>-morpholinylmethyl)phenyl]-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>14h</b>)</h4><div class="NLM_p last">To a glass pressure tube were added 4-bromo-2-iodo-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>13</b>, 1.2 g, 2.6 mmol), 4-(<i>N</i>-morpholinylmethyl)benzeneboronic acid (0.8 g, 2.6 mmol), dimethylformamide (20 mL), aq satd sodium bicarbonate (5 mL), and tetrakis(triphenylphosphine)palladium(0) (125 mg, 0.11 mmol). The reaction was purged with nitrogen, capped, and stirred at 100 °C for 16 h. After cooling to room temperature, the reaction was concentrated under vacuum, taken up in ethyl acetate, and washed with water followed by brine. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. Purification of the residue by flash chromatography on silica gel (a gradient of 100:0 to 95:5 dichloromethane/5% ammonium hydroxide in methanol) gave the product (<b>14h</b>, 1.13 g, 2.2 mmol, 84% yield) as a beige foam. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.25 (d, <i>J</i> = 5.31 Hz, 1H), 7.80−7.83 (m, 2H), 7.68 (t, <i>J</i> = 7.45 Hz, 1H), 7.61 (d, <i>J</i> = 5.31 Hz, 1H), 7.56−7.63 (m, 4H), 7.44 (d, <i>J</i> = 8.08 Hz, 2H), 6.77 (s, 1H), 3.62 (t, <i>J</i> = 4.42 Hz, 4H), 3.57 (s, 2H), 2.42 (br s, 4H). MS <i>m</i>/<i>z</i> 512.2 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_90" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> 4-[3-(4-Nitrophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(<i>N</i>-morpholinylmethyl)phenyl]-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>15h</b>)</h4><div class="NLM_p last">To a sealed pressure tube were added 4-bromo-2-[4-(<i>N</i>-morpholinylmethyl)phenyl]-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>14h</b>, 0.5 g, 1.0 mmol), 3-(4-nitrophenyl)-1-ethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (0.4 g, 1.1 mmol), dimethylformamide (16 mL), aq satd sodium bicarbonate (4 mL), and tetrakis(triphenylphosphine)palladium(0) (70 mg, 0.06 mmol). The reaction was purged with nitrogen, capped, and stirred at 100 °C for 8 h. After cooling to room temperature, the reaction was concentrated under vacuum, taken up in ethyl acetate, and washed with water followed by brine. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. Purification of the residue by flash chromatography on silica gel (98:2 dichloromethane/5% ammonium hydroxide in methanol) gave the product (<b>15h</b>, 0.64 g, 1.0 mmol, 99% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.33 (s, 1H), 8.30 (d, <i>J</i> = 5.31 Hz, 1H), 8.14 (d, <i>J</i> = 8.84 Hz, 2H), 7.82−7.84 (m, 2H), 7.72 (t, <i>J</i> = 7.45 Hz, 1H), 7.57−7.63 (m, 2H), 7.54 (d, <i>J</i> = 9.02 Hz, 2H), 7.43 (d, <i>J</i> = 8.08 Hz, 2H), 7.39 (d, <i>J</i> = 8.34 Hz, 2H), 7.05 (d, <i>J</i> = 5.05 Hz, 1H), 6.54 (s, 1H), 4.26 (q, <i>J</i> = 4.26 Hz, 2H), 3.61 (t, <i>J</i> = 4.55 Hz, 4H), 3.54 (s, 2H), 2.40 (br s, 4H), 1.47 (t, <i>J</i> = 7.33 Hz, 4H). MS <i>m</i>/<i>z</i> 649.2 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_91" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> 4-[3-(4-Aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(<i>N</i>-morpholinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16h</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-nitrophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(<i>N</i>-morpholinylmethyl)]-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>15h</b>, 0.64 g, 1.0 mmol) in acetic acid (20 mL) was added portionwise zinc dust (0.4 g, 6.1 mmol) over 5 min. The reaction was stirred at room temperature for 1 h, filtered through a pad of celite, rinsed with acetic acid, and concentrated to dryness under vacuum. The residue was re-evaporated several times from methanol followed by toluene to remove the excess acetic acid. The residue was taken up in methanol (25 mL) and treated with aq 6N sodium hydroxide (1.5 mL). The reaction mixture was stirred and heated at 70 °C for 8 h. After cooling to room temperature, the reaction was concentrated under vacuum, and the residue was triturated with cold water, filtered, washed with water, and dried under vacuum to give the crude product (<b>16h</b>, 0.46 g, mmol, 0.96 mmol, 96% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.09 (d, <i>J</i> = 1.77 Hz, 1H), 8.20 (s, 1H), 8.05 (d, <i>J</i> = 5.05 Hz, 1H), 7.85 (d, <i>J</i> = 8.34 Hz, 2H), 7.37 (d, <i>J</i> = 8.34 Hz, 2H), 7.08 (d, <i>J</i> = 8.59 Hz, 2H), 6.80 (br s, 1H), 6.80 (d, <i>J</i> = 4.80 Hz, 1H), 6.49 (d, <i>J</i> = 8.34 Hz, 2H), 5.14 (s, 2H), 4.23 (q, <i>J</i> = 7.24 Hz, 2H), 3.59 (t, <i>J</i> = 4.42 Hz, 4H), 3.49 (s, 2H), 2.37 (br s, 4H), 1.49 (t, <i>J</i> = 7.33 Hz, 3H). MS <i>m</i>/<i>z</i> 479.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_92" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> 4-[3-(4-<i>N</i>-Phenylcarbamylaminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(<i>N</i>-morpholinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>17i</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(<i>N</i>-morpholinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16h</b>, 0.22 g, 0.46 mmol) in THF (15 mL) was added phenyl isocyanate (75 uL, 0.69 mmol) and one drop of triethylamine. The reaction was stirred at room temperature for 1 h and concentrated to dryness under vacuum. Purification of the residue by reverse phase HPLC (10−90% CH<sub>3</sub>CN/H<sub>2</sub>O) gave the product (<b>17i</b>, 30 mg, 0.05 mmol, 11% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.13 (br s, 1H), 8.80 (br s, 1H), 8.75 (br s, 1H), 8.26 (s, 1H), 8.08 (d, <i>J</i> = 5.05 Hz, 1H), 7.83 (d, <i>J</i> = 8.08 Hz, 2H), 7.25−7.46 (m, 10H), 6.93−7.00 (m, 1H), 6.81 (d, <i>J</i> = 5.05 Hz, 1H), 6.74 (s, 1H), 4.27 (q, <i>J</i> = 7.16 Hz, 2H), 3.57 (br s, 4H), 3.47 (s, 2H), 2.35 (br s, 4H), 1.52 (t, <i>J</i> = 7.20 Hz, 3H). MS <i>m</i>/<i>z</i> 598.4 [M + H]<sup>+</sup>. Anal. (C<sub>36</sub>H<sub>35</sub>N<sub>7</sub>O·1.75H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_1_93" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> 4-[3-(4-<i>N</i>-Ethylcarbamylaminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(dimethylaminomethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>17j</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(dimethylaminomethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16a</b>, 0.15 g, 0.34 mmol) in THF (5 mL) was added ethyl isocyanate (55 uL, 0.70 mmol) and two drops of triethylamine. The reaction was stirred at room temperature for 2 days and concentrated to dryness under vacuum. The remaining solid was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum. Purification of the residue by reverse phase HPLC (10−90% CH<sub>3</sub>CN/H<sub>2</sub>O with 0.1% TFA) gave the TFA salt which was basified with 1N aq sodium carbonate, extracted with dichloromethane, dried (MgSO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. Trituration of the residue with (1:1) ethyl ether/petroleum ether, filtration, and drying under vacuum gave the product (<b>17j</b>, 32 mg, 0.064 mmol, 18% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.17 (br s, 1H), 8.56 (s, 1H), 8.25 (s, 1H), 8.09 (d, <i>J</i> = 4.80 Hz, 1H), 7.81−7.88 (m, 2H), 7.44 (t, <i>J</i> = 7.58 Hz, 1H), 7.30−7.37 (m, 3H), 7.24−7.30 (m, 2H), 6.80 (d, <i>J</i> = 4.80 Hz, 1H), 6.77 (s, 1H), 6.17 (t, <i>J</i> = 5.43 Hz, 1H), 5.76 (s, 1H), 4.26 (q, <i>J</i> = 7.07 Hz, 2H), 3.70 (br s, 2H), 3.05−3.13 (m, 2H), 2.35 (br s, 6H), 1.51 (t, <i>J</i> = 7.20 Hz, 3H), 1.03 (t, <i>J</i> = 7.20 Hz, 3H). MS <i>m</i>/<i>z</i> 508.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_94" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> 4-[3-(4-<i>N</i>,<i>N</i>-Dimethylcarbamylaminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(dimethylaminomethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>17k</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(dimethylaminomethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16a</b>, 0.45 g, 1.0 mmol) in tetrahydrofuran (15 mL) was added <i>p</i>-nitrophenylchloroformate (0.22 g, 1.1 mmol). After stirring for 1 h at room temperature, a solution of 2.0 M dimethylamine in tetrahydrofuran (7 mL, 14 mmol) was added. The reaction was stirred an additional 1 h at room temperature and then concentrated under vacuum. The residue which remained was triturated with aq sodium hydroxide, filtered, washed with cold water, and dried under vacuum. Purification of the residue by Gilson reverse phase HPLC afforded the title compound (<b>17k</b>, 235 mg, 0.46 mmol, 46% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.14 (d, <i>J</i> = 1.8 Hz, 1H), 8.31 (s, 1H), 8.27 (s, 1 H), 8.07 (d, <i>J</i> = 4.8 Hz, 1H), 7.78 (d, <i>J</i> = 8.1 Hz, 1H), 7.77 (s, 1H), 7.43 (d, <i>J</i> = 8.6 Hz, 2H), 7.39 (d, <i>J</i> = 8.1 Hz, 1H), 7.27 (d, <i>J</i> = 8.6 Hz, 2H), 7.27 (dd, 1H), 6.79 (d, <i>J</i> = 5.1 Hz, 1H), 6.76 (d, <i>J</i> = 2.0 Hz, 1H), 4.27 (q, <i>J</i> = 7.3 Hz, 2H), 3.43 (s, 2H), 2.91 (s, 6H), 2.18 (s, 6H), 1.51 (t, <i>J</i> = 7.2 Hz, 3H). MS <i>m</i>/<i>z</i> 508.4 [M + H]<sup>+</sup>. Anal. (C<sub>30</sub>H<sub>33</sub>N<sub>7</sub>O·1.0H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_1_95" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> 4-[3-(4-<i>N</i>-Ethylcarbamylaminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(dimethylaminomethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>17l</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(dimethylaminomethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16g</b>, 0.20 g, 0.46 mmol) in THF (5 mL) was added ethyl isocyanate (75 uL, 0.95 mmol). The reaction was stirred at room temperature for 2 days and concentrated to dryness under vacuum. The remaining solid was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum. Purification of the residue by reverse phase HPLC (10−90% CH<sub>3</sub>CN/H<sub>2</sub>O with 0.1% TFA) gave the TFA salt which was basified with 1N aq sodium carbonate, extracted with dichloromethane, dried (MgSO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. The residue was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum to give the product (<b>17l</b>, 115 mg, 0.23 mmol, 49% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.11 (br s, 1H), 8.53 (s, 1H), 8.25 (s, 1H), 8.06 (d, <i>J</i> = 5.05 Hz, 1H), 7.83 (d, <i>J</i> = 8.08 Hz, 2H), 7.33−7.35 (m, 4H), 7.26 (d, <i>J</i> = 8.59 Hz, 2H), 6.78 (d, <i>J</i> = 5.05 Hz, 1H), 6.76 (s, 1H), 6.18 (t, <i>J</i> = 5.56 Hz, 1H), 4.26 (q, <i>J</i> = 7.24 Hz, 2H), 3.40 (s, 2H), 3.05−3.11 (m, 2H), 2.16 (s, 6H), 1.51 (t, <i>J</i> = 7.33 Hz, 3H), 1.04 (t, <i>J</i> = 7.07 Hz, 3H). MS <i>m</i>/<i>z</i> 508.4 [M + H]<sup>+</sup>. Anal. (C<sub>30</sub>H<sub>33</sub>N<sub>7</sub>O·1.75H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_1_96" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> 4-[3-(4-<i>N</i>,<i>N</i>-Dimethylcarbamylaminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(dimethylaminomethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>17m</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(dimethylaminomethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16g</b>, 0.45 g, 1.0 mmol) in THF (15 mL) was added <i>p</i>-nitrophenylchloroformate (0.23 g, 1.1 mmol). After stirring for 1 h at room temperature, a solution of 2.0 M dimethylamine in THF (8 mL, 16 mmol) was added. The reaction was stirred an additional 1 h at room temperature and then concentrated under vacuum. The residue which remained was triturated with 0.5N aq sodium hydroxide, filtered, washed with cold water, and dried under vacuum. Purification of the residue by reverse phase HPLC (10−90% CH<sub>3</sub>CN/H<sub>2</sub>O with 0.1% TFA) gave the TFA salt which was basified with 1N aq sodium carbonate, extracted with dichloromethane, dried (MgSO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. The residue was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum to give the product (<b>17m</b>, 234 mg, 0.46 mmol, 46% yield) as a pale-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.12 (d, <i>J</i> = 1.52 Hz, 1H), 8.31 (s, 1H), 8.26 (s, 1H), 8.06 (d, <i>J</i> = 4.80 Hz, 1H), 7.84 (d, <i>J</i> = 8.34 Hz, 2H), 7.42 (d, <i>J</i> = 8.84 Hz, 2H), 7.35 (d, <i>J</i> = 8.34 Hz, 2H), 7.28 (d, <i>J</i> = 8.59 Hz, 2H), 6.78 (d, <i>J</i> = 4.80 Hz, 1H), 6.78 (d, <i>J</i> = 2.27 Hz, 1H), 4.27 (q, <i>J</i> = 7.33 Hz, 2H), 3.41 (s, 2H), 2.91 (s, 6H), 2.16 (s, 6H), 1.51 (t, <i>J</i> = 7.20 Hz, 3H). MS <i>m</i>/<i>z</i> 508.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_97" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> 4-[3-(4-<i>N</i>-Ethylcarbamylaminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(<i>N</i>-pyrrolidinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>17n</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(<i>N</i>-pyrrolidinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16d</b>, 240 mg, 0.51 mmol) in THF (15 mL) was added ethyl isocyanate (110 μL, 1.4 mmol). The reaction was stirred at room temperature for 4 days and concentrated to dryness under vacuum. The remaining solid was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum. Purification of the residue by reverse phase HPLC (10−90% CH<sub>3</sub>CN/H<sub>2</sub>O with 0.1% TFA) gave the TFA salt which was basified with 1N aq sodium carbonate, extracted with (9:1) chloroform/isopropyl alcohol, dried (MgSO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. The residue was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum to give the product (<b>16n</b>, 205 mg, 0.38 mmol, 73% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.13 (d, <i>J</i> = 1.52 Hz, 1H), 8.46 (s, 1H), 8.25 (s, 1H), 8.07 (d, <i>J</i> = 5.05 Hz, 1H), 7.73−7.81 (m, 2H), 7.38 (t, <i>J</i> = 7.58 Hz, 1H), 7.34 (d, <i>J</i> = 8.59 Hz, 2H), 7.28 (d, <i>J</i> = 7.07 Hz, 1H), 7.26 (d, <i>J</i> = 8.59 Hz, 2H), 6.79 (d, <i>J</i> = 4.80 Hz, 1H), 6.74 (d, <i>J</i> = 2.02 Hz, 1H), 6.10 (t, <i>J</i> = 5.56 Hz, 1H), 4.26 (q, <i>J</i> = 7.24 Hz, 2H), 3.63 (s, 2H), 3.09 (dd, <i>J</i> = 7.07, 5.81 Hz, 2H), 2.47 (br s, 4H), 1.72 (br s, 4H), 1.51 (t, <i>J</i> = 7.33 Hz, 3H), 1.04 (t, <i>J</i> = 7.07 Hz, 3H). MS <i>m</i>/<i>z</i> 534.5 [M + H]<sup>+</sup>. Anal. (C<sub>32</sub>H<sub>35</sub>N<sub>7</sub>O·1.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_1_98" class="NLM_sec NLM_sec_level_3"><div id="ac_i118" class="anchor-spacer"></div><h4 class="article-section__title" id="_i118"> 4-[3-(4-<i>N</i>,<i>N</i>-Dimethylcarbamylaminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(<i>N</i>-pyrrolidinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>17o</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(<i>N</i>-pyrrolidinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16d</b>, 0.15 g, 0.32 mmol) in THF (10 mL) was added <i>p</i>-nitrophenylchloroformate (75 mg, 0.37 mmol). The reaction quickly became a suspension. After stirring for 1 h at room temperature, a solution of 2.0 M dimethylamine in THF (1.5 mL, 3 mmol) was added. The reaction was stirred an additional 1 h at room temperature and then concentrated under vacuum. The residue which remained was triturated with 0.5N aq sodium hydroxide, filtered, washed with cold water, and dried under vacuum. Purification of the residue by reverse phase HPLC (10−90% CH<sub>3</sub>CN/H<sub>2</sub>O with 0.1% TFA) gave the TFA salt which was basified with 1N aq sodium carbonate, extracted with dichloromethane, dried (MgSO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. The residue was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum to give the product (<b>17o</b>, 69 mg, 0.13 mmol, 40% yield) as a pale-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.15 (s, 1H), 8.32 (s, 1H), 8.27 (s, 1H), 8.07 (d, <i>J</i> = 5.05 Hz, 1H), 7.74−7.81 (m, 2H), 7.43 (d, <i>J</i> = 8.59 Hz, 2H), 7.38 (t, <i>J</i> = 7.58 Hz, 1H), 7.27 (d, <i>J</i> = 8.59 Hz, 3H), 6.79 (d, <i>J</i> = 5.05 Hz, 1H), 6.76 (d, <i>J</i> = 1.77 Hz, 1H), 4.27 (q, <i>J</i> = 7.24 Hz, 2H), 3.61 (s, 2H), 2.91 (s, 6H), 2.45 (br s, 4H), 1.71 (br s, 4H), 1.51 (t, <i>J</i> = 7.20 Hz, 3H). MS <i>m</i>/<i>z</i> 534.4 [M + H]<sup>+</sup>. Anal. (C<sub>32</sub>H<sub>35</sub>N<sub>7</sub>O·1.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_1_99" class="NLM_sec NLM_sec_level_3"><div id="ac_i119" class="anchor-spacer"></div><h4 class="article-section__title" id="_i119"> 4-[4-Bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]benzaldehyde (<b>14d</b>)</h4><div class="NLM_p last">To a glass pressure tube were added 4-bromo-2-iodo-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>13</b>, 3.67 g, 7.93 mmol), 4-formylbenzeneboronic acid (1.19 g, 7.93 mmol), <i>N</i>,<i>N</i>-dimethylformamide (60 mL), aq satd sodium bicarbonate (20 mL), and tetrakis(triphenylphosphine)palladium(0) (458 mg, 0.40 mmol). The reaction was purged with nitrogen, sealed, and stirred at 100 °C overnight (20 h). After cooling to room temperature, the reaction was diluted with water, brine, and ethyl acetate. The aqueous layer was extracted with two portions of ethyl acetate and the combined extracts were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. Purification of the residue by flash chromatography on silica gel (35% ethyl acetate in hexanes) gave the product (<b>14d</b>, 2.64 g, 75% yield) as a yellow solid. MS <i>m</i>/<i>z</i> 441.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 10.13 (s, 1H), 8.29 (d, <i>J</i> = 8.0 Hz, 1H), 8.05 (d, <i>J</i> = 8.0 Hz, 2H), 7.89 (d, <i>J</i> = 8.0 Hz, 2H), 7.86 (d, <i>J</i> = 8.0 Hz, 1H), 7.72−7.65 (m, 2H), 7.58 (app t, <i>J</i> = 8.0 Hz, 2H), 6.96 (s, 2H).</div></div><div id="sec3_1_100" class="NLM_sec NLM_sec_level_3"><div id="ac_i120" class="anchor-spacer"></div><h4 class="article-section__title" id="_i120"> 4-[4-[1-Ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]benzaldehyde (<b>15d</b>)</h4><div class="NLM_p last">To a sealed pressure tube were added 4-[4-bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]benzaldehyde (<b>14d</b>, 2.64 g, 5.99 mmol), 3-(4-nitrophenyl)-1-ethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (2.05 g, 5.99 mmol), dimethylformamide (45 mL), aq satd sodium bicarbonate (15 mL), and tetrakis(triphenylphosphine)palladium(0) (346 mg, 0.30 mmol). The reaction was purged with nitrogen, capped, and stirred at 100 °C overnight (20 h). After cooling to room temperature, the reaction was concentrated under vacuum, taken up in ethyl acetate, and washed with water and brine. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. Purification of the residue by flash chromatography on silica gel (50−55% ethyl acetate in hexanes) gave the product (<b>15d</b>, 1.86 g, 1.3 mmol, 54% yield) as a yellow solid. MS <i>m</i>/<i>z</i> 578.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 10.10 (s, 1H), 8.35 (s, 1H), 8.33 (d, <i>J</i> = 8.0 Hz, 1H), 8.14 (d, <i>J</i> = 8.0 Hz, 2H), 8.01 (d, <i>J</i> = 8.0 Hz, 2H), 7.88 (app d, <i>J</i> = 4.0 Hz, 2H), 7.72−7.75 (m, 3H), 7.61 (app t, <i>J</i> = 8.0 Hz, 2H), 7.54 (d, <i>J</i> = 8.0 Hz, 2H), 7.07 (d, <i>J</i> = 4.0 Hz, 1H), 6.76 (s, 1H), 4.27 (q, <i>J</i> = 8.0 Hz, 2H), 1.47 (t, <i>J</i> = 8.0 Hz, 3H).</div></div><div id="sec3_1_101" class="NLM_sec NLM_sec_level_3"><div id="ac_i121" class="anchor-spacer"></div><h4 class="article-section__title" id="_i121"> 4-[1-Ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-1-(phenylsulfonyl)-2-[4-(1-pyrrolidinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>15n</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[4-[1-ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]benzaldehyde (<b>15d</b>, 300 mg, 0.52 mmol) in THF (5 mL) was added pyrrolidine (148 mg, 2.1 mmol) followed by sodium triacetoxyborohydride (441 mg, 2.1 mmol). The reaction was stirred at room temperature for 20 h, quenched with water, and diluted with ethyl acetate. The aqueous layer was extracted with four portions of ethyl acetate and the combined extracts were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated under vacuum. Purification of the residue by flash chromatography on silica gel (95:5 dichloromethane/5% ammonium hydroxide in methanol) gave the product (<b>15n</b>, 308 mg, 93% yield) as a golden fluffy solid. MS <i>m</i>/<i>z</i> 633.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.34 (s, 1 H), 8.30 (d, <i>J</i> = 4.0 Hz, 1H), 8.11−8.17 (m, 2H), 7.81−7.87 (m, 2H), 7.72 (t, <i>J</i> = 8.0 Hz, 1H), 7.60 (t, <i>J</i> = 8.0 Hz, 2H), 7.51−7.56 (m, 2H), 7.34−7.43 (m, 4H), 7.05 (d, <i>J</i> = 4.0 Hz, 1H), 6.54 (s, 1H), 4.26 (q, <i>J</i> = 8.0 Hz, 2H), 3.64 (s, 2H), 2.47 (br s, 4H), 1.69−1.75 (m, 4H), 1.47 (t, <i>J</i> = 8.0 Hz, 3H).</div></div><div id="sec3_1_102" class="NLM_sec NLM_sec_level_3"><div id="ac_i122" class="anchor-spacer"></div><h4 class="article-section__title" id="_i122"> [4-(1-Ethyl-4-{2-[4-(1-pyrrolidinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl}-1<i>H</i>-pyrazol-3-yl)phenyl]amine (<b>16f</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[1-ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-1-(phenylsulfonyl)-2-[4-(1-pyrrolidinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>15n</b>, 308 mg, 0.49 mmol) in acetic acid (4 mL) was added portionwise zinc dust (223 mg, 3.41 mmol) (exotherm observed). The reaction was stirred at room temperature for 1 h, filtered through a pad of celite, rinsed with acetic acid, and concentrated to dryness under vacuum. The residue was re-evaporated several times from methanol followed by toluene to remove the excess acetic acid. The residue was taken up in methanol (5 mL) and treated with aq 6N sodium hydroxide (0.24 mL, 1.46 mmol). The reaction mixture was stirred and heated at 70 °C for 5 h. After cooling to room temperature, the reaction was concentrated under vacuum, triturated with cold water, filtered, washed with water, and dried under vacuum to give the crude product (<b>16f</b>, 229 mg, 100% yield) (92% pure by LCMS) as an orange solid. The material was used as is in the subsequent reaction. MS <i>m</i>/<i>z</i> 463 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_103" class="NLM_sec NLM_sec_level_3"><div id="ac_i123" class="anchor-spacer"></div><h4 class="article-section__title" id="_i123"> <i>N</i>-Ethyl-<i>N</i>′-[4-(1-ethyl-4-{2-[4-(1-pyrrolidinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl}-1<i>H</i>-pyrazol-3-yl)phenyl]urea (<b>17p</b>)</h4><div class="NLM_p last">To a stirred solution of [4-(1-ethyl-4-{2-[4-(1-pyrrolidinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl}-1<i>H</i>-pyrazol-3-yl)phenyl]amine (<b>16f</b>, 100 mg, 0.216 mmol) in THF (2 mL) was added one drop of triethylamine followed by ethyl isocyanate (20 μL, 0.259 mmol). The reaction was stirred at room temperature for 22 h and concentrated to dryness under vacuum. The remaining solid taken up in DMSO and purified by reverse phase HPLC (10−90% CH<sub>3</sub>CN/H<sub>2</sub>O with 0.1% TFA) to give the TFA salt which was basified with satd aq sodium bicarbonate and extracted with three portions of dichloromethane. The combined organics were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to dryness under vacuum to give the product (<b>17p</b>, 22 mg, 19% yield) as a yellow solid. MS <i>m</i>/<i>z</i> 534.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 12.10 (s, 1H), 8.45 (s, 1H), 8.25 (s, 1H), 8.06 (d, <i>J</i> = 4.0 Hz, 1H), 7.82 (d, <i>J</i> = 8.0 Hz, 2H), 7.32−7.37 (m, 4H), 7.26 (d, <i>J</i> = 8.0 Hz, 2H), 6.78 (d, <i>J</i> = 4.0 Hz, 1H), 6.74 (s, 1H), 6.09 (bs, 1H), 4.26 (q, <i>J</i> = 8.0 Hz, 2H), 3.59 (bs, 2H), 3.09 (m, 2H), 2.45 (app bs, 4H), 1.71 (app bs, 4H), 1.51 (t, <i>J</i> = 8.0 Hz, 3H), 1.04 (t, <i>J</i> = 8.0 Hz, 3H).</div></div><div id="sec3_1_104" class="NLM_sec NLM_sec_level_3"><div id="ac_i124" class="anchor-spacer"></div><h4 class="article-section__title" id="_i124"> <i>N</i>′-[4-(1-Ethyl-4-{2-[4-(1-pyrrolidinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl}-1<i>H</i>-pyrazol-3-yl)phenyl]-<i>N</i>,<i>N</i>-dimethylurea (<b>17q</b>)</h4><div class="NLM_p last">To a stirred suspension of [4-(1-ethyl-4-{2-[4-(1-pyrrolidinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl}-1<i>H</i>-pyrazol-3-yl)phenyl]amine (<b>16f</b>, 130 mg, 0.281 mmol) in THF (3 mL) was added <i>p</i>-nitrophenyl chloroformate (62 mg, 0.31 mmol), giving a yellow slurry. After 45 min, dimethylamine (0.56 mL of a 2 M solution in THF, 1.12 mmol) was added. After an additional 45 min, the reaction was diluted with ethyl acetate and washed with three portions of 1N NaOH. The combined aq layers were back-extracted with ethyl acetate, and the combined extracts were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. The residue was purified by reverse phase HPLC (10−90% CH<sub>3</sub>CN/0.1% TFA in H<sub>2</sub>O) to give the TFA salt which was basified with satd aq sodium bicarbonate, extracted with three portions of dichloromethane, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to dryness under vacuum to give the product (<b>17q</b>, 62 mg, 39% yield) as a light-yellow solid. MS <i>m</i>/<i>z</i> 534.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 12.11 (s, 1H), 8.31 (s, 1H), 8.26 (s, 1H), 8.06 (d, <i>J</i> = 4.0 Hz, 1H), 7.82 (d, <i>J</i> = 8.0 Hz, 2H), 7.42 (d, <i>J</i> = 8.0 Hz, 2H), 7.36 (d, <i>J</i> = 8.0 Hz, 2H), 7.27 (d, <i>J</i> = 8.0 Hz, 2H), 6.78 (d, <i>J</i> = 8.0 Hz, 1H), 6.76 (s, 1H), 4.27 (q, <i>J</i> = 8.0 Hz, 2H), 3.59 (bs, 2H), 2.91 (s, 6H), 2.44 (app bs, 4H), 1.71 (app bs, 4H), 1.51 (t, <i>J</i> = 8.0 Hz, 3H). Anal. (C<sub>32</sub>H<sub>35</sub>N<sub>7</sub>O·1.0H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_1_105" class="NLM_sec NLM_sec_level_3"><div id="ac_i125" class="anchor-spacer"></div><h4 class="article-section__title" id="_i125"> 4-[3-(4-<i>N</i>-Ethylcarbamylaminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(<i>N</i>-morpholinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>17r</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(<i>N</i>-morpholinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16e</b>, 0.15 g, 0.31 mmol) in THF (5 mL) was added ethyl isocyanate (50 uL, 0.63 mmol) and two drops of triethylamine. The reaction was stirred at room temperature for 2 days and concentrated to dryness under vacuum. The remaining solid was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum. Purification of the residue by reverse phase HPLC (10−90% CH<sub>3</sub>CN/0.1% TFA in H<sub>2</sub>O) gave the TFA salt which was basified with 1N aq sodium carbonate, extracted with dichloromethane, dried (MgSO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. The residue was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum to give the product (<b>17r</b>, 71 mg, 0.13 mmol, 42% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.15 (s, 1H), 8.47 (s, 1H), 8.25 (s, 1H), 8.08 (d, <i>J</i> = 5.05 Hz, 1H), 7.74−7.81 (m, 2H), 7.40 (t, <i>J</i> = 7.96 Hz, 1H), 7.31−7.36 (m, 2H), 7.24−7.30 (m, 3H), 6.80 (d, <i>J</i> = 5.05 Hz, 1H), 6.73 (d, <i>J</i> = 2.02 Hz, 1H), 6.11 (t, <i>J</i> = 5.56 Hz, 1H), 4.26 (q, <i>J</i> = 7.16 Hz, 2H), 3.59 (t, <i>J</i> = 4.42 Hz, 4H), 3.51 (s, 2H), 3.09 (dd, <i>J</i> = 7.07, 5.81 Hz, 2H), 2.39 (br s, 4H), 1.51 (t, <i>J</i> = 7.33 Hz, 3H), 1.04 (t, <i>J</i> = 7.07 Hz, 3H). MS <i>m</i>/<i>z</i> 550.6 [M + H]<sup>+</sup>. Anal. (C<sub>32</sub>H<sub>35</sub>N<sub>7</sub>O·1.0H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_1_106" class="NLM_sec NLM_sec_level_3"><div id="ac_i126" class="anchor-spacer"></div><h4 class="article-section__title" id="_i126"> 4-[3-(4-<i>N</i>,<i>N</i>-Dimethylcarbamylaminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(<i>N</i>-morpholinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>17s</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[3-(<i>N</i>-morpholinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (0.41 g, 0.85 mmol) in THF (10 mL) was added <i>p</i>-nitrophenylchloroformate (207 mg, 1.0 mmol). The reaction mixture quickly became a suspension. After stirring for 1 h at room temperature, a solution of 2.0 M dimethylamine in THF (6.0 mL, 12 mmol) was added. The reaction was stirred an additional 1 h at room temperature and then concentrated under vacuum. The residue which remained was triturated with 0.5N aq sodium hydroxide, filtered, washed with cold water, and dried under vacuum. Purification of the residue by reverse phase HPLC (10−90% CH<sub>3</sub>CN/0.1% TFA in H<sub>2</sub>O) gave the TFA salt which was basified with 1N aq sodium carbonate, extracted with dichloromethane, dried (MgSO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. The residue was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum to give the product (<b>17s</b>, 204 mg, 0.37 mmol, 43% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.15 (s, 1H), 8.31 (s, 1H), 8.26 (s, 1H), 8.08 (d, <i>J</i> = 5.05 Hz, 1H), 7.74−7.81 (m, 2H), 7.37−7.45 (m, 3H), 7.26−7.29 (m, 3H), 6.80 (d, <i>J</i> = 4.80 Hz, 1H), 6.74 (d, <i>J</i> = 1.77 Hz, 1H), 4.27 (q, <i>J</i> = 7.24 Hz, 2H), 3.59 (t, <i>J</i> = 4.29 Hz, 4H), 3.51 (s, 2H), 2.91 (s, 6H), 2.39 (br s, 4H), 1.51 (t, <i>J</i> = 7.20 Hz, 3H). MS <i>m</i>/<i>z</i> 550.4 [M + H]<sup>+</sup>. Anal. (C<sub>32</sub>H<sub>35</sub>N<sub>7</sub>O·1.0H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_1_107" class="NLM_sec NLM_sec_level_3"><div id="ac_i127" class="anchor-spacer"></div><h4 class="article-section__title" id="_i127"> (4-[3-(4-<i>N</i>-Ethylcarbamylaminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(<i>N</i>-morpholinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>17t</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(N-morpholinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16h</b>, 0.18 g, 0.37 mmol) in THF (10 mL) was added ethyl isocyanate (50 μL, 0.63 mmol) and two drops of triethylamine. The reaction was stirred at room temperature for 24 h and concentrated to dryness under vacuum. The remaining solid was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum. Purification of the residue by reverse phase HPLC (10−90% CH<sub>3</sub>CN/0.1% TFA in H<sub>2</sub>O) gave the TFA salt which was basified with 1N aq sodium carbonate, extracted with dichloromethane, dried (MgSO<sub>4</sub>), filtered, and evaporated to dryness under vacuum. The residue was triturated with (1:1) ethyl ether/petroleum ether, filtered, and dried under vacuum to give the product (<b>17t</b>, 138 mg, 0.25 mmol, 68% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.12 (d, <i>J</i> = 1.52 Hz, 1H), 8.47 (s, 1H), 8.25 (s, 1H), 8.06 (d, <i>J</i> = 4.80 Hz, 1H), 7.83 (d, <i>J</i> = 8.34 Hz, 2H), 7.31−7.39 (m, 4H), 7.23−7.30 (m, 2H), 6.78 (d, <i>J</i> = 5.05 Hz, 1H), 6.75 (d, <i>J</i> = 2.02 Hz, 1H), 6.11 (t, <i>J</i> = 5.56 Hz, 1H), 4.26 (q, <i>J</i> = 7.33 Hz, 2H), 3.59 (t, <i>J</i> = 4.42 Hz, 4H), 3.48 (s, 2H), 3.09 (dd, <i>J</i> = 7.20, 5.68 Hz, 2H), 2.37 (br s, 4H) 1.51 (t, <i>J</i> = 7.33 Hz, 3H), 1.04 (t, <i>J</i> = 7.07 Hz, 3H). MS <i>m</i>/<i>z</i> 550.4 [M + H]<sup>+</sup>. Anal. (C<sub>32</sub>H<sub>35</sub>N<sub>7</sub>O·1.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_1_108" class="NLM_sec NLM_sec_level_3"><div id="ac_i128" class="anchor-spacer"></div><h4 class="article-section__title" id="_i128"> 4-[3-(4-<i>N</i>,<i>N</i>-Dimethylcarbamylaminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(<i>N</i>-morpholinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>17u</b>)</h4><div class="NLM_p last">To a stirred solution of 4-[3-(4-aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-2-[4-(N-morpholinylmethyl)phenyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16h</b>, 105 mg, 0.22 mmol) in THF (2 mL) was added <i>p</i>-nitrophenylchloroformate (50 mg, 0.25 mmol). After stirring for 1 h at room temperature, a solution of 2.0 M dimethylamine in THF (1.5 mL, 3 mmol) was added. The reaction mixture was stirred an additional 1 h at room temperature and then concentrated under vacuum. The residue which remained was triturated with 0.5N aq sodium hydroxide, filtered, washed with cold water, and dried under vacuum. The residue was purified by reverse phase HPLC (10−90% CH<sub>3</sub>CN/H<sub>2</sub>O). Trituration of the residue with (1:1) ethyl ether/petroleum ether, filtration, and drying under vacuum gave the product (<b>17u</b>, 95 mg, 0.17 mmol, 78% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.12 (br s, 1H), 8.32 (s, 1H), 8.25 (s, 1H), 8.06 (d, <i>J</i> = 4.80 Hz, 1H), 7.83 (d, <i>J</i> = 8.08 Hz, 2H), 7.42 (d, <i>J</i> = 8.59 Hz, 2H), 7.37 (d, <i>J</i> = 8.08 Hz, 2H), 7.27 (d, <i>J</i> = 8.59 Hz, 2H), 6.79 (d, <i>J</i> = 5.05 Hz, 1H), 6.76 (s, 1H), 4.26 (q, <i>J</i> = 7.24 Hz, 2H), 3.59 (br s, 4H), 3.48 (s, 2H), 2.91 (s, 6H), 2.37 (br s, 4H), 1.51 (t, <i>J</i> = 7.20 Hz, 3H). MS <i>m</i>/<i>z</i> 550.4 [M + H]<sup>+</sup>. Anal. (C<sub>32</sub>H<sub>35</sub>N<sub>7</sub>O·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_1_109" class="NLM_sec NLM_sec_level_3"><div id="ac_i129" class="anchor-spacer"></div><h4 class="article-section__title" id="_i129"> Ethyl 1<i>H</i>-Pyrrolo[2,3-<i>b</i>]pyridine-2-carboxylate 7-Oxide (<b>18</b>)</h4><div class="NLM_p last">Compound <b>18</b> was prepared as described in WO2000044753.<a onclick="showRef(event, 'cit36'); return false;" href="javascript:void(0);" class="ref cit36"></a><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ ppm 8.40 (d, <i>J</i> = 6.32 Hz, 1H), 7.80 (d, <i>J</i> = 7.33 Hz, 1H), 7.28 (s, 1H), 7.17 (dd, <i>J</i> = 8.08, 6.32 Hz, 1H), 4.45 (q, <i>J</i> = 7.07 Hz, 2H), 1.44 (t, <i>J</i> = 7.07 Hz, 3H). MS <i>m</i>/<i>z</i> 207.0 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_110" class="NLM_sec NLM_sec_level_3"><div id="ac_i130" class="anchor-spacer"></div><h4 class="article-section__title" id="_i130"> Ethyl 4-Bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carboxylate (<b>19</b>)</h4><div class="NLM_p last">To a stirred solution of ethyl 1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carboxylate 7-oxide (4.35 g, 21 mmol) and tetrabutylammoniumbromide (4.90 g, 31.8 mmol) in 1,2-dimethoxyethane (50 mL) at 0 °C was added portionwise over 5 min methanesulfonic anhydride (7.4 g, 42.5 mmol). The reaction was allowed to warm to room temperature and stirred for 18 h. The reaction was evaporated to dryness under vacuum, neutralized with cold 0.5N aq sodium bicarbonate in water, filtered, rinsed with cold water, and dried under vacuum to give the product (6.20 g, 100%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.97 (br s, 1H), 8.28 (d, <i>J</i> = 5.05 Hz, 1H), 7.48 (d, <i>J</i> = 5.05 Hz, 1H), 7.05 (d, <i>J</i> = 2.02 Hz, 1H), 4.36 (q, <i>J</i> = 7.07 Hz, 2H), 1.35 (t, <i>J</i> = 7.07 Hz, 3H). MS <i>m</i>/<i>z</i> 269.2 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_111" class="NLM_sec NLM_sec_level_3"><div id="ac_i131" class="anchor-spacer"></div><h4 class="article-section__title" id="_i131"> 4-[1-Ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carboxylic Acid (<b>20</b>)</h4><div class="NLM_p last">A solution of ethyl 4-bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carboxylate (3.31 mmol), 1-ethyl-3-(4-nitrophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (3.97 mmol), and tetrakis(triphenylphosphine)palladium(0) (0.17 mmol) in 2 M aq potassium carbonate solution (12 mL) and <i>N</i>,<i>N</i>-dimethylformamide (12 mL) was stirred at 100 °C for 17 h. The reaction mixture was cooled and saturated aq ammonium chloride solution (20 mL) was added, and the product was extracted with ethyl acetate (3 × 20 mL). The combined organic layers were dried over magnesium sulfate and concentrated in vacuo. Precipitation from ethyl acetate afforded the title compound (<b>20</b>) as a yellow solid (81%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.68 (s, 1H), 8.29 (s, 1H), 8.17 (dd, <i>J</i> = 6.82, 1.77 Hz, 3H), 7.66 (d, <i>J</i> = 8.59 Hz, 2H), 7.29 (br s, 1H), 6.80 (d, <i>J</i> = 4.80 Hz, 1H), 6.53 (s, 1H), 4.32 (q, <i>J</i> = 7.16 Hz, 2H), 1.51 (t, 3H). MS <i>m</i>/<i>z</i> 378.2 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_112" class="NLM_sec NLM_sec_level_3"><div id="ac_i132" class="anchor-spacer"></div><h4 class="article-section__title" id="_i132"> 4-[1-Ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-<i>N</i>-[2-(4-morpholinyl)ethyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carboxamide (<b>21a</b>)</h4><div class="NLM_p last">A solution of 4-[1-ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carboxylic acid (<b>20</b>, 0.212 mmol) and 1,1′-carbonyldiimidazole (0.25 mmol) in anhydrous <i>N</i>,<i>N</i>-dimethylformamide (1 mL) under nitrogen at room temperature was stirred for 30 min. 4-(2-Aminoethyl)-morpholine (0.64 mmol) was added to the mixture, and the reaction was stirred for 16.5 h at room temperature. The reaction mixture was concentrated in vacuo. Purification of the residue by reverse phase HPLC (10−90% MeCN/0.1% NH<sub>4</sub>OH in H<sub>2</sub>O) afforded the title compound (<b>21a</b>) as a white solid (15%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.20 (s, 1H), 8.36 (t, <i>J</i> = 5.81 Hz, 1H), 8.28 (s, 1H), 8.27 (d, <i>J</i> = 5.00 Hz, 1H), 8.16 (d, <i>J</i> = 8.84 Hz, 2H), 7.64 (d, <i>J</i> = 8.84 Hz, 2H), 6.95 (s, 1H), 6.89 (d, <i>J</i> = 4.80 Hz, 1H), 4.33 (q, <i>J</i> = 7.33 Hz, 2H), 3.55 (t, <i>J</i> = 4.55 Hz, 4H), 3.35−3.41 (m, 2H), 2.36−2.47 (m, 6H), 1.53 (t, <i>J</i> = 7.33 Hz, 3H). MS <i>m</i>/<i>z</i> 490.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_113" class="NLM_sec NLM_sec_level_3"><div id="ac_i133" class="anchor-spacer"></div><h4 class="article-section__title" id="_i133"> 4-[1-Ethyl-3-(4-{[(phenylamino)carbonyl]amino}phenyl)-1<i>H</i>-pyrazol-4-yl]-<i>N</i>-[2-(4-morpholinyl)ethyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carboxamide (<b>22a</b>)</h4><div class="NLM_p last">To a mixture of 4-[1-ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-<i>N</i>-[2-(4-morpholinyl)ethyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carboxamide (<b>21a</b>, 0.033 mmol) in 6N hydrochloric acid solution (1 mL) and ethanol (1 mL) under nitrogen at room temperature was added tin powder (0.164 mmol). The reaction was stirred at 70 °C for 1 h and then cooled to room temperature. The mixture was filtered through celite, and the filtrate was concentrated in vacuo to give 4-[3-(4-aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-<i>N</i>-[2-(4-morpholinyl)ethyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carboxamide as the crude HCl salt. LCMS showed <i>m</i>/<i>z</i> 460.4 [M + H]<sup>+</sup> and 100% purity (UV214). To a solution of this crude product (0.033 mmol theoretical) in anhydrous pyridine (0.5 mL) under nitrogen at room temperature was added phenyl isocyanate (0.036 mmol). The reaction was stirred at room temperature for 30 min and then concentrated in vacuo. Purification of the residue by reverse phase HPLC (MeCN/H<sub>2</sub>O + 0.1% NH<sub>4</sub>OH) provided the title compound (<b>22a</b>) as a white solid (58%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.10 (br s, 1H), 8.71 (s, 1H), 8.69 (s, 1H), 8.37 (t, <i>J</i> = 5.68 Hz, 1H), 8.21 (d, <i>J</i> = 5.05 Hz, 1H), 8.18 (s, 1H), 7.44 (d, <i>J</i> = 7.58 Hz, 2H), 7.38 (d, <i>J</i> = 8.59 Hz, 2H), 7.23−7.32 (m, 4H), 7.04 (s, 1H), 6.96 (t, <i>J</i> = 7.33 Hz, 1H), 6.83 (d, <i>J</i> = 4.80 Hz, 1H), 4.27 (q, <i>J</i> = 7.33 Hz, 2H), 3.56 (t, <i>J</i> = 4.55 Hz, 4H), 3.37−3.43 (m, 2H), 2.36−2.48 (m, 6H), 1.51 (t, <i>J</i> = 7.20 Hz, 3H). MS <i>m</i>/<i>z</i> 579.6 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_114" class="NLM_sec NLM_sec_level_3"><div id="ac_i134" class="anchor-spacer"></div><h4 class="article-section__title" id="_i134"> 4-[1-Ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-<i>N</i>-[3-(4-methyl-1-piperazinyl)propyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carboxamide (<b>21b</b>)</h4><div class="NLM_p last">A solution of 4-[1-ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carboxylic acid (<b>20</b>, 0.265 mmol), [3-(4-methyl-1-piperazinyl)propyl]amine (0.795 mmol), and <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride (0.318 mmol) in anhydrous <i>N</i>,<i>N</i>-dimethylformamide (1 mL) under nitrogen was stirred at room temperature over the weekend. LCMS showed that 41% of the starting material was still present. The reaction was concentrated in vacuo and the residue was purified by reverse phase HPLC (5−75% MeCN/0.1% NH<sub>4</sub>OH in H<sub>2</sub>O, 15 min) to afford the title compound (<b>21b</b>) as a solid (19%). This compound was used directly in the next reaction without NMR characterization. MS <i>m</i>/<i>z</i> 517.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_115" class="NLM_sec NLM_sec_level_3"><div id="ac_i135" class="anchor-spacer"></div><h4 class="article-section__title" id="_i135"> 4-[1-Ethyl-3-(4-{[(phenylamino)carbonyl]amino}phenyl)-1<i>H</i>-pyrazol-4-yl]-<i>N</i>-[3-(4-methyl-1-piperazinyl)propyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carboxamide (<b>22b</b>)</h4><div class="NLM_p last">To a mixture of 4-[1-ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-<i>N</i>-[3-(4-methyl-1-piperazinyl)propyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carboxamide (<b>21b</b>, 0.05 mmol) in 6N hydrochloric acid solution (1 mL) and ethanol (1 mL) under nitrogen at room temperature was added tin powder (0.25 mmol). The reaction was stirred at 70 °C for 1 h and then filtered through celite. The filtrate was concentrated in vacuo to give 4-[3-(4-aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-<i>N</i>-[3-(4-methyl-1-piperazinyl)propyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carboxamide as the crude HCl salt. LCMS showed <i>m</i>/<i>z</i> 487.4 [M + H]<sup>+</sup>, and 100% purity (UV214). To a solution of this crude product (0.05 mmol max) in anhydrous pyridine (0.5 mL) under nitrogen at room temperature was added phenyl isocyanate (0.055 mmol). The reaction was stirred at room temperature for 30 min and left to stand overnight. The reaction mixture was concentrated in vacuo. Purification of the residue by reverse phase HPLC (MeCN/H<sub>2</sub>O + 0.1% NH<sub>4</sub>OH) provided the title compound (<b>22b</b>) as a white solid (15%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.09 (br s, 1H), 8.70 (s, 1H), 8.67 (s, 1H), 8.43 (t, <i>J</i> = 5.56 Hz, 1H), 8.20 (d, <i>J</i> = 5.05 Hz, 1H), 8.18 (s, 1H), 7.44 (d, <i>J</i> = 7.83 Hz, 2H), 7.37 (d, <i>J</i> = 8.70 Hz, 2H), 7.24−7.32 (m, 4H), 7.03 (s, 1H), 6.96 (t, <i>J</i> = 7.33 Hz, 1H), 6.83 (d, <i>J</i> = 4.80 Hz, 1H), 4.26 (q, <i>J</i> = 7.24 Hz, 2H), 3.25−3.31 (m, 2H), 2.31 (t, <i>J</i> = 7.26 Hz, 10H), 2.09 (s, 3 H), 1.66 (quin, <i>J</i> = 7.20 Hz, 2H), 1.51 (t, <i>J</i> = 7.20 Hz, 3H). MS <i>m</i>/<i>z</i> 606.6 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_116" class="NLM_sec NLM_sec_level_3"><div id="ac_i136" class="anchor-spacer"></div><h4 class="article-section__title" id="_i136"> 4-[1-Ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-<i>N</i>-[2-(4-methyl-1-piperazinyl)ethyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carboxamide (<b>21c</b>)</h4><div class="NLM_p last">A solution of 4-[1-ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carboxylic acid (<b>20</b>, 0.331 mmol), 2-(4-methyl-piperazin-1-yl)-ethylamine (0.993 mmol), and <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride (0.397 mmol) in anhydrous <i>N</i>,<i>N</i>-dimethylformamide (1 mL) under nitrogen was stirred for 17 h at room temperature. The reaction was concentrated in vacuo, and the residue was purified by reverse phase HPLC (MeCN/0.1% NH<sub>4</sub>OH in H<sub>2</sub>O) to afford the title compound (<b>21c</b>) as a solid (20%). This compound was used directly in the next reaction without NMR characterization. MS <i>m</i>/<i>z</i> 503.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_117" class="NLM_sec NLM_sec_level_3"><div id="ac_i137" class="anchor-spacer"></div><h4 class="article-section__title" id="_i137"> 4-[1-Ethyl-3-(4-{[(phenylamino)carbonyl]amino}phenyl)-1<i>H</i>-pyrazol-4-yl]-<i>N</i>-[2-(4-methyl-1-piperazinyl)ethyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carboxamide (<b>22c</b>)</h4><div class="NLM_p last">To a mixture of 4-[1-ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazol-4-yl]-<i>N</i>-[2-(4-methyl-1-piperazinyl)ethyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carboxamide (<b>21c</b>, 0.066 mmol) in 6N hydrochloric acid solution (1 mL) and ethanol (1 mL) under nitrogen at room temperature was added tin powder (0.33 mmol). The reaction was stirred at 70 °C for 1 h and then cooled to room temperature. The mixture was filtered through celite, and the filtrate was concentrated in vacuo to give 4-[3-(4-aminophenyl)-1-ethyl-1<i>H</i>-pyrazol-4-yl]-<i>N</i>-[2-(4-methyl-1-piperazinyl)ethyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carboxamide as the crude HCl salt. LCMS showed <i>m</i>/<i>z</i> 473.4 [M + H]<sup>+</sup> and 100% purity (UV214). To a solution of this crude product (0.066 mmol theoretical) in anhydrous pyridine (0.5 mL) under nitrogen at room temperature was added phenyl isocyanate (0.072 mmol). The reaction was stirred at room temperature for 30 min and left to stand overnight. The reaction mixture was concentrated in vacuo. Purification of the residue by reverse phase HPLC (MeCN/H<sub>2</sub>O + 0.1% NH<sub>4</sub>OH) provided the title compound (<b>22c</b>) as a white solid (52%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.11 (br s, 1H), 8.72 (br s, 1H), 8.70 (s, 1H), 8.35 (t, <i>J</i> = 5.56 Hz, 1H), 8.21 (d, <i>J</i> = 4.80 Hz, 1H), 8.17 (s, 1H), 7.44 (d, <i>J</i> = 7.83 Hz, 2H), 7.38 (d, <i>J</i> = 8.59 Hz, 2H), 7.22−7.34 (m, 4H), 7.04 (s, 1H), 6.96 (t, <i>J</i> = 7.60 Hz, 1H), 6.83 (d, <i>J</i> = 4.80 Hz, 1H), 4.27 (q, <i>J</i> = 7.24 Hz, 2H), 3.35−3.44 (m, 4H), 2.22−2.48 (m, 8H), 2.13 (s, 3H), 1.51 (t, <i>J</i> = 7.33 Hz, 3H). MS <i>m</i>/<i>z</i> 592.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_118" class="NLM_sec NLM_sec_level_3"><div id="ac_i138" class="anchor-spacer"></div><h4 class="article-section__title" id="_i138"> [4-(4-Bromo-1-ethyl-1<i>H</i>-pyrazol-3-yl)phenyl]amine</h4><div class="NLM_p last">In a sealed tube, a mixture of 4-bromo-1-ethyl-3-(4-nitrophenyl)-1<i>H</i>-pyrazole (<b>7b</b>, 7.63 mmol) and tin powder (38.16 mmol) in 6N HCl (25 mL) and ethanol (25 mL) was stirred at 70 °C for 1 h. The reaction mixture was cooled to room temperature, filtered through celite, and concentrated in vacuo. The residue was treated with ethyl acetate (30 mL) and neutralized using saturated aq sodium bicarbonate solution. The organic layer was dried over magnesium sulfate and concentrated in vacuo to give the title compound as a solid. This crude product was used as is in the next reaction. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 7.98 (s, 1H), 7.48 (d, <i>J</i> = 8.59 Hz, 2H), 6.60 (d, <i>J</i> = 8.34 Hz, 2H), 5.26 (s, 2H), 4.11 (q, <i>J</i> = 7.33 Hz, 2H), 1.38 (t, <i>J</i> = 7.33 Hz, 3H). MS <i>m</i>/<i>z</i> 266.0 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_119" class="NLM_sec NLM_sec_level_3"><div id="ac_i139" class="anchor-spacer"></div><h4 class="article-section__title" id="_i139"> <i>N</i>-[4-(4-Bromo-1-ethyl-1<i>H</i>-pyrazol-3-yl)phenyl]-<i>N</i>′-phenylurea (<b>10c</b>)</h4><div class="NLM_p last">To a solution of [4-(4-bromo-1-ethyl-1<i>H</i>-pyrazol-3-yl)phenyl]amine (7.63 mmol) in anhydrous pyridine (30 mL) under nitrogen was added phenyl isocyanate (8.39 mmol). The reaction was stirred at room temperature for 1 h and then concentrated in vacuo. The residue was triturated with ethyl acetate to give the title compound (<b>10c</b>) as an off-white solid (63% over 2 steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.80 (s, 1H), 8.71 (s, 1H), 8.07 (s, 1H), 7.74 (m, <i>J</i> = 8.59 Hz, 2H), 7.53 (m, <i>J</i> = 8.59 Hz, 2H), 7.47 (d, <i>J</i> = 7.58 Hz, 2H), 7.29 (t, <i>J</i> = 7.96 Hz, 2H), 6.98 (t, <i>J</i> = 7.33 Hz, 1H), 4.16 (q, <i>J</i> = 7.33 Hz, 2H), 1.40 (t, <i>J</i> = 7.20 Hz, 3H). MS <i>m</i>/<i>z</i> 385.0 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_120" class="NLM_sec NLM_sec_level_3"><div id="ac_i140" class="anchor-spacer"></div><h4 class="article-section__title" id="_i140"> 4-Bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carbaldehyde (<b>24</b>)</h4><div class="NLM_p last"><i>n</i>-Butyllithium (2.5 M in hexanes, 3.56 mmol) was added dropwise to a solution of diisopropylamine (3.56 mmol) in anhydrous THF (5 mL) at −78 °C under nitrogen. The reaction was stirred for 30 min at −78 °C, and then a solution of 4-bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (2.97 mmol) in anhydrous THF (1 mL) was added dropwise by syringe. The resulting reaction was stirred at −78 °C for 2 h and then a solution of <i>N</i>,<i>N</i>-dimethylformamide (11.88 mmol) in THF (1 mL) was added dropwise by syringe. The reaction was stirred at −78 °C for 2 h and then quenched with saturated aq ammonium chloride solution (10 mL). The mixture was extracted with ethyl acetate (2 × 20 mL), and the combined organic layers were dried over magnesium sulfate and concentrated in vacuo. Purification of the residue by silica gel chromatography (Analogix IF280, 70−100% CH<sub>2</sub>Cl<sub>2</sub>/hexanes) afforded the title compound (<b>24</b>) as a white solid (66%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 10.45 (s, 1H), 8.45 (d, <i>J</i> = 5.30 Hz, 1H), 8.24 (d, <i>J</i> = 8.34 Hz, 2H), 7.72−7.90 (m, 2H), 7.59−7.72 (m, 2H), 7.46 (s, 1H). MS <i>m</i>/<i>z</i> 365.0 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_121" class="NLM_sec NLM_sec_level_3"><div id="ac_i141" class="anchor-spacer"></div><h4 class="article-section__title" id="_i141"> {[4-Bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]methyl}dimethylamine (<b>25a</b>)</h4><div class="NLM_p last">A solution of 4-bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carbaldehyde (<b>24</b>, 0.55 mmol), dimethylamine (1.1 mmol, 2 M solution in tetrahydrofuran), and sodium triacetoxyborohydride (1.1 mmol) in dichloromethane (4 mL) and acetic acid (1 mL) under nitrogen was stirred at room temperature for 30 min. The reaction was quenched with 1N sodium hydroxide solution (5 mL) and extracted with ethyl acetate (3 × 5 mL). The combined organic layers were washed with brine (5 mL), dried over magnesium sulfate, and concentrated in vacuo. Purification of the residue by silica gel chromatography (Analogix IF280, 0−10% MeOH/CH<sub>2</sub>Cl<sub>2</sub> with 10% NH<sub>4</sub>OH) afforded recovered starting material and the title product (<b>25a</b>) as a solid (46%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 7.43−7.50 (m, 2H), 7.33−7.40 (m, 1H), 6.84 (t, <i>J</i> = 7.71 Hz, 1H), 6.71−6.77 (m, 2H), 6.66−6.70 (m, 1H), 5.88 (br s, 1H), 3.16 (br s, 2H), 1.52 (s, 6H). MS <i>m</i>/<i>z</i> 394.2 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_122" class="NLM_sec NLM_sec_level_3"><div id="ac_i142" class="anchor-spacer"></div><h4 class="article-section__title" id="_i142"> <i>N</i>-(4-{4-[2-[(Dimethylamino)methyl]-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl]-1-ethyl-1<i>H</i>-pyrazol-3-yl}phenyl)-<i>N</i>′-phenylurea (<b>27a</b>)</h4><div class="NLM_p last">A suspension of {[4-bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]methyl}dimethylamine (<b>25a</b>, 0.25 mmol), bis(pinacolato)diboron (0.30 mmol), potassium acetate (0.76 mmol), and dichloro[1,1′-bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane adduct (0.01 mmol) in anhydrous 1,4-dioxane (2 mL) was stirred at 90 °C for 16 h. The reaction was cooled to room temperature, filtered through celite, washed with dioxane, and concentrated in vacuo to give the boronic ester. LCMS showed [M + H]<sup>+</sup> = 359.2 for the boronic acid because the ester cleaves to the acid due to the presence of TFA in the LCMS solvent mixture. A solution of this crude boronic ester (0.25 mmol), <i>N</i>-[4-(4-bromo-1-ethyl-1<i>H</i>-pyrazol-3-yl)phenyl]-<i>N</i>′-phenylurea (<b>10c</b>, 0.21 mmol), and tetrakis(triphenylphosphine) palladium(0) (0.01 mmol) in saturated aq sodium bicarbonate solution (0.64 mmol, assume 1 M solution) and <i>N</i>,<i>N</i>-dimethylformamide (2 mL) was stirred at 100 °C for 17 h. The reaction mixture was cooled to room temperature, and water (5 mL) and ethyl acetate (5 mL) were added. The layers were separated and the organic layer was washed with brine (5 mL), dried over magnesium sulfate, and concentrated in vacuo. Purification of the residue by reverse phase HPLC (10−90% MeCN/H<sub>2</sub>O + 0.1% NH<sub>4</sub>OH) provided the title compound (<b>27a</b>, 45%). This product was 100% pure by LCMS and was used without further characterization. MS <i>m</i>/<i>z</i> 620.6 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_123" class="NLM_sec NLM_sec_level_3"><div id="ac_i143" class="anchor-spacer"></div><h4 class="article-section__title" id="_i143"> <i>N</i>-[4-(4-{2-[(Dimethylamino)methyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl}-1-ethyl-1<i>H</i>-pyrazol-3-yl)phenyl]-<i>N</i>′-phenylurea (<b>28a</b>)</h4><div class="NLM_p last">A solution of <i>N</i>-(4-{4-[2-[(dimethylamino)methyl]-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl]-1-ethyl-1<i>H</i>-pyrazol-3-yl}phenyl)-<i>N</i>′-phenylurea (0.1 mmol) and 6N sodium hydroxide solution (0.29 mmol) in methanol (1 mL) was stirred at 70 °C for 1 h. The reaction was cooled to room temperature and concentrated in vacuo. Purification of the residue by reverse phase HPLC (10−90% MeCN/0.1% NH<sub>4</sub>OH in H<sub>2</sub>O) provided the title compound as a white solid (24%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.54 (s, 1H), 8.77 (br s, 1H), 8.74 (br s, 1H), 8.13 (s, 1H), 8.04 (d, <i>J</i> = 4.80 Hz, 1H), 7.45 (d, <i>J</i> = 8.08 Hz, 2H), 7.37 (d, <i>J</i> = 8.59 Hz, 2H), 7.24−7.31 (m, 4H), 6.96 (t, <i>J</i> = 7.33 Hz, 1H), 6.79 (d, <i>J</i> = 5.05 Hz, 1H), 6.05 (d, <i>J</i> = 1.01 Hz, 1H), 4.25 (q, <i>J</i> = 7.33 Hz, 2H), 3.46 (s, 2H), 2.12 (s, 6H), 1.49 (t, <i>J</i> = 7.20 Hz, 3H). MS <i>m</i>/<i>z</i> 480.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_124" class="NLM_sec NLM_sec_level_3"><div id="ac_i144" class="anchor-spacer"></div><h4 class="article-section__title" id="_i144"> 2-({[4-Bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]methyl}amino)ethanol (<b>25b</b>)</h4><div class="NLM_p last">A solution of 4-bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carbaldehyde (<b>24</b>, 0.55 mmol), ethanolamine (1.1 mmol), and sodium triacetoxyborohydride (1.1 mmol) in dichloromethane (4 mL) and acetic acid (1 mL) under nitrogen was stirred at room temperature for 30 min. The reaction was quenched with 1N sodium hydroxide solution (5 mL) and extracted with ethyl acetate (3 × 5 mL). The combined organic layers were washed with brine (5 mL), dried over magnesium sulfate, and concentrated in vacuo to provide crude product as the title compound (<b>25b</b>). This crude product was used as is in the next reaction without further characterization. MS <i>m</i>/<i>z</i> 409.2 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_125" class="NLM_sec NLM_sec_level_3"><div id="ac_i145" class="anchor-spacer"></div><h4 class="article-section__title" id="_i145"> <i>N</i>-(4-{1-Ethyl-4-[2-{[(2-hydroxyethyl)amino]methyl}-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl]-1<i>H</i>-pyrazol-3-yl}phenyl)-<i>N</i>′-phenylurea (<b>27b</b>)</h4><div class="NLM_p last">A suspension of 2-({[4-bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]methyl}amino)ethanol (<b>25b</b>, 0.55 mmol), bis(pinacolato)diboron (0.66 mmol), potassium acetate (1.64 mmol), and dichloro[1,1′-bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane adduct (0.02 mmol) in anhydrous 1,4-dioxane (3 mL) was stirred at 90 °C for 16 h. The reaction was cooled to room temperature, filtered through celite, washed with dioxane, and concentrated in vacuo to give the boronic ester. LCMS showed [M + H]<sup>+</sup> = 375.2 for the boronic acid because the ester cleaves to the acid due to the presence of TFA in the LCMS mobile phase. A solution of this crude boronic ester (0.55 mmol), <i>N</i>-[4-(4-bromo-1-ethyl-1<i>H</i>-pyrazol-3-yl)phenyl]-<i>N</i>′-phenylurea (<b>10c</b>, 0.46 mmol), and tetrakis(triphenylphosphine)palladium(0) (0.02 mmol) in saturated aq sodium bicarbonate solution (1.37 mmol) and <i>N</i>,<i>N</i>-dimethylformamide (5 mL) was stirred at 100 °C for 5 h. The reaction mixture was cooled to room temperature, and water (10 mL) and ethyl acetate (10 mL) were added. The layers were separated, and the organic layer was washed with brine (10 mL), dried over magnesium sulfate, and concentrated in vacuo. Purification of the residue by reverse phase HPLC (10−90% MeCN/H<sub>2</sub>O + 0.1% NH<sub>4</sub>OH) provided the title compound (<b>27b</b>, 52%). This product was used in the next reaction without further characterization. MS <i>m</i>/<i>z</i> 636.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_126" class="NLM_sec NLM_sec_level_3"><div id="ac_i146" class="anchor-spacer"></div><h4 class="article-section__title" id="_i146"> <i>N</i>-{4-[1-Ethyl-4-(2-{[(2-hydroxyethyl)amino]methyl}-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-1<i>H</i>-pyrazol-3-yl]phenyl}-<i>N</i>′-phenylurea (<b>28b</b>)</h4><div class="NLM_p last">A solution of <i>N</i>-(4-{1-ethyl-4-[2-{[(2-hydroxyethyl)amino]methyl}-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl]-1<i>H</i>-pyrazol-3-yl}phenyl)-<i>N</i>′-phenylurea (<b>27b</b>, 0.24 mmol) and 6N sodium hydroxide solution (0.71 mmol) in methanol (1 mL) was stirred at 70 °C for 1 h. The reaction was cooled to room temperature and concentrated in vacuo. Purification of the residue by reverse phase HPLC (10−90% MeCN/0.1% NH<sub>4</sub>OH in H<sub>2</sub>O) provided the title compound (<b>28b</b>) as a tan solid (14%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.48 (s, 1H), 8.75 (br s, 1H), 8.73 (br s, 1H), 8.12 (s, 1H), 8.01 (d, <i>J</i> = 4.80 Hz, 1H), 7.45 (d, <i>J</i> = 7.58 Hz, 2H), 7.37 (d, <i>J</i> = 8.84 Hz, 2H), 7.21−7.32 (m, 4H), 6.96 (t, <i>J</i> = 7.07 Hz, 1H), 6.75 (d, <i>J</i> = 5.05 Hz, 1H), 6.16 (s, 1H), 4.45 (t, <i>J</i> = 5.43 Hz, 1H), 4.25 (q, <i>J</i> = 7.49 Hz, 2H), 3.79 (s, 2H), 3.44 (q, <i>J</i> = 5.56 Hz, 3H), 2.08 (br s, 1H), 1.49 (t, <i>J</i> = 7.20 Hz, 3H). MS <i>m</i>/<i>z</i> 496.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_127" class="NLM_sec NLM_sec_level_3"><div id="ac_i147" class="anchor-spacer"></div><h4 class="article-section__title" id="_i147"> <i>N</i>-(4-{4-[2-Formyl-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl]-1-ethyl-1<i>H</i>-pyrazol-3-yl}phenyl)-<i>N</i>′-phenylurea (<b>26</b>)</h4><div class="NLM_p last">A suspension of 4-bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carbaldehyde (<b>24</b>, 1.31 mmol), bis(pinacolato)diboron (1.57 mmol), potassium acetate (3.92 mmol), and dichloro[1,1′-bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane adduct (0.05 mmol) in anhydrous 1,4-dioxane (13 mL) was stirred at 90 °C for 18 h. The reaction was cooled to room temperature and quenched with saturated aq ammonium chloride solution (10 mL). The mixture was extracted with ethyl acetate (2 × 20 mL), and the combined organic layers were dried over magnesium sulfate and concentrated in vacuo to give 1-(phenylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carbaldehyde as the crude product. MS <i>m</i>/<i>z</i> 330.2 [M + H]<sup>+</sup> for boronic acid because the ester cleaves to the acid due to the presence of TFA in the LCMS mobile phase. A solution of this crude 1-(phenylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carbaldehyde (1.33 mmol), <i>N</i>-[4-(4-bromo-1-ethyl-1<i>H</i>-pyrazol-3-yl)phenyl]-<i>N</i>′-phenylurea (1.21 mmol), and tetrakis(triphenylphosphine)palladium(0) (0.06 mmol) in saturated aq sodium bicarbonate solution (3.63 mmol, assume 1 M solution) and <i>N</i>,<i>N</i>-dimethylformamide (6 mL) was stirred at 100 °C for 17 h. The reaction mixture was cooled to room temperature, and water (5 mL) and ethyl acetate (10 mL) were added. The layers were separated, and the organic layer was washed with brine (10 mL), dried over magnesium sulfate, and concentrated in vacuo. Purification of the residue by silica gel chromatography (Analogix IF280, 15−100% ethyl acetate/hexanes) afforded the title product (<b>26</b>, 21%). MS <i>m</i>/<i>z</i> 591.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_128" class="NLM_sec NLM_sec_level_3"><div id="ac_i148" class="anchor-spacer"></div><h4 class="article-section__title" id="_i148"> <i>N</i>-(4-{4-[2-({[2-(Dimethylamino)ethyl]amino}methyl)-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl]-1-ethyl-1<i>H</i>-pyrazol-3-yl}phenyl)-<i>N</i>′-phenylurea (<b>27c</b>)</h4><div class="NLM_p last">A solution of <i>N</i>-(4-{4-[2-formyl-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl]-1-ethyl-1<i>H</i>-pyrazol-3-yl}phenyl)-<i>N</i>′-phenylurea (<b>26</b>, 0.1 mmol), (2-aminoethyl)dimethylamine (0.2 mmol), and sodium triacetoxyborohydride (0.2 mmol) in dichloromethane (1 mL) and acetic acid (0.25 mL) under nitrogen was stirred at room temperature for 30 min. The reaction was quenched with 1N sodium hydroxide solution (5 mL) and extracted with ethyl acetate (3 × 5 mL). The combined organic layers were washed with brine (5 mL), dried over magnesium sulfate, and concentrated in vacuo to give the title compound as the crude product (<b>27c</b>). This crude product was used as is without NMR characterization in the next reaction. MS <i>m</i>/<i>z</i> 663.4 [M + H]<sup>+</sup>. LCMS purity 93%.</div></div><div id="sec3_1_129" class="NLM_sec NLM_sec_level_3"><div id="ac_i149" class="anchor-spacer"></div><h4 class="article-section__title" id="_i149"> <i>N</i>-(4-{4-[2-({[2-(Dimethylamino)ethyl]amino}methyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl]-1-ethyl-1<i>H</i>-pyrazol-3-yl}phenyl)-<i>N</i>′-phenylurea (<b>28c</b>)</h4><div class="NLM_p last">To a solution of <i>N</i>-(4-{4-[2-({[2-(dimethylamino)ethyl]amino}methyl)-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl]-1-ethyl-1<i>H</i>-pyrazol-3-yl}phenyl)-<i>N</i>′-phenylurea (<b>27c</b>, 0.1 mmol) and 6N sodium hydroxide solution (0.3 mmol) in methanol (1 mL) was stirred at 70 °C for 1 h. The reaction was cooled to room temperature and concentrated in vacuo. Purification of the residue by reverse phase HPLC (MeCN/0.1% TFA in H<sub>2</sub>O) provided the desired product. The product from purification was neutralized using saturated aq sodium bicarbonate solution. The product was extracted with ethyl acetate (2 × 10 mL). The organic layers were combined, dried over magnesium sulfate, and concentrated in vacuo to give the title compound as a white solid (<b>28c</b>, 5%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.54 (s, 1H), 8.86 (br s, 2H), 8.13 (s, 1H), 8.04 (d, <i>J</i> = 4.80 Hz, 1H), 7.45 (d, <i>J</i> = 8.08 Hz, 2H), 7.37 (d, <i>J</i> = 8.59 Hz, 2H), 7.21−7.34 (m, 4H), 6.92−6.99 (m, 1H), 6.79 (d, <i>J</i> = 4.80 Hz, 1H), 6.06 (s, 1H), 4.25 (q, <i>J</i> = 6.74 Hz, 2H), 3.55 (s, 2H), 2.29−2.43 (m, 5H), 2.24 (s, 3H), 2.09 (s, 3H), 1.49 (t, <i>J</i> = 7.20 Hz, 3H). MS <i>m</i>/<i>z</i> 523.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_130" class="NLM_sec NLM_sec_level_3"><div id="ac_i150" class="anchor-spacer"></div><h4 class="article-section__title" id="_i150"> <i>N</i>-{[4-Bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]methyl}-2-(methylsulfonyl)ethanamine (<b>25c</b>)</h4><div class="NLM_p last">A solution of 4-bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carbaldehyde (<b>24</b>, 0.685 mmol), 2-aminoethylmethylsulfone hydrochloride (1.37 mmol), and sodium triacetoxyborohydride (1.37 mmol) in dichloromethane (4 mL) and acetic acid (1 mL) under nitrogen was stirred at room temperature for 30 min. The reaction was quenched with 1N sodium hydroxide solution (5 mL) and extracted with ethyl acetate (3 × 5 mL). The combined organic layers were washed with brine (5 mL), dried over magnesium sulfate, and concentrated in vacuo. Purification of the residue by silica gel chromatography (Analogix IF280, 25−80% ethyl acetate/hexanes) afforded recovered starting material and the title product (<b>25c</b>) as a solid (34%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.20 (s, 1H), 8.18 (dd, <i>J</i> = 3.28, 1.77 Hz, 2H), 7.73 (t, <i>J</i> = 7.45 Hz, 1H), 7.62 (t, <i>J</i> = 7.83 Hz, 2H), 7.57 (d, <i>J</i> = 5.31 Hz, 1H), 6.77 (s, 1H), 4.25 (d, <i>J</i> = 5.31 Hz, 2H), 3.05 (s, 3H), 3.01−3.08 (m, 2H), 2.62−2.69 (m, 1H). MS <i>m</i>/<i>z</i> 472.2 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_131" class="NLM_sec NLM_sec_level_3"><div id="ac_i151" class="anchor-spacer"></div><h4 class="article-section__title" id="_i151"> <i>N</i>-(4-{1-Ethyl-4-[2-({[2-(methylsulfonyl)ethyl]amino}methyl)-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl]-1<i>H</i>-pyrazol-3-yl}phenyl)-<i>N</i>′-phenylurea (<b>27d</b>)</h4><div class="NLM_p last">To a suspension of <i>N</i>-{[4-bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]methyl}-2-(methylsulfonyl)ethanamine (<b>25c</b>, 0.23 mmol), bis(pinacolato)diboron (0.28 mmol), potassium acetate (0.69 mmol), and dichloro[1,1′-bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane adduct (0.01 mmol) in anhydrous 1,4-dioxane (2 mL) was stirred at 90 °C for 16 h. The reaction was cooled to room temperature, filtered through celite, washed with dioxane, and concentrated in vacuo to give the boronic ester. LCMS showed [M + H]<sup>+</sup> = 437.4 for the boronic acid because the ester cleaves to the acid due to the presence of TFA in the LCMS mobile pahase. A solution of this crude boronic ester (0.23 mmol), <i>N</i>-[4-(4-bromo-1-ethyl-1<i>H</i>-pyrazol-3-yl)phenyl]-<i>N</i>′-phenylurea (<b>10c</b>, 0.19 mmol), and tetrakis(triphenylphosphine)palladium(0) (0.01 mmol) in saturated aq sodium bicarbonate solution (0.58 mmol, assume 1 M solution) and <i>N</i>,<i>N</i>-dimethylformamide (2 mL) was stirred at 100 °C for 17 h. The reaction mixture was cooled to room temperature, and water (5 mL) and ethyl acetate (10 mL) were added. The layers were separated and the organic layer was washed with brine (10 mL), dried over magnesium sulfate, and concentrated in vacuo. Purification of the residue by reverse phase HPLC (10−90% MeCN/H<sub>2</sub>O + 0.1% NH<sub>4</sub>OH) provided the title compound (<b>27d</b>, 46%), which was used as is without NMR characterization. MS <i>m</i>/<i>z</i> 698.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_132" class="NLM_sec NLM_sec_level_3"><div id="ac_i152" class="anchor-spacer"></div><h4 class="article-section__title" id="_i152"> <i>N</i>-(4-{1-Ethyl-4-[2-({[2-(methylsulfonyl)ethyl]amino}methyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl]-1<i>H</i>-pyrazol-3-yl}phenyl)-<i>N</i>′-phenylurea (<b>28d</b>)</h4><div class="NLM_p last">A solution of <i>N</i>-(4-{1-ethyl-4-[2-({[2-(methylsulfonyl)ethyl]amino}methyl)-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl]-1<i>H</i>-pyrazol-3-yl}phenyl)-<i>N</i>′-phenylurea (<b>27d</b>, 0.09 mmol) and 6N sodium hydroxide solution (0.27 mmol) in methanol (1 mL) was stirred at 70 °C for 1 h. The reaction was cooled to room temperature and concentrated in vacuo. Purification of the residue by reverse phase HPLC (10−90% MeCN/0.1% NH<sub>4</sub>OH in H<sub>2</sub>O) provided the title compound (<b>28d</b>) as a tan solid (28%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.49 (s, 1H), 8.79 (br s, 1H), 8.77 (br s, 1H), 8.12 (s, 1H), 8.02 (d, <i>J</i> = 5.05 Hz, 1H), 7.45 (d, <i>J</i> = 8.08 Hz, 2H), 7.38 (d, <i>J</i> = 8.36 Hz, 2H), 7.24−7.32 (m, 4H), 6.96 (t, <i>J</i> = 7.45 Hz, 1H), 6.76 (d, <i>J</i> = 5.05 Hz, 1H), 6.19 (s, 1H), 4.25 (q, <i>J</i> = 7.33 Hz, 2H), 3.80 (br s, 2H), 3.22 (t, <i>J</i> = 6.44 Hz, 2H), 3.00 (s, 3H), 2.84−2.90 (m, 2H), 2.37 (br s, 1H), 1.49 (t, <i>J</i> = 7.20 Hz, 3H). MS <i>m</i>/<i>z</i> 558.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_133" class="NLM_sec NLM_sec_level_3"><div id="ac_i153" class="anchor-spacer"></div><h4 class="article-section__title" id="_i153"> <i>N</i>-(4-{1-Ethyl-4-[2-({[2-(4-morpholinyl)ethyl]amino}methyl)-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl]-1<i>H</i>-pyrazol-3-yl}phenyl)-<i>N</i>′-phenylurea (<b>27e</b>)</h4><div class="NLM_p last">A solution of <i>N</i>-(4-{4-[2-formyl-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl]-1-ethyl-1<i>H</i>-pyrazol-3-yl}phenyl)-<i>N</i>′-phenylurea (<b>26</b>, 0.1 mmol), 4-(2-aminoethyl)-morpholine (0.2 mmol), and sodium triacetoxyborohydride (0.2 mmol) in dichloromethane (1 mL) and acetic acid (0.25 mL) under nitrogen was stirred at room temperature for 30 min. The reaction was quenched with 1N sodium hydroxide solution (5 mL) and extracted with ethyl acetate (3 × 5 mL). The combined organic layers were washed with brine (5 mL), dried over magnesium sulfate, and concentrated in vacuo to give the title compound (<b>27e</b>) as the crude product. MS <i>m</i>/<i>z</i> 705.6 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_134" class="NLM_sec NLM_sec_level_3"><div id="ac_i154" class="anchor-spacer"></div><h4 class="article-section__title" id="_i154"> <i>N</i>-(4-{1-Ethyl-4-[2-({[2-(4-morpholinyl)ethyl]amino}methyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl]-1<i>H</i>-pyrazol-3-yl}phenyl)-<i>N</i>′-phenylurea (<b>28e</b>)</h4><div class="NLM_p last">A solution of <i>N</i>-(4-{1-ethyl-4-[2-({[2-(4-morpholinyl)ethyl]amino}methyl)-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl]-1<i>H</i>-pyrazol-3-yl}phenyl)-<i>N</i>′-phenylurea (<b>27e</b>, 0.1 mmol) and 6N sodium hydroxide solution (0.3 mmol) in methanol (1 mL) was stirred at 70 °C for 1 h. The reaction was cooled and concentrated in vacuo. Purification of the residue by reverse phase HPLC (MeCN/0.1% TFA in H<sub>2</sub>O) followed by subsequent purification by reverse phase HPLC (MeCN/0.1% NH<sub>4</sub>OH in H<sub>2</sub>O) provided the title compound (<b>28e</b>) as a white solid (10%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.50 (s, 1H), 8.91 (br s, 2H), 8.11 (s, 1H), 8.02 (d, <i>J</i> = 4.80 Hz, 1H), 7.45 (d, <i>J</i> = 7.83 Hz, 2H), 7.37 (d, <i>J</i> = 8.59 Hz, 2H), 7.23−7.30 (m, 4H), 6.95 (t, <i>J</i> = 7.20 Hz, 1H), 6.76 (d, <i>J</i> = 5.05 Hz, 1H), 6.10 (s, 1H), 4.24 (q, <i>J</i> = 7.07 Hz, 2H), 3.77 (br s, 2H), 3.52 (t, <i>J</i> = 4.42 Hz, 4H), 2.68 (dt, <i>J</i> = 3.73, 1.80 Hz, 1H), 2.17−2.40 (m, 8H), 1.49 (t, <i>J</i> = 7.33 Hz, 3H). MS <i>m</i>/<i>z</i> 565.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_135" class="NLM_sec NLM_sec_level_3"><div id="ac_i155" class="anchor-spacer"></div><h4 class="article-section__title" id="_i155"> <i>N</i>-{[4-Bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]methyl}-3-(4-methyl-1-piperazinyl)-1-propanamine (<b>25d</b>)</h4><div class="NLM_p last">A solution of 4-bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-2-carbaldehyde (<b>24</b>, 0.55 mmol), 1-(3-aminopropyl)-4-methylpiperazine (1.1 mmol), and sodium triacetoxyborohydride (1.1 mmol) in dichloromethane (4 mL) and acetic acid (1 mL) under nitrogen was stirred at room temperature for 30 min. The reaction was quenched with 1N sodium hydroxide solution (5 mL) and extracted with ethyl acetate (3 × 5 mL). The combined organic layers were washed with brine (5 mL), dried over magnesium sulfate, and concentrated in vacuo. Purification of the residue by silica gel chromatography (Analogix IF280, 0−10% MeOH/CH<sub>2</sub>Cl<sub>2</sub> with 10% NH<sub>4</sub>OH) afforded the title product (<b>25d</b>) as a solid (83%). MS <i>m</i>/<i>z</i> 505.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_136" class="NLM_sec NLM_sec_level_3"><div id="ac_i156" class="anchor-spacer"></div><h4 class="article-section__title" id="_i156"> <i>N</i>-(4-{1-Ethyl-4-[2-({[3-(4-methyl-1-piperazinyl)propyl]amino}methyl)-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl]-1<i>H</i>-pyrazol-3-yl}phenyl)-<i>N</i>′-phenylurea (<b>27f</b>)</h4><div class="NLM_p last">A suspension of <i>N</i>-{[4-bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl]methyl}-3-(4-methyl-1-piperazinyl)-1-propanamine (<b>25d</b>, 0.45 mmol), bis(pinacolato)diboron (0.54 mmol), potassium acetate (1.36 mmol), and dichloro[1,1′-bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane adduct (0.02 mmol) in anhydrous 1,4-dioxane (3 mL) was stirred at 90 °C for 16 h. The reaction was cooled to room temperature, filtered through celite, washed with dioxane, and concentrated in vacuo to give the boronic ester. LCMS showed [M + H]<sup>+</sup> = 471.6 for the boronic acid because the ester cleaves to the acid due to the presence of TFA in the LCMS mobile phase. A solution of this boronic ester (0.45 mmol), <i>N</i>-[4-(4-bromo-1-ethyl-1<i>H</i>-pyrazol-3-yl)phenyl]-<i>N</i>′-phenylurea (<b>10c</b>, 0.38 mmol), and tetrakis(triphenylphosphine)palladium(0) (0.02 mmol) in saturated aq sodium bicarbonate solution (1.13 mmol, assume 1 M solution) and <i>N</i>,<i>N</i>-dimethylformamide (5 mL) was stirred at 100 °C for 5 h. The reaction mixture was cooled to room temperature, and water (10 mL) and ethyl acetate (15 mL) were added. The layers were separated and the organic layer was washed with brine (15 mL), dried over magnesium sulfate, and concentrated in vacuo. Purification of the residue by reverse phase HPLC (10−90% MeCN/H<sub>2</sub>O + 0.1% NH<sub>4</sub>OH) provided the title compound (<b>27f</b>) as a solid (31%). MS <i>m</i>/<i>z</i> 732.4 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_137" class="NLM_sec NLM_sec_level_3"><div id="ac_i157" class="anchor-spacer"></div><h4 class="article-section__title" id="_i157"> <i>N</i>-(4-{1-Ethyl-4-[2-({[3-(4-methyl-1-piperazinyl)propyl]amino}methyl)-1<i>H</i>-pyrrolo[2,3-b]pyridin-4-yl]-1<i>H</i>-pyrazol-3-yl}phenyl)-<i>N</i>′-phenylurea (<b>28f</b>)</h4><div class="NLM_p last">A solution of <i>N</i>-(4-{1-ethyl-4-[2-({[3-(4-methyl-1-piperazinyl)propyl]amino}methyl)-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl]-1<i>H</i>-pyrazol-3-yl}phenyl)-<i>N</i>′-phenylurea (<b>27f</b>, 0.12 mmol) and 6N sodium hydroxide solution (0.35 mmol) in methanol (1 mL) was stirred at 70 °C for 1 h. The reaction was cooled to room temperature and concentrated in vacuo. Purification of the residue by reverse phase HPLC (10−90% MeCN/0.1% NH<sub>4</sub>OH in H<sub>2</sub>O) provided the title compound (<b>28f</b>) as a light-brown solid (42%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.43 (br s, 1H), 8.87 (br s, 2H), 8.10 (s, 1H), 8.01 (d, <i>J</i> = 4.80 Hz, 1H), 7.45 (d, <i>J</i> = 7.58 Hz, 2H), 7.38 (d, <i>J</i> = 8.34 Hz, 2H), 7.23−7.31 (m, 4H), 6.96 (t, <i>J</i> = 7.45 Hz, 1H), 6.76 (d, <i>J</i> = 4.55 Hz, 1H), 6.11 (s, 1H), 4.24 (q, <i>J</i> = 7.16 Hz, 2H), 3.74 (br s, 2H), 2.09−2.47 (m, 13H), 2.08 (s, 3H), 1.51−1.60 (m, 2H), 1.49 (t, <i>J</i> = 7.33 Hz, 3H). MS <i>m</i>/<i>z</i> 592.4 [M + H]<sup>+</sup>.</div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i158" class="anchor-spacer"></div><h3 class="article-section__title" id="_i158"> Biology. Biochemical Characterization of Aurora Inhibitors</h3><div class="NLM_p last">Experimental details describing the (1) in vitro Aurora B/INCENP, Aurora C/INCENP and Aurora A/TPX2 inhibition assays for IC<sub>50</sub> determination, (2) determination of dissociation rates of <b>12c</b>, <b>17a</b>, <b>17c</b>, <b>17j</b>, and <b>17k</b> from human Aurora B/INCENP by rapid dilution, and (3) Aurora B/INCENP, Aurora C/INCENP, and Aurora A/TPX2 <i>K</i><sub>i</sub>* determination of <b>17k</b> by progress curve analysis are described in separate publications.<a onclick="showRef(event, 'ref30 ref34'); return false;" href="javascript:void(0);" class="ref ref30 ref34">(30, 34)</a></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i159" class="anchor-spacer"></div><h3 class="article-section__title" id="_i159"> Tissue Culture and in Vivo Studies</h3><div class="NLM_p last">Details of the cellular proliferation (A549 cells) and in vivo pharmacodynamic and efficacy in tumor xenograft studies are described in a separate publication.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i160"><a href="/doi/suppl/10.1021/jm901870q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02330" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02330" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Liquid chromatography−mass spectrometry purities and retention times for all tested compounds. Full combustion analysis results for <b>17a</b>−<b>d</b>, <b>17f</b>−<b>i</b>, <b>17k</b>−<b>l</b>, <b>17n</b>−<b>o</b>, and <b>17q</b>−<b>u</b>. Statistical limits for biological data in Tables 1−3. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm901870q/suppl_file/jm901870q_si_001.pdf">jm901870q_si_001.pdf (59.57 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm901870q" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27725" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27725" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas D. Adams</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c8a6a1aba0a7a4a9bbe6ace6a9aca9a5bb88afbba3e6aba7a5"><span class="__cf_email__" data-cfemail="a9c7c0cac1c6c5c8da87cd87c8cdc8c4dae9cedac287cac6c4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jerry L. Adams</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joelle L. Burgess</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amita M. Chaudhari</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert A. Copeland</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carla A. Donatelli</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David H. Drewry</span> - <span class="hlFld-Affiliation affiliation">Molecular Discovery Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kelly E. Fisher</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Toshihiro Hamajima</span> - <span class="hlFld-Affiliation affiliation">Tsukuba Research Laboratories, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary Ann Hardwicke</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William F. Huffman</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristin K. Koretke-Brown</span> - <span class="hlFld-Affiliation affiliation">Molecular Discovery Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhihong V. Lai</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Octerloney B. McDonald</span> - <span class="hlFld-Affiliation affiliation">Molecular Discovery Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hiroko Nakamura</span> - <span class="hlFld-Affiliation affiliation">Tsukuba Research Laboratories, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ken A. Newlander</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Catherine A. Oleykowski</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cynthia A. Parrish</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Denis R. Patrick</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramona Plant</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martha A. Sarpong</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kosuke Sasaki</span> - <span class="hlFld-Affiliation affiliation">Tsukuba Research Laboratories, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stanley J. Schmidt</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Domingos J. Silva</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Sutton</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jun Tang</span> - <span class="hlFld-Affiliation affiliation">Molecular Discovery Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine S. Thompson</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter J. Tummino</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jamin C. Wang</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Xiang</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jingsong Yang</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dashyant Dhanak</span> - <span class="hlFld-Affiliation affiliation">Cancer Research, Oncology R&D</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i161">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52553" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52553" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 43 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Andrews, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knatko, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swedlow, J. R.</span><span> </span><span class="NLM_article-title">Mitotic mechanics: the auroras come into view</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">672</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1016%2Fj.ceb.2003.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=14644191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlyks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=672-683&author=P.+D.+Andrewsauthor=E.+Knatkoauthor=W.+J.+Mooreauthor=J.+R.+Swedlow&title=Mitotic+mechanics%3A+the+auroras+come+into+view"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Mitotic mechanics: the auroras come into view</span></div><div class="casAuthors">Andrews, Paul D.; Knatko, Elena; Moore, William J.; Swedlow, Jason R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">672-683</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review and discussion.  Aurora kinases have recently taken center stage in the regulation of key cell cycle processes.  Aurora A kinase is emerging as a crit. regulator of centrosome and spindle function.  Aurora B kinase mediates chromosome segregation by ensuring proper biorientation of sister chromatids, possibly through the regulation of microtubule dynamics.  This enzyme also functions in cytokinesis, apparently by interacting with a crit. GTPase and a kinesin-like protein.  Recent work on both kinases has revealed functional links between aurora kinase activity and the mechanics of cell division.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6JjO4SUgejLVg90H21EOLACvtfcHk0ljLqY-vx8EZSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlyks74%253D&md5=ef80357f3cec8790ba4cf9742907cc74</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2003.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2003.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DAndrews%26aufirst%3DP.%2BD.%26aulast%3DKnatko%26aufirst%3DE.%26aulast%3DMoore%26aufirst%3DW.%2BJ.%26aulast%3DSwedlow%26aufirst%3DJ.%2BR.%26atitle%3DMitotic%2520mechanics%253A%2520the%2520auroras%2520come%2520into%2520view%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2003%26volume%3D15%26spage%3D672%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Giet, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petretti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prigent, C.</span><span> </span><span class="NLM_article-title">Aurora kinases, aneuploidy and cancer, a coincidence or a real link?</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1016%2Fj.tcb.2005.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=15866028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslKhsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=241-250&author=R.+Gietauthor=C.+Petrettiauthor=C.+Prigent&title=Aurora+kinases%2C+aneuploidy+and+cancer%2C+a+coincidence+or+a+real+link%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Aurora kinases, aneuploidy and cancer, a coincidence or a real link?</span></div><div class="casAuthors">Giet, Regis; Petretti, Clotilde; Prigent, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">241-250</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  As Aurora kinases are overexpressed in a large no. of cancers, and ectopic expression of Aurora generates polyploid cells contg. multiple centrosomes, it has been tempting to suggest that Aurora overexpression provokes genetic instability underlying the tumorigenesis.  However, examn. of the evidence suggests a more complex relationship.  Overexpression of Aurora-A readily transforms rat-1 and NIH3T3 cells, but not primary cells, whereas overexpression of Aurora-B induces metastasis after implantation of tumors in nude mice.  Why do polyploid cells contg. abnormal centrosome nos. induced by Aurora not get eliminated at cell-cycle checkpoints Does this phenotype det. the origin of cancer or does it only promote tumor progression Would drugs against aurora family members be of any help for cancer treatment These and related questions are addressed in this review (which is part of the Chromosome Segregation and Aneuploidy series).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX73sij-ymh7Vg90H21EOLACvtfcHk0ljLqY-vx8EZSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslKhsLc%253D&md5=b792bc5419b14c00fbef86e0b2909c2d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2005.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2005.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DGiet%26aufirst%3DR.%26aulast%3DPetretti%26aufirst%3DC.%26aulast%3DPrigent%26aufirst%3DC.%26atitle%3DAurora%2520kinases%252C%2520aneuploidy%2520and%2520cancer%252C%2520a%2520coincidence%2520or%2520a%2520real%2520link%253F%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2005%26volume%3D15%26spage%3D241%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dar, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P. S.</span><span> </span><span class="NLM_article-title">Targeted anti-mitotic therapies: can we improve on tubulin agents?</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1038%2Fnrc2049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=17251917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFOjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=107-117&author=J.+R.+Jacksonauthor=D.+R.+Patrickauthor=M.+M.+Darauthor=P.+S.+Huang&title=Targeted+anti-mitotic+therapies%3A+can+we+improve+on+tubulin+agents%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted anti-mitotic therapies: can we improve on tubulin agents?</span></div><div class="casAuthors">Jackson, Jeffrey R.; Patrick, Denis R.; Dar, Mohammed M.; Huang, Pearl S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-117</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The advent of molecularly targeted drug discovery has facilitated the identification of a new generation of anti-mitotic therapies that target proteins with specific functions in mitosis.  The exquisite selectivity for mitosis and the distinct ways in which these new agents interfere with mitosis provides the potential to not only overcome certain limitations of current tubulin-targeted anti-mitotic drugs, but to expand the scope of clin. efficacy that those drugs have established.  The development of these new anti-mitotic drugs as targeted therapies faces significant challenges; nevertheless, these potential therapies also serve as unique tools to dissect the mol. mechanisms of the mitotic-checkpoint response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTEI9t3GggVrVg90H21EOLACvtfcHk0ljLqY-vx8EZSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFOjtA%253D%253D&md5=67a94114629154b9be66428e697835bc</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc2049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2049%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DPatrick%26aufirst%3DD.%2BR.%26aulast%3DDar%26aufirst%3DM.%2BM.%26aulast%3DHuang%26aufirst%3DP.%2BS.%26atitle%3DTargeted%2520anti-mitotic%2520therapies%253A%2520can%2520we%2520improve%2520on%2520tubulin%2520agents%253F%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D107%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Keen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span> </span><span class="NLM_article-title">Aurora-kinase inhibitors as anticancer agents</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">936</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1038%2Fnrc1502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=15573114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVarsLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=927-936&author=N.+Keenauthor=S.+Taylor&title=Aurora-kinase+inhibitors+as+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Aurora-kinase inhibitors as anticancer agents</span></div><div class="casAuthors">Keen, Nicholas; Taylor, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">927-936</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Errors in mitosis can provide a source of the genomic instability that is typically assocd. with tumorigenesis.  Many mitotic regulators are aberrantly expressed in tumor cells.  These proteins could therefore make useful therapeutic targets.  The kinases Aurora-A, -B and -C represent a family of such targets and several small-mol. inhibitors have been shown to block their function.  Not only have these inhibitors advanced our understanding of mitosis, but, importantly, their in vivo antitumor activity has recently been reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs8iFKi78djbVg90H21EOLACvtfcHk0lhao3pd-g4dhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVarsLjN&md5=f1ecc438d3e92963ddc960d0fb1db67c</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc1502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1502%26sid%3Dliteratum%253Aachs%26aulast%3DKeen%26aufirst%3DN.%26aulast%3DTaylor%26aufirst%3DS.%26atitle%3DAurora-kinase%2520inhibitors%2520as%2520anticancer%2520agents%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D927%26epage%3D936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Bischoff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plowman, G. D.</span><span> </span><span class="NLM_article-title">The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">454</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1016%2FS0962-8924%2899%2901658-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=10511710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADyaK1MXmvVGksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=454-459&author=J.+R.+Bischoffauthor=G.+D.+Plowman&title=The+Aurora%2FIpl1p+kinase+family%3A+regulators+of+chromosome+segregation+and+cytokinesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis</span></div><div class="casAuthors">Bischoff, J. R.; Plowman, G. D.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">454-459</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 38 refs.  Members of the Aurora/Ipl1p family of mitotically regulated serine/threonine kinases are emerging as key regulators of chromosome segregation and cytokinesis.  Proper chromosome segregation and cytokinesis ensure that each daughter cell receives the full complement of genetic material.  Defects in these processes can lead to aneuploidy and the propagation of genetic abnormalities.  This review discusses the Aurora/Ipl1p kinases in terms of their protein structure and proposed function in mitotic cells and also the potential role of aurora2 in human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt7ReUrgpYB7Vg90H21EOLACvtfcHk0lhao3pd-g4dhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvVGksrs%253D&md5=0fc0d81ce1e56a53016800793bc19e27</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2899%2901658-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252899%252901658-X%26sid%3Dliteratum%253Aachs%26aulast%3DBischoff%26aufirst%3DJ.%2BR.%26aulast%3DPlowman%26aufirst%3DG.%2BD.%26atitle%3DThe%2520Aurora%252FIpl1p%2520kinase%2520family%253A%2520regulators%2520of%2520chromosome%2520segregation%2520and%2520cytokinesis%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D1999%26volume%3D9%26spage%3D454%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Cowley, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera-Perez, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schliekelman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Quinn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmon, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Dyke, T.</span><span> </span><span class="NLM_article-title">Aurora-A kinase is essential for bipolar spindle assembly and early development</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1059</span><span class="NLM_x">–</span> <span class="NLM_lpage">1071</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1128%2FMCB.01062-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=19075002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisF2mtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=1059-1071&author=D.+O.+Cowleyauthor=J.+A.+Rivera-Perezauthor=M.+Schliekelmanauthor=Y.+J.+Heauthor=T.+G.+Oliverauthor=L.+Luauthor=R.+O%E2%80%99Quinnauthor=E.+D.+Salmonauthor=T.+Magnusonauthor=T.+Van+Dyke&title=Aurora-A+kinase+is+essential+for+bipolar+spindle+assembly+and+early+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Aurora-A kinase is essential for bipolar spindle formation and early development</span></div><div class="casAuthors">Cowley, Dale O.; Rivera-Perez, Jaime A.; Schliekelman, Mark; He, Yizhou Joseph; Oliver, Trudy G.; Lu, Lucy; O'Quinn, Ryan; Salmon, E. D.; Magnuson, Terry; Van Dyke, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1059-1071</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Aurora-A kinase (I) is a conserved protein kinase implicated in mitotic regulation and carcinogenesis.  I was previously implicated in mitotic entry and spindle assembly, although contradictory results prevented a clear understanding of the roles of I in mammals.  The authors report having developed a conditional null mutation in the mouse I gene to investigate I functions in primary cells ex vivo and in vivo.  Here, the authors show that conditional I ablation in cultured embryonic fibroblasts caused impaired mitotic entry and mitotic arrest with a profound defect in bipolar spindle formation.  Germ line I deficiency caused embryonic death at the blastocyst stage with pronounced cell proliferation failure, mitotic arrest, and monopolar spindle formation.  I deletion in mid-gestation embryos caused an increase in mitotic and apoptotic cells.  These results indicate that murine I facilitates, but is not absolutely required for, mitotic entry in murine embryonic fibroblasts and is essential for centrosome sepn. and bipolar spindle formation in vitro and in vivo.  I deletion increases apoptosis, suggesting that mol. therapies targeting I may be effective in inducing tumor cell apoptosis.  I conditional mutant mice provide a valuable system for further defining I functions and for predicting effects of I therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnHz9s8fPzQLVg90H21EOLACvtfcHk0lhao3pd-g4dhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisF2mtbw%253D&md5=3063b7056fa2de04305dde7b90af5fd9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1128%2FMCB.01062-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01062-08%26sid%3Dliteratum%253Aachs%26aulast%3DCowley%26aufirst%3DD.%2BO.%26aulast%3DRivera-Perez%26aufirst%3DJ.%2BA.%26aulast%3DSchliekelman%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DY.%2BJ.%26aulast%3DOliver%26aufirst%3DT.%2BG.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Quinn%26aufirst%3DR.%26aulast%3DSalmon%26aufirst%3DE.%2BD.%26aulast%3DMagnuson%26aufirst%3DT.%26aulast%3DVan%2BDyke%26aufirst%3DT.%26atitle%3DAurora-A%2520kinase%2520is%2520essential%2520for%2520bipolar%2520spindle%2520assembly%2520and%2520early%2520development%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2009%26volume%3D29%26spage%3D1059%26epage%3D1071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Anderson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koretke, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurse, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calamari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Z.</span><span> </span><span class="NLM_article-title">Binding of TPX2 to Aurora A alters substrate and inhibitor interactions</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">10287</span><span class="NLM_x">–</span> <span class="NLM_lpage">10295</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi7011355" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=10287-10295&author=K.+Andersonauthor=J.+Yangauthor=K.+Koretkeauthor=K.+Nurseauthor=A.+Calamariauthor=R.+B.+Kirkpatrickauthor=D.+Patrickauthor=D.+Silvaauthor=P.+J.+Tumminoauthor=R.+A.+Copelandauthor=Z.+Lai&title=Binding+of+TPX2+to+Aurora+A+alters+substrate+and+inhibitor+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fbi7011355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi7011355%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DKoretke%26aufirst%3DK.%26aulast%3DNurse%26aufirst%3DK.%26aulast%3DCalamari%26aufirst%3DA.%26aulast%3DKirkpatrick%26aufirst%3DR.%2BB.%26aulast%3DPatrick%26aufirst%3DD.%26aulast%3DSilva%26aufirst%3DD.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DLai%26aufirst%3DZ.%26atitle%3DBinding%2520of%2520TPX2%2520to%2520Aurora%2520A%2520alters%2520substrate%2520and%2520inhibitor%2520interactions%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D10287%26epage%3D10295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smallwood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koretke, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurse, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calamari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Z.</span><span> </span><span class="NLM_article-title">Modulation of kinase-inhibitor interactions by auxiliary protein binding: cyrystallography studies on Aurora A interactions with VX-680 and with TPX2</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1791</span><span class="NLM_x">–</span> <span class="NLM_lpage">1797</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1110%2Fps.036590.108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=18662907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Cit7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1791-1797&author=B.+Zhaoauthor=A.+Smallwoodauthor=J.+Yangauthor=K.+Koretkeauthor=K.+Nurseauthor=A.+Calamariauthor=R.+B.+Kirkpatrickauthor=Z.+Lai&title=Modulation+of+kinase-inhibitor+interactions+by+auxiliary+protein+binding%3A+cyrystallography+studies+on+Aurora+A+interactions+with+VX-680+and+with+TPX2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of kinase-inhibitor interactions by auxiliary protein binding: crystallography studies on Aurora A interactions with VX-680 and with TPX2</span></div><div class="casAuthors">Zhao, Baoguang; Smallwood, Angela; Yang, Jingsong; Koretke, Kristin; Nurse, Kelvin; Calamari, Amy; Kirkpatrick, Robert B.; Lai, Zhihong</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1791-1797</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">VX-680, also known as MK-0457, is an ATP-competitive small mol. inhibitor of the Aurora kinases that has entered phase II clin. trials for the treatment of cancer.  We have solved the cocrystal structure of AurA/TPX2/VX-680 at 2.3 Å resoln.  In the crystal structure, VX-680 binds to the active conformation of AurA.  The glycine-rich loop in AurA adopts a unique bent conformation, forming a π-π interaction with the Ph group of VX-680.  In contrast, in the published AurA/VX-680 structure, VX-680 binds to AurA in the inactive conformation, interacting with a hydrophobic pocket only present in the inactive conformation.  These data suggest that TPX2, a protein cofactor, can alter the binding mode of VX-680 with AurA.  More generally, the presence of physiol. relevant cofactor proteins can alter the kinetics, binding interactions, and inhibition of enzymes, and studies with these multiprotein complexes may be beneficial to the discovery and optimization of enzyme inhibitors as therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7jnb6hGH-SbVg90H21EOLACvtfcHk0lg9vmSFRSq5-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Cit7rM&md5=622cf5907d6af38a1bc53481fd0b35d4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1110%2Fps.036590.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.036590.108%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DSmallwood%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DKoretke%26aufirst%3DK.%26aulast%3DNurse%26aufirst%3DK.%26aulast%3DCalamari%26aufirst%3DA.%26aulast%3DKirkpatrick%26aufirst%3DR.%2BB.%26aulast%3DLai%26aufirst%3DZ.%26atitle%3DModulation%2520of%2520kinase-inhibitor%2520interactions%2520by%2520auxiliary%2520protein%2520binding%253A%2520cyrystallography%2520studies%2520on%2520Aurora%2520A%2520interactions%2520with%2520VX-680%2520and%2520with%2520TPX2%26jtitle%3DProtein%2520Sci.%26date%3D2008%26volume%3D17%26spage%3D1791%26epage%3D1797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Marumoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saya, H</span><span> </span><span class="NLM_article-title">Aurora A—a guardian of poles</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1038%2Fnrc1526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=15630414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvVen" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=42-50&author=T.+Marumotoauthor=D+Zhangauthor=H+Saya&title=Aurora+A%E2%80%94a+guardian+of+poles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Aurora-A - A guardian of poles</span></div><div class="casAuthors">Marumoto, Tomotoshi; Zhang, Dongwei; Saya, Hideyuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-50</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The three human homologs of Aurora kinases (A, B and C) are essential for proper execution of various mitotic events and are important for maintaining genomic integrity.  Aurora-A is mainly localized at spindle poles and the mitotic spindle during mitosis, where it regulates the functions of centrosomes, spindles and kinetochores required for proper mitotic progression.  Recent studies have revealed that Aurora-A is frequently overexpressed in various cancer cells, indicating its involvement in tumorigenesis.  What are the normal physiol. roles of Aurora-A, how are these regulated and how might the enzyme function during tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ5DkKXAtszrVg90H21EOLACvtfcHk0lg9vmSFRSq5-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvVen&md5=5eef2a40508d408be784301b20e6822d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrc1526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1526%26sid%3Dliteratum%253Aachs%26aulast%3DMarumoto%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DD%26aulast%3DSaya%26aufirst%3DH%26atitle%3DAurora%2520A%25E2%2580%2594a%2520guardian%2520of%2520poles%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D42%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Girdler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascoigne, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eyers, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmuth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crafter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foote, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keen, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span> </span><span class="NLM_article-title">Validating Aurora B as an anti-cancer drug target</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">3664</span><span class="NLM_x">–</span> <span class="NLM_lpage">3675</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1242%2Fjcs.03145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=16912073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVymu7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2006&pages=3664-3675&author=F.+Girdlerauthor=K.+E.+Gascoigneauthor=P.+A.+Eyersauthor=S.+Hartmuthauthor=C.+Crafterauthor=K.+M.+Footeauthor=N.+J.+Keenauthor=S.+S.+Taylor&title=Validating+Aurora+B+as+an+anti-cancer+drug+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Validating Aurora B as an anti-cancer drug target</span></div><div class="casAuthors">Girdler, Fiona; Gascoigne, Karen E.; Eyers, Patrick A.; Hartmuth, Sonya; Crafter, Claire; Foote, Kevin M.; Keen, Nicholas J.; Taylor, Stephen S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3664-3675</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">The Aurora kinases, a family of mitotic regulators, have received much attention as potential targets for novel anti-cancer therapeutics.  Several Aurora kinase inhibitors have been described including ZM447439, which prevents chromosome alignment, spindle checkpoint function and cytokinesis.  Subsequently, ZM447439-treated cells exit mitosis without dividing and lose viability.  Because ZM447439 inhibits both Aurora A and B, we set out to det. which phenotypes are due to inhibition of which kinase.  Using mol. genetic approaches, we show that inhibition of Aurora B kinase activity phenocopies ZM447439.  Furthermore, a novel ZM compd., which is 100 times more selective for Aurora B over Aurora A in vitro, induces identical phenotypes.  Importantly, inhibition of Aurora B kinase activity induces a penetrant anti-proliferative phenotype, indicating that Aurora B is an attractive anti-cancer drug target.  Using mol. genetic and chem.-genetic approaches, we also probe the role of Aurora A kinase activity.  We show that simultaneous repression of Aurora A plus induction of a catalytic mutant induces a monopolar phenotype.  Consistently, another novel ZM-related inhibitor, which is 20 times as potent against Aurora A compared with ZM447439, induces a monopolar phenotype.  Expression of a drug-resistant Aurora A mutant reverts this phenotype, demonstrating that Aurora A kinase activity is required for spindle bipolarity in human cells.  Because small mol.-mediated inhibition of Aurora A and Aurora B yields distinct phenotypes, our observations indicate that the Auroras may present two avenues for anti-cancer drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXyhwkCpOaDrVg90H21EOLACvtfcHk0lg9vmSFRSq5-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVymu7zP&md5=707af873d03b36f20a389470e0aab1ff</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1242%2Fjcs.03145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.03145%26sid%3Dliteratum%253Aachs%26aulast%3DGirdler%26aufirst%3DF.%26aulast%3DGascoigne%26aufirst%3DK.%2BE.%26aulast%3DEyers%26aufirst%3DP.%2BA.%26aulast%3DHartmuth%26aufirst%3DS.%26aulast%3DCrafter%26aufirst%3DC.%26aulast%3DFoote%26aufirst%3DK.%2BM.%26aulast%3DKeen%26aufirst%3DN.%2BJ.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26atitle%3DValidating%2520Aurora%2520B%2520as%2520an%2520anti-cancer%2520drug%2520target%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2006%26volume%3D119%26spage%3D3664%26epage%3D3675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Bishop, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, J. M.</span><span> </span><span class="NLM_article-title">Phosphorylation of the carboxyl terminus of inner centromere protein (INCENP) by the Aurora B kinase stimulates Aurora B kinase activity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">27577</span><span class="NLM_x">–</span> <span class="NLM_lpage">27580</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=27577-27580&author=J.+D.+Bishopauthor=J.+M.+Schumacher&title=Phosphorylation+of+the+carboxyl+terminus+of+inner+centromere+protein+%28INCENP%29+by+the+Aurora+B+kinase+stimulates+Aurora+B+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBishop%26aufirst%3DJ.%2BD.%26aulast%3DSchumacher%26aufirst%3DJ.%2BM.%26atitle%3DPhosphorylation%2520of%2520the%2520carboxyl%2520terminus%2520of%2520inner%2520centromere%2520protein%2520%2528INCENP%2529%2520by%2520the%2520Aurora%2520B%2520kinase%2520stimulates%2520Aurora%2520B%2520kinase%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D27577%26epage%3D27580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bolton, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleland, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stukenberg, P. T.</span><span> </span><span class="NLM_article-title">Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation</span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3064</span><span class="NLM_x">–</span> <span class="NLM_lpage">3077</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1091%2Fmbc.E02-02-0092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=12221116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD38XntlGis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=3064-3077&author=M.+A.+Boltonauthor=W.+Lanauthor=S.+E.+Powersauthor=M.+L.+McClelandauthor=J.+Kuangauthor=P.+T.+Stukenberg&title=Aurora+B+kinase+exists+in+a+complex+with+survivin+and+INCENP+and+its+kinase+activity+is+stimulated+by+survivin+binding+and+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation</span></div><div class="casAuthors">Bolton, Margaret A.; Lan, Weijie; Powers, Shannon E.; McCleland, Mark L.; Kuang, Jian; Stukenberg, P. Todd</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3064-3077</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Aurora B regulates chromosome segregation and cytokinesis and is the first protein to be implicated as a regulator of bipolar attachment of spindle microtubules to kinetochores.  Evidence from several systems suggests that Aurora B is phys. assocd. with inner centromere protein (INCENP) in mitosis and has genetic interactions with Survivin.  It is unclear whether the Aurora B and INCENP interaction is cell cycle regulated and if Survivin phys. interacts in this complex.  In this study, we cloned the Xenopus Survivin gene, examd. its assocn. with Aurora B and INCENP, and detd. the effect of its binding on Aurora B kinase activity.  We demonstrate that in the Xenopus early embryo, all of the detectable Survivin is in a complex with both Aurora B and INCENP throughout the cell cycle.  Survivin and Aurora B bind different domains on INCENP.  Aurora B activity is stimulated >10-fold in mitotic exts.; this activation is phosphatase sensitive, and the binding of Survivin is required for full Aurora B activity.  We also find the hydrodynamic properties of the Aurora B/Survivin/INCENP complex are cell cycle regulated.  Our data indicate that Aurora B kinase activity is regulated by both Survivin binding and cell cycle-dependent phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiuqF6FaT1qLVg90H21EOLACvtfcHk0lg2p7RLT-t8tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntlGis78%253D&md5=d8beedfbfd40e859e5511beee7d200a5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1091%2Fmbc.E02-02-0092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.E02-02-0092%26sid%3Dliteratum%253Aachs%26aulast%3DBolton%26aufirst%3DM.%2BA.%26aulast%3DLan%26aufirst%3DW.%26aulast%3DPowers%26aufirst%3DS.%2BE.%26aulast%3DMcCleland%26aufirst%3DM.%2BL.%26aulast%3DKuang%26aufirst%3DJ.%26aulast%3DStukenberg%26aufirst%3DP.%2BT.%26atitle%3DAurora%2520B%2520kinase%2520exists%2520in%2520a%2520complex%2520with%2520survivin%2520and%2520INCENP%2520and%2520its%2520kinase%2520activity%2520is%2520stimulated%2520by%2520survivin%2520binding%2520and%2520phosphorylation%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2002%26volume%3D13%26spage%3D3064%26epage%3D3077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Sessa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mapelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciferri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarricone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Areces, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stukenberg, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musacchio, A.</span><span> </span><span class="NLM_article-title">Mechanism of Aurora B activation by INCENP and inhibition by hesperadin</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=379-391&author=F.+Sessaauthor=M.+Mapelliauthor=C.+Ciferriauthor=C.+Tarriconeauthor=L.+B.+Arecesauthor=T.+R.+Schneiderauthor=P.+T.+Stukenbergauthor=A.+Musacchio&title=Mechanism+of+Aurora+B+activation+by+INCENP+and+inhibition+by+hesperadin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSessa%26aufirst%3DF.%26aulast%3DMapelli%26aufirst%3DM.%26aulast%3DCiferri%26aufirst%3DC.%26aulast%3DTarricone%26aufirst%3DC.%26aulast%3DAreces%26aufirst%3DL.%2BB.%26aulast%3DSchneider%26aufirst%3DT.%2BR.%26aulast%3DStukenberg%26aufirst%3DP.%2BT.%26aulast%3DMusacchio%26aufirst%3DA.%26atitle%3DMechanism%2520of%2520Aurora%2520B%2520activation%2520by%2520INCENP%2520and%2520inhibition%2520by%2520hesperadin%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D18%26spage%3D379%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Hsu, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuben, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatchell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grushcow, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brame, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allis, C. D.</span><span> </span><span class="NLM_article-title">Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=279-291&author=J.-Y.+Hsuauthor=Z.-W.+Sunauthor=X.+Liauthor=M.+Reubenauthor=K.+Tatchellauthor=D.+K.+Bishopauthor=J.+M.+Grushcowauthor=C.+J.+Brameauthor=J.+A.+Caldwellauthor=D.+F.+Huntauthor=R.+Linauthor=M.+M.+Smithauthor=C.+D.+Allis&title=Mitotic+phosphorylation+of+histone+H3+is+governed+by+Ipl1%2Faurora+kinase+and+Glc7%2FPP1+phosphatase+in+budding+yeast+and+nematodes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHsu%26aufirst%3DJ.-Y.%26aulast%3DSun%26aufirst%3DZ.-W.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DReuben%26aufirst%3DM.%26aulast%3DTatchell%26aufirst%3DK.%26aulast%3DBishop%26aufirst%3DD.%2BK.%26aulast%3DGrushcow%26aufirst%3DJ.%2BM.%26aulast%3DBrame%26aufirst%3DC.%2BJ.%26aulast%3DCaldwell%26aufirst%3DJ.%2BA.%26aulast%3DHunt%26aufirst%3DD.%2BF.%26aulast%3DLin%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DM.%2BM.%26aulast%3DAllis%26aufirst%3DC.%2BD.%26atitle%3DMitotic%2520phosphorylation%2520of%2520histone%2520H3%2520is%2520governed%2520by%2520Ipl1%252Faurora%2520kinase%2520and%2520Glc7%252FPP1%2520phosphatase%2520in%2520budding%2520yeast%2520and%2520nematodes%26jtitle%3DCell%26date%3D2000%26volume%3D102%26spage%3D279%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Schumacher, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashcroft, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donovan, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golden, A.</span><span> </span><span class="NLM_article-title">A highly conserved centrosomal kinase, AIR-1, is required for accurate cell cycle progression and segregation of developmental factors in <i>Caenorhabditis elegans</i> embryos</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">1635</span><span class="NLM_x">–</span> <span class="NLM_lpage">1646</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADyaK1MXht1w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=1998&pages=1635-1646&author=J.+M.+Schumacherauthor=N.+Ashcroftauthor=P.+J.+Donovanauthor=A.+Golden&title=A+highly+conserved+centrosomal+kinase%2C+AIR-1%2C+is+required+for+accurate+cell+cycle+progression+and+segregation+of+developmental+factors+in+Caenorhabditis+elegans+embryos"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">AIR-2: an Aurora/Ipl1-related protein kinase associated with chromosomes and midbody microtubules is required for polar body extrusion and cytokinesis in Caenorhabditis elegans embryos</span></div><div class="casAuthors">Schumacher, Jill M.; Golden, Andy; Donovan, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1635-1646</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">An emerging family of kinases related to the Drosophila Aurora and budding yeast Ipl1 proteins has been implicated in chromosome segregation and mitotic spindle formation in a no. of organisms.  Unlike other Aurora/Ip11-related kinases, the C. elegans orthologue, AIR-2, is assocd. with meiotic and mitotic chromosomes.  AIR-2 is initially localized to the chromosomes of the most mature prophase I-arrested oocyte residing next to the spermatheca.  This localization is dependent on the presence of sperm in the spermatheca.  After fertilization, AIR-2 remains assocd. with chromosomes during each meiotic division.  However, during both meiotic anaphases, AIR-2 is present between the sepg. chromosomes.  AIR-2 also remains assocd. with both extruded polar bodies.  In the embryo, AIR-2 is found on metaphase chromosomes, moves to midbody microtubules at anaphase, and then persists at the cytokinesis remnant.  Disruption of AIR-2 expression by RNA-mediated interference produces entire broods of 1-cell embryos that have executed multiple cell cycles in the complete absence of cytokinesis.  The embryos accumulate large amts. of DNA and microtubule asters.  Polar bodies are not extruded, but remain in the embryo where they continue to replicate.  The cytokinesis defect appears to be late in the cell cycle because transient cleavage furrows initiate at the proper location, but regress before the division is complete.  Addnl., staining with a marker of midbody microtubules revealed that at least some of the components of the midbody are not well localized in the absence of AIR-2 activity.  Our results suggest that during each meiotic and mitotic division, AIR-2 may coordinate the congression of metaphase chromosomes with the subsequent events of polar body extrusion and cytokinesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW5Q3myKmyE7Vg90H21EOLACvtfcHk0lghvTGZb3wYTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXht1w%253D&md5=cc1a95cc8bc3922b6a0c8c10c8d99c1f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchumacher%26aufirst%3DJ.%2BM.%26aulast%3DAshcroft%26aufirst%3DN.%26aulast%3DDonovan%26aufirst%3DP.%2BJ.%26aulast%3DGolden%26aufirst%3DA.%26atitle%3DA%2520highly%2520conserved%2520centrosomal%2520kinase%252C%2520AIR-1%252C%2520is%2520required%2520for%2520accurate%2520cell%2520cycle%2520progression%2520and%2520segregation%2520of%2520developmental%2520factors%2520in%2520Caenorhabditis%2520elegans%2520embryos%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D1998%26volume%3D143%26spage%3D1635%26epage%3D1646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kallio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleland, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stukenberg, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorbsky, G. J.</span><span> </span><span class="NLM_article-title">Inhibition of Aurora B Kinase Blocks Chromosome Segregation, Overrides the Spindle Checkpoint, and Perturbs Microtubule Dynamics in Mitosis</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">900</span><span class="NLM_x">–</span> <span class="NLM_lpage">905</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1016%2FS0960-9822%2802%2900887-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=12062053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD38XksFOjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=900-905&author=M.+J.+Kallioauthor=M.+L.+McClelandauthor=P.+T.+Stukenbergauthor=G.+J.+Gorbsky&title=Inhibition+of+Aurora+B+Kinase+Blocks+Chromosome+Segregation%2C+Overrides+the+Spindle+Checkpoint%2C+and+Perturbs+Microtubule+Dynamics+in+Mitosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Aurora B Kinase Blocks Chromosome Segregation, Overrides the Spindle Checkpoint, and Perturbs Microtubule Dynamics in Mitosis</span></div><div class="casAuthors">Kallio, Marko J.; McCleland, Mark L.; Stukenberg, P. Todd; Gorbsky, Gary J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">900-905</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">How kinetochores correct improper microtubule attachments and regulate the spindle checkpoint signal is unclear.  In budding yeast, kinetochores harboring mutations in the mitotic kinase Ipl1 fail to bind chromosomes in a bipolar fashion.  In C. elegans and Drosophila, inhibition of the Ipl1 homolog, Aurora B kinase, induces aberrant anaphase and cytokinesis.  To study Aurora B kinase in vertebrates, we microinjected mitotic XTC cells with inhibitory antibody and found several related effects.  After injection of the antibody, some chromosomes failed to congress to the metaphase plate, consistent with a conserved role for Aurora B in bipolar attachment of chromosomes.  Injected cells exited mitosis with no evidence of anaphase or cytokinesis.  Injection of anti-Xaurora B antibody also altered the microtubule network in mitotic cells with an extension of the astral microtubules and a redn. of kinetochore microtubules.  Finally, inhibition of Aurora B in cultured cells and in cycling Xenopus egg exts. caused escape from the spindle checkpoint arrest induced by microtubule drugs.  Our findings implicate Aurora B as a crit. coordinator relating changes in microtubule dynamics in mitosis, chromosome movement in prometaphase and anaphase, signaling of the spindle checkpoint, and cytokinesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphFem_nwvBgLVg90H21EOLACvtfcHk0lghvTGZb3wYTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksFOjtLk%253D&md5=2da604a569f186444340a722d8bac9d5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0960-9822%2802%2900887-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-9822%252802%252900887-4%26sid%3Dliteratum%253Aachs%26aulast%3DKallio%26aufirst%3DM.%2BJ.%26aulast%3DMcCleland%26aufirst%3DM.%2BL.%26aulast%3DStukenberg%26aufirst%3DP.%2BT.%26aulast%3DGorbsky%26aufirst%3DG.%2BJ.%26atitle%3DInhibition%2520of%2520Aurora%2520B%2520Kinase%2520Blocks%2520Chromosome%2520Segregation%252C%2520Overrides%2520the%2520Spindle%2520Checkpoint%252C%2520and%2520Perturbs%2520Microtubule%2520Dynamics%2520in%2520Mitosis%26jtitle%3DCurr.%2520Biol.%26date%3D2002%26volume%3D12%26spage%3D900%26epage%3D905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ditchfield, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tighe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellston, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haworth, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortlock, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span> </span><span class="NLM_article-title">Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2003&pages=267-280&author=C.+Ditchfieldauthor=V.+L.+Johnsonauthor=A.+Tigheauthor=R.+Ellstonauthor=C.+Haworthauthor=T.+Johnsonauthor=A.+Mortlockauthor=N.+Keenauthor=S.+S.+Taylor&title=Aurora+B+couples+chromosome+alignment+with+anaphase+by+targeting+BubR1%2C+Mad2%2C+and+Cenp-E+to+kinetochores"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDitchfield%26aufirst%3DC.%26aulast%3DJohnson%26aufirst%3DV.%2BL.%26aulast%3DTighe%26aufirst%3DA.%26aulast%3DEllston%26aufirst%3DR.%26aulast%3DHaworth%26aufirst%3DC.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DMortlock%26aufirst%3DA.%26aulast%3DKeen%26aufirst%3DN.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26atitle%3DAurora%2520B%2520couples%2520chromosome%2520alignment%2520with%2520anaphase%2520by%2520targeting%2520BubR1%252C%2520Mad2%252C%2520and%2520Cenp-E%2520to%2520kinetochores%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2003%26volume%3D161%26spage%3D267%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Hauf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaTerra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnapp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Meel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieder, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J. M.</span><span> </span><span class="NLM_article-title">The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1083%2Fjcb.200208092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=12707311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtl2isb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2003&pages=281-294&author=S.+Haufauthor=R.+W.+Coleauthor=S.+LaTerraauthor=C.+Zimmerauthor=G.+Schnappauthor=R.+Walterauthor=A.+Heckelauthor=J.+van+Meelauthor=C.+L.+Riederauthor=J.+M.+Peters&title=The+small+molecule+Hesperadin+reveals+a+role+for+Aurora+B+in+correcting+kinetochore-microtubule+attachment+and+in+maintaining+the+spindle+assembly+checkpoint"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint</span></div><div class="casAuthors">Hauf, Silke; Cole, Richard W.; LaTerra, Sabrina; Zimmer, Christine; Schnapp, Gisela; Walter, Rainer; Heckel, Armin; van Meel, Jacques; Rieder, Conly L.; Peters, Jan-Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">281-294</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The proper segregation of sister chromatids in mitosis depends on bipolar attachment of all chromosomes to the mitotic spindle.  We have identified the small mol. Hesperadin as an inhibitor of chromosome alignment and segregation.  Our data imply that Hesperadin causes this phenotype by inhibiting the function of the mitotic kinase Aurora B.  Mammalian cells treated with Hesperadin enter anaphase in the presence of numerous monooriented chromosomes, many of which may have both sister kinetochores attached to one spindle pole (syntelic attachment).  Hesperadin also causes cells arrested by taxol or monastrol to enter anaphase within <1 h, whereas cells in nocodazole stay arrested for 3-5 h.  Together, our data suggest that Aurora B is required to generate unattached kinetochores on monooriented chromosomes, which in turn could promote bipolar attachment as well as maintain checkpoint signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG-9s78ZbJorVg90H21EOLACvtfcHk0lghvTGZb3wYTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtl2isb8%253D&md5=a79851e7d015a1530340a38e86b1943f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200208092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200208092%26sid%3Dliteratum%253Aachs%26aulast%3DHauf%26aufirst%3DS.%26aulast%3DCole%26aufirst%3DR.%2BW.%26aulast%3DLaTerra%26aufirst%3DS.%26aulast%3DZimmer%26aufirst%3DC.%26aulast%3DSchnapp%26aufirst%3DG.%26aulast%3DWalter%26aufirst%3DR.%26aulast%3DHeckel%26aufirst%3DA.%26aulast%3Dvan%2BMeel%26aufirst%3DJ.%26aulast%3DRieder%26aufirst%3DC.%2BL.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520small%2520molecule%2520Hesperadin%2520reveals%2520a%2520role%2520for%2520Aurora%2520B%2520in%2520correcting%2520kinetochore-microtubule%2520attachment%2520and%2520in%2520maintaining%2520the%2520spindle%2520assembly%2520checkpoint%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2003%26volume%3D161%26spage%3D281%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, Y.</span><span> </span><span class="NLM_article-title">Cell cycle-dependent expression and centrosome localization of a third human Aurora/Ipl1-related protein kinase, AIK3</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">7334</span><span class="NLM_x">–</span> <span class="NLM_lpage">7340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=7334-7340&author=M.+Kimuraauthor=Y.+Matsudaauthor=T.+Yoshiokaauthor=Y.+Okano&title=Cell+cycle-dependent+expression+and+centrosome+localization+of+a+third+human+Aurora%2FIpl1-related+protein+kinase%2C+AIK3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DM.%26aulast%3DMatsuda%26aufirst%3DY.%26aulast%3DYoshioka%26aufirst%3DT.%26aulast%3DOkano%26aufirst%3DY.%26atitle%3DCell%2520cycle-dependent%2520expression%2520and%2520centrosome%2520localization%2520of%2520a%2520third%2520human%2520Aurora%252FIpl1-related%2520protein%2520kinase%252C%2520AIK3%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D7334%26epage%3D7340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakashita, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuzaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanaoka, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urano, T.</span><span> </span><span class="NLM_article-title">Direct Association with Inner Centromere Protein (INCENP) Activates the Novel Chromosomal Passenger Protein, Aurora-C</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">47201</span><span class="NLM_x">–</span> <span class="NLM_lpage">47211</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=47201-47211&author=X.+Liauthor=G.+Sakashitaauthor=H.+Matsuzakiauthor=K.+Sugimotoauthor=K.+Kimuraauthor=F.+Hanaokaauthor=H.+Taniguchiauthor=K.+Furukawaauthor=T.+Urano&title=Direct+Association+with+Inner+Centromere+Protein+%28INCENP%29+Activates+the+Novel+Chromosomal+Passenger+Protein%2C+Aurora-C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DSakashita%26aufirst%3DG.%26aulast%3DMatsuzaki%26aufirst%3DH.%26aulast%3DSugimoto%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DHanaoka%26aufirst%3DF.%26aulast%3DTaniguchi%26aufirst%3DH.%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DUrano%26aufirst%3DT.%26atitle%3DDirect%2520Association%2520with%2520Inner%2520Centromere%2520Protein%2520%2528INCENP%2529%2520Activates%2520the%2520Novel%2520Chromosomal%2520Passenger%2520Protein%252C%2520Aurora-C%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D47201%26epage%3D47211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiyin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span> </span><span class="NLM_article-title">Aurora C is directly associated with survivin and required for cytokinesis</span> <span class="citation_source-journal">Genes Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">617</span><span class="NLM_x">–</span> <span class="NLM_lpage">626</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1111%2Fj.1365-2443.2005.00863.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=15938719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvF2lt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=617-626&author=X.+Yanauthor=L.+Caoauthor=Q.+Liauthor=Y.+Wuauthor=H.+Zhangauthor=H.+Saiyinauthor=X.+Liuauthor=X.+Zhangauthor=Q.+Shiauthor=L.+Yu&title=Aurora+C+is+directly+associated+with+survivin+and+required+for+cytokinesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Aurora C is directly associated with survivin and required for cytokinesis</span></div><div class="casAuthors">Yan, Xiaomei; Cao, Lihuan; Li, Qiang; Wu, Yanhua; Zhang, Haoxing; Saiyin, Hexige; Liu, Xianghua; Zhang, Xuqing; Shi, Qinghua; Yu, Long</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">617-626</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1356-9597</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Much recent attention has been focused on Aurora C kinase (I), the 3rd member of the mammalian Aurora kinase family that plays significant roles in mitosis.  Here, the authors report that using sensitive RT-PCR to amplify the C-terminus, they found that I was not only expressed highly in the testis, but also among 16 other human tissues in a broad-spectrum way.  I, as a chromosomal passenger protein, was co-localized with survivin (II) and Aurora B kinase (III) in mitotic cells.  I could also be assocd. with II and III in vivo, and directly bound to II but not to III in vitro.  Overexpression of a catalytically inactive mutant of I impaired the localization of I to the spindle midzone and severely disturbed the cytokinesis, resulting in multinucleation, all of which were consistent with the results induced by the mutant of III.  Furthermore, evidence was provided that I could rescue the multinucleate phenotype produced by the III mutant, and vice versa.  Overall, these findings demonstrated that I, a member of the chromosomal passenger complex, is required for cytokinesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ-9YVMj0imLVg90H21EOLACvtfcHk0lgZobwVrXZODQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvF2lt7g%253D&md5=6d1b2a8550decab60209382d08337962</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2443.2005.00863.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2443.2005.00863.x%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DX.%26aulast%3DCao%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSaiyin%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DL.%26atitle%3DAurora%2520C%2520is%2520directly%2520associated%2520with%2520survivin%2520and%2520required%2520for%2520cytokinesis%26jtitle%3DGenes%2520Cells%26date%3D2005%26volume%3D10%26spage%3D617%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Sasai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenoien, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earnshaw, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkley, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sen, S.</span><span> </span><span class="NLM_article-title">Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells</span> <span class="citation_source-journal">Cell Motil. Cytoskeleton</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1002%2Fcm.20039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=15499654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVOisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2004&pages=249-263&author=K.+Sasaiauthor=H.+Katayamaauthor=D.+L.+Stenoienauthor=S.+Fujiiauthor=R.+Hondaauthor=M.+Kimuraauthor=Y.+Okanoauthor=M.+Tatsukaauthor=F.+Suzukiauthor=E.+A.+Niggauthor=W.+C.+Earnshawauthor=W.+R.+Brinkleyauthor=S.+Sen&title=Aurora-C+kinase+is+a+novel+chromosomal+passenger+protein+that+can+complement+Aurora-B+kinase+function+in+mitotic+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells</span></div><div class="casAuthors">Sasai, Kaori; Katayama, Hiroshi; Stenoien, David L.; Fujii, Satoshi; Honda, Reiko; Kimura, Masashi; Okano, Yukio; Tatsuka, Masaaki; Suzuki, Fumio; Nigg, Erich A.; Earnshaw, William C.; Brinkley, William R.; Sen, Subrata</div><div class="citationInfo"><span class="NLM_cas:title">Cell Motility and the Cytoskeleton</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">249-263</span>CODEN:
                <span class="NLM_cas:coden">CMCYEO</span>;
        ISSN:<span class="NLM_cas:issn">0886-1544</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The function of Aurora-C kinase, a member of the Aurora kinase family identified in mammals, is currently unknown.  We present evidence that Aurora-C, like Aurora-B kinase, is a chromosomal passenger protein localizing first to centromeres and then to the midzone of mitotic cells.  Aurora-C transcript is expressed at a moderate level albeit about an order of magnitude lower than Aurora-B transcript in diploid human fibroblasts.  The level of Aurora-C transcript is elevated in several human cancer cell types.  Aurora-C and Aurora-B mRNA and protein expressions are maximally elevated during the G2/M phase but their expression profiles in synchronized cells reveal differential temporal regulation through the cell cycle with Aurora-C level peaking after that of Aurora-B during the later part of the M phase.  Aurora-C, like Aurora-B, interacts with the inner centromere protein (INCENP) at the carboxyl terminal end spanning the conserved IN box domain.  Competition binding assays and transfection expts. revealed that, compared with Aurora-C, Aurora-B has preferential binding affinity to INCENP and co-expression of the two in vivo interferes with INCENP binding, localization, and stability of these proteins.  A kinase-dead mutant of Aurora-C had a dominant neg. effect inducing multi-nucleation in a dose-dependent manner.  SiRNA mediated silencing of Aurora-C and Aurora-B also gave rise to multi-nucleated cells with the two kinases silenced at the same time displaying an additive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEZfK2erbuk7Vg90H21EOLACvtfcHk0lgZobwVrXZODQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVOisQ%253D%253D&md5=6091dca535ee530fbd5e8e8c41d98f79</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fcm.20039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcm.20039%26sid%3Dliteratum%253Aachs%26aulast%3DSasai%26aufirst%3DK.%26aulast%3DKatayama%26aufirst%3DH.%26aulast%3DStenoien%26aufirst%3DD.%2BL.%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DHonda%26aufirst%3DR.%26aulast%3DKimura%26aufirst%3DM.%26aulast%3DOkano%26aufirst%3DY.%26aulast%3DTatsuka%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DF.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26aulast%3DEarnshaw%26aufirst%3DW.%2BC.%26aulast%3DBrinkley%26aufirst%3DW.%2BR.%26aulast%3DSen%26aufirst%3DS.%26atitle%3DAurora-C%2520kinase%2520is%2520a%2520novel%2520chromosomal%2520passenger%2520protein%2520that%2520can%2520complement%2520Aurora-B%2520kinase%2520function%2520in%2520mitotic%2520cells%26jtitle%3DCell%2520Motil.%2520Cytoskeleton%26date%3D2004%26volume%3D59%26spage%3D249%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Mortlock, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keen, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heron, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foote, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span> </span><span class="NLM_article-title">Progress in the development of selective inhibitors of Aurora kinases</span> <span class="citation_source-journal">Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.2174%2F1568026053507651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=15853647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFyksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=199-213&author=A.+Mortlockauthor=N.+J.+Keenauthor=F.+H.+Jungauthor=N.+M.+Heronauthor=K.+M.+Footeauthor=R.+Wilkinsonauthor=S.+Green&title=Progress+in+the+development+of+selective+inhibitors+of+Aurora+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the development of selective inhibitors of Aurora kinases</span></div><div class="casAuthors">Mortlock, Andrew; Keen, Nicholas J.; Jung, Frederic H.; Heron, Nicola M.; Foote, Kevin M.; Wilkinson, Robert; Green, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-213</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Errors in the mitotic process are thought to be one of the principal sources of the genetic instability that hallmarks cancer.  Unsurprisingly, many of the proteins that regulate mitosis are aberrantly expressed in tumor cells when compared to their normal counterparts.  These may represent a good source of targets for the development of novel anti-cancer agents.  The Aurora kinases represent one such family of mitotic regulators.  In recent years there was intense interest in both understanding the role of the Aurora kinases in cell cycle regulation and also in developing small mol. inhibitors as potential novel anti-cancer drugs.  With several companies now starting to take Aurora kinase inhibitors into clin. development, the time is right to review the medicinal chem. contribution to developing the field, in particular to review the increasingly broad range of small mol. inhibitors with activity against this kinase family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoju_DzoN6iDLVg90H21EOLACvtfcHk0ljGhSXL3E2tTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFyksbo%253D&md5=af7a9db23deded41e433b70e517e25aa</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F1568026053507651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053507651%26sid%3Dliteratum%253Aachs%26aulast%3DMortlock%26aufirst%3DA.%26aulast%3DKeen%26aufirst%3DN.%2BJ.%26aulast%3DJung%26aufirst%3DF.%2BH.%26aulast%3DHeron%26aufirst%3DN.%2BM.%26aulast%3DFoote%26aufirst%3DK.%2BM.%26aulast%3DWilkinson%26aufirst%3DR.%26aulast%3DGreen%26aufirst%3DS.%26atitle%3DProgress%2520in%2520the%2520development%2520of%2520selective%2520inhibitors%2520of%2520Aurora%2520kinases%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%2520%2528Sharjah%252C%2520United%2520Arab%2520Emirates%2529%26date%3D2005%26volume%3D5%26spage%3D199%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Gautschi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lara, P. N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandara, D. R.</span><span> </span><span class="NLM_article-title">Aurora kinase inhibitors: a new class of targeted drugs in cancer</span> <span class="citation_source-journal">Clin. Lung Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.3816%2FCLC.2006.n.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=17026809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKhsLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=93-98&author=O.+Gautschiauthor=P.+C.+Mackauthor=A.+M.+Daviesauthor=P.+N.+Laraauthor=D.+R.+Gandara&title=Aurora+kinase+inhibitors%3A+a+new+class+of+targeted+drugs+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Aurora kinase inhibitors: a new class of targeted drugs in cancer</span></div><div class="casAuthors">Gautschi, Oliver; Mack, Philip C.; Davies, Angela M.; Lara, Primo N., Jr.; Gandara, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Lung Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">93-98</span>CODEN:
                <span class="NLM_cas:coden">CLCLCA</span>;
        ISSN:<span class="NLM_cas:issn">1525-7304</span>.
    
            (<span class="NLM_cas:orgname">CIG Media Group, LP</span>)
        </div><div class="casAbstract">A review.  Aurora kinases (A, B, and C) are essential for spindle assembly, centrosome maturation, chromosomal segregation, and cytokinesis.  Aurora kinases A and B are overexpressed in many cancers, including non-small-cell lung cancer and mesothelioma.  Small-mol. inhibitors selective for aurora kinases have shown promising activity in preclin. tumor models.  To date, phase I studies with aurora kinase inhibitors have shown that myelosuppression is the dose-limiting toxicity, and disease stabilization was achieved in a no. of tumor types, including non-small-cell lung cancer.  Phase II trials are under way in selected tumor types.  This article reviews the biol. of aurora kinases, their potential role in the treatment of lung cancer, and challenges in the clin. development of this unique class of antineoplastic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGihF3FISrzLVg90H21EOLACvtfcHk0ljGhSXL3E2tTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKhsLzJ&md5=5ac64b0a9a7c3b3d55497460d96d3dce</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3816%2FCLC.2006.n.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3816%252FCLC.2006.n.036%26sid%3Dliteratum%253Aachs%26aulast%3DGautschi%26aufirst%3DO.%26aulast%3DMack%26aufirst%3DP.%2BC.%26aulast%3DDavies%26aufirst%3DA.%2BM.%26aulast%3DLara%26aufirst%3DP.%2BN.%26aulast%3DGandara%26aufirst%3DD.%2BR.%26atitle%3DAurora%2520kinase%2520inhibitors%253A%2520a%2520new%2520class%2520of%2520targeted%2520drugs%2520in%2520cancer%26jtitle%3DClin.%2520Lung%2520Cancer%26date%3D2006%26volume%3D8%26spage%3D93%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Pollard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortimore, M.</span><span> </span><span class="NLM_article-title">Discovery and Development of Aurora Kinase Inhibitors as Anticancer Agent</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2629</span><span class="NLM_x">–</span> <span class="NLM_lpage">2651</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8012129" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2629-2651&author=J.+R.+Pollardauthor=M.+Mortimore&title=Discovery+and+Development+of+Aurora+Kinase+Inhibitors+as+Anticancer+Agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm8012129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8012129%26sid%3Dliteratum%253Aachs%26aulast%3DPollard%26aufirst%3DJ.%2BR.%26aulast%3DMortimore%26aufirst%3DM.%26atitle%3DDiscovery%2520and%2520Development%2520of%2520Aurora%2520Kinase%2520Inhibitors%2520as%2520Anticancer%2520Agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2629%26epage%3D2651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Harrington, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebbington, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajose-Adeogun, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hercend, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diu-Hercend, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golec, J. M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. M.</span><span> </span><span class="NLM_article-title">VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=262-267&author=E.+A.+Harringtonauthor=D.+Bebbingtonauthor=J.+Mooreauthor=R.+K.+Rasmussenauthor=A.+O.+Ajose-Adeogunauthor=T.+Nakayamaauthor=J.+A.+Grahamauthor=C.+Demurauthor=T.+Hercendauthor=A.+Diu-Hercendauthor=M.+Suauthor=J.+M.+C.+Golecauthor=K.+M.+Miller&title=VX-680%2C+a+potent+and+selective+small-molecule+inhibitor+of+the+Aurora+kinases%2C+suppresses+tumor+growth+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarrington%26aufirst%3DE.%2BA.%26aulast%3DBebbington%26aufirst%3DD.%26aulast%3DMoore%26aufirst%3DJ.%26aulast%3DRasmussen%26aufirst%3DR.%2BK.%26aulast%3DAjose-Adeogun%26aufirst%3DA.%2BO.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DJ.%2BA.%26aulast%3DDemur%26aufirst%3DC.%26aulast%3DHercend%26aufirst%3DT.%26aulast%3DDiu-Hercend%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DGolec%26aufirst%3DJ.%2BM.%2BC.%26aulast%3DMiller%26aufirst%3DK.%2BM.%26atitle%3DVX-680%252C%2520a%2520potent%2520and%2520selective%2520small-molecule%2520inhibitor%2520of%2520the%2520Aurora%2520kinases%252C%2520suppresses%2520tumor%2520growth%2520in%2520vivo%26jtitle%3DNature%2520Med.%26date%3D2004%26volume%3D10%26spage%3D262%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Mortlock, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foote, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heron, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Savi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dousson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odedra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keen, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crafter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brightwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kearney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKillop, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhead, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parry, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span> </span><span class="NLM_article-title">Discovery, Synthesis, and in Vivo Activity of a New Class of Pyrazolylamino Quinazolines as Selective Inhibitors of Aurora B Kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2213</span><span class="NLM_x">–</span> <span class="NLM_lpage">2224</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061335f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2213-2224&author=A.+A.+Mortlockauthor=K.+M.+Footeauthor=N.+M.+Heronauthor=F.+H.+Jungauthor=G.+Pasquetauthor=J.+J.+Lohmannauthor=N.+Warinauthor=F.+Renaudauthor=C.+De+Saviauthor=N.+J.+Robertsauthor=T.+Johnsonauthor=C.+B.+Doussonauthor=G.+B.+Hillauthor=D.+Perkinsauthor=G.+Hatterauthor=R.+W.+Wilkinsonauthor=S.+R.+Wedgeauthor=S.+P.+Heatonauthor=R.+Odedraauthor=N.+J.+Keenauthor=C.+Crafterauthor=E.+Brownauthor=K.+Thompsonauthor=S.+Brightwellauthor=L.+Khatriauthor=M.+C.+Bradyauthor=S.+Kearneyauthor=D.+McKillopauthor=S.+Rheadauthor=T.+Parryauthor=S.+Green&title=Discovery%2C+Synthesis%2C+and+in+Vivo+Activity+of+a+New+Class+of+Pyrazolylamino+Quinazolines+as+Selective+Inhibitors+of+Aurora+B+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm061335f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061335f%26sid%3Dliteratum%253Aachs%26aulast%3DMortlock%26aufirst%3DA.%2BA.%26aulast%3DFoote%26aufirst%3DK.%2BM.%26aulast%3DHeron%26aufirst%3DN.%2BM.%26aulast%3DJung%26aufirst%3DF.%2BH.%26aulast%3DPasquet%26aufirst%3DG.%26aulast%3DLohmann%26aufirst%3DJ.%2BJ.%26aulast%3DWarin%26aufirst%3DN.%26aulast%3DRenaud%26aufirst%3DF.%26aulast%3DDe%2BSavi%26aufirst%3DC.%26aulast%3DRoberts%26aufirst%3DN.%2BJ.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DDousson%26aufirst%3DC.%2BB.%26aulast%3DHill%26aufirst%3DG.%2BB.%26aulast%3DPerkins%26aufirst%3DD.%26aulast%3DHatter%26aufirst%3DG.%26aulast%3DWilkinson%26aufirst%3DR.%2BW.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DHeaton%26aufirst%3DS.%2BP.%26aulast%3DOdedra%26aufirst%3DR.%26aulast%3DKeen%26aufirst%3DN.%2BJ.%26aulast%3DCrafter%26aufirst%3DC.%26aulast%3DBrown%26aufirst%3DE.%26aulast%3DThompson%26aufirst%3DK.%26aulast%3DBrightwell%26aufirst%3DS.%26aulast%3DKhatri%26aufirst%3DL.%26aulast%3DBrady%26aufirst%3DM.%2BC.%26aulast%3DKearney%26aufirst%3DS.%26aulast%3DMcKillop%26aufirst%3DD.%26aulast%3DRhead%26aufirst%3DS.%26aulast%3DParry%26aufirst%3DT.%26aulast%3DGreen%26aufirst%3DS.%26atitle%3DDiscovery%252C%2520Synthesis%252C%2520and%2520in%2520Vivo%2520Activity%2520of%2520a%2520New%2520Class%2520of%2520Pyrazolylamino%2520Quinazolines%2520as%2520Selective%2520Inhibitors%2520of%2520Aurora%2520B%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2213%26epage%3D2224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Manfredi, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ecsedy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meetze, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balani, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burenkova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoar, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huck, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeRoy, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sells, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stringer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroud, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vos, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wysong, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claiborne, C. F.</span><span> </span><span class="NLM_article-title">Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">4106</span><span class="NLM_x">–</span> <span class="NLM_lpage">4111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=4106-4111&author=M.+G.+Manfrediauthor=J.+A.+Ecsedyauthor=K.+A.+Meetzeauthor=S.+K.+Balaniauthor=O.+Burenkovaauthor=W.+Chenauthor=K.+M.+Galvinauthor=K.+M.+Hoarauthor=J.+J.+Huckauthor=P.+J.+LeRoyauthor=E.+T.+Rayauthor=T.+B.+Sellsauthor=B.+Stringerauthor=S.+G.+Stroudauthor=T.+J.+Vosauthor=G.+S.+Weatherheadauthor=D.+R.+Wysongauthor=M.+Zhangauthor=J.+B.+Bolenauthor=C.+F.+Claiborne&title=Antitumor+activity+of+MLN8054%2C+an+orally+active+small-molecule+inhibitor+of+Aurora+A+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManfredi%26aufirst%3DM.%2BG.%26aulast%3DEcsedy%26aufirst%3DJ.%2BA.%26aulast%3DMeetze%26aufirst%3DK.%2BA.%26aulast%3DBalani%26aufirst%3DS.%2BK.%26aulast%3DBurenkova%26aufirst%3DO.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DGalvin%26aufirst%3DK.%2BM.%26aulast%3DHoar%26aufirst%3DK.%2BM.%26aulast%3DHuck%26aufirst%3DJ.%2BJ.%26aulast%3DLeRoy%26aufirst%3DP.%2BJ.%26aulast%3DRay%26aufirst%3DE.%2BT.%26aulast%3DSells%26aufirst%3DT.%2BB.%26aulast%3DStringer%26aufirst%3DB.%26aulast%3DStroud%26aufirst%3DS.%2BG.%26aulast%3DVos%26aufirst%3DT.%2BJ.%26aulast%3DWeatherhead%26aufirst%3DG.%2BS.%26aulast%3DWysong%26aufirst%3DD.%2BR.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DBolen%26aufirst%3DJ.%2BB.%26aulast%3DClaiborne%26aufirst%3DC.%2BF.%26atitle%3DAntitumor%2520activity%2520of%2520MLN8054%252C%2520an%2520orally%2520active%2520small-molecule%2520inhibitor%2520of%2520Aurora%2520A%2520kinase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D4106%26epage%3D4111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Shimomura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasako, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakatsuru, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanishi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkubo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, Y.</span><span> </span><span class="NLM_article-title">MK-5108, a Highly Selective Aurora-A Kinase Inhibitor, Shows Antitumor Activity Alone and in Combination with Docetaxel</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1158%2F1535-7163.MCT-09-0609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=20053775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktVOisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=157-166&author=T.+Shimomuraauthor=S.+Hasakoauthor=Y.+Nakatsuruauthor=T.+Mitaauthor=K.+Ichikawaauthor=T.+Koderaauthor=T.+Sakaiauthor=T.+Nambuauthor=M.+Miyamotoauthor=I.+Takahashiauthor=S.+Mikiauthor=N.+Kawanishiauthor=M.+Ohkuboauthor=H.+Kotaniauthor=Y.+Iwasawa&title=MK-5108%2C+a+Highly+Selective+Aurora-A+Kinase+Inhibitor%2C+Shows+Antitumor+Activity+Alone+and+in+Combination+with+Docetaxel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">MK-5108, a Highly Selective Aurora-A Kinase Inhibitor, Shows Antitumor Activity Alone and in Combination with Docetaxel</span></div><div class="casAuthors">Shimomura, Toshiyasu; Hasako, Shinichi; Nakatsuru, Yoko; Mita, Takashi; Ichikawa, Koji; Kodera, Tsutomu; Sakai, Takumi; Nambu, Tadahiro; Miyamoto, Mayu; Takahashi, Ikuko; Miki, Satomi; Kawanishi, Nobuhiko; Ohkubo, Mitsuru; Kotani, Hidehito; Iwasawa, Yoshikazu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">157-166</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Aurora-A kinase is a one of the key regulators during mitosis progression.  Aurora-A kinase is a potential target for anticancer therapies because overexpression of Aurora-A, which is frequently obsd. in some human cancers, results in aberrant mitosis leading to chromosomal instability and possibly tumorigenesis.  MK-5108 is a novel small mol. with potent inhibitory activity against Aurora-A kinase.  Although most of the Aurora-kinase inhibitors target both Aurora-A and Aurora-B, MK-5108 specifically inhibited Aurora-A kinase in a panel of protein kinase assays.  Inhibition of Aurora-A by MK-5108 in cultured cells induced cell cycle arrest at the G2-M phase in flow cytometry anal.  The effect was confirmed by the accumulation of cells with expression of phosphorylated Histone H3 and inhibition of Aurora-A autophosphorylation by immunostaining assays.  MK-5108 also induced phosphorylated Histone H3 in skin and xenograft tumor tissues in a nude rat xenograft model.  MK-5108 inhibited growth of human tumor cell lines in culture and in different xenograft models.  Furthermore, the combination of MK-5108 and docetaxel showed enhanced antitumor activities compared with control and docetaxel alone-treated animals without exacerbating the adverse effects of docetaxel.  MK-5108 is currently tested in clin. trials and offers a new therapeutic approach to combat human cancers as a single agent or in combination with existing taxane therapies.  Mol Cancer Ther; 9(1); 157-66.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRD-HWMVBoWrVg90H21EOLACvtfcHk0lhjr0K_9F9-ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktVOisQ%253D%253D&md5=267f0e3f702e2489e8b0c942f9299850</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0609%26sid%3Dliteratum%253Aachs%26aulast%3DShimomura%26aufirst%3DT.%26aulast%3DHasako%26aufirst%3DS.%26aulast%3DNakatsuru%26aufirst%3DY.%26aulast%3DMita%26aufirst%3DT.%26aulast%3DIchikawa%26aufirst%3DK.%26aulast%3DKodera%26aufirst%3DT.%26aulast%3DSakai%26aufirst%3DT.%26aulast%3DNambu%26aufirst%3DT.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DI.%26aulast%3DMiki%26aufirst%3DS.%26aulast%3DKawanishi%26aufirst%3DN.%26aulast%3DOhkubo%26aufirst%3DM.%26aulast%3DKotani%26aufirst%3DH.%26aulast%3DIwasawa%26aufirst%3DY.%26atitle%3DMK-5108%252C%2520a%2520Highly%2520Selective%2520Aurora-A%2520Kinase%2520Inhibitor%252C%2520Shows%2520Antitumor%2520Activity%2520Alone%2520and%2520in%2520Combination%2520with%2520Docetaxel%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D157%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Dhanak, D.; Newlander, K. A.</span><span> </span><span class="NLM_article-title">Preparation of azaindoles as aurora kinase inhibitors for the treatment of cancer</span>. U.S. Patent US20070149561A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=D.+Dhanak&author=K.+A.+Newlander&title=Preparation+of+azaindoles+as+aurora+kinase+inhibitors+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDhanak%26aufirst%3DD.%26atitle%3DPreparation%2520of%2520azaindoles%2520as%2520aurora%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520cancer%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="note"><p class="first last">A homology model of human Aurora B was generated using a cocrystal structure of human Aurora A with an analogue related to <b>12d</b>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompliano, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span> </span><span class="NLM_article-title">Drug-target residence time and its implications for lead optimization</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">730</span><span class="NLM_x">–</span> <span class="NLM_lpage">739</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1038%2Fnrd2082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=16888652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=730-739&author=R.+A.+Copelandauthor=D.+L.+Pomplianoauthor=T.+D.+Meek&title=Drug-target+residence+time+and+its+implications+for+lead+optimization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-target residence time and its implications for lead optimization</span></div><div class="casAuthors">Copeland, Robert A.; Pompliano, David L.; Meek, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">730-739</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Much of drug discovery today is predicated on the concept of selective targeting of particular bioactive macromols. by low-mol.-mass drugs.  The binding of drugs to their macromol. targets is therefore seen as paramount for pharmacol. activity.  In vitro assessment of drug-target interactions is classically quantified in terms of binding parameters such as IC50 or Kd.  This article presents an alternative perspective on drug optimization in terms of drug-target binary complex residence time, as quantified by the dissociative half-life of the drug-target binary complex.  We describe the potential advantages of long residence time in terms of duration of pharmacol. effect and target selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry6SJrMlrrTbVg90H21EOLACvtfcHk0lhjr0K_9F9-ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D&md5=60ede2301584b10ac4e8fa18e1e6d107</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnrd2082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2082%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DDrug-target%2520residence%2520time%2520and%2520its%2520implications%2520for%2520lead%2520optimization%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D730%26epage%3D739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span> </span><span class="NLM_article-title">Residence time of receptor-ligand complexes and its effect on biological function</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5481</span><span class="NLM_x">–</span> <span class="NLM_lpage">5492</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi8002023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1Ont7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=5481-5492&author=P.+J.+Tumminoauthor=R.+A.+Copeland&title=Residence+time+of+receptor-ligand+complexes+and+its+effect+on+biological+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Residence Time of Receptor-Ligand Complexes and Its Effect on Biological Function</span></div><div class="casAuthors">Tummino, Peter J.; Copeland, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5481-5492</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The formation and duration of binary receptor-ligand complexes are fundamental to many physiol. processes.  Most often, the effectiveness of interaction between a receptor and its ligand is quantified in terms of closed system, equil. affinity measurements, such as IC50 and Kd.  In the context of in vivo biol., however, the extent and duration of responses to receptor-ligand interactions depend greatly on the time period over which the ligand is in residence on its receptor.  Here we define receptor-ligand complex residence time in quant. terms and describe its significance to biol. function.  Examples of the importance of residence time are presented for natural ligands of different receptor types.  The impact of residence time on the optimization of potential ligands as drugs for human medicine is also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHshN2Bt_r9LVg90H21EOLACvtfcHk0liPn0zd7UdKGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1Ont7s%253D&md5=57f79f69f12c6ed14e3347638381d943</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fbi8002023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi8002023%26sid%3Dliteratum%253Aachs%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DResidence%2520time%2520of%2520receptor-ligand%2520complexes%2520and%2520its%2520effect%2520on%2520biological%2520function%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D5481%26epage%3D5492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Anderson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuart, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nartey, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardwicke, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newlander, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span> </span><span class="NLM_article-title">Biochemical characterization of GSK1070916, a potent and selective inhibitor of Aurora A and Aurora C kinases with an extremely long residence time</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">420</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=420&publication_year=2009&pages=259-265&author=K.+Andersonauthor=Z.+Laiauthor=O.+B.+McDonaldauthor=J.+D.+Stuartauthor=E.+N.+Narteyauthor=M.+A.+Hardwickeauthor=K.+Newlanderauthor=D.+Dhanakauthor=J.+Adamsauthor=D.+Patrickauthor=R.+A.+Copelandauthor=P.+J.+Tumminoauthor=J.+Yang&title=Biochemical+characterization+of+GSK1070916%2C+a+potent+and+selective+inhibitor+of+Aurora+A+and+Aurora+C+kinases+with+an+extremely+long+residence+time"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DLai%26aufirst%3DZ.%26aulast%3DMcDonald%26aufirst%3DO.%2BB.%26aulast%3DStuart%26aufirst%3DJ.%2BD.%26aulast%3DNartey%26aufirst%3DE.%2BN.%26aulast%3DHardwicke%26aufirst%3DM.%2BA.%26aulast%3DNewlander%26aufirst%3DK.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DPatrick%26aufirst%3DD.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DBiochemical%2520characterization%2520of%2520GSK1070916%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520Aurora%2520A%2520and%2520Aurora%2520C%2520kinases%2520with%2520an%2520extremely%2520long%2520residence%2520time%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D420%26spage%3D259%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Majid, T.; Duprets, S. D.; Peifer, C.</span><span> </span><span class="NLM_article-title">The Synthesis of Heterocyclic Compounds Employing Microwave Technology</span>. Patent WO03000690A1,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=T.+Majid&author=S.+D.+Duprets&author=C.+Peifer&title=The+Synthesis+of+Heterocyclic+Compounds+Employing+Microwave+Technology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMajid%26aufirst%3DT.%26atitle%3DThe%2520Synthesis%2520of%2520Heterocyclic%2520Compounds%2520Employing%2520Microwave%2520Technology%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Adams, D. R.; Bentley, J. M.; Davidson, J.; Duncton, M. A. J.; Porter, R. H. P.</span><span> </span><span class="NLM_article-title">Preparation of hexahydropyrazino[1,2-a]indoles as 5-HT2 receptor ligands</span>. Patent WO2000044753A1,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=D.+R.+Adams&author=J.+M.+Bentley&author=J.+Davidson&author=M.+A.+J.+Duncton&author=R.+H.+P.+Porter&title=Preparation+of+hexahydropyrazino%5B1%2C2-a%5Dindoles+as+5-HT2+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DD.%2BR.%26atitle%3DPreparation%2520of%2520hexahydropyrazino%255B1%252C2-a%255Dindoles%2520as%25205-HT2%2520receptor%2520ligands%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Hardwicke, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleykowski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plant, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, Q. M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newlander, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Z. S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D.</span><span> </span><span class="NLM_article-title">GSK1070916, a potent Aurora B/C kinase inhibitor with broad antitumor activity in tissue culture cells and human tumor xenograft models</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1808</span><span class="NLM_x">–</span> <span class="NLM_lpage">1817</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1158%2F1535-7163.MCT-09-0041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=19567821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVymsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1808-1817&author=M.+A.+Hardwickeauthor=C.+A.+Oleykowskiauthor=R.+Plantauthor=J.+Wangauthor=Q.+M.+K.+Liaoauthor=K.+Newlanderauthor=J.+L.+Adamsauthor=D.+Dhanakauthor=J.+Yangauthor=Z.+S.+D.+Laiauthor=D.+Patrick&title=GSK1070916%2C+a+potent+Aurora+B%2FC+kinase+inhibitor+with+broad+antitumor+activity+in+tissue+culture+cells+and+human+tumor+xenograft+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">GSK1070916, a potent Aurora B/C kinase inhibitor with broad antitumor activity in tissue culture cells and human tumor xenograft models</span></div><div class="casAuthors">Hardwicke, Mary Ann; Oleykowski, Catherine A.; Plant, Ramona; Wang, Jamin; Liao, Qiaoyin; Moss, Katherine; Newlander, Ken; Adams, Jerry L.; Dhanak, Dashyant; Yang, Jingsong; Lai, Zhihong; Sutton, David; Patrick, Denis</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1808-1817</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The protein kinases, Aurora A, B, and C have crit. roles in the regulation of mitosis and are frequently overexpressed or amplified in human tumors.  GSK1070916, is a novel ATP competitive inhibitor that is highly potent and selective for Aurora B/C kinases.  Human tumor cells treated with GSK1070916 show dose-dependent inhibition of phosphorylation on serine 10 of Histone H3, a substrate specific for Aurora B kinase.  Moreover, GSK1070916 inhibits the proliferation of tumor cells with EC50 values of <10 nmol/L in over 100 cell lines spanning a broad range of tumor types.  Although GSK1070916 has potent activity against proliferating cells, a dramatic shift in potency is obsd. in primary, nondividing, normal human vein endothelial cells, consistent with the proposed mechanism.  We further detd. that treated cells do not arrest in mitosis but instead fail to divide and become polyploid, ultimately leading to apoptosis.  GSK1070916 shows dose-dependent inhibition of phosphorylation of an Aurora B-specific substrate in mice and consistent with its broad cellular activity, has antitumor effects in 10 human tumor xenograft models including breast, colon, lung, and two leukemia models.  These results show that GSK1070916 is a potent Aurora B/C kinase inhibitor that has the potential for antitumor activity in a wide range of human cancers. [Mol Cancer Ther 2009;8(7):1808-17].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKuBTcujcY3bVg90H21EOLACvtfcHk0liPn0zd7UdKGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVymsrw%253D&md5=36d705aae85b8583c54af4aa4cee7e1f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0041%26sid%3Dliteratum%253Aachs%26aulast%3DHardwicke%26aufirst%3DM.%2BA.%26aulast%3DOleykowski%26aufirst%3DC.%2BA.%26aulast%3DPlant%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DQ.%2BM.%2BK.%26aulast%3DNewlander%26aufirst%3DK.%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DZ.%2BS.%2BD.%26aulast%3DPatrick%26aufirst%3DD.%26atitle%3DGSK1070916%252C%2520a%2520potent%2520Aurora%2520B%252FC%2520kinase%2520inhibitor%2520with%2520broad%2520antitumor%2520activity%2520in%2520tissue%2520culture%2520cells%2520and%2520human%2520tumor%2520xenograft%2520models%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D1808%26epage%3D1817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><div class="note"><p class="first last">Artificial membrane permeability data was generated using an unpublished in house method that is similar to PAMPA. For PAMPA, see:</p></div><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubernator, K.</span><span> </span><span class="NLM_article-title">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970530e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1007-1010&author=M.+Kansyauthor=F.+Sennerauthor=K.+Gubernator&title=Physicochemical+High+Throughput+Screening%3A+Parallel+Artificial+Membrane+Permeation+Assay+in+the+Description+of+Passive+Absorption+Processes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span></div><div class="casAuthors">Kansy, Manfred; Senner, Frank; Gubernator, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1010</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of pharmaceutical discovery projects aim for an orally available form of a new therapeutic principle.  One obstacle for per oral treatment is intestinal absorption.  A simple predictive exptl. method to assess the potential of intestinal absorption is therefore highly welcome.  The authors describe here the PAMPA (Parallel Artificial Membrane Permeation Assay) method, a simple, robust, high throughput screen (HTS) which has been shown to be predictive for passive diffusion through membranes and thus for oral absorption.  In addn. PAMPA can deliver information in parallel on the lipophilicity, the ionization state and the soly. of a compd.  Therefore PAMPA complements HTS, combinatorial chem. and parallel synthesis efforts in preclin. pharmaceutical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqcwCGodCr1rVg90H21EOLACvtfcHk0lj-uiK7ey7CxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D&md5=85d8ab409313b583de52348eb4d895da</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm970530e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970530e%26sid%3Dliteratum%253Aachs%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DSenner%26aufirst%3DF.%26aulast%3DGubernator%26aufirst%3DK.%26atitle%3DPhysicochemical%2520High%2520Throughput%2520Screening%253A%2520Parallel%2520Artificial%2520Membrane%2520Permeation%2520Assay%2520in%2520the%2520Description%2520of%2520Passive%2520Absorption%2520Processes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1007%26epage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="note"><p class="first last">The ability of <b>17k</b> to inhibit 328 human protein/lipid kinases in either in vitro activity or binding assays was determined at a combination of GlaxoSmithKline, University of Dundee, Millipore Research and Development, and Ambit Biosciences.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Hardwicke, M. A.; Liao, Q.; Oleykowski, K. A.; Plant, R.; Wang, J.; Anderson, K.; Jingsong, Y.; Lai, Z.; Silva, D.; Adams, J.; Copeland, R. A.; Patrick, D.</span><span> </span><span class="NLM_article-title">Biological Characterization of GSK1070916, a Highly Potent and Selective Inhibitor of Aurora B Kinase</span>. April<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="citation_source-journal">AACR</span>, <i>Abstract 5650</i>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+A.+Hardwicke&author=Q.+Liao&author=K.+A.+Oleykowski&author=R.+Plant&author=J.+Wang&author=K.+Anderson&author=Y.+Jingsong&author=Z.+Lai&author=D.+Silva&author=J.+Adams&author=R.+A.+Copeland&author=D.+Patrick&title=Biological+Characterization+of+GSK1070916%2C+a+Highly+Potent+and+Selective+Inhibitor+of+Aurora+B+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHardwicke%26aufirst%3DM.%2BA.%26atitle%3DBiological%2520Characterization%2520of%2520GSK1070916%252C%2520a%2520Highly%2520Potent%2520and%2520Selective%2520Inhibitor%2520of%2520Aurora%2520B%2520Kinase%26date%3D2008%26jtitle%3DAACR" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Silva, D. J.</span><span> </span><span class="NLM_article-title">Investigation of 7-Azaindoles as Developable Kinase Inhibitors: Identification of GSK1070916 as a Highly Potent and Selective Inhibitor of Aurora B Kinase</span>. April<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="citation_source-journal">AACR</span>, <i>Abstract 1296</i>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=D.+J.+Silva&title=Investigation+of+7-Azaindoles+as+Developable+Kinase+Inhibitors%3A+Identification+of+GSK1070916+as+a+Highly+Potent+and+Selective+Inhibitor+of+Aurora+B+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSilva%26aufirst%3DD.%2BJ.%26atitle%3DInvestigation%2520of%25207-Azaindoles%2520as%2520Developable%2520Kinase%2520Inhibitors%253A%2520Identification%2520of%2520GSK1070916%2520as%2520a%2520Highly%2520Potent%2520and%2520Selective%2520Inhibitor%2520of%2520Aurora%2520B%2520Kinase%26date%3D2008%26jtitle%3DAACR" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Nguyen, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnappan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravid, K.</span><span> </span><span class="NLM_article-title">Mechanism of Aurora-B degradation and its dependency on intact KEN and A-boxes: identification of an aneuploidy-promoting property</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4977</span><span class="NLM_x">–</span> <span class="NLM_lpage">4992</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1128%2FMCB.25.12.4977-4992.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=15923616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlt1Ortb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=4977-4992&author=H.+G.+Nguyenauthor=D.+Chinnappanauthor=T.+Uranoauthor=K.+Ravid&title=Mechanism+of+Aurora-B+degradation+and+its+dependency+on+intact+KEN+and+A-boxes%3A+identification+of+an+aneuploidy-promoting+property"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of Aurora-B degradation and its dependency on intact KEN and A-boxes: Identification of an aneuploidy-promoting property</span></div><div class="casAuthors">Nguyen, Hao G.; Chinnappan, Dharmaraj; Urano, Takeshi; Ravid, Katya</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4977-4992</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The kinase Aurora-B, a regulator of chromosome segregation and cytokinesis, is highly expressed in a variety of tumors.  During the cell cycle, the level of this protein is tightly controlled, and its deregulated abundance is suspected to contribute to aneuploidy.  Here, the authors provide evidence that Aurora-B is a short-lived protein degraded by the proteasome via the anaphase-promoting cyclosome complex (APC/c) pathway.  Aurora-B interacts with the APC/c through the Cdc27 subunit, Aurora-B is ubiquitinated, and its level is increased upon treatment with inhibitors of the proteasome.  Aurora-B binds in vivo to the degrdn.-targeting proteins Cdh1 and Cdc20, the overexpression of which accelerates Aurora-B degrdn.  Using deletions or point mutations of the five putative degrdn. signals in Aurora-B, the authors show that degrdn. of this protein does not depend on its D-boxes (RXXL), but it does require intact KEN boxes and A-boxes (QRVL) located within the first 65 amino acids.  Cells transfected with wild-type or A-box-mutated or KEN box-mutated Aurora-B fused to green fluorescent protein display the protein localized to the chromosomes and then to the midzone during mitosis, but the mutated forms are detected at greater intensities.  Hence, the authors identified the degrdn. pathway for Aurora-B as well as crit. regions for its clearance.  Intriguingly, overexpression of a stable form of Aurora-B alone induces aneuploidy and anchorage-independent growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXXKuVhdZdMLVg90H21EOLACvtfcHk0lj-uiK7ey7CxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlt1Ortb8%253D&md5=969b448dde6cc68de3ee868b337e2b05</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1128%2FMCB.25.12.4977-4992.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.25.12.4977-4992.2005%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DH.%2BG.%26aulast%3DChinnappan%26aufirst%3DD.%26aulast%3DUrano%26aufirst%3DT.%26aulast%3DRavid%26aufirst%3DK.%26atitle%3DMechanism%2520of%2520Aurora-B%2520degradation%2520and%2520its%2520dependency%2520on%2520intact%2520KEN%2520and%2520A-boxes%253A%2520identification%2520of%2520an%2520aneuploidy-promoting%2520property%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2005%26volume%3D25%26spage%3D4977%26epage%3D4992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="ref43_1"><span><span class="NLM_contrib-group">Thibault, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhide, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruel, R.</span><span> </span><span class="NLM_article-title">Concise and Efficient Synthesis of 4-Fluoro-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">5023</span><span class="NLM_x">–</span> <span class="NLM_lpage">5025</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol036030z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=5023-5025&author=C.+Thibaultauthor=A.+author=R.+S.+Bhideauthor=R.+Ruel&title=Concise+and+Efficient+Synthesis+of+4-Fluoro-1H-pyrrolo%5B2%2C3-b%5Dpyridine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref43_1&amp;dbid=16384&amp;doi=10.1021%2Fol036030z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol036030z%26sid%3Dliteratum%253Aachs%26aulast%3DThibault%26aufirst%3DC.%26aulast%3D%26aufirst%3DA.%26aulast%3DBhide%26aufirst%3DR.%2BS.%26aulast%3DRuel%26aufirst%3DR.%26atitle%3DConcise%2520and%2520Efficient%2520Synthesis%2520of%25204-Fluoro-1H-pyrrolo%255B2%252C3-b%255Dpyridine%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26spage%3D5023%26epage%3D5025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':[],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':[],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['ref43_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 72 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Andreas Ekebergh, Jerker Mårtensson, <span class="NLM_string-name hlFld-ContribAuthor">Christine Lingblom Ekebergh</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclopenta[b]indole Derivative Inhibits Aurora B in Primary Cells. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (51)
                                     , 33455-33460. <a href="https://doi.org/10.1021/acsomega.0c05491" title="DOI URL">https://doi.org/10.1021/acsomega.0c05491</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c05491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c05491%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DCyclopenta%25255Bb%25255Dindole%252BDerivative%252BInhibits%252BAurora%252BB%252Bin%252BPrimary%252BCells%26aulast%3DEkebergh%26aufirst%3DAndreas%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10112020%26date%3D27112020%26date%3D16122020%26volume%3D5%26issue%3D51%26spage%3D33455%26epage%3D33460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Amit Mahindra, Omar Janha, Kopano Mapesa, Ana Sanchez-Azqueta, Mahmood M. Alam, Alfred Amambua-Ngwa, Davis C. Nwakanma, Andrew B. Tobin, <span class="NLM_string-name hlFld-ContribAuthor">Andrew G. Jamieson</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Potent PfCLK3 Inhibitors Based on TCMDC-135051 as a New Class of Antimalarials. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9300-9315. <a href="https://doi.org/10.1021/acs.jmedchem.0c00451" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00451</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00451%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BPotent%252BPfCLK3%252BInhibitors%252BBased%252Bon%252BTCMDC-135051%252Bas%252Ba%252BNew%252BClass%252Bof%252BAntimalarials%26aulast%3DMahindra%26aufirst%3DAmit%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17032020%26date%3D11082020%26date%3D28072020%26volume%3D63%26issue%3D17%26spage%3D9300%26epage%3D9315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">William
R. F. Goundry, Kuangchu Dai, Miguel Gonzalez, Daniel Legg, Anne O’Kearney-McMullan, James Morrison, Andrew Stark, Paul Siedlecki, Paula Tomlin, <span class="NLM_string-name hlFld-ContribAuthor">Jianbo Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Development and Scale-up of a Route to ATR Inhibitor AZD6738. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2019,</strong> <em>23 </em>
                                    (7)
                                     , 1333-1342. <a href="https://doi.org/10.1021/acs.oprd.9b00075" title="DOI URL">https://doi.org/10.1021/acs.oprd.9b00075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.9b00075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.9b00075%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DDevelopment%252Band%252BScale-up%252Bof%252Ba%252BRoute%252Bto%252BATR%252BInhibitor%252BAZD6738%26aulast%3DGoundry%26aufirst%3DWilliam%2BR.%2BF.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D12022019%26date%3D02072019%26date%3D21062019%26volume%3D23%26issue%3D7%26spage%3D1333%26epage%3D1342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara I.  Purificação</span>, <span class="hlFld-ContribAuthor ">Marina J. D.  Pires</span>, <span class="hlFld-ContribAuthor ">Rafael  Rippel</span>, <span class="hlFld-ContribAuthor ">A. Sofia  Santos</span>, and <span class="hlFld-ContribAuthor ">M. Manuel B.  Marques</span>  . </span><span class="cited-content_cbyCitation_article-title">One-Pot Synthesis of 1,2-Disubstituted 4-, 5-, 6-, and 7-Azaindoles from Amino-o-halopyridines via N-Arylation/Sonogashira/Cyclization Reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (19)
                                     , 5118-5121. <a href="https://doi.org/10.1021/acs.orglett.7b02403" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b02403</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b02403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b02403%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DOne-Pot%252BSynthesis%252Bof%252B1%25252C2-Disubstituted%252B4-%25252C%252B5-%25252C%252B6-%25252C%252Band%252B7-Azaindoles%252Bfrom%252BAmino-o-halopyridines%252Bvia%252BN-Arylation%25252FSonogashira%25252FCyclization%252BReaction%26aulast%3DPurifica%25C3%25A7%25C3%25A3o%26aufirst%3DSara%2BI.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D03082017%26date%3D15092017%26date%3D06102017%26volume%3D19%26issue%3D19%26spage%3D5118%26epage%3D5121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalie  Palaychuk</span>, <span class="hlFld-ContribAuthor ">Travis J.  DeLano</span>, <span class="hlFld-ContribAuthor ">Michael J.  Boyd</span>, <span class="hlFld-ContribAuthor ">Jeremy  Green</span>, and <span class="hlFld-ContribAuthor ">Upul K.  Bandarage</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of Cycloalkyl Substituted 7-Azaindoles via Photoredox Nickel Dual Catalytic Cross-Coupling in Batch and Continuous Flow. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2016,</strong> <em>18 </em>
                                    (23)
                                     , 6180-6183. <a href="https://doi.org/10.1021/acs.orglett.6b03223" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b03223</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b03223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b03223%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252BCycloalkyl%252BSubstituted%252B7-Azaindoles%252Bvia%252BPhotoredox%252BNickel%252BDual%252BCatalytic%252BCross-Coupling%252Bin%252BBatch%252Band%252BContinuous%252BFlow%26aulast%3DPalaychuk%26aufirst%3DNatalie%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D27102016%26date%3D18112016%26date%3D02122016%26volume%3D18%26issue%3D23%26spage%3D6180%26epage%3D6183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marina J. D.  Pires</span>, <span class="hlFld-ContribAuthor ">Diogo L.  Poeira</span>, <span class="hlFld-ContribAuthor ">Sara I.  Purificação</span>, and <span class="hlFld-ContribAuthor ">M. Manuel B.  Marques</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of Substituted 4-, 5-, 6-, and 7-Azaindoles from Aminopyridines via a Cascade C–N Cross-Coupling/Heck Reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2016,</strong> <em>18 </em>
                                    (13)
                                     , 3250-3253. <a href="https://doi.org/10.1021/acs.orglett.6b01500" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b01500</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b01500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b01500%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252BSubstituted%252B4-%25252C%252B5-%25252C%252B6-%25252C%252Band%252B7-Azaindoles%252Bfrom%252BAminopyridines%252Bvia%252Ba%252BCascade%252BC%2525E2%252580%252593N%252BCross-Coupling%25252FHeck%252BReaction%26aulast%3DPires%26aufirst%3DMarina%2BJ.%2BD.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D24052016%26date%3D22062016%26date%3D01072016%26volume%3D18%26issue%3D13%26spage%3D3250%26epage%3D3253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aurélie  Plas</span>, <span class="hlFld-ContribAuthor ">Camille  Martin</span>, <span class="hlFld-ContribAuthor ">Nicolas  Joubert</span>, and <span class="hlFld-ContribAuthor ">Marie-Claude  Viaud-Massuard</span>  . </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Amination of N-Free 2-Chloro-7-azaindole. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2015,</strong> <em>17 </em>
                                    (19)
                                     , 4710-4713. <a href="https://doi.org/10.1021/acs.orglett.5b02173" title="DOI URL">https://doi.org/10.1021/acs.orglett.5b02173</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.5b02173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.5b02173%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPalladium-Catalyzed%252BAmination%252Bof%252BN-Free%252B2-Chloro-7-azaindole%26aulast%3DPlas%26aufirst%3DAur%25C3%25A9lie%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D27072015%26date%3D21092015%26date%3D02102015%26volume%3D17%26issue%3D19%26spage%3D4710%26epage%3D4713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephanie  Geuns-Meyer</span>, <span class="hlFld-ContribAuthor ">Victor J.  Cee</span>, <span class="hlFld-ContribAuthor ">Holly L.  Deak</span>, <span class="hlFld-ContribAuthor ">Bingfan  Du</span>, <span class="hlFld-ContribAuthor ">Brian L.  Hodous</span>, <span class="hlFld-ContribAuthor ">Hanh Nho  Nguyen</span>, <span class="hlFld-ContribAuthor ">Philip R.  Olivieri</span>, <span class="hlFld-ContribAuthor ">Laurie B.  Schenkel</span>, <span class="hlFld-ContribAuthor ">Karina R.  Vaida</span>, <span class="hlFld-ContribAuthor ">Paul  Andrews</span>, <span class="hlFld-ContribAuthor ">Annette  Bak</span>, <span class="hlFld-ContribAuthor ">Xuhai  Be</span>, <span class="hlFld-ContribAuthor ">Pedro J.  Beltran</span>, <span class="hlFld-ContribAuthor ">Tammy L.  Bush</span>, <span class="hlFld-ContribAuthor ">Mary K.  Chaves</span>, <span class="hlFld-ContribAuthor ">Grace  Chung</span>, <span class="hlFld-ContribAuthor ">Yang  Dai</span>, <span class="hlFld-ContribAuthor ">Patrick  Eden</span>, <span class="hlFld-ContribAuthor ">Kelly  Hanestad</span>, <span class="hlFld-ContribAuthor ">Liyue  Huang</span>, <span class="hlFld-ContribAuthor ">Min-Hwa Jasmine  Lin</span>, <span class="hlFld-ContribAuthor ">Jin  Tang</span>, <span class="hlFld-ContribAuthor ">Beth  Ziegler</span>, <span class="hlFld-ContribAuthor ">Robert  Radinsky</span>, <span class="hlFld-ContribAuthor ">Richard  Kendall</span>, <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>, and <span class="hlFld-ContribAuthor ">Marc  Payton</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of N-(4-(3-(2-Aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine (AMG 900), A Highly Selective, Orally Bioavailable Inhibitor of Aurora Kinases with Activity against Multidrug-Resistant Cancer Cell Lines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (13)
                                     , 5189-5207. <a href="https://doi.org/10.1021/acs.jmedchem.5b00183" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00183</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00183%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-%2525284-%2525283-%2525282-Aminopyrimidin-4-yl%252529pyridin-2-yloxy%252529phenyl%252529-4-%2525284-methylthiophen-2-yl%252529phthalazin-1-amine%252B%252528AMG%252B900%252529%25252C%252BA%252BHighly%252BSelective%25252C%252BOrally%252BBioavailable%252BInhibitor%252Bof%252BAurora%252BKinases%252Bwith%252BActivity%252Bagainst%252BMultidrug-Resistant%252BCancer%252BCell%252BLines%26aulast%3DGeuns-Meyer%26aufirst%3DStephanie%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D01022015%26date%3D31052015%26date%3D09072015%26date%3D13052015%26volume%3D58%26issue%3D13%26spage%3D5189%26epage%3D5207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter W.  Jurutka</span>, <span class="hlFld-ContribAuthor ">Ichiro  Kaneko</span>, <span class="hlFld-ContribAuthor ">Joanna  Yang</span>, <span class="hlFld-ContribAuthor ">Jaskaran S.  Bhogal</span>, <span class="hlFld-ContribAuthor ">Johnathon C.  Swierski</span>, <span class="hlFld-ContribAuthor ">Christa R.  Tabacaru</span>, <span class="hlFld-ContribAuthor ">Luis A.  Montano</span>, <span class="hlFld-ContribAuthor ">Chanh C.  Huynh</span>, <span class="hlFld-ContribAuthor ">Rabia A.  Jama</span>, <span class="hlFld-ContribAuthor ">Ryan D.  Mahelona</span>, <span class="hlFld-ContribAuthor ">Joseph T.  Sarnowski</span>, <span class="hlFld-ContribAuthor ">Lisa M.  Marcus</span>, <span class="hlFld-ContribAuthor ">Alexis  Quezada</span>, <span class="hlFld-ContribAuthor ">Brittney  Lemming</span>, <span class="hlFld-ContribAuthor ">Maria A.  Tedesco</span>, <span class="hlFld-ContribAuthor ">Audra J.  Fischer</span>, <span class="hlFld-ContribAuthor ">Said A.  Mohamed</span>, <span class="hlFld-ContribAuthor ">Joseph W.  Ziller</span>, <span class="hlFld-ContribAuthor ">Ning  Ma</span>, <span class="hlFld-ContribAuthor ">Geoffrey M.  Gray</span>, <span class="hlFld-ContribAuthor ">Arjan  van der Vaart</span>, <span class="hlFld-ContribAuthor ">Pamela A.  Marshall</span>, and <span class="hlFld-ContribAuthor ">Carl E.  Wagner</span>  . </span><span class="cited-content_cbyCitation_article-title">Modeling, Synthesis, and Biological Evaluation of Potential Retinoid X Receptor (RXR) Selective Agonists: Novel Analogues of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and (E)-3-(3-(1,2,3,4-tetrahydro-1,1,4,4,6-pentamethylnaphthalen-7-yl)-4-hydroxyphenyl)acrylic Acid (CD3254). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (21)
                                     , 8432-8454. <a href="https://doi.org/10.1021/jm4008517" title="DOI URL">https://doi.org/10.1021/jm4008517</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4008517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4008517%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DModeling%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BPotential%252BRetinoid%252BX%252BReceptor%252B%252528RXR%252529%252BSelective%252BAgonists%25253A%252BNovel%252BAnalogues%252Bof%252B4-%25255B1-%2525283%25252C5%25252C5%25252C8%25252C8-Pentamethyl-5%25252C6%25252C7%25252C8-tetrahydro-2-naphthyl%252529ethynyl%25255Dbenzoic%252BAcid%252B%252528Bexarotene%252529%252Band%252B%252528E%252529-3-%2525283-%2525281%25252C2%25252C3%25252C4-tetrahydro-1%25252C1%25252C4%25252C4%25252C6-pentamethylnaphthalen-7-yl%252529-4-hydroxyphenyl%252529acrylic%252BAcid%252B%252528CD3254%252529%26aulast%3DJurutka%26aufirst%3DPeter%2BW.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D10062013%26date%3D01112013%26date%3D14112013%26volume%3D56%26issue%3D21%26spage%3D8432%26epage%3D8454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harshani R.  Lawrence</span>, <span class="hlFld-ContribAuthor ">Mathew P.  Martin</span>, <span class="hlFld-ContribAuthor ">Yunting  Luo</span>, <span class="hlFld-ContribAuthor ">Roberta  Pireddu</span>, <span class="hlFld-ContribAuthor ">Hua  Yang</span>, <span class="hlFld-ContribAuthor ">Harsukh  Gevariya</span>, <span class="hlFld-ContribAuthor ">Sevil  Ozcan</span>, <span class="hlFld-ContribAuthor ">Jin-Yi  Zhu</span>, <span class="hlFld-ContribAuthor ">Robert  Kendig</span>, <span class="hlFld-ContribAuthor ">Mercedes  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Roy  Elias</span>, <span class="hlFld-ContribAuthor ">Jin Q.  Cheng</span>, <span class="hlFld-ContribAuthor ">Saïd M.  Sebti</span>, <span class="hlFld-ContribAuthor ">Ernst  Schonbrunn</span>, and <span class="hlFld-ContribAuthor ">Nicholas J.  Lawrence</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of o-Chlorophenyl Substituted Pyrimidines as Exceptionally Potent Aurora Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (17)
                                     , 7392-7416. <a href="https://doi.org/10.1021/jm300334d" title="DOI URL">https://doi.org/10.1021/jm300334d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300334d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300334d%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Bo-Chlorophenyl%252BSubstituted%252BPyrimidines%252Bas%252BExceptionally%252BPotent%252BAurora%252BKinase%252BInhibitors%26aulast%3DLawrence%26aufirst%3DHarshani%2BR.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D09032012%26date%3D30082012%26date%3D13092012%26date%3D17072012%26volume%3D55%26issue%3D17%26spage%3D7392%26epage%3D7416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan M.  Elkins</span>, <span class="hlFld-ContribAuthor ">Stefano  Santaguida</span>, <span class="hlFld-ContribAuthor ">Andrea  Musacchio</span>, and <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>  . </span><span class="cited-content_cbyCitation_article-title">Crystal Structure of Human Aurora B in Complex with INCENP and VX-680. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (17)
                                     , 7841-7848. <a href="https://doi.org/10.1021/jm3008954" title="DOI URL">https://doi.org/10.1021/jm3008954</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3008954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3008954%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCrystal%252BStructure%252Bof%252BHuman%252BAurora%252BB%252Bin%252BComplex%252Bwith%252BINCENP%252Band%252BVX-680%26aulast%3DElkins%26aufirst%3DJonathan%2BM.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D25062012%26date%3D04092012%26date%3D13092012%26date%3D27082012%26volume%3D55%26issue%3D17%26spage%3D7841%26epage%3D7848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael E.  Prime</span>, <span class="hlFld-ContribAuthor ">Stephen M.  Courtney</span>, <span class="hlFld-ContribAuthor ">Frederick A.  Brookfield</span>, <span class="hlFld-ContribAuthor ">Richard W.  Marston</span>, <span class="hlFld-ContribAuthor ">Victoria  Walker</span>, <span class="hlFld-ContribAuthor ">Justin  Warne</span>, <span class="hlFld-ContribAuthor ">Andrew E.  Boyd</span>, <span class="hlFld-ContribAuthor ">Norman A.  Kairies</span>, <span class="hlFld-ContribAuthor ">Wolfgang  von der Saal</span>, <span class="hlFld-ContribAuthor ">Anja  Limberg</span>, <span class="hlFld-ContribAuthor ">Guy  Georges</span>, <span class="hlFld-ContribAuthor ">Richard A.  Engh</span>, <span class="hlFld-ContribAuthor ">Bernhard  Goller</span>, <span class="hlFld-ContribAuthor ">Petra  Rueger</span>, and <span class="hlFld-ContribAuthor ">Matthias  Rueth</span>  . </span><span class="cited-content_cbyCitation_article-title">Phthalazinone Pyrazoles as Potent, Selective, and Orally Bioavailable Inhibitors of Aurora-A Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (1)
                                     , 312-319. <a href="https://doi.org/10.1021/jm101346r" title="DOI URL">https://doi.org/10.1021/jm101346r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm101346r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm101346r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPhthalazinone%252BPyrazoles%252Bas%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BInhibitors%252Bof%252BAurora-A%252BKinase%26aulast%3DPrime%26aufirst%3DMichael%2BE.%26date%3D2011%26date%3D2010%26date%3D2010%26date%3D18102010%26date%3D03122010%26date%3D13012011%26volume%3D54%26issue%3D1%26spage%3D312%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaksha  Sankhe</span>, <span class="hlFld-ContribAuthor ">Arati  Prabhu</span>, <span class="hlFld-ContribAuthor ">Tabassum  Khan</span>. </span><span class="cited-content_cbyCitation_article-title">Design strategies, SAR, and mechanistic insight of Aurora kinase inhibitors in cancer. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2021,</strong> <em>98 </em>
                                    (1)
                                     , 73-93. <a href="https://doi.org/10.1111/cbdd.13850" title="DOI URL">https://doi.org/10.1111/cbdd.13850</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13850%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDesign%252Bstrategies%25252C%252BSAR%25252C%252Band%252Bmechanistic%252Binsight%252Bof%252BAurora%252Bkinase%252Binhibitors%252Bin%252Bcancer%26aulast%3DSankhe%26aufirst%3DKaksha%26date%3D2021%26date%3D2021%26volume%3D98%26issue%3D1%26spage%3D73%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roman S.  Malykhin</span>, <span class="hlFld-ContribAuthor ">Alexey Yu.  Sukhorukov</span>. </span><span class="cited-content_cbyCitation_article-title">Nucleophilic Halogenation of Heterocyclic
              N
              ‐Oxides: Recent Progress and a Practical Guide. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2021,</strong> <em>363 </em>
                                    (13)
                                     , 3170-3188. <a href="https://doi.org/10.1002/adsc.202100284" title="DOI URL">https://doi.org/10.1002/adsc.202100284</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202100284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202100284%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DNucleophilic%252BHalogenation%252Bof%252BHeterocyclic%252BN%252B%2525E2%252580%252590Oxides%25253A%252BRecent%252BProgress%252Band%252Ba%252BPractical%252BGuide%26aulast%3DMalykhin%26aufirst%3DRoman%2BS.%26date%3D2021%26date%3D2021%26volume%3D363%26issue%3D13%26spage%3D3170%26epage%3D3188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pedro  Novais</span>, <span class="hlFld-ContribAuthor ">Patrícia M. A.  Silva</span>, <span class="hlFld-ContribAuthor ">Isabel  Amorim</span>, <span class="hlFld-ContribAuthor ">Hassan  Bousbaa</span>. </span><span class="cited-content_cbyCitation_article-title">Second-Generation Antimitotics in Cancer Clinical Trials. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutics</span><span> <strong>2021,</strong> <em>13 </em>
                                    (7)
                                     , 1011. <a href="https://doi.org/10.3390/pharmaceutics13071011" title="DOI URL">https://doi.org/10.3390/pharmaceutics13071011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pharmaceutics13071011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpharmaceutics13071011%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutics%26atitle%3DSecond-Generation%252BAntimitotics%252Bin%252BCancer%252BClinical%252BTrials%26aulast%3DNovais%26aufirst%3DPedro%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D7%26spage%3D1011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naheed Arfin  Borah</span>, <span class="hlFld-ContribAuthor ">Mamatha M.  Reddy</span>. </span><span class="cited-content_cbyCitation_article-title">Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (7)
                                     , 1981. <a href="https://doi.org/10.3390/molecules26071981" title="DOI URL">https://doi.org/10.3390/molecules26071981</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26071981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26071981%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAurora%252BKinase%252BB%252BInhibition%25253A%252BA%252BPotential%252BTherapeutic%252BStrategy%252Bfor%252BCancer%26aulast%3DBorah%26aufirst%3DNaheed%2BArfin%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D7%26spage%3D1981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhuo-Xun  Wu</span>, <span class="hlFld-ContribAuthor ">Qiuyan  Mai</span>, <span class="hlFld-ContribAuthor ">Yuqi  Yang</span>, <span class="hlFld-ContribAuthor ">Jing-Quan  Wang</span>, <span class="hlFld-ContribAuthor ">Hansu  Ma</span>, <span class="hlFld-ContribAuthor ">Leli  Zeng</span>, <span class="hlFld-ContribAuthor ">Zhe-Sheng  Chen</span>, <span class="hlFld-ContribAuthor ">Yihang  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">Overexpression of human ATP-binding cassette transporter ABCG2 contributes to reducing the cytotoxicity of GSK1070916 in cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2021,</strong> <em>136 </em>, 111223. <a href="https://doi.org/10.1016/j.biopha.2021.111223" title="DOI URL">https://doi.org/10.1016/j.biopha.2021.111223</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2021.111223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2021.111223%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DOverexpression%252Bof%252Bhuman%252BATP-binding%252Bcassette%252Btransporter%252BABCG2%252Bcontributes%252Bto%252Breducing%252Bthe%252Bcytotoxicity%252Bof%252BGSK1070916%252Bin%252Bcancer%252Bcells%26aulast%3DWu%26aufirst%3DZhuo-Xun%26date%3D2021%26volume%3D136%26spage%3D111223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhuo-Xun  Wu</span>, <span class="hlFld-ContribAuthor ">Yuqi  Yang</span>, <span class="hlFld-ContribAuthor ">Jing-Quan  Wang</span>, <span class="hlFld-ContribAuthor ">Wen-Min  Zhou</span>, <span class="hlFld-ContribAuthor ">Junyu  Chen</span>, <span class="hlFld-ContribAuthor ">Yi-Ge  Fu</span>, <span class="hlFld-ContribAuthor ">Ketankumar  Patel</span>, <span class="hlFld-ContribAuthor ">Zhe-Sheng  Chen</span>, <span class="hlFld-ContribAuthor ">Jian-Ye  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Elevated ABCB1 Expression Confers Acquired Resistance to Aurora Kinase Inhibitor GSK-1070916 in Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.615824" title="DOI URL">https://doi.org/10.3389/fphar.2020.615824</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.615824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.615824%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DElevated%252BABCB1%252BExpression%252BConfers%252BAcquired%252BResistance%252Bto%252BAurora%252BKinase%252BInhibitor%252BGSK-1070916%252Bin%252BCancer%252BCells%26aulast%3DWu%26aufirst%3DZhuo-Xun%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Majd S.  Hijjawi</span>, <span class="hlFld-ContribAuthor ">Reem Fawaz  Abutayeh</span>, <span class="hlFld-ContribAuthor ">Mutasem O.  Taha</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Discovery and Bioactivity Evaluation of Novel Aurora-A Kinase Inhibitors as Anticancer Agents via Docking-Based Comparative Intermolecular Contacts Analysis (dbCICA). </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (24)
                                     , 6003. <a href="https://doi.org/10.3390/molecules25246003" title="DOI URL">https://doi.org/10.3390/molecules25246003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25246003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25246003%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DStructure-Based%252BDiscovery%252Band%252BBioactivity%252BEvaluation%252Bof%252BNovel%252BAurora-A%252BKinase%252BInhibitors%252Bas%252BAnticancer%252BAgents%252Bvia%252BDocking-Based%252BComparative%252BIntermolecular%252BContacts%252BAnalysis%252B%252528dbCICA%252529%26aulast%3DHijjawi%26aufirst%3DMajd%2BS.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D24%26spage%3D6003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Han</span>, <span class="hlFld-ContribAuthor ">Wei  Dong</span>, <span class="hlFld-ContribAuthor ">Qunqun  Guo</span>, <span class="hlFld-ContribAuthor ">Xiufen  Li</span>, <span class="hlFld-ContribAuthor ">Longjiang  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">The importance of indole and azaindole scaffold in the development of antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>203 </em>, 112506. <a href="https://doi.org/10.1016/j.ejmech.2020.112506" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112506</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112506%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bimportance%252Bof%252Bindole%252Band%252Bazaindole%252Bscaffold%252Bin%252Bthe%252Bdevelopment%252Bof%252Bantitumor%252Bagents%26aulast%3DHan%26aufirst%3DYu%26date%3D2020%26volume%3D203%26spage%3D112506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naga Rajiv  Lakkaniga</span>, <span class="hlFld-ContribAuthor ">Lingtian  Zhang</span>, <span class="hlFld-ContribAuthor ">Binyam  Belachew</span>, <span class="hlFld-ContribAuthor ">Naresh  Gunaganti</span>, <span class="hlFld-ContribAuthor ">Brendan  Frett</span>, <span class="hlFld-ContribAuthor ">Hong-yu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of SP-96, the first non-ATP-competitive Aurora Kinase B inhibitor, for reduced myelosuppression. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>203 </em>, 112589. <a href="https://doi.org/10.1016/j.ejmech.2020.112589" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112589</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112589%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BSP-96%25252C%252Bthe%252Bfirst%252Bnon-ATP-competitive%252BAurora%252BKinase%252BB%252Binhibitor%25252C%252Bfor%252Breduced%252Bmyelosuppression%26aulast%3DLakkaniga%26aufirst%3DNaga%2BRajiv%26date%3D2020%26volume%3D203%26spage%3D112589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Urvashi</span>, <span class="hlFld-ContribAuthor ">Mohammad Ovais  Dar</span>, <span class="hlFld-ContribAuthor ">Prasad V.  Bharatam</span>, <span class="hlFld-ContribAuthor ">Parthasarathi  Das</span>, <span class="hlFld-ContribAuthor ">Shrikant  Kukreti</span>, <span class="hlFld-ContribAuthor ">Vibha  Tandon</span>. </span><span class="cited-content_cbyCitation_article-title">Cu(II)-catalyzed sulfonylation of 7-azaindoles using DABSO as SO2-Source and its mechanistic study. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (28-29)
                                     , 131337. <a href="https://doi.org/10.1016/j.tet.2020.131337" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131337</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131337%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DCu%252528II%252529-catalyzed%252Bsulfonylation%252Bof%252B7-azaindoles%252Busing%252BDABSO%252Bas%252BSO2-Source%252Band%252Bits%252Bmechanistic%252Bstudy%26aulast%3DUrvashi%26date%3D2020%26volume%3D76%26issue%3D28-29%26spage%3D131337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiyuan  Li</span>, <span class="hlFld-ContribAuthor ">Xiaofei  Tian</span>, <span class="hlFld-ContribAuthor ">Xinmiao  Ji</span>, <span class="hlFld-ContribAuthor ">Junjun  Wang</span>, <span class="hlFld-ContribAuthor ">Hanxiao  Chen</span>, <span class="hlFld-ContribAuthor ">Dongmei  Wang</span>, <span class="hlFld-ContribAuthor ">Xin  Zhang</span>, . </span><span class="cited-content_cbyCitation_article-title">ULK1-ATG13 and their mitotic phospho-regulation by CDK1 connect autophagy to cell cycle. </span><span class="cited-content_cbyCitation_journal-name">PLOS Biology</span><span> <strong>2020,</strong> <em>18 </em>
                                    (6)
                                     , e3000288. <a href="https://doi.org/10.1371/journal.pbio.3000288" title="DOI URL">https://doi.org/10.1371/journal.pbio.3000288</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pbio.3000288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pbio.3000288%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Biology%26atitle%3DULK1-ATG13%252Band%252Btheir%252Bmitotic%252Bphospho-regulation%252Bby%252BCDK1%252Bconnect%252Bautophagy%252Bto%252Bcell%252Bcycle%26aulast%3DLi%26aufirst%3DZhiyuan%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D6%26spage%3De3000288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi  Le</span>, <span class="hlFld-ContribAuthor ">Zhisong  Yang</span>, <span class="hlFld-ContribAuthor ">Yumei  Chen</span>, <span class="hlFld-ContribAuthor ">Dongmei  Chen</span>, <span class="hlFld-ContribAuthor ">Longjia  Yan</span>, <span class="hlFld-ContribAuthor ">Zhenchao  Wang</span>, <span class="hlFld-ContribAuthor ">Guiping  Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-assisted synthesis of 7-azaindoles
              via
              iron-catalyzed cyclization of an
              o
              -haloaromatic amine with terminal alkynes. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (68)
                                     , 39684-39688. <a href="https://doi.org/10.1039/C9RA08742G" title="DOI URL">https://doi.org/10.1039/C9RA08742G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA08742G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA08742G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DMicrowave-assisted%252Bsynthesis%252Bof%252B7-azaindoles%252Bvia%252Biron-catalyzed%252Bcyclization%252Bof%252Ban%252Bo%252B-haloaromatic%252Bamine%252Bwith%252Bterminal%252Balkynes%26aulast%3DLe%26aufirst%3DYi%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D68%26spage%3D39684%26epage%3D39688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khadija  Belasri</span>, <span class="hlFld-ContribAuthor ">Ferenc  Fülöp</span>, <span class="hlFld-ContribAuthor ">István  Szatmári</span>. </span><span class="cited-content_cbyCitation_article-title">Solvent-Free C-3 Coupling of Azaindoles with Cyclic Imines. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (19)
                                     , 3578. <a href="https://doi.org/10.3390/molecules24193578" title="DOI URL">https://doi.org/10.3390/molecules24193578</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24193578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24193578%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSolvent-Free%252BC-3%252BCoupling%252Bof%252BAzaindoles%252Bwith%252BCyclic%252BImines%26aulast%3DBelasri%26aufirst%3DKhadija%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D19%26spage%3D3578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah  Wang</span>, <span class="hlFld-ContribAuthor ">Elizabeth E.  Hwang</span>, <span class="hlFld-ContribAuthor ">Rajarshi  Guha</span>, <span class="hlFld-ContribAuthor ">Allison F.  O'Neill</span>, <span class="hlFld-ContribAuthor ">Nicole  Melong</span>, <span class="hlFld-ContribAuthor ">Chansey J.  Veinotte</span>, <span class="hlFld-ContribAuthor ">Amy  Conway Saur</span>, <span class="hlFld-ContribAuthor ">Kellsey  Wuerthele</span>, <span class="hlFld-ContribAuthor ">Min  Shen</span>, <span class="hlFld-ContribAuthor ">Crystal  McKnight</span>, <span class="hlFld-ContribAuthor ">Gabriela  Alexe</span>, <span class="hlFld-ContribAuthor ">Madeleine E.  Lemieux</span>, <span class="hlFld-ContribAuthor ">Amy  Wang</span>, <span class="hlFld-ContribAuthor ">Emma  Hughes</span>, <span class="hlFld-ContribAuthor ">Xin  Xu</span>, <span class="hlFld-ContribAuthor ">Matthew B.  Boxer</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Hall</span>, <span class="hlFld-ContribAuthor ">Andrew  Kung</span>, <span class="hlFld-ContribAuthor ">Jason N.  Berman</span>, <span class="hlFld-ContribAuthor ">Mindy I.  Davis</span>, <span class="hlFld-ContribAuthor ">Kimberly  Stegmaier</span>, <span class="hlFld-ContribAuthor ">Brian D.  Crompton</span>. </span><span class="cited-content_cbyCitation_article-title">High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2019,</strong> <em>25 </em>
                                    (14)
                                     , 4552-4566. <a href="https://doi.org/10.1158/1078-0432.CCR-17-0375" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-17-0375</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-17-0375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-17-0375%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DHigh-throughput%252BChemical%252BScreening%252BIdentifies%252BFocal%252BAdhesion%252BKinase%252Band%252BAurora%252BKinase%252BB%252BInhibition%252Bas%252Ba%252BSynergistic%252BTreatment%252BCombination%252Bin%252BEwing%252BSarcoma%26aulast%3DWang%26aufirst%3DSarah%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D14%26spage%3D4552%26epage%3D4566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael E.  Dalziel</span>, <span class="hlFld-ContribAuthor ">Jignesh J.  Patel</span>, <span class="hlFld-ContribAuthor ">Meagan K.  Kaye</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Cosman</span>, <span class="hlFld-ContribAuthor ">Matthew O.  Kitching</span>, <span class="hlFld-ContribAuthor ">Victor  Snieckus</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective Functionalization of 7‐Azaindole by Controlled Annular Isomerism: The Directed Metalation‐Group Dance. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2019,</strong> <em>131 </em>
                                    (22)
                                     , 7391-7395. <a href="https://doi.org/10.1002/ange.201901724" title="DOI URL">https://doi.org/10.1002/ange.201901724</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201901724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201901724%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DRegioselective%252BFunctionalization%252Bof%252B7%2525E2%252580%252590Azaindole%252Bby%252BControlled%252BAnnular%252BIsomerism%25253A%252BThe%252BDirected%252BMetalation%2525E2%252580%252590Group%252BDance%26aulast%3DDalziel%26aufirst%3DMichael%2BE.%26date%3D2019%26date%3D2019%26volume%3D131%26issue%3D22%26spage%3D7391%26epage%3D7395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael E.  Dalziel</span>, <span class="hlFld-ContribAuthor ">Jignesh J.  Patel</span>, <span class="hlFld-ContribAuthor ">Meagan K.  Kaye</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Cosman</span>, <span class="hlFld-ContribAuthor ">Matthew O.  Kitching</span>, <span class="hlFld-ContribAuthor ">Victor  Snieckus</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective Functionalization of 7‐Azaindole by Controlled Annular Isomerism: The Directed Metalation‐Group Dance. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2019,</strong> <em>58 </em>
                                    (22)
                                     , 7313-7317. <a href="https://doi.org/10.1002/anie.201901724" title="DOI URL">https://doi.org/10.1002/anie.201901724</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201901724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201901724%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DRegioselective%252BFunctionalization%252Bof%252B7%2525E2%252580%252590Azaindole%252Bby%252BControlled%252BAnnular%252BIsomerism%25253A%252BThe%252BDirected%252BMetalation%2525E2%252580%252590Group%252BDance%26aulast%3DDalziel%26aufirst%3DMichael%2BE.%26date%3D2019%26volume%3D58%26issue%3D22%26spage%3D7313%26epage%3D7317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric W.  Lake</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Muretta</span>, <span class="hlFld-ContribAuthor ">Andrew R.  Thompson</span>, <span class="hlFld-ContribAuthor ">Damien M.  Rasmussen</span>, <span class="hlFld-ContribAuthor ">Abir  Majumdar</span>, <span class="hlFld-ContribAuthor ">Erik B.  Faber</span>, <span class="hlFld-ContribAuthor ">Emily F.  Ruff</span>, <span class="hlFld-ContribAuthor ">David D.  Thomas</span>, <span class="hlFld-ContribAuthor ">Nicholas M.  Levinson</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative conformational profiling of kinase inhibitors reveals origins of selectivity for Aurora kinase activation states. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2018,</strong> <em>115 </em>
                                    (51)
                                     , E11894-E11903. <a href="https://doi.org/10.1073/pnas.1811158115" title="DOI URL">https://doi.org/10.1073/pnas.1811158115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1811158115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1811158115%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DQuantitative%252Bconformational%252Bprofiling%252Bof%252Bkinase%252Binhibitors%252Breveals%252Borigins%252Bof%252Bselectivity%252Bfor%252BAurora%252Bkinase%252Bactivation%252Bstates%26aulast%3DLake%26aufirst%3DEric%2BW.%26date%3D2018%26date%3D2018%26volume%3D115%26issue%3D51%26spage%3DE11894%26epage%3DE11903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vasileios  Stathias</span>, <span class="hlFld-ContribAuthor ">Anna M.  Jermakowicz</span>, <span class="hlFld-ContribAuthor ">Marie E.  Maloof</span>, <span class="hlFld-ContribAuthor ">Michele  Forlin</span>, <span class="hlFld-ContribAuthor ">Winston  Walters</span>, <span class="hlFld-ContribAuthor ">Robert K.  Suter</span>, <span class="hlFld-ContribAuthor ">Michael A.  Durante</span>, <span class="hlFld-ContribAuthor ">Sion L.  Williams</span>, <span class="hlFld-ContribAuthor ">J. William  Harbour</span>, <span class="hlFld-ContribAuthor ">Claude-Henry  Volmar</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Lyons</span>, <span class="hlFld-ContribAuthor ">Claes  Wahlestedt</span>, <span class="hlFld-ContribAuthor ">Regina M.  Graham</span>, <span class="hlFld-ContribAuthor ">Michael E.  Ivan</span>, <span class="hlFld-ContribAuthor ">Ricardo J.  Komotar</span>, <span class="hlFld-ContribAuthor ">Jann N.  Sarkaria</span>, <span class="hlFld-ContribAuthor ">Aravind  Subramanian</span>, <span class="hlFld-ContribAuthor ">Todd R.  Golub</span>, <span class="hlFld-ContribAuthor ">Stephan C.  Schürer</span>, <span class="hlFld-ContribAuthor ">Nagi G.  Ayad</span>. </span><span class="cited-content_cbyCitation_article-title">Drug and disease signature integration identifies synergistic combinations in glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2018,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-018-07659-z" title="DOI URL">https://doi.org/10.1038/s41467-018-07659-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-018-07659-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-018-07659-z%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DDrug%252Band%252Bdisease%252Bsignature%252Bintegration%252Bidentifies%252Bsynergistic%252Bcombinations%252Bin%252Bglioblastoma%26aulast%3DStathias%26aufirst%3DVasileios%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manjunatha  Narayanarao</span>, <span class="hlFld-ContribAuthor ">Lokesh  Koodlur</span>, <span class="hlFld-ContribAuthor ">Subramanya  Gopal</span>, <span class="hlFld-ContribAuthor ">Suman Y.  Reddy</span>, <span class="hlFld-ContribAuthor ">Susmita  Kamila</span>. </span><span class="cited-content_cbyCitation_article-title">A one-pot three-component synthesis of fused Spiro-Indoline/Indene derivatives derived from ethynyl azaindole by 1,3-dipolar cycloaddition reaction. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2018,</strong> <em>48 </em>
                                    (18)
                                     , 2441-2451. <a href="https://doi.org/10.1080/00397911.2018.1508722" title="DOI URL">https://doi.org/10.1080/00397911.2018.1508722</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2018.1508722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2018.1508722%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DA%252Bone-pot%252Bthree-component%252Bsynthesis%252Bof%252Bfused%252BSpiro-Indoline%25252FIndene%252Bderivatives%252Bderived%252Bfrom%252Bethynyl%252Bazaindole%252Bby%252B1%25252C3-dipolar%252Bcycloaddition%252Breaction%26aulast%3DNarayanarao%26aufirst%3DManjunatha%26date%3D2018%26date%3D2018%26volume%3D48%26issue%3D18%26spage%3D2441%26epage%3D2451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel J.  Price</span>, <span class="hlFld-ContribAuthor ">David H.  Drewry</span>, <span class="hlFld-ContribAuthor ">Lee T.  Schaller</span>, <span class="hlFld-ContribAuthor ">Brian D.  Thompson</span>, <span class="hlFld-ContribAuthor ">Paul R.  Reid</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Maloney</span>, <span class="hlFld-ContribAuthor ">Xi  Liang</span>, <span class="hlFld-ContribAuthor ">Periette  Banker</span>, <span class="hlFld-ContribAuthor ">Richard G.  Buckholz</span>, <span class="hlFld-ContribAuthor ">Paula K.  Selley</span>, <span class="hlFld-ContribAuthor ">Octerloney B.  McDonald</span>, <span class="hlFld-ContribAuthor ">Jeffery L.  Smith</span>, <span class="hlFld-ContribAuthor ">Todd W.  Shearer</span>, <span class="hlFld-ContribAuthor ">Richard F.  Cox</span>, <span class="hlFld-ContribAuthor ">Shawn P.  Williams</span>, <span class="hlFld-ContribAuthor ">Robert A.  Reid</span>, <span class="hlFld-ContribAuthor ">Stefano  Tacconi</span>, <span class="hlFld-ContribAuthor ">Federico  Faggioni</span>, <span class="hlFld-ContribAuthor ">Chiara  Piubelli</span>, <span class="hlFld-ContribAuthor ">Ilaria  Sartori</span>, <span class="hlFld-ContribAuthor ">Michela  Tessari</span>, <span class="hlFld-ContribAuthor ">Tony Y.  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">An orally available, brain-penetrant CAMKK2 inhibitor reduces food intake in rodent model. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (10)
                                     , 1958-1963. <a href="https://doi.org/10.1016/j.bmcl.2018.03.034" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.03.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.03.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.03.034%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAn%252Borally%252Bavailable%25252C%252Bbrain-penetrant%252BCAMKK2%252Binhibitor%252Breduces%252Bfood%252Bintake%252Bin%252Brodent%252Bmodel%26aulast%3DPrice%26aufirst%3DDaniel%2BJ.%26date%3D2018%26volume%3D28%26issue%3D10%26spage%3D1958%26epage%3D1963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina  Viganó</span>, <span class="hlFld-ContribAuthor ">Conrad  von Schubert</span>, <span class="hlFld-ContribAuthor ">Erik  Ahrné</span>, <span class="hlFld-ContribAuthor ">Alexander  Schmidt</span>, <span class="hlFld-ContribAuthor ">Thomas  Lorber</span>, <span class="hlFld-ContribAuthor ">Lukas  Bubendorf</span>, <span class="hlFld-ContribAuthor ">Judith R. F.  De Vetter</span>, <span class="hlFld-ContribAuthor ">Guido J. R.  Zaman</span>, <span class="hlFld-ContribAuthor ">Zuzana  Storchova</span>, <span class="hlFld-ContribAuthor ">Erich A.  Nigg</span>, . </span><span class="cited-content_cbyCitation_article-title">Quantitative proteomic and phosphoproteomic comparison of human colon cancer DLD-1 cells differing in ploidy and chromosome stability. </span><span class="cited-content_cbyCitation_journal-name">Molecular Biology of the Cell</span><span> <strong>2018,</strong> <em>29 </em>
                                    (9)
                                     , 1031-1047. <a href="https://doi.org/10.1091/mbc.E17-10-0577" title="DOI URL">https://doi.org/10.1091/mbc.E17-10-0577</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1091/mbc.E17-10-0577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1091%2Fmbc.E17-10-0577%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Biology%2520of%2520the%2520Cell%26atitle%3DQuantitative%252Bproteomic%252Band%252Bphosphoproteomic%252Bcomparison%252Bof%252Bhuman%252Bcolon%252Bcancer%252BDLD-1%252Bcells%252Bdiffering%252Bin%252Bploidy%252Band%252Bchromosome%252Bstability%26aulast%3DVigan%25C3%25B3%26aufirst%3DCristina%26date%3D2018%26volume%3D29%26issue%3D9%26spage%3D1031%26epage%3D1047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaokun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Discovery of FGF/FGFR Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 339-383. <a href="https://doi.org/10.1016/B978-0-12-816142-5.00006-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-816142-5.00006-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816142-5.00006-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816142-5.00006-0%26sid%3Dliteratum%253Aachs%26atitle%3DDesign%252Band%252BDiscovery%252Bof%252BFGF%25252FFGFR%252BInhibitors%26aulast%3DLi%26aufirst%3DXiaokun%26date%3D2018%26spage%3D339%26epage%3D383%26pub%3DElsevier%26atitle%3DFibroblast%252BGrowth%252BFactors%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takayuki  Irie</span>, <span class="hlFld-ContribAuthor ">Masaaki  Sawa</span>. </span><span class="cited-content_cbyCitation_article-title">7-Azaindole: A Versatile Scaffold for Developing Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">CHEMICAL & PHARMACEUTICAL BULLETIN</span><span> <strong>2018,</strong> <em>66 </em>
                                    (1)
                                     , 29-36. <a href="https://doi.org/10.1248/cpb.c17-00380" title="DOI URL">https://doi.org/10.1248/cpb.c17-00380</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c17-00380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c17-00380%26sid%3Dliteratum%253Aachs%26jtitle%3DCHEMICAL%2520%2526%2520PHARMACEUTICAL%2520BULLETIN%26atitle%3D7-Azaindole%25253A%252BA%252BVersatile%252BScaffold%252Bfor%252BDeveloping%252BKinase%252BInhibitors%26aulast%3DIrie%26aufirst%3DTakayuki%26date%3D2018%26volume%3D66%26issue%3D1%26spage%3D29%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ankit C.  Borisa</span>, <span class="hlFld-ContribAuthor ">Hardik G.  Bhatt</span>. </span><span class="cited-content_cbyCitation_article-title">A comprehensive review on Aurora kinase: Small molecule inhibitors and clinical trial studies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>140 </em>, 1-19. <a href="https://doi.org/10.1016/j.ejmech.2017.08.045" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.08.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.08.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.08.045%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bcomprehensive%252Breview%252Bon%252BAurora%252Bkinase%25253A%252BSmall%252Bmolecule%252Binhibitors%252Band%252Bclinical%252Btrial%252Bstudies%26aulast%3DBorisa%26aufirst%3DAnkit%2BC.%26date%3D2017%26volume%3D140%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vânia  Diogo</span>, <span class="hlFld-ContribAuthor ">Joana  Teixeira</span>, <span class="hlFld-ContribAuthor ">Patrícia M.A.  Silva</span>, <span class="hlFld-ContribAuthor ">Hassan  Bousbaa</span>. </span><span class="cited-content_cbyCitation_article-title">Spindle Assembly Checkpoint as a Potential Target in Colorectal Cancer: Current Status and Future Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Clinical Colorectal Cancer</span><span> <strong>2017,</strong> <em>16 </em>
                                    (1)
                                     , 1-8. <a href="https://doi.org/10.1016/j.clcc.2016.06.006" title="DOI URL">https://doi.org/10.1016/j.clcc.2016.06.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.clcc.2016.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.clcc.2016.06.006%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Colorectal%2520Cancer%26atitle%3DSpindle%252BAssembly%252BCheckpoint%252Bas%252Ba%252BPotential%252BTarget%252Bin%252BColorectal%252BCancer%25253A%252BCurrent%252BStatus%252Band%252BFuture%252BPerspectives%26aulast%3DDiogo%26aufirst%3DV%25C3%25A2nia%26date%3D2017%26volume%3D16%26issue%3D1%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prakash  Kannaboina</span>, <span class="hlFld-ContribAuthor ">Gaurav  Raina</span>, <span class="hlFld-ContribAuthor ">K.  Anil Kumar</span>, <span class="hlFld-ContribAuthor ">Parthasarathi  Das</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-catalyzed aminocarbonylation of halo-substituted 7-azaindoles and other heteroarenes using chloroform as a carbon monoxide source. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2017,</strong> <em>53 </em>
                                    (68)
                                     , 9446-9449. <a href="https://doi.org/10.1039/C7CC04339B" title="DOI URL">https://doi.org/10.1039/C7CC04339B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7CC04339B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7CC04339B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DPalladium-catalyzed%252Baminocarbonylation%252Bof%252Bhalo-substituted%252B7-azaindoles%252Band%252Bother%252Bheteroarenes%252Busing%252Bchloroform%252Bas%252Ba%252Bcarbon%252Bmonoxide%252Bsource%26aulast%3DKannaboina%26aufirst%3DPrakash%26date%3D2017%26date%3D2017%26volume%3D53%26issue%3D68%26spage%3D9446%26epage%3D9449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi  Hu</span>, <span class="hlFld-ContribAuthor ">Jian-Hua  Mao</span>, <span class="hlFld-ContribAuthor ">Christina  Curtis</span>, <span class="hlFld-ContribAuthor ">Ge  Huang</span>, <span class="hlFld-ContribAuthor ">Shenda  Gu</span>, <span class="hlFld-ContribAuthor ">Laura  Heiser</span>, <span class="hlFld-ContribAuthor ">Marc E.  Lenburg</span>, <span class="hlFld-ContribAuthor ">James E.  Korkola</span>, <span class="hlFld-ContribAuthor ">Nora  Bayani</span>, <span class="hlFld-ContribAuthor ">Shamith  Samarajiwa</span>, <span class="hlFld-ContribAuthor ">Jose A.  Seoane</span>, <span class="hlFld-ContribAuthor ">Mark A.  Dane</span>, <span class="hlFld-ContribAuthor ">Amanda  Esch</span>, <span class="hlFld-ContribAuthor ">Heidi S.  Feiler</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Wang</span>, <span class="hlFld-ContribAuthor ">Mary Ann  Hardwicke</span>, <span class="hlFld-ContribAuthor ">Sylvie  Laquerre</span>, <span class="hlFld-ContribAuthor ">Jeff  Jackson</span>, <span class="hlFld-ContribAuthor ">Kenneth  W. Wood</span>, <span class="hlFld-ContribAuthor ">Barbara  Weber</span>, <span class="hlFld-ContribAuthor ">Paul T.  Spellman</span>, <span class="hlFld-ContribAuthor ">Samuel  Aparicio</span>, <span class="hlFld-ContribAuthor ">Richard  Wooster</span>, <span class="hlFld-ContribAuthor ">Carlos  Caldas</span>, <span class="hlFld-ContribAuthor ">Joe W.  Gray</span>. </span><span class="cited-content_cbyCitation_article-title">Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Breast Cancer Research</span><span> <strong>2016,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13058-016-0728-y" title="DOI URL">https://doi.org/10.1186/s13058-016-0728-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13058-016-0728-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13058-016-0728-y%26sid%3Dliteratum%253Aachs%26jtitle%3DBreast%2520Cancer%2520Research%26atitle%3DGenome%252Bco-amplification%252Bupregulates%252Ba%252Bmitotic%252Bgene%252Bnetwork%252Bactivity%252Bthat%252Bpredicts%252Boutcome%252Band%252Bresponse%252Bto%252Bmitotic%252Bprotein%252Binhibitors%252Bin%252Bbreast%252Bcancer%26aulast%3DHu%26aufirst%3DZhi%26date%3D2016%26date%3D2016%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeffrey G.  Varnes</span>, <span class="hlFld-ContribAuthor ">Thomas  McGuire</span>, <span class="hlFld-ContribAuthor ">Rebecca E.  Meadows</span>, <span class="hlFld-ContribAuthor ">Bernard  Barlaam</span>, <span class="hlFld-ContribAuthor ">Jemma  Clark</span>, <span class="hlFld-ContribAuthor ">Calum R.  Cook</span>, <span class="hlFld-ContribAuthor ">Gemma  Davison</span>, <span class="hlFld-ContribAuthor ">Allan  Dishington</span>, <span class="hlFld-ContribAuthor ">Chris  De Savi</span>, <span class="hlFld-ContribAuthor ">Craig  Donald</span>, <span class="hlFld-ContribAuthor ">Tyler  Grebe</span>, <span class="hlFld-ContribAuthor ">Sudhir  Hande</span>, <span class="hlFld-ContribAuthor ">Janet  Hawkins</span>, <span class="hlFld-ContribAuthor ">Alexander W.  Hird</span>, <span class="hlFld-ContribAuthor ">Jane  Holmes</span>, <span class="hlFld-ContribAuthor ">Andrew  Lister</span>, <span class="hlFld-ContribAuthor ">Simon  Lucas</span>, <span class="hlFld-ContribAuthor ">Jane  Moore</span>, <span class="hlFld-ContribAuthor ">Esther  Moore</span>, <span class="hlFld-ContribAuthor ">Anil  Patel</span>, <span class="hlFld-ContribAuthor ">Kurt G.  Pike</span>, <span class="hlFld-ContribAuthor ">Bryan  Roberts</span>, <span class="hlFld-ContribAuthor ">Andrew  Stark</span>, <span class="hlFld-ContribAuthor ">Darren  Stead</span>, <span class="hlFld-ContribAuthor ">Kumar  Thakur</span>, <span class="hlFld-ContribAuthor ">Paul  Turner</span>, <span class="hlFld-ContribAuthor ">Melissa  Vasbinder</span>, <span class="hlFld-ContribAuthor ">Bin  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">General methods for the synthesis and late-stage diversification of 2,4-substituted 7-azaindoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2016,</strong> <em>57 </em>
                                    (42)
                                     , 4718-4722. <a href="https://doi.org/10.1016/j.tetlet.2016.09.029" title="DOI URL">https://doi.org/10.1016/j.tetlet.2016.09.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2016.09.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2016.09.029%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DGeneral%252Bmethods%252Bfor%252Bthe%252Bsynthesis%252Band%252Blate-stage%252Bdiversification%252Bof%252B2%25252C4-substituted%252B7-azaindoles%26aulast%3DVarnes%26aufirst%3DJeffrey%2BG.%26date%3D2016%26volume%3D57%26issue%3D42%26spage%3D4718%26epage%3D4722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonas  Cicenas</span>. </span><span class="cited-content_cbyCitation_article-title">The Aurora kinase inhibitors in cancer research and therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cancer Research and Clinical Oncology</span><span> <strong>2016,</strong> <em>142 </em>
                                    (9)
                                     , 1995-2012. <a href="https://doi.org/10.1007/s00432-016-2136-1" title="DOI URL">https://doi.org/10.1007/s00432-016-2136-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00432-016-2136-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00432-016-2136-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cancer%2520Research%2520and%2520Clinical%2520Oncology%26atitle%3DThe%252BAurora%252Bkinase%252Binhibitors%252Bin%252Bcancer%252Bresearch%252Band%252Btherapy%26aulast%3DCicenas%26aufirst%3DJonas%26date%3D2016%26date%3D2016%26volume%3D142%26issue%3D9%26spage%3D1995%26epage%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cameron T  Durlacher</span>, <span class="hlFld-ContribAuthor ">Zhi-Ling  Li</span>, <span class="hlFld-ContribAuthor ">Xiao-Wu  Chen</span>, <span class="hlFld-ContribAuthor ">Zhi-Xu  He</span>, <span class="hlFld-ContribAuthor ">Shu-Feng  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">An update on the pharmacokinetics and pharmacodynamics of alisertib, a selective Aurora kinase A inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Clinical and Experimental Pharmacology and Physiology</span><span> <strong>2016,</strong> <em>43 </em>
                                    (6)
                                     , 585-601. <a href="https://doi.org/10.1111/1440-1681.12571" title="DOI URL">https://doi.org/10.1111/1440-1681.12571</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/1440-1681.12571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2F1440-1681.12571%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520and%2520Experimental%2520Pharmacology%2520and%2520Physiology%26atitle%3DAn%252Bupdate%252Bon%252Bthe%252Bpharmacokinetics%252Band%252Bpharmacodynamics%252Bof%252Balisertib%25252C%252Ba%252Bselective%252BAurora%252Bkinase%252BA%252Binhibitor%26aulast%3DDurlacher%26aufirst%3DCameron%2BT%26date%3D2016%26date%3D2016%26volume%3D43%26issue%3D6%26spage%3D585%26epage%3D601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Morzyk-Ociepa</span>, <span class="hlFld-ContribAuthor ">Karolina  Dysz</span>, <span class="hlFld-ContribAuthor ">Ilona  Turowska-Tyrk</span>, <span class="hlFld-ContribAuthor ">Danuta  Michalska</span>. </span><span class="cited-content_cbyCitation_article-title">New trans-dichloropalladium(II) complexes of 7-azaindole: Crystal and molecular structures, FT-IR, FT-Raman and DFT studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2016,</strong> <em>1103 </em>, 202-211. <a href="https://doi.org/10.1016/j.molstruc.2015.09.019" title="DOI URL">https://doi.org/10.1016/j.molstruc.2015.09.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2015.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2015.09.019%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DNew%252Btrans-dichloropalladium%252528II%252529%252Bcomplexes%252Bof%252B7-azaindole%25253A%252BCrystal%252Band%252Bmolecular%252Bstructures%25252C%252BFT-IR%25252C%252BFT-Raman%252Band%252BDFT%252Bstudies%26aulast%3DMorzyk-Ociepa%26aufirst%3DBarbara%26date%3D2016%26volume%3D1103%26spage%3D202%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian O.  de Groot</span>, <span class="hlFld-ContribAuthor ">Judy E.  Hsia</span>, <span class="hlFld-ContribAuthor ">John V.  Anzola</span>, <span class="hlFld-ContribAuthor ">Amir  Motamedi</span>, <span class="hlFld-ContribAuthor ">Michelle  Yoon</span>, <span class="hlFld-ContribAuthor ">Yao Liang  Wong</span>, <span class="hlFld-ContribAuthor ">David  Jenkins</span>, <span class="hlFld-ContribAuthor ">Hyun J.  Lee</span>, <span class="hlFld-ContribAuthor ">Mallory B.  Martinez</span>, <span class="hlFld-ContribAuthor ">Robert L.  Davis</span>, <span class="hlFld-ContribAuthor ">Timothy C.  Gahman</span>, <span class="hlFld-ContribAuthor ">Arshad  Desai</span>, <span class="hlFld-ContribAuthor ">Andrew K.  Shiau</span>. </span><span class="cited-content_cbyCitation_article-title">A Cell Biologist’s Field Guide to Aurora Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2015,</strong> <em>5 </em><a href="https://doi.org/10.3389/fonc.2015.00285" title="DOI URL">https://doi.org/10.3389/fonc.2015.00285</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2015.00285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2015.00285%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DA%252BCell%252BBiologist%2525E2%252580%252599s%252BField%252BGuide%252Bto%252BAurora%252BKinase%252BInhibitors%26aulast%3Dde%2BGroot%26aufirst%3DChristian%2BO.%26date%3D2015%26date%3D2015%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eman Z.  Elrazaz</span>, <span class="hlFld-ContribAuthor ">Rabah A.T.  Serya</span>, <span class="hlFld-ContribAuthor ">Nasser S.M.  Ismail</span>, <span class="hlFld-ContribAuthor ">Dalal A.  Abou El Ella</span>, <span class="hlFld-ContribAuthor ">Khaled A.M.  Abouzid</span>. </span><span class="cited-content_cbyCitation_article-title">Thieno[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Future Journal of Pharmaceutical Sciences</span><span> <strong>2015,</strong> <em>1 </em>
                                    (2)
                                     , 33-41. <a href="https://doi.org/10.1016/j.fjps.2015.09.001" title="DOI URL">https://doi.org/10.1016/j.fjps.2015.09.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.fjps.2015.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.fjps.2015.09.001%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DThieno%25255B2%25252C3-d%25255Dpyrimidine%252Bbased%252Bderivatives%252Bas%252Bkinase%252Binhibitors%252Band%252Banticancer%252Bagents%26aulast%3DElrazaz%26aufirst%3DEman%2BZ.%26date%3D2015%26volume%3D1%26issue%3D2%26spage%3D33%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iqra  Choudary</span>, <span class="hlFld-ContribAuthor ">Paul M.  Barr</span>, <span class="hlFld-ContribAuthor ">Jonathan  Friedberg</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the development of Aurora kinases inhibitors in hematological malignancies. </span><span class="cited-content_cbyCitation_journal-name">Therapeutic Advances in Hematology</span><span> <strong>2015,</strong> <em>6 </em>
                                    (6)
                                     , 282-294. <a href="https://doi.org/10.1177/2040620715607415" title="DOI URL">https://doi.org/10.1177/2040620715607415</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2040620715607415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2040620715607415%26sid%3Dliteratum%253Aachs%26jtitle%3DTherapeutic%2520Advances%2520in%2520Hematology%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdevelopment%252Bof%252BAurora%252Bkinases%252Binhibitors%252Bin%252Bhematological%252Bmalignancies%26aulast%3DChoudary%26aufirst%3DIqra%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D6%26spage%3D282%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marina J.  Dias Pires</span>, <span class="hlFld-ContribAuthor ">Diogo L.  Poeira</span>, <span class="hlFld-ContribAuthor ">M. Manuel B.  Marques</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-Catalyzed Cross-Coupling Reactions of Aminopyridines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>2015 </em>
                                    (33)
                                     , 7197-7234. <a href="https://doi.org/10.1002/ejoc.201500952" title="DOI URL">https://doi.org/10.1002/ejoc.201500952</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201500952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201500952%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMetal-Catalyzed%252BCross-Coupling%252BReactions%252Bof%252BAminopyridines%26aulast%3DDias%2BPires%26aufirst%3DMarina%2BJ.%26date%3D2015%26date%3D2015%26volume%3D2015%26issue%3D33%26spage%3D7197%26epage%3D7234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael J.  Waring</span>, <span class="hlFld-ContribAuthor ">Andrew G.  Leach</span>, <span class="hlFld-ContribAuthor ">Duncan C.  Miller</span>. </span><span class="cited-content_cbyCitation_article-title">Challenges in the Medicinal Chemical Optimization of Binding Kinetics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 191-210. <a href="https://doi.org/10.1002/9783527673025.ch10" title="DOI URL">https://doi.org/10.1002/9783527673025.ch10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527673025.ch10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527673025.ch10%26sid%3Dliteratum%253Aachs%26atitle%3DChallenges%252Bin%252Bthe%252BMedicinal%252BChemical%252BOptimization%252Bof%252BBinding%252BKinetics%26aulast%3DWaring%26aufirst%3DMichael%2BJ.%26date%3D2015%26date%3D2015%26spage%3D191%26epage%3D210%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DThermodynamics%252Band%252BKinetics%252Bof%252BDrug%252BBinding%26aulast%3DKeser%25C3%25BC%26aufirst%3DGy%25C3%25B6rgy%2BM.%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leilei  Zhang</span>, <span class="hlFld-ContribAuthor ">Tianming  Yang</span>, <span class="hlFld-ContribAuthor ">Xilei  Xie</span>, <span class="hlFld-ContribAuthor ">Gang  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of 3,5,6-substituted indolin-2-one’s inhibitors of Aurora B by development of a luminescent kinase assay. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (15)
                                     , 2937-2942. <a href="https://doi.org/10.1016/j.bmcl.2015.05.043" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.05.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.05.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.05.043%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252B3%25252C5%25252C6-substituted%252Bindolin-2-one%2525E2%252580%252599s%252Binhibitors%252Bof%252BAurora%252BB%252Bby%252Bdevelopment%252Bof%252Ba%252Bluminescent%252Bkinase%252Bassay%26aulast%3DZhang%26aufirst%3DLeilei%26date%3D2015%26volume%3D25%26issue%3D15%26spage%3D2937%26epage%3D2942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joost C. M.  Uitdehaag</span>, <span class="hlFld-ContribAuthor ">Jeroen A. D. M.  de Roos</span>, <span class="hlFld-ContribAuthor ">Antoon M.  van Doornmalen</span>, <span class="hlFld-ContribAuthor ">Martine B. W.  Prinsen</span>, <span class="hlFld-ContribAuthor ">Jill A. P.  Spijkers-Hagelstein</span>, <span class="hlFld-ContribAuthor ">Judith R. F.  de Vetter</span>, <span class="hlFld-ContribAuthor ">Jos  de Man</span>, <span class="hlFld-ContribAuthor ">Rogier C.  Buijsman</span>, <span class="hlFld-ContribAuthor ">Guido J. R.  Zaman</span>, . </span><span class="cited-content_cbyCitation_article-title">Selective Targeting of CTNNB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing Drugs. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (5)
                                     , e0125021. <a href="https://doi.org/10.1371/journal.pone.0125021" title="DOI URL">https://doi.org/10.1371/journal.pone.0125021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0125021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0125021%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DSelective%252BTargeting%252Bof%252BCTNNB1-%25252C%252BKRAS-%252Bor%252BMYC-Driven%252BCell%252BGrowth%252Bby%252BCombinations%252Bof%252BExisting%252BDrugs%26aulast%3DUitdehaag%26aufirst%3DJoost%2BC.%2BM.%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D5%26spage%3De0125021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanhua  Fan</span>, <span class="hlFld-ContribAuthor ">Hongyuan  Lu</span>, <span class="hlFld-ContribAuthor ">Hongda  Ma</span>, <span class="hlFld-ContribAuthor ">Fan  Feng</span>, <span class="hlFld-ContribAuthor ">Xiaolong  Hu</span>, <span class="hlFld-ContribAuthor ">Qiao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Yongnan  Xu</span>, <span class="hlFld-ContribAuthor ">Qingchun  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Bioactive compounds of Eriocaulon sieboldianum blocking proliferation and inducing apoptosis of HepG2 cells might be involved in Aurora kinase inhibition. </span><span class="cited-content_cbyCitation_journal-name">Food & Function</span><span> <strong>2015,</strong> <em>6 </em>
                                    (12)
                                     , 3746-3759. <a href="https://doi.org/10.1039/C5FO00371G" title="DOI URL">https://doi.org/10.1039/C5FO00371G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5FO00371G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5FO00371G%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520%2526%2520Function%26atitle%3DBioactive%252Bcompounds%252Bof%252BEriocaulon%252Bsieboldianum%252Bblocking%252Bproliferation%252Band%252Binducing%252Bapoptosis%252Bof%252BHepG2%252Bcells%252Bmight%252Bbe%252Binvolved%252Bin%252BAurora%252Bkinase%252Binhibition%26aulast%3DFan%26aufirst%3DYanhua%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D12%26spage%3D3746%26epage%3D3759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Yves  Mérour</span>, <span class="hlFld-ContribAuthor ">Frédéric  Buron</span>, <span class="hlFld-ContribAuthor ">Karen  Plé</span>, <span class="hlFld-ContribAuthor ">Pascal  Bonnet</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>. </span><span class="cited-content_cbyCitation_article-title">The Azaindole Framework in the Design of Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2014,</strong> <em>19 </em>
                                    (12)
                                     , 19935-19979. <a href="https://doi.org/10.3390/molecules191219935" title="DOI URL">https://doi.org/10.3390/molecules191219935</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules191219935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules191219935%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DThe%252BAzaindole%252BFramework%252Bin%252Bthe%252BDesign%252Bof%252BKinase%252BInhibitors%26aulast%3DM%25C3%25A9rour%26aufirst%3DJean-Yves%26date%3D2014%26date%3D2014%26volume%3D19%26issue%3D12%26spage%3D19935%26epage%3D19979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Doohee  Song</span>, <span class="hlFld-ContribAuthor ">Yunjeong  Park</span>, <span class="hlFld-ContribAuthor ">Jieun  Yoon</span>, <span class="hlFld-ContribAuthor ">Waqar  Aman</span>, <span class="hlFld-ContribAuthor ">Jung-Mi  Hah</span>, <span class="hlFld-ContribAuthor ">Jae-Sang  Ryu</span>. </span><span class="cited-content_cbyCitation_article-title">Click approach to the discovery of 1,2,3-triazolylsalicylamides as potent Aurora kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (17)
                                     , 4855-4866. <a href="https://doi.org/10.1016/j.bmc.2014.06.047" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.06.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.06.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.06.047%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DClick%252Bapproach%252Bto%252Bthe%252Bdiscovery%252Bof%252B1%25252C2%25252C3-triazolylsalicylamides%252Bas%252Bpotent%252BAurora%252Bkinase%252Binhibitors%26aulast%3DSong%26aufirst%3DDoohee%26date%3D2014%26volume%3D22%26issue%3D17%26spage%3D4855%26epage%3D4866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonino Maria  Spartà</span>, <span class="hlFld-ContribAuthor ">Daniela  Bressanin</span>, <span class="hlFld-ContribAuthor ">Francesca  Chiarini</span>, <span class="hlFld-ContribAuthor ">Annalisa  Lonetti</span>, <span class="hlFld-ContribAuthor ">Alessandra  Cappellini</span>, <span class="hlFld-ContribAuthor ">Cecilia  Evangelisti</span>, <span class="hlFld-ContribAuthor ">Camilla  Evangelisti</span>, <span class="hlFld-ContribAuthor ">Fraia  Melchionda</span>, <span class="hlFld-ContribAuthor ">Andrea  Pession</span>, <span class="hlFld-ContribAuthor ">Alice  Bertaina</span>, <span class="hlFld-ContribAuthor ">Franco  Locatelli</span>, <span class="hlFld-ContribAuthor ">James A  McCubrey</span>, <span class="hlFld-ContribAuthor ">Alberto M  Martelli</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia. </span><span class="cited-content_cbyCitation_journal-name">Cell Cycle</span><span> <strong>2014,</strong> <em>13 </em>
                                    (14)
                                     , 2237-2247. <a href="https://doi.org/10.4161/cc.29267" title="DOI URL">https://doi.org/10.4161/cc.29267</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4161/cc.29267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4161%2Fcc.29267%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Cycle%26atitle%3DTherapeutic%252Btargeting%252Bof%252BPolo-like%252Bkinase-1%252Band%252BAurora%252Bkinases%252Bin%252BT-cell%252Bacute%252Blymphoblastic%252Bleukemia%26aulast%3DSpart%25C3%25A0%26aufirst%3DAntonino%2BMaria%26date%3D2014%26date%3D2014%26volume%3D13%26issue%3D14%26spage%3D2237%26epage%3D2247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien  Defaux</span>, <span class="hlFld-ContribAuthor ">Maud  Antoine</span>, <span class="hlFld-ContribAuthor ">Marc  Le Borgne</span>, <span class="hlFld-ContribAuthor ">Tilmann  Schuster</span>, <span class="hlFld-ContribAuthor ">Irene  Seipelt</span>, <span class="hlFld-ContribAuthor ">Babette  Aicher</span>, <span class="hlFld-ContribAuthor ">Michael  Teifel</span>, <span class="hlFld-ContribAuthor ">Eckhard  Günther</span>, <span class="hlFld-ContribAuthor ">Matthias  Gerlach</span>, <span class="hlFld-ContribAuthor ">Pascal  Marchand</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 7-Aryl-Substituted (1,5-Naphthyridin-4-yl)ureas as Aurora Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2014,</strong> <em>9 </em>
                                    (1)
                                     , 217-232. <a href="https://doi.org/10.1002/cmdc.201300384" title="DOI URL">https://doi.org/10.1002/cmdc.201300384</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201300384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201300384%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDiscovery%252Bof%252B7-Aryl-Substituted%252B%2525281%25252C5-Naphthyridin-4-yl%252529ureas%252Bas%252BAurora%252BKinase%252BInhibitors%26aulast%3DDefaux%26aufirst%3DJulien%26date%3D2014%26date%3D2013%26volume%3D9%26issue%3D1%26spage%3D217%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Mortlock</span>, <span class="hlFld-ContribAuthor ">K.  Foote</span>, <span class="hlFld-ContribAuthor ">J.  Kettle</span>, <span class="hlFld-ContribAuthor ">B.  Aquila</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.11033-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.11033-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.11033-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.11033-9%26sid%3Dliteratum%253Aachs%26atitle%3DKinase%252BInhibitors%252Bin%252BCancer%26aulast%3DMortlock%26aufirst%3DA.%26date%3D2014%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2014%26volume%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Yves  Mérour</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>, <span class="hlFld-ContribAuthor ">Franck  Suzenet</span>, <span class="hlFld-ContribAuthor ">Benoît  Joseph</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the synthesis and properties of 4-, 5-, 6- or 7-azaindoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2013,</strong> <em>69 </em>
                                    (24)
                                     , 4767-4834. <a href="https://doi.org/10.1016/j.tet.2013.03.081" title="DOI URL">https://doi.org/10.1016/j.tet.2013.03.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2013.03.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2013.03.081%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bsynthesis%252Band%252Bproperties%252Bof%252B4-%25252C%252B5-%25252C%252B6-%2525C2%2525A0or%2525C2%2525A07-azaindoles%26aulast%3DM%25C3%25A9rour%26aufirst%3DJean-Yves%26date%3D2013%26volume%3D69%26issue%3D24%26spage%3D4767%26epage%3D4834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srinivasa  Karra</span>, <span class="hlFld-ContribAuthor ">Yufang  Xiao</span>, <span class="hlFld-ContribAuthor ">Xiaoling  Chen</span>, <span class="hlFld-ContribAuthor ">Lesley  Liu-Bujalski</span>, <span class="hlFld-ContribAuthor ">Bayard  Huck</span>, <span class="hlFld-ContribAuthor ">Amanda  Sutton</span>, <span class="hlFld-ContribAuthor ">Andreas  Goutopoulos</span>, <span class="hlFld-ContribAuthor ">Ben  Askew</span>, <span class="hlFld-ContribAuthor ">Kristopher  Josephson</span>, <span class="hlFld-ContribAuthor ">Xuliang  Jiang</span>, <span class="hlFld-ContribAuthor ">Adam  Shutes</span>, <span class="hlFld-ContribAuthor ">Vikram  Shankar</span>, <span class="hlFld-ContribAuthor ">Tom  Noonan</span>, <span class="hlFld-ContribAuthor ">Gaianne  Garcia-Berrios</span>, <span class="hlFld-ContribAuthor ">Rong  Dong</span>, <span class="hlFld-ContribAuthor ">Mohanraj  Dhanabal</span>, <span class="hlFld-ContribAuthor ">Hui  Tian</span>, <span class="hlFld-ContribAuthor ">Zhenxiong  Wang</span>, <span class="hlFld-ContribAuthor ">A.  Clark</span>, <span class="hlFld-ContribAuthor ">Samantha  Goodstal</span>. </span><span class="cited-content_cbyCitation_article-title">SAR and evaluation of novel 5H-benzo[c][1,8]naphthyridin-6-one analogs as Aurora kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (10)
                                     , 3081-3087. <a href="https://doi.org/10.1016/j.bmcl.2013.03.008" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.03.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.03.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSAR%252Band%252Bevaluation%252Bof%252Bnovel%252B5H-benzo%25255Bc%25255D%25255B1%25252C8%25255Dnaphthyridin-6-one%252Banalogs%252Bas%252BAurora%252Bkinase%252Binhibitors%26aulast%3DKarra%26aufirst%3DSrinivasa%26date%3D2013%26volume%3D23%26issue%3D10%26spage%3D3081%26epage%3D3087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michel D  Wissing</span>, <span class="hlFld-ContribAuthor ">Paul J  van Diest</span>, <span class="hlFld-ContribAuthor ">Elsken  van der Wall</span>, <span class="hlFld-ContribAuthor ">Hans  Gelderblom</span>. </span><span class="cited-content_cbyCitation_article-title">Antimitotic agents for the treatment of patients with metastatic castrate-resistant prostate cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2013,</strong> <em>22 </em>
                                    (5)
                                     , 635-661. <a href="https://doi.org/10.1517/13543784.2013.789858" title="DOI URL">https://doi.org/10.1517/13543784.2013.789858</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2013.789858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2013.789858%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DAntimitotic%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252Bpatients%252Bwith%252Bmetastatic%252Bcastrate-resistant%252Bprostate%252Bcancer%26aulast%3DWissing%26aufirst%3DMichel%2BD%26date%3D2013%26date%3D2013%26volume%3D22%26issue%3D5%26spage%3D635%26epage%3D661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aixia  Yan</span>, <span class="hlFld-ContribAuthor ">Xianglei  Nie</span>, <span class="hlFld-ContribAuthor ">Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Maolin  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Classification of Aurora kinase inhibitors by self-organizing map (SOM) and support vector machine (SVM). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>61 </em>, 73-83. <a href="https://doi.org/10.1016/j.ejmech.2012.06.037" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.06.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.06.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.06.037%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DClassification%252Bof%252BAurora%252Bkinase%252Binhibitors%252Bby%252Bself-organizing%252Bmap%252B%252528SOM%252529%252Band%252Bsupport%252Bvector%252Bmachine%252B%252528SVM%252529%26aulast%3DYan%26aufirst%3DAixia%26date%3D2013%26volume%3D61%26spage%3D73%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Madhu  Kollareddy</span>, <span class="hlFld-ContribAuthor ">Daniella  Zheleva</span>, <span class="hlFld-ContribAuthor ">Petr  Dzubak</span>, <span class="hlFld-ContribAuthor ">Pathik Subhashchandra  Brahmkshatriya</span>, <span class="hlFld-ContribAuthor ">Martin  Lepsik</span>, <span class="hlFld-ContribAuthor ">Marian  Hajduch</span>. </span><span class="cited-content_cbyCitation_article-title">Aurora kinase inhibitors: Progress towards the clinic. </span><span class="cited-content_cbyCitation_journal-name">Investigational New Drugs</span><span> <strong>2012,</strong> <em>30 </em>
                                    (6)
                                     , 2411-2432. <a href="https://doi.org/10.1007/s10637-012-9798-6" title="DOI URL">https://doi.org/10.1007/s10637-012-9798-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10637-012-9798-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10637-012-9798-6%26sid%3Dliteratum%253Aachs%26jtitle%3DInvestigational%2520New%2520Drugs%26atitle%3DAurora%252Bkinase%252Binhibitors%25253A%252BProgress%252Btowards%252Bthe%252Bclinic%26aulast%3DKollareddy%26aufirst%3DMadhu%26date%3D2012%26date%3D2012%26volume%3D30%26issue%3D6%26spage%3D2411%26epage%3D2432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guang  Liang</span>, <span class="hlFld-ContribAuthor ">Zhiguo  Liu</span>, <span class="hlFld-ContribAuthor ">Jianzhang  Wu</span>, <span class="hlFld-ContribAuthor ">Yuepiao  Cai</span>, <span class="hlFld-ContribAuthor ">Xiaokun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer molecules targeting fibroblast growth factor receptors. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2012,</strong> <em>33 </em>
                                    (10)
                                     , 531-541. <a href="https://doi.org/10.1016/j.tips.2012.07.001" title="DOI URL">https://doi.org/10.1016/j.tips.2012.07.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2012.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2012.07.001%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DAnticancer%252Bmolecules%252Btargeting%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptors%26aulast%3DLiang%26aufirst%3DGuang%26date%3D2012%26volume%3D33%26issue%3D10%26spage%3D531%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joost CM  Uitdehaag</span>, <span class="hlFld-ContribAuthor ">Folkert  Verkaar</span>, <span class="hlFld-ContribAuthor ">Husam  Alwan</span>, <span class="hlFld-ContribAuthor ">Jos  de Man</span>, <span class="hlFld-ContribAuthor ">Rogier C  Buijsman</span>, <span class="hlFld-ContribAuthor ">Guido JR  Zaman</span>. </span><span class="cited-content_cbyCitation_article-title">A guide to picking the most selective kinase inhibitor tool compounds for pharmacological validation of drug targets. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2012,</strong> <em>166 </em>
                                    (3)
                                     , 858-876. <a href="https://doi.org/10.1111/j.1476-5381.2012.01859.x" title="DOI URL">https://doi.org/10.1111/j.1476-5381.2012.01859.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1476-5381.2012.01859.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1476-5381.2012.01859.x%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DA%252Bguide%252Bto%252Bpicking%252Bthe%252Bmost%252Bselective%252Bkinase%252Binhibitor%252Btool%252Bcompounds%252Bfor%252Bpharmacological%252Bvalidation%252Bof%252Bdrug%252Btargets%26aulast%3DUitdehaag%26aufirst%3DJoost%2BCM%26date%3D2012%26date%3D2012%26volume%3D166%26issue%3D3%26spage%3D858%26epage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan  How</span>, <span class="hlFld-ContribAuthor ">Karen  Yee</span>. </span><span class="cited-content_cbyCitation_article-title">ENMD-2076 for hematological malignancies. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2012,</strong> <em>21 </em>
                                    (5)
                                     , 717-732. <a href="https://doi.org/10.1517/13543784.2012.668882" title="DOI URL">https://doi.org/10.1517/13543784.2012.668882</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2012.668882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2012.668882%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DENMD-2076%252Bfor%252Bhematological%252Bmalignancies%26aulast%3DHow%26aufirst%3DJonathan%26date%3D2012%26date%3D2012%26volume%3D21%26issue%3D5%26spage%3D717%26epage%3D732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramsay E.  Beveridge</span>, <span class="hlFld-ContribAuthor ">Brian S.  Gerstenberger</span>. </span><span class="cited-content_cbyCitation_article-title">A direct copper-catalyzed route to pyrrolo-fused heterocycles from boronic acids. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2012,</strong> <em>53 </em>
                                    (5)
                                     , 564-569. <a href="https://doi.org/10.1016/j.tetlet.2011.11.091" title="DOI URL">https://doi.org/10.1016/j.tetlet.2011.11.091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2011.11.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2011.11.091%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bdirect%252Bcopper-catalyzed%252Broute%252Bto%252Bpyrrolo-fused%252Bheterocycles%252Bfrom%252Bboronic%252Bacids%26aulast%3DBeveridge%26aufirst%3DRamsay%2BE.%26date%3D2012%26volume%3D53%26issue%3D5%26spage%3D564%26epage%3D569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sudipta  Roy</span>, <span class="hlFld-ContribAuthor ">Sujata  Roy</span>, <span class="hlFld-ContribAuthor ">Gordon W.  Gribble</span>. </span><span class="cited-content_cbyCitation_article-title">Metalation of Pyrazoles and Indazoles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 155-260. <a href="https://doi.org/10.1007/7081_2012_82" title="DOI URL">https://doi.org/10.1007/7081_2012_82</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7081_2012_82&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7081_2012_82%26sid%3Dliteratum%253Aachs%26atitle%3DMetalation%252Bof%252BPyrazoles%252Band%252BIndazoles%26aulast%3DRoy%26aufirst%3DSudipta%26date%3D2012%26date%3D2012%26spage%3D155%26epage%3D260%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DMetalation%252Bof%252BAzoles%252Band%252BRelated%252BFive-Membered%252BRing%252BHeterocycles%26aulast%3DGribble%26aufirst%3DGordon%2BW.%26date%3D2012%26volume%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher  Moy</span>, <span class="hlFld-ContribAuthor ">Catherine A  Oleykowski</span>, <span class="hlFld-ContribAuthor ">Ramona  Plant</span>, <span class="hlFld-ContribAuthor ">Joel  Greshock</span>, <span class="hlFld-ContribAuthor ">Junping  Jing</span>, <span class="hlFld-ContribAuthor ">Kurtis  Bachman</span>, <span class="hlFld-ContribAuthor ">Mary Ann  Hardwicke</span>, <span class="hlFld-ContribAuthor ">Richard  Wooster</span>, <span class="hlFld-ContribAuthor ">Yan  Degenhardt</span>. </span><span class="cited-content_cbyCitation_article-title">High Chromosome Number in hematological cancer cell lines is a Negative Predictor of Response to the inhibition of Aurora B and C by GSK1070916. </span><span class="cited-content_cbyCitation_journal-name">Journal of Translational Medicine</span><span> <strong>2011,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/1479-5876-9-110" title="DOI URL">https://doi.org/10.1186/1479-5876-9-110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/1479-5876-9-110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2F1479-5876-9-110%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Translational%2520Medicine%26atitle%3DHigh%252BChromosome%252BNumber%252Bin%252Bhematological%252Bcancer%252Bcell%252Blines%252Bis%252Ba%252BNegative%252BPredictor%252Bof%252BResponse%252Bto%252Bthe%252Binhibition%252Bof%252BAurora%252BB%252Band%252BC%252Bby%252BGSK1070916%26aulast%3DMoy%26aufirst%3DChristopher%26date%3D2011%26date%3D2011%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chun Hei Antonio  Cheung</span>, <span class="hlFld-ContribAuthor ">Mohane Selvaraj  Coumar</span>, <span class="hlFld-ContribAuthor ">Jang-Yang  Chang</span>, <span class="hlFld-ContribAuthor ">Hsing-Pang  Hsieh</span>. </span><span class="cited-content_cbyCitation_article-title">Aurora kinase inhibitor patents and agents in clinical testing: an update (2009 – 10). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2011,</strong> <em>21 </em>
                                    (6)
                                     , 857-884. <a href="https://doi.org/10.1517/13543776.2011.574614" title="DOI URL">https://doi.org/10.1517/13543776.2011.574614</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2011.574614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2011.574614%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DAurora%252Bkinase%252Binhibitor%252Bpatents%252Band%252Bagents%252Bin%252Bclinical%252Btesting%25253A%252Ban%252Bupdate%252B%2525282009%252B%2525E2%252580%252593%252B10%252529%26aulast%3DCheung%26aufirst%3DChun%2BHei%2BAntonio%26date%3D2011%26date%3D2011%26volume%3D21%26issue%3D6%26spage%3D857%26epage%3D884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Lan</span>, <span class="hlFld-ContribAuthor ">Wan-Na  Chen</span>, <span class="hlFld-ContribAuthor ">Ping-Hua  Sun</span>, <span class="hlFld-ContribAuthor ">Wei-Min  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR and molecular docking studies of azaindole derivatives as Aurora B kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2011,</strong> <em>17 </em>
                                    (5)
                                     , 1191-1205. <a href="https://doi.org/10.1007/s00894-010-0820-7" title="DOI URL">https://doi.org/10.1007/s00894-010-0820-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-010-0820-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-010-0820-7%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3D3D-QSAR%252Band%252Bmolecular%252Bdocking%252Bstudies%252Bof%252Bazaindole%252Bderivatives%252Bas%252BAurora%252BB%252Bkinase%252Binhibitors%26aulast%3DLan%26aufirst%3DPing%26date%3D2011%26date%3D2010%26volume%3D17%26issue%3D5%26spage%3D1191%26epage%3D1205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Lan</span>, <span class="hlFld-ContribAuthor ">Wan-Na  Chen</span>, <span class="hlFld-ContribAuthor ">Wei-Min  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular modeling studies on imidazo[4,5-b]pyridine derivatives as Aurora A kinase inhibitors using 3D-QSAR and docking approaches. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>46 </em>
                                    (1)
                                     , 77-94. <a href="https://doi.org/10.1016/j.ejmech.2010.10.017" title="DOI URL">https://doi.org/10.1016/j.ejmech.2010.10.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2010.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2010.10.017%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMolecular%252Bmodeling%252Bstudies%252Bon%252Bimidazo%25255B4%25252C5-b%25255Dpyridine%252Bderivatives%252Bas%252BAurora%252BA%252Bkinase%252Binhibitors%252Busing%252B3D-QSAR%252Band%252Bdocking%252Bapproaches%26aulast%3DLan%26aufirst%3DPing%26date%3D2011%26volume%3D46%26issue%3D1%26spage%3D77%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jarosław  Sławiński</span>, <span class="hlFld-ContribAuthor ">Kamil  Brożewicz</span>, <span class="hlFld-ContribAuthor ">Andrzej  Fruziński</span>, <span class="hlFld-ContribAuthor ">Marek  L. Główka</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Antitumor Activity of Novel N’-(2-Benzylthiobenzenesulfonyl)-1H-pyrazole-1-amidine Derivatives. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2011,</strong> <em>83 </em>
                                    (5)
                                     , 1093. <a href="https://doi.org/10.3987/COM-11-12164" title="DOI URL">https://doi.org/10.3987/COM-11-12164</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-11-12164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-11-12164%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DSynthesis%252Band%252BAntitumor%252BActivity%252Bof%252BNovel%252BN%2525E2%252580%252599-%2525282-Benzylthiobenzenesulfonyl%252529-1H-pyrazole-1-amidine%252BDerivatives%26aulast%3DS%25C5%2582awi%25C5%2584ski%26aufirst%3DJaros%25C5%2582aw%26date%3D2011%26volume%3D83%26issue%3D5%26spage%3D1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Baidong  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Huixiao  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunzhi  Ai</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR and Molecular Docking Studies on Derivatives of MK-0457, GSK1070916 and SNS-314 as Inhibitors against Aurora B Kinase. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2010,</strong> <em>11 </em>
                                    (11)
                                     , 4326-4347. <a href="https://doi.org/10.3390/ijms11114326" title="DOI URL">https://doi.org/10.3390/ijms11114326</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms11114326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms11114326%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3D3D-QSAR%252Band%252BMolecular%252BDocking%252BStudies%252Bon%252BDerivatives%252Bof%252BMK-0457%25252C%252BGSK1070916%252Band%252BSNS-314%252Bas%252BInhibitors%252Bagainst%252BAurora%252BB%252BKinase%26aulast%3DZhang%26aufirst%3DBaidong%26date%3D2010%26date%3D2010%26volume%3D11%26issue%3D11%26spage%3D4326%26epage%3D4347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901870q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures and activities of lead Aurora inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901870q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Biological profile and putative binding mode of inhibitor <b>12c</b> in an Aurora B homology model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901870q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of R1 Substituted Azaindole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901870q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DMF·DMA, DMF, 80 °C; (b) hydrazine monohydrate or <i>t</i>-butylhydrazine·hydrochloride, EtOH, 70 °C; (c) NBS, DMF, rt; (d) R1-Br, NaH, DMF, 0 °C to rt; (e) bis(pinacolato)diboron, KOAc, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 1,4-dioxane, 100 °C; (f) Sn(0), 6N HCl, EtOH, 70 °C or Zn, AcOH, rt; (g) PhNCO, pyr, rt; (h) Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF, NaHCO<sub>3</sub> (aq), 100 °C; (i) <b>12i</b>: OsO<sub>4</sub>, NMO, <i>t</i>-BuOH, H<sub>2</sub>O, acetone, rt; <b>12j</b>: 9-BBN, 6N NaOH, 30% H<sub>2</sub>O<sub>2</sub> (aq), THF, H<sub>2</sub>O, 0 °C to rt; (j) <b>12m</b>: ethyl chloroformate, NH<sub>4</sub>OH, TEA, THF, 0 °C to rt; <b>12n</b>: NH<sub>2</sub>Et, EDCI, DMAP, DMF, rt; <b>12o</b>: morpholine, CDI, DMF, rt .</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of R2 and R3 Substituted Azaindole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901870q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R2-Ph-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF, NaHCO<sub>3</sub> (aq), 100 °C; (b) <b>8a</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF, NaHCO<sub>3</sub> (aq), 100 °C; (c) amine, NaBH(OAc)<sub>3</sub>, THF, rt; (d) Sn(0), 6N HCl, EtOH, 70 °C or Zn, AcOH, rt; then 6N NaOH (aq), MeOH, 70 °C; (e) PhNCO or EtNCO, pyr, rt (or TEA, THF, rt), or 4-nitrophenyl chloroformate, TEA, THF, rt, HNMe<sub>2</sub>. *Compounds <b>17a</b> and <b>17b</b> were prepared from <b>15e</b> and <b>15f</b>, respectively, through reduction of the nitro group with palladium hydroxide/hydrogen, urea formation with PhNCO and subsequent deprotection of the phenylsulfonyl group with 6N NaOH (aq); see the <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a> for details.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of R2 Amide Azaindole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901870q&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Me<sub>4</sub>NBr, (MeSO<sub>2</sub>)<sub>2</sub>O, DME; (b) <b>8a</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M K<sub>2</sub>CO<sub>3</sub> (aq), dioxane, 100 °C; (c) EDC or 1,1-carbonyldiimidazole, NH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>R2′′, DMF, rt; (d) Sn(0), 6N HCl, EtOH, 70 °C; (e) PhNCO, pyr, rt.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of R2 Methylamino Azaindole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901870q&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) LDA, THF, hexanes, −78 °C, (ii) DMF; (b) HNR′′′, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>:AcOH (4:1); (c) bis(pinacolato)diboron, KOAc, PdCl<sub>2</sub>(dppf)·CH<sub>2</sub>Cl<sub>2</sub>, 1,4-dioxane, 90 °C; (d) <b>10c</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, satd aq NaHCO<sub>3</sub>, DMF, 100 °C; (e) 6N NaOH, MeOH, 70 °C.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0013.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Kinase selectivity comparison for compounds <b>12c</b>, <b>17c</b>, <b>17j</b>, and <b>17k</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901870q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0014.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of pHH3 after treatment of advanced Colo205 tumors in mice with <b>17k</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901870q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/medium/jm-2009-01870q_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0015.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Evaluation of <b>17k</b> against advanced HL-60 (acute monocytic human leukemia) tumors in nude mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm901870q/production/images/large/jm-2009-01870q_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901870q&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i161">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22422" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22422" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 43 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Andrews, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knatko, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swedlow, J. R.</span><span> </span><span class="NLM_article-title">Mitotic mechanics: the auroras come into view</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">672</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1016%2Fj.ceb.2003.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=14644191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlyks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=672-683&author=P.+D.+Andrewsauthor=E.+Knatkoauthor=W.+J.+Mooreauthor=J.+R.+Swedlow&title=Mitotic+mechanics%3A+the+auroras+come+into+view"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Mitotic mechanics: the auroras come into view</span></div><div class="casAuthors">Andrews, Paul D.; Knatko, Elena; Moore, William J.; Swedlow, Jason R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">672-683</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review and discussion.  Aurora kinases have recently taken center stage in the regulation of key cell cycle processes.  Aurora A kinase is emerging as a crit. regulator of centrosome and spindle function.  Aurora B kinase mediates chromosome segregation by ensuring proper biorientation of sister chromatids, possibly through the regulation of microtubule dynamics.  This enzyme also functions in cytokinesis, apparently by interacting with a crit. GTPase and a kinesin-like protein.  Recent work on both kinases has revealed functional links between aurora kinase activity and the mechanics of cell division.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6JjO4SUgejLVg90H21EOLACvtfcHk0lg69XT14NfmXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlyks74%253D&md5=ef80357f3cec8790ba4cf9742907cc74</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2003.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2003.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DAndrews%26aufirst%3DP.%2BD.%26aulast%3DKnatko%26aufirst%3DE.%26aulast%3DMoore%26aufirst%3DW.%2BJ.%26aulast%3DSwedlow%26aufirst%3DJ.%2BR.%26atitle%3DMitotic%2520mechanics%253A%2520the%2520auroras%2520come%2520into%2520view%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2003%26volume%3D15%26spage%3D672%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Giet, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petretti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prigent, C.</span><span> </span><span class="NLM_article-title">Aurora kinases, aneuploidy and cancer, a coincidence or a real link?</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1016%2Fj.tcb.2005.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=15866028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslKhsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=241-250&author=R.+Gietauthor=C.+Petrettiauthor=C.+Prigent&title=Aurora+kinases%2C+aneuploidy+and+cancer%2C+a+coincidence+or+a+real+link%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Aurora kinases, aneuploidy and cancer, a coincidence or a real link?</span></div><div class="casAuthors">Giet, Regis; Petretti, Clotilde; Prigent, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">241-250</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  As Aurora kinases are overexpressed in a large no. of cancers, and ectopic expression of Aurora generates polyploid cells contg. multiple centrosomes, it has been tempting to suggest that Aurora overexpression provokes genetic instability underlying the tumorigenesis.  However, examn. of the evidence suggests a more complex relationship.  Overexpression of Aurora-A readily transforms rat-1 and NIH3T3 cells, but not primary cells, whereas overexpression of Aurora-B induces metastasis after implantation of tumors in nude mice.  Why do polyploid cells contg. abnormal centrosome nos. induced by Aurora not get eliminated at cell-cycle checkpoints Does this phenotype det. the origin of cancer or does it only promote tumor progression Would drugs against aurora family members be of any help for cancer treatment These and related questions are addressed in this review (which is part of the Chromosome Segregation and Aneuploidy series).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX73sij-ymh7Vg90H21EOLACvtfcHk0ljVgRgFSp9E0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslKhsLc%253D&md5=b792bc5419b14c00fbef86e0b2909c2d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2005.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2005.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DGiet%26aufirst%3DR.%26aulast%3DPetretti%26aufirst%3DC.%26aulast%3DPrigent%26aufirst%3DC.%26atitle%3DAurora%2520kinases%252C%2520aneuploidy%2520and%2520cancer%252C%2520a%2520coincidence%2520or%2520a%2520real%2520link%253F%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2005%26volume%3D15%26spage%3D241%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dar, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P. S.</span><span> </span><span class="NLM_article-title">Targeted anti-mitotic therapies: can we improve on tubulin agents?</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1038%2Fnrc2049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=17251917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFOjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=107-117&author=J.+R.+Jacksonauthor=D.+R.+Patrickauthor=M.+M.+Darauthor=P.+S.+Huang&title=Targeted+anti-mitotic+therapies%3A+can+we+improve+on+tubulin+agents%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted anti-mitotic therapies: can we improve on tubulin agents?</span></div><div class="casAuthors">Jackson, Jeffrey R.; Patrick, Denis R.; Dar, Mohammed M.; Huang, Pearl S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-117</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The advent of molecularly targeted drug discovery has facilitated the identification of a new generation of anti-mitotic therapies that target proteins with specific functions in mitosis.  The exquisite selectivity for mitosis and the distinct ways in which these new agents interfere with mitosis provides the potential to not only overcome certain limitations of current tubulin-targeted anti-mitotic drugs, but to expand the scope of clin. efficacy that those drugs have established.  The development of these new anti-mitotic drugs as targeted therapies faces significant challenges; nevertheless, these potential therapies also serve as unique tools to dissect the mol. mechanisms of the mitotic-checkpoint response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTEI9t3GggVrVg90H21EOLACvtfcHk0ljVgRgFSp9E0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFOjtA%253D%253D&md5=67a94114629154b9be66428e697835bc</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc2049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2049%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DPatrick%26aufirst%3DD.%2BR.%26aulast%3DDar%26aufirst%3DM.%2BM.%26aulast%3DHuang%26aufirst%3DP.%2BS.%26atitle%3DTargeted%2520anti-mitotic%2520therapies%253A%2520can%2520we%2520improve%2520on%2520tubulin%2520agents%253F%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D107%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Keen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span> </span><span class="NLM_article-title">Aurora-kinase inhibitors as anticancer agents</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">936</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1038%2Fnrc1502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=15573114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVarsLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=927-936&author=N.+Keenauthor=S.+Taylor&title=Aurora-kinase+inhibitors+as+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Aurora-kinase inhibitors as anticancer agents</span></div><div class="casAuthors">Keen, Nicholas; Taylor, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">927-936</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Errors in mitosis can provide a source of the genomic instability that is typically assocd. with tumorigenesis.  Many mitotic regulators are aberrantly expressed in tumor cells.  These proteins could therefore make useful therapeutic targets.  The kinases Aurora-A, -B and -C represent a family of such targets and several small-mol. inhibitors have been shown to block their function.  Not only have these inhibitors advanced our understanding of mitosis, but, importantly, their in vivo antitumor activity has recently been reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs8iFKi78djbVg90H21EOLACvtfcHk0ljVgRgFSp9E0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVarsLjN&md5=f1ecc438d3e92963ddc960d0fb1db67c</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc1502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1502%26sid%3Dliteratum%253Aachs%26aulast%3DKeen%26aufirst%3DN.%26aulast%3DTaylor%26aufirst%3DS.%26atitle%3DAurora-kinase%2520inhibitors%2520as%2520anticancer%2520agents%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D927%26epage%3D936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Bischoff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plowman, G. D.</span><span> </span><span class="NLM_article-title">The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">454</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1016%2FS0962-8924%2899%2901658-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=10511710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADyaK1MXmvVGksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=454-459&author=J.+R.+Bischoffauthor=G.+D.+Plowman&title=The+Aurora%2FIpl1p+kinase+family%3A+regulators+of+chromosome+segregation+and+cytokinesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis</span></div><div class="casAuthors">Bischoff, J. R.; Plowman, G. D.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">454-459</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 38 refs.  Members of the Aurora/Ipl1p family of mitotically regulated serine/threonine kinases are emerging as key regulators of chromosome segregation and cytokinesis.  Proper chromosome segregation and cytokinesis ensure that each daughter cell receives the full complement of genetic material.  Defects in these processes can lead to aneuploidy and the propagation of genetic abnormalities.  This review discusses the Aurora/Ipl1p kinases in terms of their protein structure and proposed function in mitotic cells and also the potential role of aurora2 in human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt7ReUrgpYB7Vg90H21EOLACvtfcHk0ljg6_ETmHNTMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvVGksrs%253D&md5=0fc0d81ce1e56a53016800793bc19e27</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2899%2901658-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252899%252901658-X%26sid%3Dliteratum%253Aachs%26aulast%3DBischoff%26aufirst%3DJ.%2BR.%26aulast%3DPlowman%26aufirst%3DG.%2BD.%26atitle%3DThe%2520Aurora%252FIpl1p%2520kinase%2520family%253A%2520regulators%2520of%2520chromosome%2520segregation%2520and%2520cytokinesis%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D1999%26volume%3D9%26spage%3D454%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Cowley, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera-Perez, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schliekelman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Quinn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmon, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Dyke, T.</span><span> </span><span class="NLM_article-title">Aurora-A kinase is essential for bipolar spindle assembly and early development</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1059</span><span class="NLM_x">–</span> <span class="NLM_lpage">1071</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1128%2FMCB.01062-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=19075002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisF2mtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=1059-1071&author=D.+O.+Cowleyauthor=J.+A.+Rivera-Perezauthor=M.+Schliekelmanauthor=Y.+J.+Heauthor=T.+G.+Oliverauthor=L.+Luauthor=R.+O%E2%80%99Quinnauthor=E.+D.+Salmonauthor=T.+Magnusonauthor=T.+Van+Dyke&title=Aurora-A+kinase+is+essential+for+bipolar+spindle+assembly+and+early+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Aurora-A kinase is essential for bipolar spindle formation and early development</span></div><div class="casAuthors">Cowley, Dale O.; Rivera-Perez, Jaime A.; Schliekelman, Mark; He, Yizhou Joseph; Oliver, Trudy G.; Lu, Lucy; O'Quinn, Ryan; Salmon, E. D.; Magnuson, Terry; Van Dyke, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1059-1071</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Aurora-A kinase (I) is a conserved protein kinase implicated in mitotic regulation and carcinogenesis.  I was previously implicated in mitotic entry and spindle assembly, although contradictory results prevented a clear understanding of the roles of I in mammals.  The authors report having developed a conditional null mutation in the mouse I gene to investigate I functions in primary cells ex vivo and in vivo.  Here, the authors show that conditional I ablation in cultured embryonic fibroblasts caused impaired mitotic entry and mitotic arrest with a profound defect in bipolar spindle formation.  Germ line I deficiency caused embryonic death at the blastocyst stage with pronounced cell proliferation failure, mitotic arrest, and monopolar spindle formation.  I deletion in mid-gestation embryos caused an increase in mitotic and apoptotic cells.  These results indicate that murine I facilitates, but is not absolutely required for, mitotic entry in murine embryonic fibroblasts and is essential for centrosome sepn. and bipolar spindle formation in vitro and in vivo.  I deletion increases apoptosis, suggesting that mol. therapies targeting I may be effective in inducing tumor cell apoptosis.  I conditional mutant mice provide a valuable system for further defining I functions and for predicting effects of I therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnHz9s8fPzQLVg90H21EOLACvtfcHk0ljg6_ETmHNTMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisF2mtbw%253D&md5=3063b7056fa2de04305dde7b90af5fd9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1128%2FMCB.01062-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01062-08%26sid%3Dliteratum%253Aachs%26aulast%3DCowley%26aufirst%3DD.%2BO.%26aulast%3DRivera-Perez%26aufirst%3DJ.%2BA.%26aulast%3DSchliekelman%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DY.%2BJ.%26aulast%3DOliver%26aufirst%3DT.%2BG.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Quinn%26aufirst%3DR.%26aulast%3DSalmon%26aufirst%3DE.%2BD.%26aulast%3DMagnuson%26aufirst%3DT.%26aulast%3DVan%2BDyke%26aufirst%3DT.%26atitle%3DAurora-A%2520kinase%2520is%2520essential%2520for%2520bipolar%2520spindle%2520assembly%2520and%2520early%2520development%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2009%26volume%3D29%26spage%3D1059%26epage%3D1071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Anderson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koretke, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurse, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calamari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Z.</span><span> </span><span class="NLM_article-title">Binding of TPX2 to Aurora A alters substrate and inhibitor interactions</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">10287</span><span class="NLM_x">–</span> <span class="NLM_lpage">10295</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi7011355" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=10287-10295&author=K.+Andersonauthor=J.+Yangauthor=K.+Koretkeauthor=K.+Nurseauthor=A.+Calamariauthor=R.+B.+Kirkpatrickauthor=D.+Patrickauthor=D.+Silvaauthor=P.+J.+Tumminoauthor=R.+A.+Copelandauthor=Z.+Lai&title=Binding+of+TPX2+to+Aurora+A+alters+substrate+and+inhibitor+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fbi7011355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi7011355%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DKoretke%26aufirst%3DK.%26aulast%3DNurse%26aufirst%3DK.%26aulast%3DCalamari%26aufirst%3DA.%26aulast%3DKirkpatrick%26aufirst%3DR.%2BB.%26aulast%3DPatrick%26aufirst%3DD.%26aulast%3DSilva%26aufirst%3DD.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DLai%26aufirst%3DZ.%26atitle%3DBinding%2520of%2520TPX2%2520to%2520Aurora%2520A%2520alters%2520substrate%2520and%2520inhibitor%2520interactions%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D10287%26epage%3D10295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smallwood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koretke, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurse, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calamari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Z.</span><span> </span><span class="NLM_article-title">Modulation of kinase-inhibitor interactions by auxiliary protein binding: cyrystallography studies on Aurora A interactions with VX-680 and with TPX2</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1791</span><span class="NLM_x">–</span> <span class="NLM_lpage">1797</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1110%2Fps.036590.108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=18662907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Cit7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1791-1797&author=B.+Zhaoauthor=A.+Smallwoodauthor=J.+Yangauthor=K.+Koretkeauthor=K.+Nurseauthor=A.+Calamariauthor=R.+B.+Kirkpatrickauthor=Z.+Lai&title=Modulation+of+kinase-inhibitor+interactions+by+auxiliary+protein+binding%3A+cyrystallography+studies+on+Aurora+A+interactions+with+VX-680+and+with+TPX2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of kinase-inhibitor interactions by auxiliary protein binding: crystallography studies on Aurora A interactions with VX-680 and with TPX2</span></div><div class="casAuthors">Zhao, Baoguang; Smallwood, Angela; Yang, Jingsong; Koretke, Kristin; Nurse, Kelvin; Calamari, Amy; Kirkpatrick, Robert B.; Lai, Zhihong</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1791-1797</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">VX-680, also known as MK-0457, is an ATP-competitive small mol. inhibitor of the Aurora kinases that has entered phase II clin. trials for the treatment of cancer.  We have solved the cocrystal structure of AurA/TPX2/VX-680 at 2.3 Å resoln.  In the crystal structure, VX-680 binds to the active conformation of AurA.  The glycine-rich loop in AurA adopts a unique bent conformation, forming a π-π interaction with the Ph group of VX-680.  In contrast, in the published AurA/VX-680 structure, VX-680 binds to AurA in the inactive conformation, interacting with a hydrophobic pocket only present in the inactive conformation.  These data suggest that TPX2, a protein cofactor, can alter the binding mode of VX-680 with AurA.  More generally, the presence of physiol. relevant cofactor proteins can alter the kinetics, binding interactions, and inhibition of enzymes, and studies with these multiprotein complexes may be beneficial to the discovery and optimization of enzyme inhibitors as therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7jnb6hGH-SbVg90H21EOLACvtfcHk0lgsS905MVXjnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Cit7rM&md5=622cf5907d6af38a1bc53481fd0b35d4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1110%2Fps.036590.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.036590.108%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DSmallwood%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DKoretke%26aufirst%3DK.%26aulast%3DNurse%26aufirst%3DK.%26aulast%3DCalamari%26aufirst%3DA.%26aulast%3DKirkpatrick%26aufirst%3DR.%2BB.%26aulast%3DLai%26aufirst%3DZ.%26atitle%3DModulation%2520of%2520kinase-inhibitor%2520interactions%2520by%2520auxiliary%2520protein%2520binding%253A%2520cyrystallography%2520studies%2520on%2520Aurora%2520A%2520interactions%2520with%2520VX-680%2520and%2520with%2520TPX2%26jtitle%3DProtein%2520Sci.%26date%3D2008%26volume%3D17%26spage%3D1791%26epage%3D1797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Marumoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saya, H</span><span> </span><span class="NLM_article-title">Aurora A—a guardian of poles</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1038%2Fnrc1526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=15630414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvVen" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=42-50&author=T.+Marumotoauthor=D+Zhangauthor=H+Saya&title=Aurora+A%E2%80%94a+guardian+of+poles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Aurora-A - A guardian of poles</span></div><div class="casAuthors">Marumoto, Tomotoshi; Zhang, Dongwei; Saya, Hideyuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-50</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The three human homologs of Aurora kinases (A, B and C) are essential for proper execution of various mitotic events and are important for maintaining genomic integrity.  Aurora-A is mainly localized at spindle poles and the mitotic spindle during mitosis, where it regulates the functions of centrosomes, spindles and kinetochores required for proper mitotic progression.  Recent studies have revealed that Aurora-A is frequently overexpressed in various cancer cells, indicating its involvement in tumorigenesis.  What are the normal physiol. roles of Aurora-A, how are these regulated and how might the enzyme function during tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ5DkKXAtszrVg90H21EOLACvtfcHk0lgsS905MVXjnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvVen&md5=5eef2a40508d408be784301b20e6822d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrc1526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1526%26sid%3Dliteratum%253Aachs%26aulast%3DMarumoto%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DD%26aulast%3DSaya%26aufirst%3DH%26atitle%3DAurora%2520A%25E2%2580%2594a%2520guardian%2520of%2520poles%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D42%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Girdler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascoigne, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eyers, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmuth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crafter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foote, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keen, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span> </span><span class="NLM_article-title">Validating Aurora B as an anti-cancer drug target</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">3664</span><span class="NLM_x">–</span> <span class="NLM_lpage">3675</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1242%2Fjcs.03145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=16912073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVymu7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2006&pages=3664-3675&author=F.+Girdlerauthor=K.+E.+Gascoigneauthor=P.+A.+Eyersauthor=S.+Hartmuthauthor=C.+Crafterauthor=K.+M.+Footeauthor=N.+J.+Keenauthor=S.+S.+Taylor&title=Validating+Aurora+B+as+an+anti-cancer+drug+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Validating Aurora B as an anti-cancer drug target</span></div><div class="casAuthors">Girdler, Fiona; Gascoigne, Karen E.; Eyers, Patrick A.; Hartmuth, Sonya; Crafter, Claire; Foote, Kevin M.; Keen, Nicholas J.; Taylor, Stephen S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3664-3675</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">The Aurora kinases, a family of mitotic regulators, have received much attention as potential targets for novel anti-cancer therapeutics.  Several Aurora kinase inhibitors have been described including ZM447439, which prevents chromosome alignment, spindle checkpoint function and cytokinesis.  Subsequently, ZM447439-treated cells exit mitosis without dividing and lose viability.  Because ZM447439 inhibits both Aurora A and B, we set out to det. which phenotypes are due to inhibition of which kinase.  Using mol. genetic approaches, we show that inhibition of Aurora B kinase activity phenocopies ZM447439.  Furthermore, a novel ZM compd., which is 100 times more selective for Aurora B over Aurora A in vitro, induces identical phenotypes.  Importantly, inhibition of Aurora B kinase activity induces a penetrant anti-proliferative phenotype, indicating that Aurora B is an attractive anti-cancer drug target.  Using mol. genetic and chem.-genetic approaches, we also probe the role of Aurora A kinase activity.  We show that simultaneous repression of Aurora A plus induction of a catalytic mutant induces a monopolar phenotype.  Consistently, another novel ZM-related inhibitor, which is 20 times as potent against Aurora A compared with ZM447439, induces a monopolar phenotype.  Expression of a drug-resistant Aurora A mutant reverts this phenotype, demonstrating that Aurora A kinase activity is required for spindle bipolarity in human cells.  Because small mol.-mediated inhibition of Aurora A and Aurora B yields distinct phenotypes, our observations indicate that the Auroras may present two avenues for anti-cancer drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXyhwkCpOaDrVg90H21EOLACvtfcHk0lgsS905MVXjnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVymu7zP&md5=707af873d03b36f20a389470e0aab1ff</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1242%2Fjcs.03145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.03145%26sid%3Dliteratum%253Aachs%26aulast%3DGirdler%26aufirst%3DF.%26aulast%3DGascoigne%26aufirst%3DK.%2BE.%26aulast%3DEyers%26aufirst%3DP.%2BA.%26aulast%3DHartmuth%26aufirst%3DS.%26aulast%3DCrafter%26aufirst%3DC.%26aulast%3DFoote%26aufirst%3DK.%2BM.%26aulast%3DKeen%26aufirst%3DN.%2BJ.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26atitle%3DValidating%2520Aurora%2520B%2520as%2520an%2520anti-cancer%2520drug%2520target%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2006%26volume%3D119%26spage%3D3664%26epage%3D3675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Bishop, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, J. M.</span><span> </span><span class="NLM_article-title">Phosphorylation of the carboxyl terminus of inner centromere protein (INCENP) by the Aurora B kinase stimulates Aurora B kinase activity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">27577</span><span class="NLM_x">–</span> <span class="NLM_lpage">27580</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=27577-27580&author=J.+D.+Bishopauthor=J.+M.+Schumacher&title=Phosphorylation+of+the+carboxyl+terminus+of+inner+centromere+protein+%28INCENP%29+by+the+Aurora+B+kinase+stimulates+Aurora+B+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBishop%26aufirst%3DJ.%2BD.%26aulast%3DSchumacher%26aufirst%3DJ.%2BM.%26atitle%3DPhosphorylation%2520of%2520the%2520carboxyl%2520terminus%2520of%2520inner%2520centromere%2520protein%2520%2528INCENP%2529%2520by%2520the%2520Aurora%2520B%2520kinase%2520stimulates%2520Aurora%2520B%2520kinase%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D27577%26epage%3D27580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bolton, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleland, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stukenberg, P. T.</span><span> </span><span class="NLM_article-title">Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation</span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3064</span><span class="NLM_x">–</span> <span class="NLM_lpage">3077</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1091%2Fmbc.E02-02-0092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=12221116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD38XntlGis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=3064-3077&author=M.+A.+Boltonauthor=W.+Lanauthor=S.+E.+Powersauthor=M.+L.+McClelandauthor=J.+Kuangauthor=P.+T.+Stukenberg&title=Aurora+B+kinase+exists+in+a+complex+with+survivin+and+INCENP+and+its+kinase+activity+is+stimulated+by+survivin+binding+and+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation</span></div><div class="casAuthors">Bolton, Margaret A.; Lan, Weijie; Powers, Shannon E.; McCleland, Mark L.; Kuang, Jian; Stukenberg, P. Todd</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3064-3077</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Aurora B regulates chromosome segregation and cytokinesis and is the first protein to be implicated as a regulator of bipolar attachment of spindle microtubules to kinetochores.  Evidence from several systems suggests that Aurora B is phys. assocd. with inner centromere protein (INCENP) in mitosis and has genetic interactions with Survivin.  It is unclear whether the Aurora B and INCENP interaction is cell cycle regulated and if Survivin phys. interacts in this complex.  In this study, we cloned the Xenopus Survivin gene, examd. its assocn. with Aurora B and INCENP, and detd. the effect of its binding on Aurora B kinase activity.  We demonstrate that in the Xenopus early embryo, all of the detectable Survivin is in a complex with both Aurora B and INCENP throughout the cell cycle.  Survivin and Aurora B bind different domains on INCENP.  Aurora B activity is stimulated >10-fold in mitotic exts.; this activation is phosphatase sensitive, and the binding of Survivin is required for full Aurora B activity.  We also find the hydrodynamic properties of the Aurora B/Survivin/INCENP complex are cell cycle regulated.  Our data indicate that Aurora B kinase activity is regulated by both Survivin binding and cell cycle-dependent phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiuqF6FaT1qLVg90H21EOLACvtfcHk0lgNohQUNzXWDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntlGis78%253D&md5=d8beedfbfd40e859e5511beee7d200a5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1091%2Fmbc.E02-02-0092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.E02-02-0092%26sid%3Dliteratum%253Aachs%26aulast%3DBolton%26aufirst%3DM.%2BA.%26aulast%3DLan%26aufirst%3DW.%26aulast%3DPowers%26aufirst%3DS.%2BE.%26aulast%3DMcCleland%26aufirst%3DM.%2BL.%26aulast%3DKuang%26aufirst%3DJ.%26aulast%3DStukenberg%26aufirst%3DP.%2BT.%26atitle%3DAurora%2520B%2520kinase%2520exists%2520in%2520a%2520complex%2520with%2520survivin%2520and%2520INCENP%2520and%2520its%2520kinase%2520activity%2520is%2520stimulated%2520by%2520survivin%2520binding%2520and%2520phosphorylation%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2002%26volume%3D13%26spage%3D3064%26epage%3D3077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Sessa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mapelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciferri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarricone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Areces, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stukenberg, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musacchio, A.</span><span> </span><span class="NLM_article-title">Mechanism of Aurora B activation by INCENP and inhibition by hesperadin</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=379-391&author=F.+Sessaauthor=M.+Mapelliauthor=C.+Ciferriauthor=C.+Tarriconeauthor=L.+B.+Arecesauthor=T.+R.+Schneiderauthor=P.+T.+Stukenbergauthor=A.+Musacchio&title=Mechanism+of+Aurora+B+activation+by+INCENP+and+inhibition+by+hesperadin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSessa%26aufirst%3DF.%26aulast%3DMapelli%26aufirst%3DM.%26aulast%3DCiferri%26aufirst%3DC.%26aulast%3DTarricone%26aufirst%3DC.%26aulast%3DAreces%26aufirst%3DL.%2BB.%26aulast%3DSchneider%26aufirst%3DT.%2BR.%26aulast%3DStukenberg%26aufirst%3DP.%2BT.%26aulast%3DMusacchio%26aufirst%3DA.%26atitle%3DMechanism%2520of%2520Aurora%2520B%2520activation%2520by%2520INCENP%2520and%2520inhibition%2520by%2520hesperadin%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D18%26spage%3D379%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Hsu, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuben, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatchell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grushcow, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brame, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allis, C. D.</span><span> </span><span class="NLM_article-title">Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=279-291&author=J.-Y.+Hsuauthor=Z.-W.+Sunauthor=X.+Liauthor=M.+Reubenauthor=K.+Tatchellauthor=D.+K.+Bishopauthor=J.+M.+Grushcowauthor=C.+J.+Brameauthor=J.+A.+Caldwellauthor=D.+F.+Huntauthor=R.+Linauthor=M.+M.+Smithauthor=C.+D.+Allis&title=Mitotic+phosphorylation+of+histone+H3+is+governed+by+Ipl1%2Faurora+kinase+and+Glc7%2FPP1+phosphatase+in+budding+yeast+and+nematodes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHsu%26aufirst%3DJ.-Y.%26aulast%3DSun%26aufirst%3DZ.-W.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DReuben%26aufirst%3DM.%26aulast%3DTatchell%26aufirst%3DK.%26aulast%3DBishop%26aufirst%3DD.%2BK.%26aulast%3DGrushcow%26aufirst%3DJ.%2BM.%26aulast%3DBrame%26aufirst%3DC.%2BJ.%26aulast%3DCaldwell%26aufirst%3DJ.%2BA.%26aulast%3DHunt%26aufirst%3DD.%2BF.%26aulast%3DLin%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DM.%2BM.%26aulast%3DAllis%26aufirst%3DC.%2BD.%26atitle%3DMitotic%2520phosphorylation%2520of%2520histone%2520H3%2520is%2520governed%2520by%2520Ipl1%252Faurora%2520kinase%2520and%2520Glc7%252FPP1%2520phosphatase%2520in%2520budding%2520yeast%2520and%2520nematodes%26jtitle%3DCell%26date%3D2000%26volume%3D102%26spage%3D279%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Schumacher, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashcroft, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donovan, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golden, A.</span><span> </span><span class="NLM_article-title">A highly conserved centrosomal kinase, AIR-1, is required for accurate cell cycle progression and segregation of developmental factors in <i>Caenorhabditis elegans</i> embryos</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">1635</span><span class="NLM_x">–</span> <span class="NLM_lpage">1646</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADyaK1MXht1w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=1998&pages=1635-1646&author=J.+M.+Schumacherauthor=N.+Ashcroftauthor=P.+J.+Donovanauthor=A.+Golden&title=A+highly+conserved+centrosomal+kinase%2C+AIR-1%2C+is+required+for+accurate+cell+cycle+progression+and+segregation+of+developmental+factors+in+Caenorhabditis+elegans+embryos"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">AIR-2: an Aurora/Ipl1-related protein kinase associated with chromosomes and midbody microtubules is required for polar body extrusion and cytokinesis in Caenorhabditis elegans embryos</span></div><div class="casAuthors">Schumacher, Jill M.; Golden, Andy; Donovan, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1635-1646</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">An emerging family of kinases related to the Drosophila Aurora and budding yeast Ipl1 proteins has been implicated in chromosome segregation and mitotic spindle formation in a no. of organisms.  Unlike other Aurora/Ip11-related kinases, the C. elegans orthologue, AIR-2, is assocd. with meiotic and mitotic chromosomes.  AIR-2 is initially localized to the chromosomes of the most mature prophase I-arrested oocyte residing next to the spermatheca.  This localization is dependent on the presence of sperm in the spermatheca.  After fertilization, AIR-2 remains assocd. with chromosomes during each meiotic division.  However, during both meiotic anaphases, AIR-2 is present between the sepg. chromosomes.  AIR-2 also remains assocd. with both extruded polar bodies.  In the embryo, AIR-2 is found on metaphase chromosomes, moves to midbody microtubules at anaphase, and then persists at the cytokinesis remnant.  Disruption of AIR-2 expression by RNA-mediated interference produces entire broods of 1-cell embryos that have executed multiple cell cycles in the complete absence of cytokinesis.  The embryos accumulate large amts. of DNA and microtubule asters.  Polar bodies are not extruded, but remain in the embryo where they continue to replicate.  The cytokinesis defect appears to be late in the cell cycle because transient cleavage furrows initiate at the proper location, but regress before the division is complete.  Addnl., staining with a marker of midbody microtubules revealed that at least some of the components of the midbody are not well localized in the absence of AIR-2 activity.  Our results suggest that during each meiotic and mitotic division, AIR-2 may coordinate the congression of metaphase chromosomes with the subsequent events of polar body extrusion and cytokinesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW5Q3myKmyE7Vg90H21EOLACvtfcHk0lgNohQUNzXWDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXht1w%253D&md5=cc1a95cc8bc3922b6a0c8c10c8d99c1f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchumacher%26aufirst%3DJ.%2BM.%26aulast%3DAshcroft%26aufirst%3DN.%26aulast%3DDonovan%26aufirst%3DP.%2BJ.%26aulast%3DGolden%26aufirst%3DA.%26atitle%3DA%2520highly%2520conserved%2520centrosomal%2520kinase%252C%2520AIR-1%252C%2520is%2520required%2520for%2520accurate%2520cell%2520cycle%2520progression%2520and%2520segregation%2520of%2520developmental%2520factors%2520in%2520Caenorhabditis%2520elegans%2520embryos%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D1998%26volume%3D143%26spage%3D1635%26epage%3D1646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kallio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleland, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stukenberg, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorbsky, G. J.</span><span> </span><span class="NLM_article-title">Inhibition of Aurora B Kinase Blocks Chromosome Segregation, Overrides the Spindle Checkpoint, and Perturbs Microtubule Dynamics in Mitosis</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">900</span><span class="NLM_x">–</span> <span class="NLM_lpage">905</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1016%2FS0960-9822%2802%2900887-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=12062053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD38XksFOjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=900-905&author=M.+J.+Kallioauthor=M.+L.+McClelandauthor=P.+T.+Stukenbergauthor=G.+J.+Gorbsky&title=Inhibition+of+Aurora+B+Kinase+Blocks+Chromosome+Segregation%2C+Overrides+the+Spindle+Checkpoint%2C+and+Perturbs+Microtubule+Dynamics+in+Mitosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Aurora B Kinase Blocks Chromosome Segregation, Overrides the Spindle Checkpoint, and Perturbs Microtubule Dynamics in Mitosis</span></div><div class="casAuthors">Kallio, Marko J.; McCleland, Mark L.; Stukenberg, P. Todd; Gorbsky, Gary J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">900-905</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">How kinetochores correct improper microtubule attachments and regulate the spindle checkpoint signal is unclear.  In budding yeast, kinetochores harboring mutations in the mitotic kinase Ipl1 fail to bind chromosomes in a bipolar fashion.  In C. elegans and Drosophila, inhibition of the Ipl1 homolog, Aurora B kinase, induces aberrant anaphase and cytokinesis.  To study Aurora B kinase in vertebrates, we microinjected mitotic XTC cells with inhibitory antibody and found several related effects.  After injection of the antibody, some chromosomes failed to congress to the metaphase plate, consistent with a conserved role for Aurora B in bipolar attachment of chromosomes.  Injected cells exited mitosis with no evidence of anaphase or cytokinesis.  Injection of anti-Xaurora B antibody also altered the microtubule network in mitotic cells with an extension of the astral microtubules and a redn. of kinetochore microtubules.  Finally, inhibition of Aurora B in cultured cells and in cycling Xenopus egg exts. caused escape from the spindle checkpoint arrest induced by microtubule drugs.  Our findings implicate Aurora B as a crit. coordinator relating changes in microtubule dynamics in mitosis, chromosome movement in prometaphase and anaphase, signaling of the spindle checkpoint, and cytokinesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphFem_nwvBgLVg90H21EOLACvtfcHk0ljBIMGA2T0fgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksFOjtLk%253D&md5=2da604a569f186444340a722d8bac9d5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0960-9822%2802%2900887-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-9822%252802%252900887-4%26sid%3Dliteratum%253Aachs%26aulast%3DKallio%26aufirst%3DM.%2BJ.%26aulast%3DMcCleland%26aufirst%3DM.%2BL.%26aulast%3DStukenberg%26aufirst%3DP.%2BT.%26aulast%3DGorbsky%26aufirst%3DG.%2BJ.%26atitle%3DInhibition%2520of%2520Aurora%2520B%2520Kinase%2520Blocks%2520Chromosome%2520Segregation%252C%2520Overrides%2520the%2520Spindle%2520Checkpoint%252C%2520and%2520Perturbs%2520Microtubule%2520Dynamics%2520in%2520Mitosis%26jtitle%3DCurr.%2520Biol.%26date%3D2002%26volume%3D12%26spage%3D900%26epage%3D905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ditchfield, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tighe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellston, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haworth, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortlock, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span> </span><span class="NLM_article-title">Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2003&pages=267-280&author=C.+Ditchfieldauthor=V.+L.+Johnsonauthor=A.+Tigheauthor=R.+Ellstonauthor=C.+Haworthauthor=T.+Johnsonauthor=A.+Mortlockauthor=N.+Keenauthor=S.+S.+Taylor&title=Aurora+B+couples+chromosome+alignment+with+anaphase+by+targeting+BubR1%2C+Mad2%2C+and+Cenp-E+to+kinetochores"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDitchfield%26aufirst%3DC.%26aulast%3DJohnson%26aufirst%3DV.%2BL.%26aulast%3DTighe%26aufirst%3DA.%26aulast%3DEllston%26aufirst%3DR.%26aulast%3DHaworth%26aufirst%3DC.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DMortlock%26aufirst%3DA.%26aulast%3DKeen%26aufirst%3DN.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26atitle%3DAurora%2520B%2520couples%2520chromosome%2520alignment%2520with%2520anaphase%2520by%2520targeting%2520BubR1%252C%2520Mad2%252C%2520and%2520Cenp-E%2520to%2520kinetochores%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2003%26volume%3D161%26spage%3D267%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Hauf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaTerra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnapp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Meel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieder, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J. M.</span><span> </span><span class="NLM_article-title">The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1083%2Fjcb.200208092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=12707311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtl2isb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2003&pages=281-294&author=S.+Haufauthor=R.+W.+Coleauthor=S.+LaTerraauthor=C.+Zimmerauthor=G.+Schnappauthor=R.+Walterauthor=A.+Heckelauthor=J.+van+Meelauthor=C.+L.+Riederauthor=J.+M.+Peters&title=The+small+molecule+Hesperadin+reveals+a+role+for+Aurora+B+in+correcting+kinetochore-microtubule+attachment+and+in+maintaining+the+spindle+assembly+checkpoint"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint</span></div><div class="casAuthors">Hauf, Silke; Cole, Richard W.; LaTerra, Sabrina; Zimmer, Christine; Schnapp, Gisela; Walter, Rainer; Heckel, Armin; van Meel, Jacques; Rieder, Conly L.; Peters, Jan-Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">281-294</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The proper segregation of sister chromatids in mitosis depends on bipolar attachment of all chromosomes to the mitotic spindle.  We have identified the small mol. Hesperadin as an inhibitor of chromosome alignment and segregation.  Our data imply that Hesperadin causes this phenotype by inhibiting the function of the mitotic kinase Aurora B.  Mammalian cells treated with Hesperadin enter anaphase in the presence of numerous monooriented chromosomes, many of which may have both sister kinetochores attached to one spindle pole (syntelic attachment).  Hesperadin also causes cells arrested by taxol or monastrol to enter anaphase within <1 h, whereas cells in nocodazole stay arrested for 3-5 h.  Together, our data suggest that Aurora B is required to generate unattached kinetochores on monooriented chromosomes, which in turn could promote bipolar attachment as well as maintain checkpoint signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG-9s78ZbJorVg90H21EOLACvtfcHk0ljBIMGA2T0fgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtl2isb8%253D&md5=a79851e7d015a1530340a38e86b1943f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200208092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200208092%26sid%3Dliteratum%253Aachs%26aulast%3DHauf%26aufirst%3DS.%26aulast%3DCole%26aufirst%3DR.%2BW.%26aulast%3DLaTerra%26aufirst%3DS.%26aulast%3DZimmer%26aufirst%3DC.%26aulast%3DSchnapp%26aufirst%3DG.%26aulast%3DWalter%26aufirst%3DR.%26aulast%3DHeckel%26aufirst%3DA.%26aulast%3Dvan%2BMeel%26aufirst%3DJ.%26aulast%3DRieder%26aufirst%3DC.%2BL.%26aulast%3DPeters%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520small%2520molecule%2520Hesperadin%2520reveals%2520a%2520role%2520for%2520Aurora%2520B%2520in%2520correcting%2520kinetochore-microtubule%2520attachment%2520and%2520in%2520maintaining%2520the%2520spindle%2520assembly%2520checkpoint%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2003%26volume%3D161%26spage%3D281%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, Y.</span><span> </span><span class="NLM_article-title">Cell cycle-dependent expression and centrosome localization of a third human Aurora/Ipl1-related protein kinase, AIK3</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">7334</span><span class="NLM_x">–</span> <span class="NLM_lpage">7340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=7334-7340&author=M.+Kimuraauthor=Y.+Matsudaauthor=T.+Yoshiokaauthor=Y.+Okano&title=Cell+cycle-dependent+expression+and+centrosome+localization+of+a+third+human+Aurora%2FIpl1-related+protein+kinase%2C+AIK3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DM.%26aulast%3DMatsuda%26aufirst%3DY.%26aulast%3DYoshioka%26aufirst%3DT.%26aulast%3DOkano%26aufirst%3DY.%26atitle%3DCell%2520cycle-dependent%2520expression%2520and%2520centrosome%2520localization%2520of%2520a%2520third%2520human%2520Aurora%252FIpl1-related%2520protein%2520kinase%252C%2520AIK3%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D7334%26epage%3D7340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakashita, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuzaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanaoka, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urano, T.</span><span> </span><span class="NLM_article-title">Direct Association with Inner Centromere Protein (INCENP) Activates the Novel Chromosomal Passenger Protein, Aurora-C</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">47201</span><span class="NLM_x">–</span> <span class="NLM_lpage">47211</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=47201-47211&author=X.+Liauthor=G.+Sakashitaauthor=H.+Matsuzakiauthor=K.+Sugimotoauthor=K.+Kimuraauthor=F.+Hanaokaauthor=H.+Taniguchiauthor=K.+Furukawaauthor=T.+Urano&title=Direct+Association+with+Inner+Centromere+Protein+%28INCENP%29+Activates+the+Novel+Chromosomal+Passenger+Protein%2C+Aurora-C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DSakashita%26aufirst%3DG.%26aulast%3DMatsuzaki%26aufirst%3DH.%26aulast%3DSugimoto%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DHanaoka%26aufirst%3DF.%26aulast%3DTaniguchi%26aufirst%3DH.%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DUrano%26aufirst%3DT.%26atitle%3DDirect%2520Association%2520with%2520Inner%2520Centromere%2520Protein%2520%2528INCENP%2529%2520Activates%2520the%2520Novel%2520Chromosomal%2520Passenger%2520Protein%252C%2520Aurora-C%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D47201%26epage%3D47211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiyin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span> </span><span class="NLM_article-title">Aurora C is directly associated with survivin and required for cytokinesis</span> <span class="citation_source-journal">Genes Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">617</span><span class="NLM_x">–</span> <span class="NLM_lpage">626</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1111%2Fj.1365-2443.2005.00863.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=15938719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvF2lt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=617-626&author=X.+Yanauthor=L.+Caoauthor=Q.+Liauthor=Y.+Wuauthor=H.+Zhangauthor=H.+Saiyinauthor=X.+Liuauthor=X.+Zhangauthor=Q.+Shiauthor=L.+Yu&title=Aurora+C+is+directly+associated+with+survivin+and+required+for+cytokinesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Aurora C is directly associated with survivin and required for cytokinesis</span></div><div class="casAuthors">Yan, Xiaomei; Cao, Lihuan; Li, Qiang; Wu, Yanhua; Zhang, Haoxing; Saiyin, Hexige; Liu, Xianghua; Zhang, Xuqing; Shi, Qinghua; Yu, Long</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">617-626</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1356-9597</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Much recent attention has been focused on Aurora C kinase (I), the 3rd member of the mammalian Aurora kinase family that plays significant roles in mitosis.  Here, the authors report that using sensitive RT-PCR to amplify the C-terminus, they found that I was not only expressed highly in the testis, but also among 16 other human tissues in a broad-spectrum way.  I, as a chromosomal passenger protein, was co-localized with survivin (II) and Aurora B kinase (III) in mitotic cells.  I could also be assocd. with II and III in vivo, and directly bound to II but not to III in vitro.  Overexpression of a catalytically inactive mutant of I impaired the localization of I to the spindle midzone and severely disturbed the cytokinesis, resulting in multinucleation, all of which were consistent with the results induced by the mutant of III.  Furthermore, evidence was provided that I could rescue the multinucleate phenotype produced by the III mutant, and vice versa.  Overall, these findings demonstrated that I, a member of the chromosomal passenger complex, is required for cytokinesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ-9YVMj0imLVg90H21EOLACvtfcHk0ljqcDwyMH5GiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvF2lt7g%253D&md5=6d1b2a8550decab60209382d08337962</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2443.2005.00863.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2443.2005.00863.x%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DX.%26aulast%3DCao%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSaiyin%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DL.%26atitle%3DAurora%2520C%2520is%2520directly%2520associated%2520with%2520survivin%2520and%2520required%2520for%2520cytokinesis%26jtitle%3DGenes%2520Cells%26date%3D2005%26volume%3D10%26spage%3D617%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Sasai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenoien, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earnshaw, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkley, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sen, S.</span><span> </span><span class="NLM_article-title">Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells</span> <span class="citation_source-journal">Cell Motil. Cytoskeleton</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1002%2Fcm.20039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=15499654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVOisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2004&pages=249-263&author=K.+Sasaiauthor=H.+Katayamaauthor=D.+L.+Stenoienauthor=S.+Fujiiauthor=R.+Hondaauthor=M.+Kimuraauthor=Y.+Okanoauthor=M.+Tatsukaauthor=F.+Suzukiauthor=E.+A.+Niggauthor=W.+C.+Earnshawauthor=W.+R.+Brinkleyauthor=S.+Sen&title=Aurora-C+kinase+is+a+novel+chromosomal+passenger+protein+that+can+complement+Aurora-B+kinase+function+in+mitotic+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells</span></div><div class="casAuthors">Sasai, Kaori; Katayama, Hiroshi; Stenoien, David L.; Fujii, Satoshi; Honda, Reiko; Kimura, Masashi; Okano, Yukio; Tatsuka, Masaaki; Suzuki, Fumio; Nigg, Erich A.; Earnshaw, William C.; Brinkley, William R.; Sen, Subrata</div><div class="citationInfo"><span class="NLM_cas:title">Cell Motility and the Cytoskeleton</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">249-263</span>CODEN:
                <span class="NLM_cas:coden">CMCYEO</span>;
        ISSN:<span class="NLM_cas:issn">0886-1544</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The function of Aurora-C kinase, a member of the Aurora kinase family identified in mammals, is currently unknown.  We present evidence that Aurora-C, like Aurora-B kinase, is a chromosomal passenger protein localizing first to centromeres and then to the midzone of mitotic cells.  Aurora-C transcript is expressed at a moderate level albeit about an order of magnitude lower than Aurora-B transcript in diploid human fibroblasts.  The level of Aurora-C transcript is elevated in several human cancer cell types.  Aurora-C and Aurora-B mRNA and protein expressions are maximally elevated during the G2/M phase but their expression profiles in synchronized cells reveal differential temporal regulation through the cell cycle with Aurora-C level peaking after that of Aurora-B during the later part of the M phase.  Aurora-C, like Aurora-B, interacts with the inner centromere protein (INCENP) at the carboxyl terminal end spanning the conserved IN box domain.  Competition binding assays and transfection expts. revealed that, compared with Aurora-C, Aurora-B has preferential binding affinity to INCENP and co-expression of the two in vivo interferes with INCENP binding, localization, and stability of these proteins.  A kinase-dead mutant of Aurora-C had a dominant neg. effect inducing multi-nucleation in a dose-dependent manner.  SiRNA mediated silencing of Aurora-C and Aurora-B also gave rise to multi-nucleated cells with the two kinases silenced at the same time displaying an additive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEZfK2erbuk7Vg90H21EOLACvtfcHk0ljqcDwyMH5GiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVOisQ%253D%253D&md5=6091dca535ee530fbd5e8e8c41d98f79</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fcm.20039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcm.20039%26sid%3Dliteratum%253Aachs%26aulast%3DSasai%26aufirst%3DK.%26aulast%3DKatayama%26aufirst%3DH.%26aulast%3DStenoien%26aufirst%3DD.%2BL.%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DHonda%26aufirst%3DR.%26aulast%3DKimura%26aufirst%3DM.%26aulast%3DOkano%26aufirst%3DY.%26aulast%3DTatsuka%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DF.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26aulast%3DEarnshaw%26aufirst%3DW.%2BC.%26aulast%3DBrinkley%26aufirst%3DW.%2BR.%26aulast%3DSen%26aufirst%3DS.%26atitle%3DAurora-C%2520kinase%2520is%2520a%2520novel%2520chromosomal%2520passenger%2520protein%2520that%2520can%2520complement%2520Aurora-B%2520kinase%2520function%2520in%2520mitotic%2520cells%26jtitle%3DCell%2520Motil.%2520Cytoskeleton%26date%3D2004%26volume%3D59%26spage%3D249%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Mortlock, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keen, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heron, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foote, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span> </span><span class="NLM_article-title">Progress in the development of selective inhibitors of Aurora kinases</span> <span class="citation_source-journal">Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.2174%2F1568026053507651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=15853647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFyksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=199-213&author=A.+Mortlockauthor=N.+J.+Keenauthor=F.+H.+Jungauthor=N.+M.+Heronauthor=K.+M.+Footeauthor=R.+Wilkinsonauthor=S.+Green&title=Progress+in+the+development+of+selective+inhibitors+of+Aurora+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the development of selective inhibitors of Aurora kinases</span></div><div class="casAuthors">Mortlock, Andrew; Keen, Nicholas J.; Jung, Frederic H.; Heron, Nicola M.; Foote, Kevin M.; Wilkinson, Robert; Green, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-213</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Errors in the mitotic process are thought to be one of the principal sources of the genetic instability that hallmarks cancer.  Unsurprisingly, many of the proteins that regulate mitosis are aberrantly expressed in tumor cells when compared to their normal counterparts.  These may represent a good source of targets for the development of novel anti-cancer agents.  The Aurora kinases represent one such family of mitotic regulators.  In recent years there was intense interest in both understanding the role of the Aurora kinases in cell cycle regulation and also in developing small mol. inhibitors as potential novel anti-cancer drugs.  With several companies now starting to take Aurora kinase inhibitors into clin. development, the time is right to review the medicinal chem. contribution to developing the field, in particular to review the increasingly broad range of small mol. inhibitors with activity against this kinase family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoju_DzoN6iDLVg90H21EOLACvtfcHk0ljqcDwyMH5GiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFyksbo%253D&md5=af7a9db23deded41e433b70e517e25aa</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F1568026053507651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053507651%26sid%3Dliteratum%253Aachs%26aulast%3DMortlock%26aufirst%3DA.%26aulast%3DKeen%26aufirst%3DN.%2BJ.%26aulast%3DJung%26aufirst%3DF.%2BH.%26aulast%3DHeron%26aufirst%3DN.%2BM.%26aulast%3DFoote%26aufirst%3DK.%2BM.%26aulast%3DWilkinson%26aufirst%3DR.%26aulast%3DGreen%26aufirst%3DS.%26atitle%3DProgress%2520in%2520the%2520development%2520of%2520selective%2520inhibitors%2520of%2520Aurora%2520kinases%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%2520%2528Sharjah%252C%2520United%2520Arab%2520Emirates%2529%26date%3D2005%26volume%3D5%26spage%3D199%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Gautschi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lara, P. N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandara, D. R.</span><span> </span><span class="NLM_article-title">Aurora kinase inhibitors: a new class of targeted drugs in cancer</span> <span class="citation_source-journal">Clin. Lung Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.3816%2FCLC.2006.n.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=17026809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKhsLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=93-98&author=O.+Gautschiauthor=P.+C.+Mackauthor=A.+M.+Daviesauthor=P.+N.+Laraauthor=D.+R.+Gandara&title=Aurora+kinase+inhibitors%3A+a+new+class+of+targeted+drugs+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Aurora kinase inhibitors: a new class of targeted drugs in cancer</span></div><div class="casAuthors">Gautschi, Oliver; Mack, Philip C.; Davies, Angela M.; Lara, Primo N., Jr.; Gandara, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Lung Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">93-98</span>CODEN:
                <span class="NLM_cas:coden">CLCLCA</span>;
        ISSN:<span class="NLM_cas:issn">1525-7304</span>.
    
            (<span class="NLM_cas:orgname">CIG Media Group, LP</span>)
        </div><div class="casAbstract">A review.  Aurora kinases (A, B, and C) are essential for spindle assembly, centrosome maturation, chromosomal segregation, and cytokinesis.  Aurora kinases A and B are overexpressed in many cancers, including non-small-cell lung cancer and mesothelioma.  Small-mol. inhibitors selective for aurora kinases have shown promising activity in preclin. tumor models.  To date, phase I studies with aurora kinase inhibitors have shown that myelosuppression is the dose-limiting toxicity, and disease stabilization was achieved in a no. of tumor types, including non-small-cell lung cancer.  Phase II trials are under way in selected tumor types.  This article reviews the biol. of aurora kinases, their potential role in the treatment of lung cancer, and challenges in the clin. development of this unique class of antineoplastic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGihF3FISrzLVg90H21EOLACvtfcHk0ljArWrpHtFxgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKhsLzJ&md5=5ac64b0a9a7c3b3d55497460d96d3dce</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3816%2FCLC.2006.n.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3816%252FCLC.2006.n.036%26sid%3Dliteratum%253Aachs%26aulast%3DGautschi%26aufirst%3DO.%26aulast%3DMack%26aufirst%3DP.%2BC.%26aulast%3DDavies%26aufirst%3DA.%2BM.%26aulast%3DLara%26aufirst%3DP.%2BN.%26aulast%3DGandara%26aufirst%3DD.%2BR.%26atitle%3DAurora%2520kinase%2520inhibitors%253A%2520a%2520new%2520class%2520of%2520targeted%2520drugs%2520in%2520cancer%26jtitle%3DClin.%2520Lung%2520Cancer%26date%3D2006%26volume%3D8%26spage%3D93%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Pollard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortimore, M.</span><span> </span><span class="NLM_article-title">Discovery and Development of Aurora Kinase Inhibitors as Anticancer Agent</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2629</span><span class="NLM_x">–</span> <span class="NLM_lpage">2651</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8012129" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2629-2651&author=J.+R.+Pollardauthor=M.+Mortimore&title=Discovery+and+Development+of+Aurora+Kinase+Inhibitors+as+Anticancer+Agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm8012129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8012129%26sid%3Dliteratum%253Aachs%26aulast%3DPollard%26aufirst%3DJ.%2BR.%26aulast%3DMortimore%26aufirst%3DM.%26atitle%3DDiscovery%2520and%2520Development%2520of%2520Aurora%2520Kinase%2520Inhibitors%2520as%2520Anticancer%2520Agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2629%26epage%3D2651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Harrington, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebbington, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajose-Adeogun, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hercend, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diu-Hercend, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golec, J. M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. M.</span><span> </span><span class="NLM_article-title">VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=262-267&author=E.+A.+Harringtonauthor=D.+Bebbingtonauthor=J.+Mooreauthor=R.+K.+Rasmussenauthor=A.+O.+Ajose-Adeogunauthor=T.+Nakayamaauthor=J.+A.+Grahamauthor=C.+Demurauthor=T.+Hercendauthor=A.+Diu-Hercendauthor=M.+Suauthor=J.+M.+C.+Golecauthor=K.+M.+Miller&title=VX-680%2C+a+potent+and+selective+small-molecule+inhibitor+of+the+Aurora+kinases%2C+suppresses+tumor+growth+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarrington%26aufirst%3DE.%2BA.%26aulast%3DBebbington%26aufirst%3DD.%26aulast%3DMoore%26aufirst%3DJ.%26aulast%3DRasmussen%26aufirst%3DR.%2BK.%26aulast%3DAjose-Adeogun%26aufirst%3DA.%2BO.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DJ.%2BA.%26aulast%3DDemur%26aufirst%3DC.%26aulast%3DHercend%26aufirst%3DT.%26aulast%3DDiu-Hercend%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DGolec%26aufirst%3DJ.%2BM.%2BC.%26aulast%3DMiller%26aufirst%3DK.%2BM.%26atitle%3DVX-680%252C%2520a%2520potent%2520and%2520selective%2520small-molecule%2520inhibitor%2520of%2520the%2520Aurora%2520kinases%252C%2520suppresses%2520tumor%2520growth%2520in%2520vivo%26jtitle%3DNature%2520Med.%26date%3D2004%26volume%3D10%26spage%3D262%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Mortlock, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foote, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heron, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Savi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dousson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odedra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keen, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crafter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brightwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kearney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKillop, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhead, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parry, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span> </span><span class="NLM_article-title">Discovery, Synthesis, and in Vivo Activity of a New Class of Pyrazolylamino Quinazolines as Selective Inhibitors of Aurora B Kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2213</span><span class="NLM_x">–</span> <span class="NLM_lpage">2224</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061335f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2213-2224&author=A.+A.+Mortlockauthor=K.+M.+Footeauthor=N.+M.+Heronauthor=F.+H.+Jungauthor=G.+Pasquetauthor=J.+J.+Lohmannauthor=N.+Warinauthor=F.+Renaudauthor=C.+De+Saviauthor=N.+J.+Robertsauthor=T.+Johnsonauthor=C.+B.+Doussonauthor=G.+B.+Hillauthor=D.+Perkinsauthor=G.+Hatterauthor=R.+W.+Wilkinsonauthor=S.+R.+Wedgeauthor=S.+P.+Heatonauthor=R.+Odedraauthor=N.+J.+Keenauthor=C.+Crafterauthor=E.+Brownauthor=K.+Thompsonauthor=S.+Brightwellauthor=L.+Khatriauthor=M.+C.+Bradyauthor=S.+Kearneyauthor=D.+McKillopauthor=S.+Rheadauthor=T.+Parryauthor=S.+Green&title=Discovery%2C+Synthesis%2C+and+in+Vivo+Activity+of+a+New+Class+of+Pyrazolylamino+Quinazolines+as+Selective+Inhibitors+of+Aurora+B+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm061335f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061335f%26sid%3Dliteratum%253Aachs%26aulast%3DMortlock%26aufirst%3DA.%2BA.%26aulast%3DFoote%26aufirst%3DK.%2BM.%26aulast%3DHeron%26aufirst%3DN.%2BM.%26aulast%3DJung%26aufirst%3DF.%2BH.%26aulast%3DPasquet%26aufirst%3DG.%26aulast%3DLohmann%26aufirst%3DJ.%2BJ.%26aulast%3DWarin%26aufirst%3DN.%26aulast%3DRenaud%26aufirst%3DF.%26aulast%3DDe%2BSavi%26aufirst%3DC.%26aulast%3DRoberts%26aufirst%3DN.%2BJ.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DDousson%26aufirst%3DC.%2BB.%26aulast%3DHill%26aufirst%3DG.%2BB.%26aulast%3DPerkins%26aufirst%3DD.%26aulast%3DHatter%26aufirst%3DG.%26aulast%3DWilkinson%26aufirst%3DR.%2BW.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DHeaton%26aufirst%3DS.%2BP.%26aulast%3DOdedra%26aufirst%3DR.%26aulast%3DKeen%26aufirst%3DN.%2BJ.%26aulast%3DCrafter%26aufirst%3DC.%26aulast%3DBrown%26aufirst%3DE.%26aulast%3DThompson%26aufirst%3DK.%26aulast%3DBrightwell%26aufirst%3DS.%26aulast%3DKhatri%26aufirst%3DL.%26aulast%3DBrady%26aufirst%3DM.%2BC.%26aulast%3DKearney%26aufirst%3DS.%26aulast%3DMcKillop%26aufirst%3DD.%26aulast%3DRhead%26aufirst%3DS.%26aulast%3DParry%26aufirst%3DT.%26aulast%3DGreen%26aufirst%3DS.%26atitle%3DDiscovery%252C%2520Synthesis%252C%2520and%2520in%2520Vivo%2520Activity%2520of%2520a%2520New%2520Class%2520of%2520Pyrazolylamino%2520Quinazolines%2520as%2520Selective%2520Inhibitors%2520of%2520Aurora%2520B%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2213%26epage%3D2224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Manfredi, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ecsedy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meetze, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balani, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burenkova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoar, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huck, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeRoy, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sells, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stringer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroud, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vos, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wysong, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claiborne, C. F.</span><span> </span><span class="NLM_article-title">Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">4106</span><span class="NLM_x">–</span> <span class="NLM_lpage">4111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=4106-4111&author=M.+G.+Manfrediauthor=J.+A.+Ecsedyauthor=K.+A.+Meetzeauthor=S.+K.+Balaniauthor=O.+Burenkovaauthor=W.+Chenauthor=K.+M.+Galvinauthor=K.+M.+Hoarauthor=J.+J.+Huckauthor=P.+J.+LeRoyauthor=E.+T.+Rayauthor=T.+B.+Sellsauthor=B.+Stringerauthor=S.+G.+Stroudauthor=T.+J.+Vosauthor=G.+S.+Weatherheadauthor=D.+R.+Wysongauthor=M.+Zhangauthor=J.+B.+Bolenauthor=C.+F.+Claiborne&title=Antitumor+activity+of+MLN8054%2C+an+orally+active+small-molecule+inhibitor+of+Aurora+A+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManfredi%26aufirst%3DM.%2BG.%26aulast%3DEcsedy%26aufirst%3DJ.%2BA.%26aulast%3DMeetze%26aufirst%3DK.%2BA.%26aulast%3DBalani%26aufirst%3DS.%2BK.%26aulast%3DBurenkova%26aufirst%3DO.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DGalvin%26aufirst%3DK.%2BM.%26aulast%3DHoar%26aufirst%3DK.%2BM.%26aulast%3DHuck%26aufirst%3DJ.%2BJ.%26aulast%3DLeRoy%26aufirst%3DP.%2BJ.%26aulast%3DRay%26aufirst%3DE.%2BT.%26aulast%3DSells%26aufirst%3DT.%2BB.%26aulast%3DStringer%26aufirst%3DB.%26aulast%3DStroud%26aufirst%3DS.%2BG.%26aulast%3DVos%26aufirst%3DT.%2BJ.%26aulast%3DWeatherhead%26aufirst%3DG.%2BS.%26aulast%3DWysong%26aufirst%3DD.%2BR.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DBolen%26aufirst%3DJ.%2BB.%26aulast%3DClaiborne%26aufirst%3DC.%2BF.%26atitle%3DAntitumor%2520activity%2520of%2520MLN8054%252C%2520an%2520orally%2520active%2520small-molecule%2520inhibitor%2520of%2520Aurora%2520A%2520kinase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D4106%26epage%3D4111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Shimomura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasako, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakatsuru, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanishi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkubo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, Y.</span><span> </span><span class="NLM_article-title">MK-5108, a Highly Selective Aurora-A Kinase Inhibitor, Shows Antitumor Activity Alone and in Combination with Docetaxel</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1158%2F1535-7163.MCT-09-0609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=20053775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktVOisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=157-166&author=T.+Shimomuraauthor=S.+Hasakoauthor=Y.+Nakatsuruauthor=T.+Mitaauthor=K.+Ichikawaauthor=T.+Koderaauthor=T.+Sakaiauthor=T.+Nambuauthor=M.+Miyamotoauthor=I.+Takahashiauthor=S.+Mikiauthor=N.+Kawanishiauthor=M.+Ohkuboauthor=H.+Kotaniauthor=Y.+Iwasawa&title=MK-5108%2C+a+Highly+Selective+Aurora-A+Kinase+Inhibitor%2C+Shows+Antitumor+Activity+Alone+and+in+Combination+with+Docetaxel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">MK-5108, a Highly Selective Aurora-A Kinase Inhibitor, Shows Antitumor Activity Alone and in Combination with Docetaxel</span></div><div class="casAuthors">Shimomura, Toshiyasu; Hasako, Shinichi; Nakatsuru, Yoko; Mita, Takashi; Ichikawa, Koji; Kodera, Tsutomu; Sakai, Takumi; Nambu, Tadahiro; Miyamoto, Mayu; Takahashi, Ikuko; Miki, Satomi; Kawanishi, Nobuhiko; Ohkubo, Mitsuru; Kotani, Hidehito; Iwasawa, Yoshikazu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">157-166</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Aurora-A kinase is a one of the key regulators during mitosis progression.  Aurora-A kinase is a potential target for anticancer therapies because overexpression of Aurora-A, which is frequently obsd. in some human cancers, results in aberrant mitosis leading to chromosomal instability and possibly tumorigenesis.  MK-5108 is a novel small mol. with potent inhibitory activity against Aurora-A kinase.  Although most of the Aurora-kinase inhibitors target both Aurora-A and Aurora-B, MK-5108 specifically inhibited Aurora-A kinase in a panel of protein kinase assays.  Inhibition of Aurora-A by MK-5108 in cultured cells induced cell cycle arrest at the G2-M phase in flow cytometry anal.  The effect was confirmed by the accumulation of cells with expression of phosphorylated Histone H3 and inhibition of Aurora-A autophosphorylation by immunostaining assays.  MK-5108 also induced phosphorylated Histone H3 in skin and xenograft tumor tissues in a nude rat xenograft model.  MK-5108 inhibited growth of human tumor cell lines in culture and in different xenograft models.  Furthermore, the combination of MK-5108 and docetaxel showed enhanced antitumor activities compared with control and docetaxel alone-treated animals without exacerbating the adverse effects of docetaxel.  MK-5108 is currently tested in clin. trials and offers a new therapeutic approach to combat human cancers as a single agent or in combination with existing taxane therapies.  Mol Cancer Ther; 9(1); 157-66.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRD-HWMVBoWrVg90H21EOLACvtfcHk0lijFe11touNPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktVOisQ%253D%253D&md5=267f0e3f702e2489e8b0c942f9299850</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0609%26sid%3Dliteratum%253Aachs%26aulast%3DShimomura%26aufirst%3DT.%26aulast%3DHasako%26aufirst%3DS.%26aulast%3DNakatsuru%26aufirst%3DY.%26aulast%3DMita%26aufirst%3DT.%26aulast%3DIchikawa%26aufirst%3DK.%26aulast%3DKodera%26aufirst%3DT.%26aulast%3DSakai%26aufirst%3DT.%26aulast%3DNambu%26aufirst%3DT.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DI.%26aulast%3DMiki%26aufirst%3DS.%26aulast%3DKawanishi%26aufirst%3DN.%26aulast%3DOhkubo%26aufirst%3DM.%26aulast%3DKotani%26aufirst%3DH.%26aulast%3DIwasawa%26aufirst%3DY.%26atitle%3DMK-5108%252C%2520a%2520Highly%2520Selective%2520Aurora-A%2520Kinase%2520Inhibitor%252C%2520Shows%2520Antitumor%2520Activity%2520Alone%2520and%2520in%2520Combination%2520with%2520Docetaxel%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D157%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Dhanak, D.; Newlander, K. A.</span><span> </span><span class="NLM_article-title">Preparation of azaindoles as aurora kinase inhibitors for the treatment of cancer</span>. U.S. Patent US20070149561A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=D.+Dhanak&author=K.+A.+Newlander&title=Preparation+of+azaindoles+as+aurora+kinase+inhibitors+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDhanak%26aufirst%3DD.%26atitle%3DPreparation%2520of%2520azaindoles%2520as%2520aurora%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520cancer%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="note"><p class="first last">A homology model of human Aurora B was generated using a cocrystal structure of human Aurora A with an analogue related to <b>12d</b>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompliano, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span> </span><span class="NLM_article-title">Drug-target residence time and its implications for lead optimization</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">730</span><span class="NLM_x">–</span> <span class="NLM_lpage">739</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1038%2Fnrd2082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=16888652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=730-739&author=R.+A.+Copelandauthor=D.+L.+Pomplianoauthor=T.+D.+Meek&title=Drug-target+residence+time+and+its+implications+for+lead+optimization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-target residence time and its implications for lead optimization</span></div><div class="casAuthors">Copeland, Robert A.; Pompliano, David L.; Meek, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">730-739</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Much of drug discovery today is predicated on the concept of selective targeting of particular bioactive macromols. by low-mol.-mass drugs.  The binding of drugs to their macromol. targets is therefore seen as paramount for pharmacol. activity.  In vitro assessment of drug-target interactions is classically quantified in terms of binding parameters such as IC50 or Kd.  This article presents an alternative perspective on drug optimization in terms of drug-target binary complex residence time, as quantified by the dissociative half-life of the drug-target binary complex.  We describe the potential advantages of long residence time in terms of duration of pharmacol. effect and target selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry6SJrMlrrTbVg90H21EOLACvtfcHk0lijFe11touNPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D&md5=60ede2301584b10ac4e8fa18e1e6d107</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnrd2082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2082%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DDrug-target%2520residence%2520time%2520and%2520its%2520implications%2520for%2520lead%2520optimization%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D730%26epage%3D739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span> </span><span class="NLM_article-title">Residence time of receptor-ligand complexes and its effect on biological function</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5481</span><span class="NLM_x">–</span> <span class="NLM_lpage">5492</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi8002023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1Ont7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=5481-5492&author=P.+J.+Tumminoauthor=R.+A.+Copeland&title=Residence+time+of+receptor-ligand+complexes+and+its+effect+on+biological+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Residence Time of Receptor-Ligand Complexes and Its Effect on Biological Function</span></div><div class="casAuthors">Tummino, Peter J.; Copeland, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5481-5492</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The formation and duration of binary receptor-ligand complexes are fundamental to many physiol. processes.  Most often, the effectiveness of interaction between a receptor and its ligand is quantified in terms of closed system, equil. affinity measurements, such as IC50 and Kd.  In the context of in vivo biol., however, the extent and duration of responses to receptor-ligand interactions depend greatly on the time period over which the ligand is in residence on its receptor.  Here we define receptor-ligand complex residence time in quant. terms and describe its significance to biol. function.  Examples of the importance of residence time are presented for natural ligands of different receptor types.  The impact of residence time on the optimization of potential ligands as drugs for human medicine is also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHshN2Bt_r9LVg90H21EOLACvtfcHk0lhlhaAyLL1Mdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1Ont7s%253D&md5=57f79f69f12c6ed14e3347638381d943</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fbi8002023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi8002023%26sid%3Dliteratum%253Aachs%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DResidence%2520time%2520of%2520receptor-ligand%2520complexes%2520and%2520its%2520effect%2520on%2520biological%2520function%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D5481%26epage%3D5492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Anderson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuart, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nartey, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardwicke, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newlander, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span> </span><span class="NLM_article-title">Biochemical characterization of GSK1070916, a potent and selective inhibitor of Aurora A and Aurora C kinases with an extremely long residence time</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">420</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=420&publication_year=2009&pages=259-265&author=K.+Andersonauthor=Z.+Laiauthor=O.+B.+McDonaldauthor=J.+D.+Stuartauthor=E.+N.+Narteyauthor=M.+A.+Hardwickeauthor=K.+Newlanderauthor=D.+Dhanakauthor=J.+Adamsauthor=D.+Patrickauthor=R.+A.+Copelandauthor=P.+J.+Tumminoauthor=J.+Yang&title=Biochemical+characterization+of+GSK1070916%2C+a+potent+and+selective+inhibitor+of+Aurora+A+and+Aurora+C+kinases+with+an+extremely+long+residence+time"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DLai%26aufirst%3DZ.%26aulast%3DMcDonald%26aufirst%3DO.%2BB.%26aulast%3DStuart%26aufirst%3DJ.%2BD.%26aulast%3DNartey%26aufirst%3DE.%2BN.%26aulast%3DHardwicke%26aufirst%3DM.%2BA.%26aulast%3DNewlander%26aufirst%3DK.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DPatrick%26aufirst%3DD.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DBiochemical%2520characterization%2520of%2520GSK1070916%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520Aurora%2520A%2520and%2520Aurora%2520C%2520kinases%2520with%2520an%2520extremely%2520long%2520residence%2520time%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D420%26spage%3D259%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Majid, T.; Duprets, S. D.; Peifer, C.</span><span> </span><span class="NLM_article-title">The Synthesis of Heterocyclic Compounds Employing Microwave Technology</span>. Patent WO03000690A1,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=T.+Majid&author=S.+D.+Duprets&author=C.+Peifer&title=The+Synthesis+of+Heterocyclic+Compounds+Employing+Microwave+Technology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMajid%26aufirst%3DT.%26atitle%3DThe%2520Synthesis%2520of%2520Heterocyclic%2520Compounds%2520Employing%2520Microwave%2520Technology%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Adams, D. R.; Bentley, J. M.; Davidson, J.; Duncton, M. A. J.; Porter, R. H. P.</span><span> </span><span class="NLM_article-title">Preparation of hexahydropyrazino[1,2-a]indoles as 5-HT2 receptor ligands</span>. Patent WO2000044753A1,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=D.+R.+Adams&author=J.+M.+Bentley&author=J.+Davidson&author=M.+A.+J.+Duncton&author=R.+H.+P.+Porter&title=Preparation+of+hexahydropyrazino%5B1%2C2-a%5Dindoles+as+5-HT2+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DD.%2BR.%26atitle%3DPreparation%2520of%2520hexahydropyrazino%255B1%252C2-a%255Dindoles%2520as%25205-HT2%2520receptor%2520ligands%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Hardwicke, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleykowski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plant, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, Q. M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newlander, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Z. S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D.</span><span> </span><span class="NLM_article-title">GSK1070916, a potent Aurora B/C kinase inhibitor with broad antitumor activity in tissue culture cells and human tumor xenograft models</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1808</span><span class="NLM_x">–</span> <span class="NLM_lpage">1817</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1158%2F1535-7163.MCT-09-0041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=19567821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVymsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1808-1817&author=M.+A.+Hardwickeauthor=C.+A.+Oleykowskiauthor=R.+Plantauthor=J.+Wangauthor=Q.+M.+K.+Liaoauthor=K.+Newlanderauthor=J.+L.+Adamsauthor=D.+Dhanakauthor=J.+Yangauthor=Z.+S.+D.+Laiauthor=D.+Patrick&title=GSK1070916%2C+a+potent+Aurora+B%2FC+kinase+inhibitor+with+broad+antitumor+activity+in+tissue+culture+cells+and+human+tumor+xenograft+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">GSK1070916, a potent Aurora B/C kinase inhibitor with broad antitumor activity in tissue culture cells and human tumor xenograft models</span></div><div class="casAuthors">Hardwicke, Mary Ann; Oleykowski, Catherine A.; Plant, Ramona; Wang, Jamin; Liao, Qiaoyin; Moss, Katherine; Newlander, Ken; Adams, Jerry L.; Dhanak, Dashyant; Yang, Jingsong; Lai, Zhihong; Sutton, David; Patrick, Denis</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1808-1817</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The protein kinases, Aurora A, B, and C have crit. roles in the regulation of mitosis and are frequently overexpressed or amplified in human tumors.  GSK1070916, is a novel ATP competitive inhibitor that is highly potent and selective for Aurora B/C kinases.  Human tumor cells treated with GSK1070916 show dose-dependent inhibition of phosphorylation on serine 10 of Histone H3, a substrate specific for Aurora B kinase.  Moreover, GSK1070916 inhibits the proliferation of tumor cells with EC50 values of <10 nmol/L in over 100 cell lines spanning a broad range of tumor types.  Although GSK1070916 has potent activity against proliferating cells, a dramatic shift in potency is obsd. in primary, nondividing, normal human vein endothelial cells, consistent with the proposed mechanism.  We further detd. that treated cells do not arrest in mitosis but instead fail to divide and become polyploid, ultimately leading to apoptosis.  GSK1070916 shows dose-dependent inhibition of phosphorylation of an Aurora B-specific substrate in mice and consistent with its broad cellular activity, has antitumor effects in 10 human tumor xenograft models including breast, colon, lung, and two leukemia models.  These results show that GSK1070916 is a potent Aurora B/C kinase inhibitor that has the potential for antitumor activity in a wide range of human cancers. [Mol Cancer Ther 2009;8(7):1808-17].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKuBTcujcY3bVg90H21EOLACvtfcHk0lhlhaAyLL1Mdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVymsrw%253D&md5=36d705aae85b8583c54af4aa4cee7e1f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0041%26sid%3Dliteratum%253Aachs%26aulast%3DHardwicke%26aufirst%3DM.%2BA.%26aulast%3DOleykowski%26aufirst%3DC.%2BA.%26aulast%3DPlant%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DQ.%2BM.%2BK.%26aulast%3DNewlander%26aufirst%3DK.%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DZ.%2BS.%2BD.%26aulast%3DPatrick%26aufirst%3DD.%26atitle%3DGSK1070916%252C%2520a%2520potent%2520Aurora%2520B%252FC%2520kinase%2520inhibitor%2520with%2520broad%2520antitumor%2520activity%2520in%2520tissue%2520culture%2520cells%2520and%2520human%2520tumor%2520xenograft%2520models%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D1808%26epage%3D1817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><div class="note"><p class="first last">Artificial membrane permeability data was generated using an unpublished in house method that is similar to PAMPA. For PAMPA, see:</p></div><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubernator, K.</span><span> </span><span class="NLM_article-title">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970530e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1007-1010&author=M.+Kansyauthor=F.+Sennerauthor=K.+Gubernator&title=Physicochemical+High+Throughput+Screening%3A+Parallel+Artificial+Membrane+Permeation+Assay+in+the+Description+of+Passive+Absorption+Processes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span></div><div class="casAuthors">Kansy, Manfred; Senner, Frank; Gubernator, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1010</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of pharmaceutical discovery projects aim for an orally available form of a new therapeutic principle.  One obstacle for per oral treatment is intestinal absorption.  A simple predictive exptl. method to assess the potential of intestinal absorption is therefore highly welcome.  The authors describe here the PAMPA (Parallel Artificial Membrane Permeation Assay) method, a simple, robust, high throughput screen (HTS) which has been shown to be predictive for passive diffusion through membranes and thus for oral absorption.  In addn. PAMPA can deliver information in parallel on the lipophilicity, the ionization state and the soly. of a compd.  Therefore PAMPA complements HTS, combinatorial chem. and parallel synthesis efforts in preclin. pharmaceutical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqcwCGodCr1rVg90H21EOLACvtfcHk0lijRpS3GqSqvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D&md5=85d8ab409313b583de52348eb4d895da</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm970530e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970530e%26sid%3Dliteratum%253Aachs%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DSenner%26aufirst%3DF.%26aulast%3DGubernator%26aufirst%3DK.%26atitle%3DPhysicochemical%2520High%2520Throughput%2520Screening%253A%2520Parallel%2520Artificial%2520Membrane%2520Permeation%2520Assay%2520in%2520the%2520Description%2520of%2520Passive%2520Absorption%2520Processes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1007%26epage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="note"><p class="first last">The ability of <b>17k</b> to inhibit 328 human protein/lipid kinases in either in vitro activity or binding assays was determined at a combination of GlaxoSmithKline, University of Dundee, Millipore Research and Development, and Ambit Biosciences.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Hardwicke, M. A.; Liao, Q.; Oleykowski, K. A.; Plant, R.; Wang, J.; Anderson, K.; Jingsong, Y.; Lai, Z.; Silva, D.; Adams, J.; Copeland, R. A.; Patrick, D.</span><span> </span><span class="NLM_article-title">Biological Characterization of GSK1070916, a Highly Potent and Selective Inhibitor of Aurora B Kinase</span>. April<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="citation_source-journal">AACR</span>, <i>Abstract 5650</i>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+A.+Hardwicke&author=Q.+Liao&author=K.+A.+Oleykowski&author=R.+Plant&author=J.+Wang&author=K.+Anderson&author=Y.+Jingsong&author=Z.+Lai&author=D.+Silva&author=J.+Adams&author=R.+A.+Copeland&author=D.+Patrick&title=Biological+Characterization+of+GSK1070916%2C+a+Highly+Potent+and+Selective+Inhibitor+of+Aurora+B+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHardwicke%26aufirst%3DM.%2BA.%26atitle%3DBiological%2520Characterization%2520of%2520GSK1070916%252C%2520a%2520Highly%2520Potent%2520and%2520Selective%2520Inhibitor%2520of%2520Aurora%2520B%2520Kinase%26date%3D2008%26jtitle%3DAACR" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Silva, D. J.</span><span> </span><span class="NLM_article-title">Investigation of 7-Azaindoles as Developable Kinase Inhibitors: Identification of GSK1070916 as a Highly Potent and Selective Inhibitor of Aurora B Kinase</span>. April<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="citation_source-journal">AACR</span>, <i>Abstract 1296</i>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=D.+J.+Silva&title=Investigation+of+7-Azaindoles+as+Developable+Kinase+Inhibitors%3A+Identification+of+GSK1070916+as+a+Highly+Potent+and+Selective+Inhibitor+of+Aurora+B+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSilva%26aufirst%3DD.%2BJ.%26atitle%3DInvestigation%2520of%25207-Azaindoles%2520as%2520Developable%2520Kinase%2520Inhibitors%253A%2520Identification%2520of%2520GSK1070916%2520as%2520a%2520Highly%2520Potent%2520and%2520Selective%2520Inhibitor%2520of%2520Aurora%2520B%2520Kinase%26date%3D2008%26jtitle%3DAACR" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Nguyen, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnappan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravid, K.</span><span> </span><span class="NLM_article-title">Mechanism of Aurora-B degradation and its dependency on intact KEN and A-boxes: identification of an aneuploidy-promoting property</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4977</span><span class="NLM_x">–</span> <span class="NLM_lpage">4992</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm901870q&amp;key=10.1128%2FMCB.25.12.4977-4992.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm901870q&amp;key=15923616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm901870q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlt1Ortb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=4977-4992&author=H.+G.+Nguyenauthor=D.+Chinnappanauthor=T.+Uranoauthor=K.+Ravid&title=Mechanism+of+Aurora-B+degradation+and+its+dependency+on+intact+KEN+and+A-boxes%3A+identification+of+an+aneuploidy-promoting+property"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of Aurora-B degradation and its dependency on intact KEN and A-boxes: Identification of an aneuploidy-promoting property</span></div><div class="casAuthors">Nguyen, Hao G.; Chinnappan, Dharmaraj; Urano, Takeshi; Ravid, Katya</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4977-4992</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The kinase Aurora-B, a regulator of chromosome segregation and cytokinesis, is highly expressed in a variety of tumors.  During the cell cycle, the level of this protein is tightly controlled, and its deregulated abundance is suspected to contribute to aneuploidy.  Here, the authors provide evidence that Aurora-B is a short-lived protein degraded by the proteasome via the anaphase-promoting cyclosome complex (APC/c) pathway.  Aurora-B interacts with the APC/c through the Cdc27 subunit, Aurora-B is ubiquitinated, and its level is increased upon treatment with inhibitors of the proteasome.  Aurora-B binds in vivo to the degrdn.-targeting proteins Cdh1 and Cdc20, the overexpression of which accelerates Aurora-B degrdn.  Using deletions or point mutations of the five putative degrdn. signals in Aurora-B, the authors show that degrdn. of this protein does not depend on its D-boxes (RXXL), but it does require intact KEN boxes and A-boxes (QRVL) located within the first 65 amino acids.  Cells transfected with wild-type or A-box-mutated or KEN box-mutated Aurora-B fused to green fluorescent protein display the protein localized to the chromosomes and then to the midzone during mitosis, but the mutated forms are detected at greater intensities.  Hence, the authors identified the degrdn. pathway for Aurora-B as well as crit. regions for its clearance.  Intriguingly, overexpression of a stable form of Aurora-B alone induces aneuploidy and anchorage-independent growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXXKuVhdZdMLVg90H21EOLACvtfcHk0lijRpS3GqSqvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlt1Ortb8%253D&md5=969b448dde6cc68de3ee868b337e2b05</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1128%2FMCB.25.12.4977-4992.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.25.12.4977-4992.2005%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DH.%2BG.%26aulast%3DChinnappan%26aufirst%3DD.%26aulast%3DUrano%26aufirst%3DT.%26aulast%3DRavid%26aufirst%3DK.%26atitle%3DMechanism%2520of%2520Aurora-B%2520degradation%2520and%2520its%2520dependency%2520on%2520intact%2520KEN%2520and%2520A-boxes%253A%2520identification%2520of%2520an%2520aneuploidy-promoting%2520property%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2005%26volume%3D25%26spage%3D4977%26epage%3D4992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-ref43_1"><span><span class="NLM_contrib-group">Thibault, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhide, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruel, R.</span><span> </span><span class="NLM_article-title">Concise and Efficient Synthesis of 4-Fluoro-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">5023</span><span class="NLM_x">–</span> <span class="NLM_lpage">5025</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol036030z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=5023-5025&author=C.+Thibaultauthor=A.+author=R.+S.+Bhideauthor=R.+Ruel&title=Concise+and+Efficient+Synthesis+of+4-Fluoro-1H-pyrrolo%5B2%2C3-b%5Dpyridine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref43_1&amp;dbid=16384&amp;doi=10.1021%2Fol036030z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol036030z%26sid%3Dliteratum%253Aachs%26aulast%3DThibault%26aufirst%3DC.%26aulast%3D%26aufirst%3DA.%26aulast%3DBhide%26aufirst%3DR.%2BS.%26aulast%3DRuel%26aufirst%3DR.%26atitle%3DConcise%2520and%2520Efficient%2520Synthesis%2520of%25204-Fluoro-1H-pyrrolo%255B2%252C3-b%255Dpyridine%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26spage%3D5023%26epage%3D5025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i160"><a href="/doi/suppl/10.1021/jm901870q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_16525"></div></div></div></div></div><hr /></hr><p class="last">Liquid chromatography−mass spectrometry purities and retention times for all tested compounds. Full combustion analysis results for <b>17a</b>−<b>d</b>, <b>17f</b>−<b>i</b>, <b>17k</b>−<b>l</b>, <b>17n</b>−<b>o</b>, and <b>17q</b>−<b>u</b>. Statistical limits for biological data in Tables 1−3. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm901870q/suppl_file/jm901870q_si_001.pdf">jm901870q_si_001.pdf (59.57 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm901870q&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-10%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm901870q%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm901870q" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67995b715d8e248d","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
